sampleID	_EVENT	_INTEGRATION	_OS	_OS_IND	_OS_UNIT	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_OV	_PANCAN_mutation_PANCAN	_PATIENT	_RFS	_RFS_IND	_RFS_UNIT	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	clinical_stage	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	initial_weight	intermediate_dimension	is_ffpe	karnofsky_performance_score	longest_dimension	lost_follow_up	lymphatic_invasion	neoplasm_histologic_grade	new_neoplasm_event_type	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	oct_embedded	other_dx	pathology_report_file_name	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	primary_therapy_outcome_success	progression_determined_by	radiation_therapy	residual_tumor	sample_type	sample_type_id	shortest_dimension	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_residual_disease	tumor_tissue_site	venous_invasion	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_OV_PDMRNAseq	_GENOMIC_ID_data/public/TCGA/OV/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_OV_mutation_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_exp_u133a	_GENOMIC_ID_TCGA_OV_hMethyl450	_GENOMIC_ID_TCGA_OV_miRNA_HiSeq	_GENOMIC_ID_TCGA_OV_mutation_curated_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_hMethyl27	_GENOMIC_ID_TCGA_OV_mutation_wustl_hiseq_gene	_GENOMIC_ID_TCGA_OV_RPPA_RBN	_GENOMIC_ID_TCGA_OV_mutation_wustl_gene	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_OV_gistic2thd	_GENOMIC_ID_TCGA_OV_PDMarray	_GENOMIC_ID_TCGA_OV_RPPA	_GENOMIC_ID_TCGA_OV_exp_HiSeq	_GENOMIC_ID_TCGA_OV_gistic2	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_OV_exp_HiSeq_exon	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2	_GENOMIC_ID_TCGA_OV_mutation_broad_gene	_GENOMIC_ID_TCGA_OV_PDMarrayCNV	_GENOMIC_ID_TCGA_OV_PDMRNAseqCNV	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_OV_mutation	_GENOMIC_ID_TCGA_OV_G4502A_07_3	_GENOMIC_ID_TCGA_OV_G4502A_07_2
TCGA-01-0628-11	NA	TCGA-01-0628-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0628	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0628-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.4	NO	NA	0.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.4	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	78fc9d0c-7cb2-475b-bd98-e36f04d16358	NA	NA	NA	TCGA-01-0628-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0628-11A-01R-0363-07	
TCGA-01-0629-11	NA	TCGA-01-0629-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0629	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0629-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0629-11A-01R-0363-07	
TCGA-01-0630-11	NA	TCGA-01-0630-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0630	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0630-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.4	NO	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.4	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	a87c0a4d-bb41-412c-abd4-7fa010fb18d8	NA	NA	NA	TCGA-01-0630-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0630-11A-01R-0363-07
TCGA-01-0631-11	NA	TCGA-01-0631-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0631	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0631-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8	NO	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.8	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	0c490ce9-9178-4dfe-8384-208d3d2d46c5	NA	NA	NA	TCGA-01-0631-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0631-11A-01R-0363-07
TCGA-01-0633-11	NA	TCGA-01-0633-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0633	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0633-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.4	NO	NA	0.8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.3	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	eb14ef88-0adc-424d-b0a7-dd449f0907c6	NA	NA	NA	TCGA-01-0633-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0633-11A-01R-0363-07
TCGA-01-0636-11	NA	TCGA-01-0636-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0636	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0636-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8	NO	NA	1.1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.8	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	f17680d1-12eb-45ad-83bc-ba3d14485d10	NA	NA	NA	TCGA-01-0636-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0636-11A-01R-0363-07
TCGA-01-0637-11	NA	TCGA-01-0637-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0637	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0637-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.7	NO	NA	0.7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.3	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	c22da589-1714-4d0c-aa00-e16b466e8a64	NA	NA	NA	TCGA-01-0637-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0637-11A-01R-0363-07
TCGA-01-0638-11	NA	TCGA-01-0638-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0638	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0638-11A-02D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0638-11A-02R-0363-07
TCGA-01-0639-11	NA	TCGA-01-0639-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0639	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0639-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8	NO	NA	0.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.5	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	c417e63f-8714-4777-af37-5b39e34492c9	NA	NA	NA	TCGA-01-0639-11A-01D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0639-11A-01R-0363-07	
TCGA-01-0642-11	NA	TCGA-01-0642-11	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0642	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-01-0642-11A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8	NO	NA	0.8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.4	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	4a42ad28-e3d0-4ec8-9c54-40179a2e2953	NA	NA	NA	TCGA-01-0642-11A-02D-0383-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-01-0642-11A-02R-0363-07	
TCGA-04-1331-01	1	TCGA-04-1331-01	1336	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1331	NA	NA	days	1336	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	78	Bilateral	TCGA-04-1331-F23906	TCGA-04-1331	TCGA-04-1331-01A	Stage IIIC	-28848	NA	1336	0	1224	NA	459	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1331.2CF541C5-B56A-4946-A5C4-DBB4D71D7908.pdf	1331	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	04	1-10 mm	Ovary	NO	A	DECEASED	2004	NA	TCGA-04-1331-01	NA	96db4ec8-524f-4a9a-a23c-30fade0992b7	NA	TCGA-04-1331-01	NA	TCGA-04-1331-01A-01D-0432-05	NA	NA	NA	NA	TCGA-04-1331-01A-01D-0428-01	TCGA-04-1331-01	NA	NA	TCGA-04-1331-01A-01D-0428-01	NA	NA	NA	TCGA-04-1331-01A-01W-0486-08	TCGA-04-1331-01	NA	NA	TCGA-04-1331-01A-01W-0486-08	TCGA-04-1331-01A-01R-0436-07	
TCGA-04-1332-01	1	TCGA-04-1332-01	1247	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1332	NA	NA	days	1247	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-04-1332-F23911	TCGA-04-1332	NA	Stage IIIC	-25786	NA	1247	0	1247	NA	393	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	NA	1332	Preoperative	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	04	1-10 mm	Ovary	NA	NA	DECEASED	2002	NA	NA	NA	e984c174-f724-49b0-84bf-788ff370d89f	NA	NA	NA	TCGA-04-1332-01A-01D-0432-05	TCGA-04-1332-01A-01W-0488-09	NA	TCGA-04-1332-01A-01W-0488-09	NA	TCGA-04-1332-01A-01D-0428-01	TCGA-04-1332-01	NA	NA	TCGA-04-1332-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1332-01	NA	NA	TCGA-04-1332-01A-01W-0488-09	TCGA-04-1332-01A-01R-0436-07	
TCGA-04-1335-01	1	TCGA-04-1335-01	55	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-04-1335	NA	NA	days	55	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-04-1335-F23924	TCGA-04-1335	TCGA-04-1335-01A	Stage IB	-21963	NA	55	0	NA	NA	NA	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NO	G2	NA	NA	NA	NA	NA	TCGA-04-1335.A3CEAB60-287E-41D1-A0BD-12B6626BA574.pdf	1335	Preoperative	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	04	NA	Ovary	NO	A	DECEASED	2005	NA	NA	NA	51038814-3401-4377-a815-92b9ce678f3d	NA	NA	NA	TCGA-04-1335-01A-01D-0432-05	NA	TCGA-04-1335-01A-21-20	NA	NA	TCGA-04-1335-01A-01D-0428-01	TCGA-04-1335-01	b1473202-11db-484b-8896-56abe5a3296e	NA	TCGA-04-1335-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1335-01	NA	NA	NA	TCGA-04-1335-01A-01R-0436-07	
TCGA-04-1336-01	0	TCGA-04-1336-01	1495	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1336	NA	NA	days	1495	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Bilateral	TCGA-04-1336-F23926	TCGA-04-1336	TCGA-04-1336-01A	Stage IIIB	-20271	NA	NA	0	1495	NA	NA	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-04-1336.D66DA590-83E1-4607-8806-6402DF3F3385.pdf	1336	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	04	No Macroscopic disease	Ovary	NA	A	LIVING	2005	NA	TCGA-04-1336-01	NA	e53eba00-2869-4168-98aa-a6c491b69fc6	NA	TCGA-04-1336-01	NA	TCGA-04-1336-01A-01D-0432-05	TCGA-04-1336-01A-01W-0488-09	TCGA-04-1336-01A-21-20	TCGA-04-1336-01A-01W-0488-09	NA	TCGA-04-1336-01A-01D-0428-01	TCGA-04-1336-01	7892f3fd-fdb3-43a0-8fd9-390927061f7a	NA	TCGA-04-1336-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1336-01	NA	NA	TCGA-04-1336-01A-01W-0488-09	TCGA-04-1336-01A-01R-0436-07	
TCGA-04-1337-01	1	TCGA-04-1337-01	61	1	days	BRCA-LUAD+	NA	UCEC Serous c4	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1337	NA	NA	days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Bilateral	TCGA-04-1337-F23931	TCGA-04-1337	TCGA-04-1337-01A	Stage IIIC	-28626	NA	61	0	NA	NA	NA	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NO	G2	NA	NA	NA	NA	NA	TCGA-04-1337.BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31.pdf	1337	Preoperative	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	04	No Macroscopic disease	Ovary	NA	A	DECEASED	2005	NA	TCGA-04-1337-01	TCGA-04-1337-01A-01W-0484-10	543cc1e4-76ee-4e0a-80fa-7ad8477d8d40	NA	TCGA-04-1337-01	TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01A-01D-0432-05	NA	NA	NA	NA	TCGA-04-1337-01A-01D-0428-01	TCGA-04-1337-01	NA	NA	TCGA-04-1337-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1337-01	NA	NA	TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01A-01R-0436-07	
TCGA-04-1338-01	0	TCGA-04-1338-01	1418	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	NA	NA	mutation cluster 5	TCGA-04-1338	NA	NA	days	1418	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	78	Bilateral	TCGA-04-1338-F23933	TCGA-04-1338	TCGA-04-1338-01A	Stage IIIC	-28789	NA	NA	0	1418	NA	380	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1338.889AF2DB-7FF9-45B1-8FD4-28D57CF870A7.pdf	1338	Preoperative	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	04	1-10 mm	Ovary	NA	A	LIVING	2005	NA	NA	TCGA-04-1338-01A-01W-0484-10	17aa44c9-3071-4184-9692-4c04fabb5a4b	NA	NA	TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01A-01D-0432-05	NA	TCGA-04-1338-01A-21-20	NA	NA	TCGA-04-1338-01A-01D-0428-01	TCGA-04-1338-01	ee14145d-2ec8-4323-804e-c0a15371559b	NA	TCGA-04-1338-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1338-01	NA	NA	TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01A-01R-0436-07	
TCGA-04-1341-01	0	TCGA-04-1341-01	33	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	NA	TCGA-04-1341	NA	NA	days	33	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	85	NA	TCGA-04-1341-F23940	TCGA-04-1341	TCGA-04-1341-01A	NA	-31215	NA	NA	0	33	NA	NA	NA	Scheduled Follow-up Submission	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1341.9DB095E5-19F0-4ECE-9E54-2F030190FDB5.pdf	1341	NA	WITH TUMOR	NA	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NO	YES	04	NA	Ovary	NA	A	LIVING	2006	NA	TCGA-04-1341-01	NA	a9e75af6-31c2-4d32-8c4e-ee9538e77b0e	NA	TCGA-04-1341-01	NA	TCGA-04-1341-01A-01D-0432-05	NA	TCGA-04-1341-01A-21-20	NA	NA	TCGA-04-1341-01A-01D-0428-01	TCGA-04-1341-01	9e5cf025-e667-4a73-94a3-e45255194ec3	NA	TCGA-04-1341-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1341-01	NA	NA	NA	TCGA-04-1341-01A-01R-0436-07	
TCGA-04-1342-01	1	TCGA-04-1342-01	563	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1342	NA	NA	days	563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	80	Bilateral	TCGA-04-1342-F23942	TCGA-04-1342	TCGA-04-1342-01A	Stage IV	-29501	NA	563	0	NA	NA	NA	2	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	2	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-04-1342.B296EAFA-9EE4-4611-888A-FA0B58EC2A88.pdf	1342	Preoperative	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	04	>20 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-04-1342-01	NA	3cfa7f01-3d75-4c1a-8e7f-ac849f5fde70	NA	TCGA-04-1342-01	NA	TCGA-04-1342-01A-01D-0432-05	NA	TCGA-04-1342-01A-21-20	NA	NA	TCGA-04-1342-01A-01D-0428-01	TCGA-04-1342-01	e79f6986-9f15-4826-901b-1a97c2b8ae42	NA	TCGA-04-1342-01A-01D-0428-01	NA	NA	NA	TCGA-04-1342-01A-01W-0486-08	TCGA-04-1342-01	NA	NA	TCGA-04-1342-01A-01W-0486-08	TCGA-04-1342-01A-01R-0436-07	
TCGA-04-1343-01	1	TCGA-04-1343-01	361	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1343	NA	NA	days	361	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	72	Bilateral	TCGA-04-1343-F23949	TCGA-04-1343	TCGA-04-1343-01A	Stage IV	-26428	NA	361	0	NA	NA	NA	3	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1343.E62828D9-A46C-498F-9976-CC430D16057E.pdf	1343	Preoperative	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	04	>20 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-04-1343-01	NA	ecfe5ba4-b146-4757-894e-ee6e44f4ba5c	NA	TCGA-04-1343-01	NA	TCGA-04-1343-01A-01D-0432-05	TCGA-04-1343-01A-01W-0488-09	TCGA-04-1343-01A-21-20	TCGA-04-1343-01A-01W-0488-09	NA	TCGA-04-1343-01A-01D-0428-01	TCGA-04-1343-01	58f649ec-b1cd-4775-8c03-4ebdfe0ad072	NA	TCGA-04-1343-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1343-01	NA	NA	TCGA-04-1343-01A-01W-0488-09	TCGA-04-1343-01A-01R-0436-07	
TCGA-04-1346-01	0	TCGA-04-1346-01	1993	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1346	NA	NA	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-04-1346-F23959	TCGA-04-1346	TCGA-04-1346-01A	Stage IIIC	-26865	NA	NA	0	1993	NA	NA	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	100	2	NA	YES	G2	NA	NA	NA	NA	NA	TCGA-04-1346.40C05C93-8968-4FF0-855F-09E2F7FAAB68.pdf	1346	NA	TUMOR FREE	NO	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	04	NA	Ovary	NA	A	LIVING	2003	NA	TCGA-04-1346-01	NA	3b372510-9632-40d8-a82b-d58e0a0c0ba6	NA	TCGA-04-1346-01	NA	TCGA-04-1346-01A-01D-0432-05	TCGA-04-1346-01A-01W-0488-09	NA	TCGA-04-1346-01A-01W-0488-09	NA	TCGA-04-1346-01A-01D-0428-01	TCGA-04-1346-01	NA	NA	TCGA-04-1346-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1346-01	NA	NA	TCGA-04-1346-01A-01W-0488-09	TCGA-04-1346-01A-01R-0436-07	
TCGA-04-1347-01	0	TCGA-04-1347-01	1919	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1347	NA	NA	days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	81	Bilateral	TCGA-04-1347-F23961	TCGA-04-1347	TCGA-04-1347-01A	Stage IV	-29695	NA	NA	0	1919	NA	NA	0	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	100	1.1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-04-1347.18BFB10C-5EDC-4253-A2A8-93533CB4B471.pdf	1347	Preoperative	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	04	No Macroscopic disease	Ovary	NO	A	LIVING	2004	NA	TCGA-04-1347-01	NA	886f150b-23d2-4000-b550-e0fda444ca61	NA	TCGA-04-1347-01	NA	TCGA-04-1347-01A-01D-0432-05	TCGA-04-1347-01A-01W-0488-09	NA	TCGA-04-1347-01A-01W-0488-09	NA	TCGA-04-1347-01A-01D-0428-01	TCGA-04-1347-01	NA	NA	TCGA-04-1347-01A-01D-0428-01	NA	NA	NA	NA	TCGA-04-1347-01	NA	NA	TCGA-04-1347-01A-01W-0488-09	TCGA-04-1347-01A-01R-0436-07	
TCGA-04-1348-01	1	TCGA-04-1348-01	1483	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1348	NA	NA	days	1483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-04-1348-F23967	TCGA-04-1348	TCGA-04-1348-01A	Stage IIIB	-16236	NA	1483	0	NA	NA	575	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1348.51B558EF-C11B-41A7-A7BF-15D201506006.pdf	1348	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.4	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-04-1348-01	TCGA-04-1348-01	NA	6b5e9411-a6df-45a9-8281-75228283c4f4	NA	TCGA-04-1348-01	NA	TCGA-04-1348-01A-01D-0460-05	TCGA-04-1348-01A-01W-0494-09	TCGA-04-1348-01A-21-20	TCGA-04-1348-01A-01W-0494-09	1465139e-d1b2-4026-a532-08513fe0ad4d	TCGA-04-1348-01A-01D-0452-01	TCGA-04-1348-01	21a891e7-6da2-4d9e-a1e3-e760605d9dee	NA	TCGA-04-1348-01A-01D-0452-01	1465139e-d1b2-4026-a532-08513fe0ad4d	NA	1465139e-d1b2-4026-a532-08513fe0ad4d	NA	TCGA-04-1348-01	TCGA-04-1348-01	1465139e-d1b2-4026-a532-08513fe0ad4d	TCGA-04-1348-01A-01W-0494-09	TCGA-04-1348-01A-01R-0456-07	
TCGA-04-1349-01	1	TCGA-04-1349-01	656	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1349	NA	NA	days	656	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-04-1349-F23977	TCGA-04-1349	TCGA-04-1349-01A	Stage IV	-25213	NA	656	0	NA	NA	428	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1349.8D470D24-17DD-4180-987E-F33FA31535AE.pdf	1349	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	04	NA	Ovary	NA	A	DECEASED	2004	NA	TCGA-04-1349-01	NA	83332db9-57b5-40ce-ad30-cf81d48a7cd6	NA	TCGA-04-1349-01	NA	TCGA-04-1349-01A-01D-0460-05	TCGA-04-1349-01A-01W-0494-09	TCGA-04-1349-01A-21-20	TCGA-04-1349-01A-01W-0494-09	NA	TCGA-04-1349-01A-01D-0452-01	TCGA-04-1349-01	2a143727-7310-4103-beec-3522534165fe	NA	TCGA-04-1349-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1349-01	NA	NA	TCGA-04-1349-01A-01W-0494-09	TCGA-04-1349-01A-01R-0456-07	
TCGA-04-1350-01	1	TCGA-04-1350-01	1946	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1350	NA	NA	days	1946	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	46	Bilateral	TCGA-04-1350-F23988	TCGA-04-1350	TCGA-04-1350-01A	Stage IIIC	-16942	NA	1946	0	NA	NA	111	0	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1350.C4BB615C-ABBA-4136-AAB4-52EA1FE88D14.pdf	1350	Preoperative	WITH TUMOR	NO	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	04	>20 mm	Ovary	NA	A	DECEASED	2003	NA	TCGA-04-1350-01	TCGA-04-1350-01A-01W-0490-10	339c6cc0-96b2-4225-b3bc-6cac497c7b92	NA	TCGA-04-1350-01	TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01A-01D-0460-05	NA	NA	NA	NA	TCGA-04-1350-01A-01D-0452-01	TCGA-04-1350-01	NA	NA	TCGA-04-1350-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1350-01	NA	NA	TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01A-01R-0456-07	
TCGA-04-1351-01	0	TCGA-04-1351-01	1991	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-04-1351	NA	NA	days	1991	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	NA	TCGA-04-1351-F24001	TCGA-04-1351	NA	Stage IIIC	-28045	NA	NA	0	1991	NA	1658	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	NA	NA	100	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1351	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	04	NA	Ovary	NA	NA	LIVING	2004	NA	NA	TCGA-04-1351-01A-01W-0490-10	a8c3bbb4-24aa-4975-916a-50c6ba1f7eac	NA	NA	TCGA-04-1351-01A-01W-0490-10	TCGA-04-1351-01A-01D-0460-05	NA	NA	NA	NA	TCGA-04-1351-01A-01D-0452-01	TCGA-04-1351-01	NA	NA	TCGA-04-1351-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1351-01	NA	NA	NA	TCGA-04-1351-01A-01R-0456-07	
TCGA-04-1353-01	0	TCGA-04-1353-01	16	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-04-1353	NA	NA	days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	NA	TCGA-04-1353-F65201	TCGA-04-1353	NA	Stage IIIC	-23611	NA	NA	0	16	NA	NA	NA	Scheduled Follow-up Submission	NA	2014-9-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	NA	NA	NA	NA	NO	NA	NA	NA	NA	NA	NA	No	NA	1353	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NO	YES	04	NA	Ovary	NA	NA	LIVING	2003	NA	NA	NA	b4d1d595-41fa-4b9d-9f01-e820fdace4f6	NA	NA	NA	TCGA-04-1353-01A-01D-1047-05	NA	NA	TCGA-04-1353-01A-01D-1526-09	NA	TCGA-04-1353-01A-01D-1043-01	TCGA-04-1353-01	NA	NA	TCGA-04-1353-01A-01D-1043-01	NA	NA	NA	NA	TCGA-04-1353-01	NA	NA	NA	TCGA-04-1353-01A-01R-1050-07	
TCGA-04-1353-11	0	TCGA-04-1353-11	16	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1353	NA	NA	days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	NA	TCGA-04-1353-F65201	TCGA-04-1353	TCGA-04-1353-11B	Stage IIIC	-23611	NA	NA	0	16	NA	NA	NA	Scheduled Follow-up Submission	NA	2014-9-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	0.4	NO	NA	1.5	NO	NA	NA	NA	NA	NA	NA	No	NA	1353	NA	NA	NA	NA	NA	NA	NA	Solid Tissue Normal	11	0.2	NO	YES	04	NA	Ovary	NA	B	LIVING	2003	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1353-11B-01D-1047-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-04-1356-01	1	TCGA-04-1356-01	1499	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1356	NA	NA	days	1499	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-04-1356-F24005	TCGA-04-1356	TCGA-04-1356-01A	Stage IIC	-22855	NA	1499	0	NA	NA	156	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	80	1.2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1356.7D26B212-1DE7-43CC-A0DC-A9071C3A534F.pdf	1356	Preoperative	WITH TUMOR	NO	Progressive Disease	Physical Examination	NO	NA	Primary Tumor	01	0.4	NA	NA	04	NA	Ovary	YES	A	DECEASED	2004	NA	TCGA-04-1356-01	NA	9e919b59-a80e-4165-ba65-02ae5c35e910	NA	TCGA-04-1356-01	NA	TCGA-04-1356-01A-01D-0460-05	NA	TCGA-04-1356-01A-21-20	NA	NA	TCGA-04-1356-01A-01D-0452-01	TCGA-04-1356-01	6b9482bd-967a-447e-8f6f-324c7ec41b4d	NA	TCGA-04-1356-01A-01D-0452-01	NA	NA	NA	TCGA-04-1356-01A-01W-0492-08	TCGA-04-1356-01	NA	NA	TCGA-04-1356-01A-01W-0492-08	TCGA-04-1356-01A-01R-0456-07	
TCGA-04-1357-01	NA	TCGA-04-1357-01	NA	NA	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1357	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	NA	TCGA-04-1357-F24009	TCGA-04-1357	NA	Stage IIIB	-18999	NA	NA	0	NA	NA	NA	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1357	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	04	NA	Ovary	NA	NA	LIVING	2005	TCGA-04-1357-01	TCGA-04-1357-01	NA	ab3d12c9-29b5-41b0-98dd-56670fe303d9	NA	TCGA-04-1357-01	NA	TCGA-04-1357-01A-01D-0460-05	NA	TCGA-04-1357-01A-21-20	NA	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01D-0452-01	TCGA-04-1357-01	fcbf9267-5e2a-4a94-8851-9f7151aee4a0	NA	TCGA-04-1357-01A-01D-0452-01	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	NA	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01W-0492-08	TCGA-04-1357-01	TCGA-04-1357-01	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01W-0492-08	TCGA-04-1357-01A-01R-0456-07	
TCGA-04-1360-01	NA	TCGA-04-1360-01	NA	NA	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-04-1360	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	NA	TCGA-04-1360-F24011	TCGA-04-1360	TCGA-04-1360-01A	Stage IA	-23993	NA	NA	0	NA	NA	NA	NA	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	0.8	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1360.D215D37F-D04B-44BC-AF17-D3B8C804A3E9.pdf	1360	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	04	NA	Ovary	NA	A	LIVING	2005	NA	NA	NA	09afddf6-c527-4561-b476-cbc9bcc7ca24	NA	NA	NA	TCGA-04-1360-01A-01D-0460-05	NA	TCGA-04-1360-01A-21-20	NA	NA	TCGA-04-1360-01A-01D-0452-01	TCGA-04-1360-01	e470041a-5d0c-4818-8246-bd4530cc81e0	NA	TCGA-04-1360-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1360-01	NA	NA	NA	TCGA-04-1360-01A-01R-0456-07	
TCGA-04-1361-01	0	TCGA-04-1361-01	989	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1361	NA	NA	days	989	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-04-1361-F24013	TCGA-04-1361	TCGA-04-1361-01A	Stage IIIB	-20860	NA	NA	0	989	NA	927	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1361.5116FD62-7A2C-425A-A99E-D47C1B456961.pdf	1361	NA	NA	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	No Macroscopic disease	Ovary	NA	A	LIVING	2005	NA	TCGA-04-1361-01	NA	874772d1-76e5-4480-9fb5-0130d66f1b3a	NA	TCGA-04-1361-01	NA	TCGA-04-1361-01A-01D-0460-05	TCGA-04-1361-01A-01W-0494-09	TCGA-04-1361-01A-21-20	TCGA-04-1361-01A-01W-0494-09	NA	TCGA-04-1361-01A-01D-0452-01	TCGA-04-1361-01	62d06e8a-aed1-4904-8651-c9912e5b1eae	NA	TCGA-04-1361-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1361-01	NA	NA	TCGA-04-1361-01A-01W-0494-09	TCGA-04-1361-01A-01R-0456-07	
TCGA-04-1362-01	1	TCGA-04-1362-01	1348	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1362	NA	NA	days	1348	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-04-1362-F24020	TCGA-04-1362	TCGA-04-1362-01A	Stage IIC	-21745	NA	1348	0	NA	NA	223	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1362.D3757F96-E669-4D0E-BBCB-41696AB72004.pdf	1362	Pre-Adjuvant Therapy	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-04-1362-01	TCGA-04-1362-01	NA	9dcb2e40-d569-439e-8359-4178124447b5	NA	TCGA-04-1362-01	NA	TCGA-04-1362-01A-01D-0460-05	TCGA-04-1362-01A-01W-0494-09	TCGA-04-1362-01A-21-20	TCGA-04-1362-01A-01W-0494-09	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	TCGA-04-1362-01A-01D-0452-01	TCGA-04-1362-01	e6a03e2b-8fcf-4ad5-9b40-be38c0b08786	NA	TCGA-04-1362-01A-01D-0452-01	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	NA	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	NA	TCGA-04-1362-01	TCGA-04-1362-01	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	TCGA-04-1362-01A-01W-0494-09	TCGA-04-1362-01A-01R-0456-07	
TCGA-04-1364-01	1	TCGA-04-1364-01	1024	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1364	NA	NA	days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-04-1364-F24028	TCGA-04-1364	TCGA-04-1364-01A	Stage IIIC	-22294	NA	1024	0	NA	NA	288	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.2	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1364.CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4.pdf	1364	Preoperative	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2003	TCGA-04-1364-01	TCGA-04-1364-01	TCGA-04-1364-01A-01W-0490-10	0e23070a-25c9-49b4-8c4a-a9994de3a312	NA	TCGA-04-1364-01	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01A-01D-0460-05	NA	NA	NA	2fadaf5a-402b-483d-bc26-08feb3dc162d	TCGA-04-1364-01A-01D-0452-01	TCGA-04-1364-01	NA	NA	TCGA-04-1364-01A-01D-0452-01	2fadaf5a-402b-483d-bc26-08feb3dc162d	NA	2fadaf5a-402b-483d-bc26-08feb3dc162d	NA	TCGA-04-1364-01	TCGA-04-1364-01	2fadaf5a-402b-483d-bc26-08feb3dc162d	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01A-01R-0456-07	
TCGA-04-1365-01	0	TCGA-04-1365-01	2329	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1365	NA	NA	days	2329	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Left	TCGA-04-1365-F24044	TCGA-04-1365	TCGA-04-1365-01A	Stage IIIB	-31925	NA	NA	0	2329	NA	1328	1	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.2	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1365.049FC54E-4D17-4B68-9E41-268529C9F18F.pdf	1365	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.6	NA	NA	04	NA	Ovary	NA	A	LIVING	2003	TCGA-04-1365-01	TCGA-04-1365-01	TCGA-04-1365-01A-01W-0490-10	a64bec02-eddf-4723-90a8-6742267b4f51	NA	TCGA-04-1365-01	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01A-01D-0460-05	NA	NA	NA	2535da6b-39f0-41de-afd3-82cb37916b95	TCGA-04-1365-01A-01D-0452-01	TCGA-04-1365-01	NA	NA	TCGA-04-1365-01A-01D-0452-01	2535da6b-39f0-41de-afd3-82cb37916b95	NA	2535da6b-39f0-41de-afd3-82cb37916b95	NA	TCGA-04-1365-01	TCGA-04-1365-01	2535da6b-39f0-41de-afd3-82cb37916b95	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01A-01R-0456-07	
TCGA-04-1367-01	0	TCGA-04-1367-01	3145	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1367	3145	0	days	3145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-04-1367-F62486	TCGA-04-1367	TCGA-04-1367-01A	Stage IIIC	-18577	NA	NA	0	3145	NA	2997	0	Scheduled Follow-up Submission	Progressive Disease	2014-7-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	100	0.7	NO	NO	G3	Progression of Disease	NA	NO	NA	NA	TCGA-04-1367.78E00062-0996-45A9-80FC-125409EE370A.pdf	1367	Preoperative	WITH TUMOR	NO	Progressive Disease	Molecular Markers	NO	NA	Primary Tumor	01	0.5	NO	YES	04	No Macroscopic disease	Ovary	NO	A	LIVING	2003	NA	TCGA-04-1367-01	NA	69b2dded-5eff-448b-8220-8163c264e63b	NA	TCGA-04-1367-01	NA	TCGA-04-1367-01A-01D-0460-05	NA	NA	NA	NA	TCGA-04-1367-01A-01D-0452-01	TCGA-04-1367-01	NA	NA	TCGA-04-1367-01A-01D-0452-01	NA	NA	NA	TCGA-04-1367-01A-01W-0492-08	TCGA-04-1367-01	NA	NA	TCGA-04-1367-01A-01W-0492-08	TCGA-04-1367-01A-01R-0456-07	
TCGA-04-1369-01	1	TCGA-04-1369-01	642	1	days	NA	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-04-1369	NA	NA	days	642	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1369-F24056	TCGA-04-1369	TCGA-04-1369-01A	Stage IIIC	-19571	NA	642	0	NA	NA	315	0	NA	NA	2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G2	Progression of Disease	NA	NA	NA	NA	TCGA-04-1369.5C54C779-C561-4625-B8F0-029BE2D3C91B.pdf	1369	Pre-Adjuvant Therapy	WITH TUMOR	YES	NA	Imaging Study	NO	R1	Primary Tumor	01	0.2	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	NA	NA	940c48c2-f75f-498a-9c40-a33d65dfbce1	NA	NA	NA	TCGA-04-1369-01A-02D-1047-05	NA	TCGA-04-1369-01A-11-1562-20	TCGA-04-1369-01A-02D-1526-09	NA	NA	TCGA-04-1369-01	40f6f0ca-e0e0-4c0b-96b1-3d305aa93f95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1369-01A-02R-1050-07	
TCGA-04-1369-11	1	TCGA-04-1369-11	642	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1369	NA	NA	days	642	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1369-F24056	TCGA-04-1369	TCGA-04-1369-11A	Stage IIIC	-19571	NA	642	0	NA	NA	315	0	NA	NA	2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.5	NA	NA	G2	Progression of Disease	NA	NA	NA	NA	NA	1369	Pre-Adjuvant Therapy	WITH TUMOR	YES	NA	Imaging Study	NO	R1	Solid Tissue Normal	11	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1369-11A-01D-1047-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-04-1370-01	0	TCGA-04-1370-01	1824	0	days	NA	NA	NA	OV-like c4	NA	NA	NA	NA	TCGA-04-1370	NA	NA	days	1824	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-04-1370-F24062	TCGA-04-1370	TCGA-04-1370-01A	Stage IIIC	-19329	NA	NA	0	1824	NA	NA	1	NA	NA	2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1370.6E990DE9-ED0A-4152-A862-866FBF8A41DE.pdf	1370	Pre-Adjuvant Therapy	NA	YES	NA	NA	NO	R1	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	LIVING	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1370-01A-21-1562-20	NA	NA	NA	NA	4234f147-09cf-480f-bfca-5ae6c5d338f9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-04-1371-01	0	TCGA-04-1371-01	2506	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-04-1371	NA	NA	days	2506	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-04-1371-F24066	TCGA-04-1371	NA	Stage IIIC	-21243	NA	NA	0	2506	NA	NA	0	NA	NA	2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1371	Pre-Adjuvant Therapy	TUMOR FREE	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	04	1-10 mm	Ovary	NA	NA	LIVING	2001	NA	NA	NA	bf67f8d7-e33c-4b18-9801-4b78ce0b41bb	NA	NA	NA	TCGA-04-1371-01A-01D-0460-05	NA	NA	NA	NA	TCGA-04-1371-01A-01D-0452-01	TCGA-04-1371-01	NA	NA	TCGA-04-1371-01A-01D-0452-01	NA	NA	NA	NA	TCGA-04-1371-01	NA	NA	NA	TCGA-04-1371-01A-01R-0456-07	
TCGA-04-1514-01	1	TCGA-04-1514-01	1720	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1514	NA	NA	days	1720	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-04-1514-F24071	TCGA-04-1514	TCGA-04-1514-01A	Stage IIIA	-16725	NA	1720	0	NA	NA	1221	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.1	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-04-1514.A0487B93-029F-48EB-AF5C-06A2F5A3FAAA.pdf	1514	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	04	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	TCGA-04-1514-01	TCGA-04-1514-01	TCGA-04-1514-01A-01W-0552-10	c7e3fccc-4e03-4914-874c-e5034bcc6941	NA	TCGA-04-1514-01	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01A-01D-0501-05	NA	TCGA-04-1514-01A-21-1558-20	NA	cc5e2498-a9e6-48be-bbda-9aa101546ca4	TCGA-04-1514-01A-01D-0497-01	TCGA-04-1514-01	8fcd1179-3170-4ca1-b961-dbaa7a391ea4	NA	TCGA-04-1514-01A-01D-0497-01	cc5e2498-a9e6-48be-bbda-9aa101546ca4	NA	cc5e2498-a9e6-48be-bbda-9aa101546ca4	NA	TCGA-04-1514-01	TCGA-04-1514-01	cc5e2498-a9e6-48be-bbda-9aa101546ca4	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01A-01R-0504-07	
TCGA-04-1516-01	0	TCGA-04-1516-01	1265	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-04-1516	NA	NA	days	1265	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Left	TCGA-04-1516-F24087	TCGA-04-1516	TCGA-04-1516-01A	Stage IA	-17768	NA	NA	0	1265	NA	NA	0	NA	NA	2010-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.6	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1516.434BDC72-1BE6-4235-AFBA-10ADE94C8901.pdf	1516	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	0.3	NA	NA	04	No Macroscopic disease	Ovary	NA	A	LIVING	2006	NA	NA	NA	0c2520a9-0937-40b7-a09f-9f21a4726876	NA	NA	NA	TCGA-04-1516-01A-01D-1047-05	NA	TCGA-04-1516-01A-21-1558-20	TCGA-04-1516-01A-01D-1526-09	NA	TCGA-04-1516-01A-01D-1043-01	TCGA-04-1516-01	556a186c-d6ab-4f84-9cac-2b237c3bb4fc	NA	TCGA-04-1516-01A-01D-1043-01	NA	NA	NA	NA	TCGA-04-1516-01	NA	NA	NA	TCGA-04-1516-01A-01R-1050-07	
TCGA-04-1516-11	0	TCGA-04-1516-11	1265	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1516	NA	NA	days	1265	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Left	TCGA-04-1516-F24087	TCGA-04-1516	TCGA-04-1516-11B	Stage IA	-17768	NA	NA	0	1265	NA	NA	0	NA	NA	2010-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	NA	1516	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Solid Tissue Normal	11	0.5	NA	NA	04	No Macroscopic disease	Ovary	NA	B	LIVING	2006	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1516-11B-01D-1047-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-04-1517-01	1	TCGA-04-1517-01	608	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-04-1517	NA	NA	days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	79	Bilateral	TCGA-04-1517-F24092	TCGA-04-1517	TCGA-04-1517-01A	Stage IIIC	-29045	NA	608	0	NA	NA	349	NA	NA	NA	2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.5	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1517.ED992763-74E1-466F-A71A-AC0455AD40F6.pdf	1517	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	04	>20 mm	Ovary	NO	A	DECEASED	2006	NA	TCGA-04-1517-01	TCGA-04-1517-01A-01W-0615-10	663aa6bd-30d1-47fb-8aec-2baece0cbb87	NA	TCGA-04-1517-01	TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01A-01D-0536-05	NA	TCGA-04-1517-01A-21-1558-20	NA	NA	TCGA-04-1517-01A-01D-0533-01	TCGA-04-1517-01	9e4ae9f4-e1ef-40a6-af24-7ea99c9beccd	NA	TCGA-04-1517-01A-01D-0533-01	NA	NA	NA	NA	TCGA-04-1517-01	NA	NA	TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01A-01R-0540-07	
TCGA-04-1519-01	0	TCGA-04-1519-01	24	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-04-1519	NA	NA	days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	NA	TCGA-04-1519-F58470	TCGA-04-1519	TCGA-04-1519-01A	Stage IIIC	-17671	NA	NA	0	24	NA	NA	NA	Scheduled Follow-up Submission	NA	2014-4-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	0.4	NO	NA	1.3	YES	NA	G3	NA	NA	NA	NA	NA	TCGA-04-1519.53840C6E-E1AA-415E-BB85-8E1B8976F45C.pdf	1519	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	04	NA	Ovary	NA	A	LIVING	2007	TCGA-04-1519-01	TCGA-04-1519-01	TCGA-04-1519-01A-01W-0615-10	87caa261-28f0-4d9d-bec5-3842c715d23a	NA	TCGA-04-1519-01	TCGA-04-1519-01A-01W-0615-10	TCGA-04-1519-01A-01D-0536-05	NA	TCGA-04-1519-01A-21-1558-20	NA	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	TCGA-04-1519-01A-01D-0533-01	TCGA-04-1519-01	0ed2d853-f94d-49d0-856b-85d54e4817f5	NA	TCGA-04-1519-01A-01D-0533-01	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	NA	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	NA	TCGA-04-1519-01	TCGA-04-1519-01	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	NA	TCGA-04-1519-01A-01R-0540-07	
TCGA-04-1525-01	1	TCGA-04-1525-01	1167	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1525	NA	NA	days	1167	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-04-1525-F24099	TCGA-04-1525	TCGA-04-1525-01A	Stage IIIC	-17469	NA	1167	0	1167	NA	213	NA	NA	NA	2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	2	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1525.B84E0C8B-B383-453F-9099-92B5445691D6.pdf	1525	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	04	1-10 mm	Ovary	NO	A	DECEASED	2005	NA	TCGA-04-1525-01	TCGA-04-1525-01A-01W-0615-10	9fffbdac-8e68-4ea7-ba2f-b2f6156e9f15	NA	TCGA-04-1525-01	TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01A-01D-0536-05	NA	TCGA-04-1525-01A-21-1558-20	NA	NA	TCGA-04-1525-01A-01D-0533-01	TCGA-04-1525-01	1ea5f6bb-950e-4383-b76b-f3918c0a0366	NA	TCGA-04-1525-01A-01D-0533-01	NA	NA	NA	NA	TCGA-04-1525-01	NA	NA	TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01A-01R-0540-07	
TCGA-04-1530-01	1	TCGA-04-1530-01	3622	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1530	NA	NA	days	3622	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-04-1530-F24104	TCGA-04-1530	TCGA-04-1530-01A	Stage IIIC	-25013	NA	3622	0	NA	NA	350	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1530.6CB3AECE-ADBB-4AED-A036-2E2D28D68369.pdf	1530	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.4	NA	NA	04	1-10 mm	Ovary	NO	A	DECEASED	1995	NA	TCGA-04-1530-01	TCGA-04-1530-01A-02W-0552-10	4271a8fa-e416-4274-8a37-49673f212605	NA	TCGA-04-1530-01	TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01A-02D-0501-05	NA	NA	NA	NA	TCGA-04-1530-01A-02D-0497-01	TCGA-04-1530-01	NA	NA	TCGA-04-1530-01A-02D-0497-01	NA	NA	NA	NA	TCGA-04-1530-01	NA	NA	TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01A-02R-0504-07	
TCGA-04-1536-01	1	TCGA-04-1536-01	885	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	NA	TCGA-04-1536	NA	NA	days	885	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-04-1536-F24110	TCGA-04-1536	NA	Stage IV	-21939	NA	885	0	NA	NA	498	0	NA	NA	2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1536	NA	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	04	1-10 mm	Ovary	NA	NA	DECEASED	2001	NA	TCGA-04-1536-01	NA	f2c0342a-1302-47ff-8615-8d3eb700e3a5	NA	TCGA-04-1536-01	NA	TCGA-04-1536-01A-01D-0536-05	NA	NA	NA	NA	TCGA-04-1536-01A-01D-0533-01	TCGA-04-1536-01	NA	NA	TCGA-04-1536-01A-01D-0533-01	NA	NA	NA	NA	TCGA-04-1536-01	NA	NA	NA	TCGA-04-1536-01A-01R-0540-07	
TCGA-04-1542-01	1	TCGA-04-1542-01	2561	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1542	NA	NA	days	2561	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-04-1542-F24118	TCGA-04-1542	TCGA-04-1542-01A	Stage IIIB	-19263	NA	2561	0	NA	NA	1020	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-04-1542.E3103C8A-50CB-43FE-9670-2BFB5D1DC318.pdf	1542	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-04-1542-01	NA	7a29ab3a-5d05-47e9-bd87-2cf0285fc8a6	NA	TCGA-04-1542-01	NA	TCGA-04-1542-01A-01D-0501-05	TCGA-04-1542-01A-01W-0553-09	TCGA-04-1542-01A-21-1558-20	TCGA-04-1542-01A-01W-0553-09	NA	TCGA-04-1542-01A-01D-0497-01	TCGA-04-1542-01	abafb551-fa90-465c-8122-6a8c2793c2d8	NA	TCGA-04-1542-01A-01D-0497-01	NA	NA	NA	NA	TCGA-04-1542-01	NA	NA	TCGA-04-1542-01A-01W-0553-09	TCGA-04-1542-01A-01R-0504-07	
TCGA-04-1638-01	1	TCGA-04-1638-01	1686	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-04-1638	NA	NA	days	1686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	57	NA	TCGA-04-1638-F24136	TCGA-04-1638	TCGA-04-1638-01A	Stage IV	-20987	NA	1686	0	NA	NA	298	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1638.5CA47F76-8E99-4594-B84C-FAC31BB42269.pdf	1638	Pre-Adjuvant Therapy	TUMOR FREE	YES	NA	Other Method	NO	NA	Primary Tumor	01	0.3	NA	NA	04	No Macroscopic disease	Ovary	NA	A	DECEASED	2002	NA	TCGA-04-1638-01	NA	11e368d8-9506-45d7-90e6-3ddf23c9e903	NA	TCGA-04-1638-01	NA	TCGA-04-1638-01A-01D-0581-05	NA	TCGA-04-1638-01A-21-1558-20	TCGA-04-1638-01A-01W-0639-09	NA	TCGA-04-1638-01A-01D-0577-01	TCGA-04-1638-01	66049405-6d0c-4409-a9be-166eda4f96b6	NA	TCGA-04-1638-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1638-01	NA	NA	NA	TCGA-04-1638-01A-01R-0584-07	
TCGA-04-1644-01	1	TCGA-04-1644-01	1487	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-04-1644	NA	NA	days	1487	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-04-1644-F24145	TCGA-04-1644	TCGA-04-1644-01A	Stage IIIC	-17725	NA	1487	0	NA	NA	634	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-04-1644.7AA7FF0A-C1C4-42A1-A340-A1E03CED8DEB.pdf	1644	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.4	NA	NA	04	>20 mm	Ovary	NA	A	DECEASED	2002	NA	NA	NA	5c14dcb5-1dd3-4eaa-a71a-e7b62d4698ee	NA	NA	NA	TCGA-04-1644-01B-01D-1047-05	NA	TCGA-04-1644-01A-11-1562-20	TCGA-04-1644-01B-01D-1526-09	NA	TCGA-04-1644-01B-01D-1043-01	TCGA-04-1644-01	3fa1c199-830d-486c-859f-2179bb86e5bf	NA	TCGA-04-1644-01B-01D-1043-01	NA	NA	NA	NA	TCGA-04-1644-01	NA	NA	NA	TCGA-04-1644-01B-01R-1050-07	
TCGA-04-1644-11	1	TCGA-04-1644-11	1487	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1644	NA	NA	days	1487	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-04-1644-F24145	TCGA-04-1644	TCGA-04-1644-11A	Stage IIIC	-17725	NA	1487	0	NA	NA	634	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.1	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	1644	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Solid Tissue Normal	11	0.4	NA	NA	04	>20 mm	Ovary	NA	A	DECEASED	2002	NA	NA	NA	NA	NA	NA	NA	TCGA-04-1644-11A-01D-1047-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-04-1646-01	1	TCGA-04-1646-01	848	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-04-1646	NA	NA	days	848	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-04-1646-F24152	TCGA-04-1646	NA	Stage IIIC	-22207	NA	848	0	NA	NA	508	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1646	Pre-Adjuvant Therapy	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	04	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-04-1646-01	NA	d6a1fffb-cecf-4137-865c-95d7d95fae2d	NA	TCGA-04-1646-01	NA	TCGA-04-1646-01A-01D-0581-05	NA	TCGA-04-1646-01A-21-1558-20	TCGA-04-1646-01A-01W-0639-09	NA	TCGA-04-1646-01A-01D-0577-01	TCGA-04-1646-01	c278e930-af50-4be7-a706-48a80e58b24f	NA	TCGA-04-1646-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1646-01	NA	NA	NA	TCGA-04-1646-01A-01R-0584-07	
TCGA-04-1648-01	1	TCGA-04-1648-01	871	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-04-1648	NA	NA	days	871	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	NA	TCGA-04-1648-F24159	TCGA-04-1648	NA	Stage IIIC	-21113	NA	871	0	NA	NA	412	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1648	Pre-Adjuvant Therapy	NA	YES	NA	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	04	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-04-1648-01	NA	b145279e-8242-4087-9584-0519d4639d31	NA	TCGA-04-1648-01	NA	TCGA-04-1648-01A-01D-0581-05	NA	TCGA-04-1648-01A-21-1558-20	TCGA-04-1648-01A-01W-0639-09	NA	TCGA-04-1648-01A-01D-0577-01	TCGA-04-1648-01	f904c338-e425-42f1-a15e-b5eb2dcfe829	NA	TCGA-04-1648-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1648-01	NA	NA	NA	TCGA-04-1648-01A-01R-0584-07	
TCGA-04-1649-01	0	TCGA-04-1649-01	1966	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-04-1649	NA	NA	days	1966	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-04-1649-F24168	TCGA-04-1649	TCGA-04-1649-01A	Stage IIIC	-27165	NA	NA	0	1966	NA	1672	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1649.C0A1166D-7233-4843-A007-DDF16A45A5E8.pdf	1649	Preoperative	NA	NO	NA	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	LIVING	2003	NA	TCGA-04-1649-01	NA	3ae3b762-3f04-450d-86db-44daec23ca9f	NA	TCGA-04-1649-01	NA	TCGA-04-1649-01A-01D-0581-05	NA	TCGA-04-1649-01A-21-1558-20	TCGA-04-1649-01A-01W-0639-09	NA	TCGA-04-1649-01A-01D-0577-01	TCGA-04-1649-01	fd9ff078-e2fe-4ab6-9e62-445caba9e611	NA	TCGA-04-1649-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1649-01	NA	NA	NA	TCGA-04-1649-01A-01R-0584-07	
TCGA-04-1651-01	1	TCGA-04-1651-01	1102	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	NA	TCGA-04-1651	NA	NA	days	1102	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1651-F24172	TCGA-04-1651	TCGA-04-1651-01A	Stage IIIC	-19628	NA	1102	0	NA	NA	990	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.4	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-04-1651.703BEFE1-07E0-48AE-826E-133A59F97068.pdf	1651	Pre-Adjuvant Therapy	NA	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	TCGA-04-1651-01	NA	797b7d36-42e2-4f9d-9f8f-7d3fb52219ff	NA	TCGA-04-1651-01	NA	TCGA-04-1651-01A-01D-0581-05	NA	TCGA-04-1651-01A-21-1558-20	TCGA-04-1651-01A-01W-0639-09	NA	TCGA-04-1651-01A-01D-0577-01	TCGA-04-1651-01	5c0f2819-0ecd-43de-aa9b-6073e34779e5	NA	TCGA-04-1651-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1651-01	NA	NA	NA	TCGA-04-1651-01A-01R-0584-07	
TCGA-04-1652-01	1	TCGA-04-1652-01	969	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 2	NA	TCGA-04-1652	NA	NA	days	969	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Right	TCGA-04-1652-F24179	TCGA-04-1652	NA	Stage IIIC	-28101	NA	969	0	NA	NA	880	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G2	Recurrence	NA	NA	NA	NA	NA	1652	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	04	NA	Ovary	NO	NA	DECEASED	2004	NA	TCGA-04-1652-01	NA	dd1addbf-ba25-418f-98d9-efe155026fdd	NA	TCGA-04-1652-01	NA	TCGA-04-1652-01A-01D-0581-05	NA	NA	TCGA-04-1652-01A-01W-0639-09	NA	TCGA-04-1652-01A-01D-0577-01	TCGA-04-1652-01	NA	NA	TCGA-04-1652-01A-01D-0577-01	NA	NA	NA	NA	TCGA-04-1652-01	NA	NA	NA	TCGA-04-1652-01A-01R-0584-07	
TCGA-04-1654-01	1	TCGA-04-1654-01	1451	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-04-1654	NA	NA	days	1451	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-04-1654-F24185	TCGA-04-1654	TCGA-04-1654-01A	Stage IIIC	-25387	NA	1451	0	NA	NA	808	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.2	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-04-1654.E6F4CDD1-DD1B-4C69-8A9F-0DCA88F8C539.pdf	1654	Pre-Adjuvant Therapy	NA	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	04	1-10 mm	Ovary	NA	A	DECEASED	1999	NA	TCGA-04-1654-01	NA	bf9a9a62-9471-41f7-b10f-35a1316f63c3	NA	TCGA-04-1654-01	NA	TCGA-04-1654-01A-02D-0652-05	NA	TCGA-04-1654-01A-11-1562-20	NA	NA	TCGA-04-1654-01A-02D-0648-01	TCGA-04-1654-01	2b44138a-955e-46f3-bf8e-c8ace62e6389	NA	TCGA-04-1654-01A-02D-0648-01	NA	NA	NA	NA	TCGA-04-1654-01	NA	NA	NA	TCGA-04-1654-01A-02R-0655-07	
TCGA-04-1655-01	1	TCGA-04-1655-01	1380	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-04-1655	NA	NA	days	1380	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-04-1655-F24191	TCGA-04-1655	TCGA-04-1655-01A	Stage IIIB	-17988	NA	1380	0	NA	NA	819	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	1.1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-04-1655.D808763E-D67C-460C-B5D6-85CC5C1C05BC.pdf	1655	Pre-Adjuvant Therapy	NA	YES	NA	Physical Examination	NO	NA	Primary Tumor	01	0.4	NA	NA	04	No Macroscopic disease	Ovary	NA	A	DECEASED	1999	NA	TCGA-04-1655-01	NA	461a33bb-1055-403e-b7e0-7f16d1c10f7b	NA	TCGA-04-1655-01	NA	TCGA-04-1655-01A-01D-0563-05	NA	NA	TCGA-04-1655-01A-01W-0633-09	NA	TCGA-04-1655-01A-01D-0559-01	TCGA-04-1655-01	NA	NA	TCGA-04-1655-01A-01D-0559-01	NA	NA	NA	NA	TCGA-04-1655-01	NA	NA	NA	TCGA-04-1655-01A-01R-0566-07	
TCGA-09-0364-01	1	TCGA-09-0364-01	887	1	days	Squamous	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-09-0364	NA	NA	days	887	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	80	Right	TCGA-09-0364-F24198	TCGA-09-0364	TCGA-09-0364-01A	Stage IIC	-29262	NA	887	0	NA	NA	395	NA	NA	NA	2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-09-0364.27b9efd3-7748-4deb-96a2-3869a19bfa6f.pdf	0364	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	09	11-20 mm	Ovary	NO	A	DECEASED	1998	TCGA-09-0364-01	TCGA-09-0364-01	TCGA-09-0364-01A-02W-0370-10	0ba4e8de-0013-421a-8605-efb4f3ebfc0a	NA	TCGA-09-0364-01	TCGA-09-0364-01A-02W-0370-10	TCGA-09-0364-01A-02D-0359-05	NA	NA	NA	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	TCGA-09-0364-01A-02D-0356-01	TCGA-09-0364-01	NA	NA	TCGA-09-0364-01A-02D-0356-01	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	NA	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	NA	TCGA-09-0364-01	TCGA-09-0364-01	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	NA	NA	TCGA-09-0364-01A-02R-0363-07
TCGA-09-0365-01	1	TCGA-09-0365-01	288	1	days	GBM	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-09-0365	NA	NA	days	288	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Left	TCGA-09-0365-F24203	TCGA-09-0365	TCGA-09-0365-01A	Stage IIIC	-25703	NA	288	0	NA	NA	251	NA	NA	NA	2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NO	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-09-0365.459f8df7-b386-47c6-bf17-73af831441d4.pdf	0365	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	09	No Macroscopic disease	Ovary	NO	A	DECEASED	1999	NA	NA	NA	16f6b497-da7d-4156-9b83-dda375a1c04f	NA	NA	NA	TCGA-09-0365-01A-02D-0359-05	NA	NA	NA	NA	TCGA-09-0365-01A-02D-0356-01	TCGA-09-0365-01	NA	NA	TCGA-09-0365-01A-02D-0356-01	NA	NA	NA	NA	TCGA-09-0365-01	NA	NA	NA	NA	TCGA-09-0365-01A-02R-0363-07
TCGA-09-0366-01	1	TCGA-09-0366-01	1757	1	days	BRCA-LUAD+	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-09-0366	NA	NA	days	1757	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-09-0366-F24207	TCGA-09-0366	NA	Stage IIIC	-20440	NA	1757	0	NA	NA	190	NA	NA	NA	2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	NA	0366	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	09	1-10 mm	Ovary	NO	NA	DECEASED	1999	TCGA-09-0366-01	TCGA-09-0366-01	NA	e091ea57-ec3e-4357-8929-b4e149dfa3f5	NA	TCGA-09-0366-01	NA	TCGA-09-0366-01A-01D-0359-05	TCGA-09-0366-01A-01W-0372-09	NA	TCGA-09-0366-01A-01W-0372-09	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	TCGA-09-0366-01A-01D-0356-01	TCGA-09-0366-01	NA	NA	TCGA-09-0366-01A-01D-0356-01	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	NA	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	NA	TCGA-09-0366-01	TCGA-09-0366-01	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	TCGA-09-0366-01A-01W-0372-09	NA	TCGA-09-0366-01A-01R-0363-07
TCGA-09-0367-01	1	TCGA-09-0367-01	547	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-09-0367	NA	NA	days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-09-0367-F24212	TCGA-09-0367	TCGA-09-0367-01A	Stage IIIC	-24473	NA	547	0	NA	NA	NA	NA	NA	NA	2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89.pdf	0367	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	NA	NA	NA	09	1-10 mm	Ovary	YES	A	DECEASED	2001	TCGA-09-0367-01	TCGA-09-0367-01	NA	129c93c0-eb2f-47c5-acdc-4fd083e9dc8a	NA	TCGA-09-0367-01	NA	TCGA-09-0367-01A-01D-0359-05	NA	NA	NA	047e04aa-6a91-4535-b279-50430098e638	TCGA-09-0367-01A-01D-0356-01	TCGA-09-0367-01	NA	NA	TCGA-09-0367-01A-01D-0356-01	047e04aa-6a91-4535-b279-50430098e638	NA	047e04aa-6a91-4535-b279-50430098e638	NA	TCGA-09-0367-01	TCGA-09-0367-01	047e04aa-6a91-4535-b279-50430098e638	NA	NA	TCGA-09-0367-01A-01R-0363-07
TCGA-09-0369-01	1	TCGA-09-0369-01	1082	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	NA	NA	mutation cluster 5	TCGA-09-0369	NA	NA	days	1082	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Left	TCGA-09-0369-F24217	TCGA-09-0369	TCGA-09-0369-01A	Stage IIIC	-20705	NA	1082	0	NA	NA	274	NA	NA	NA	2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-09-0369.c052e190-b5c2-44bf-b5b0-2b37cde18cee.pdf	0369	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	09	No Macroscopic disease	Ovary	YES	A	DECEASED	2003	TCGA-09-0369-01	NA	NA	11197914-6f55-4542-9138-ad6b451c3350	NA	NA	NA	TCGA-09-0369-01A-01D-0359-05	TCGA-09-0369-01A-01W-0372-09	NA	TCGA-09-0369-01A-01W-0372-09	1f972766-2f58-4d41-b84c-3493ef2dd0c4	TCGA-09-0369-01A-01D-0356-01	TCGA-09-0369-01	NA	NA	TCGA-09-0369-01A-01D-0356-01	1f972766-2f58-4d41-b84c-3493ef2dd0c4	NA	1f972766-2f58-4d41-b84c-3493ef2dd0c4	NA	TCGA-09-0369-01	TCGA-09-0369-01	1f972766-2f58-4d41-b84c-3493ef2dd0c4	TCGA-09-0369-01A-01W-0372-09	NA	TCGA-09-0369-01A-01R-0363-07
TCGA-09-1659-01	1	TCGA-09-1659-01	304	1	days	High	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 5	TCGA-09-1659	NA	NA	days	304	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-09-1659-F24226	TCGA-09-1659	TCGA-09-1659-01B	Stage IIIC	-18733	NA	304	0	NA	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-09-1659.f10b2e12-02b2-42e0-a5b2-a02c1daabbdf.pdf	1659	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	09	>20 mm	Ovary	NO	B	DECEASED	1997	TCGA-09-1659-01	NA	TCGA-09-1659-01B-01W-0615-10	5203ba2e-518a-4492-8f15-25182bff1dec	NA	NA	TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01B-01D-0536-05	NA	NA	NA	32d5209e-2ef2-4ef0-b902-585542d7d16b	TCGA-09-1659-01B-01D-0533-01	TCGA-09-1659-01	NA	NA	TCGA-09-1659-01B-01D-0533-01	32d5209e-2ef2-4ef0-b902-585542d7d16b	NA	32d5209e-2ef2-4ef0-b902-585542d7d16b	NA	TCGA-09-1659-01	TCGA-09-1659-01	32d5209e-2ef2-4ef0-b902-585542d7d16b	TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01B-01R-0540-07	
TCGA-09-1661-01	1	TCGA-09-1661-01	1169	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1661	NA	NA	days	1169	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	75	Right	TCGA-09-1661-F24233	TCGA-09-1661	TCGA-09-1661-01B	Stage IIIC	-27486	NA	1169	0	NA	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.6	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-1661.1910251f-8c5c-4067-91dc-87bfdaf77283.pdf	1661	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	09	1-10 mm	Ovary	NO	B	DECEASED	2000	NA	TCGA-09-1661-01	TCGA-09-1661-01B-01W-0615-10	956ee2ec-8a47-417a-a82b-dc4c91f9cf46	NA	TCGA-09-1661-01	TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01B-01D-0536-05	NA	NA	NA	NA	TCGA-09-1661-01B-01D-0533-01	TCGA-09-1661-01	NA	NA	TCGA-09-1661-01B-01D-0533-01	NA	NA	NA	NA	TCGA-09-1661-01	NA	NA	TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01B-01R-0540-07	
TCGA-09-1662-01	1	TCGA-09-1662-01	2717	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1662	NA	NA	days	2717	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Left	TCGA-09-1662-F24243	TCGA-09-1662	TCGA-09-1662-01A	Stage IV	-21246	NA	2717	0	NA	NA	1046	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-09-1662.8e2676a4-2ac3-42af-be7d-cf74b6d82f2f.pdf	1662	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	09	1-10 mm	Ovary	YES	A	DECEASED	2001	TCGA-09-1662-01	TCGA-09-1662-01	TCGA-09-1662-01A-01W-0615-10	0fc0fc51-c5b7-428e-92c6-d55c8514b689	NA	TCGA-09-1662-01	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01A-01D-0536-05	NA	TCGA-09-1662-01A-21-1558-20	NA	759060d9-af2e-4098-b4ee-7aa2214acba8	TCGA-09-1662-01A-01D-0533-01	TCGA-09-1662-01	253b785e-f10b-4d0e-88cb-4db4a3610c7c	NA	TCGA-09-1662-01A-01D-0533-01	759060d9-af2e-4098-b4ee-7aa2214acba8	NA	759060d9-af2e-4098-b4ee-7aa2214acba8	NA	TCGA-09-1662-01	TCGA-09-1662-01	759060d9-af2e-4098-b4ee-7aa2214acba8	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01A-01R-0540-07	
TCGA-09-1664-01	1	TCGA-09-1664-01	2279	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-09-1664	NA	NA	days	2279	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	37	Bilateral	TCGA-09-1664-F24268	TCGA-09-1664	NA	Stage IIIC	-13739	NA	2279	0	NA	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G1	NA	NA	NA	NA	NA	NA	1664	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	09	1-10 mm	Ovary	NO	NA	DECEASED	2002	NA	NA	NA	ab246047-1519-4cd8-b1c5-abb4ef58697a	NA	NA	NA	TCGA-09-1664-01A-01D-0581-05	NA	TCGA-09-1664-01A-21-1558-20	TCGA-09-1664-01A-01W-0639-09	NA	TCGA-09-1664-01A-01D-0577-01	TCGA-09-1664-01	e2007adb-55b1-4b8b-99c0-4e6a61a2da29	NA	TCGA-09-1664-01A-01D-0577-01	NA	NA	NA	NA	TCGA-09-1664-01	NA	NA	NA	TCGA-09-1664-01A-01R-0584-07	
TCGA-09-1665-01	1	TCGA-09-1665-01	1266	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1665	NA	NA	days	1266	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	73	Left	TCGA-09-1665-F24272	TCGA-09-1665	TCGA-09-1665-01B	Stage IIIC	-27010	NA	1266	0	NA	NA	468	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	YES	G2	Recurrence	NA	NA	NA	NA	TCGA-09-1665.0e311879-9b25-453d-b41a-7cc3048bb05e.pdf	1665	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	09	No Macroscopic disease	Ovary	YES	B	DECEASED	2002	NA	TCGA-09-1665-01	TCGA-09-1665-01B-01W-0615-10	5b880786-e40d-41ff-9fee-f542f1b5a27c	NA	TCGA-09-1665-01	TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01B-01D-0536-05	NA	TCGA-09-1665-01B-21-1558-20	NA	NA	TCGA-09-1665-01B-01D-0533-01	TCGA-09-1665-01	a565c52a-a226-47db-b68c-d579055e4c06	NA	TCGA-09-1665-01B-01D-0533-01	NA	NA	NA	NA	TCGA-09-1665-01	NA	NA	TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01B-01R-0540-07	
TCGA-09-1666-01	0	TCGA-09-1666-01	1752	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-1666	NA	NA	days	1752	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-09-1666-F24279	TCGA-09-1666	TCGA-09-1666-01A	Stage IIIC	-21066	NA	NA	0	1752	NA	480	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-09-1666.2de50dd9-b607-4a87-baae-468c4bf43205.pdf	1666	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	09	No Macroscopic disease	Ovary	NO	A	LIVING	2003	TCGA-09-1666-01	TCGA-09-1666-01	TCGA-09-1666-01A-01W-0615-10	fc1d50d5-b097-41f0-a9b2-0efd207d6ebd	NA	TCGA-09-1666-01	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01A-01D-0536-05	NA	TCGA-09-1666-01A-21-1558-20	NA	529b7dd2-075c-4e93-b8c8-6990d3297c30	TCGA-09-1666-01A-01D-0533-01	TCGA-09-1666-01	aa4fad88-9a21-4085-9ac7-21b349113168	NA	TCGA-09-1666-01A-01D-0533-01	529b7dd2-075c-4e93-b8c8-6990d3297c30	NA	529b7dd2-075c-4e93-b8c8-6990d3297c30	NA	TCGA-09-1666-01	TCGA-09-1666-01	529b7dd2-075c-4e93-b8c8-6990d3297c30	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01A-01R-0540-07	
TCGA-09-1667-01	0	TCGA-09-1667-01	1882	0	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-09-1667	NA	NA	days	1882	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-09-1667-F24292	TCGA-09-1667	TCGA-09-1667-01C	Stage IIC	-22306	NA	NA	0	1882	NA	460	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-09-1667.0f3fbc34-6dce-467f-a837-442815ebc159.pdf	1667	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	09	No Macroscopic disease	Ovary	NO	C	LIVING	2004	TCGA-09-1667-01	TCGA-09-1667-01	NA	64fbf0df-6693-4ea5-a868-925636d9d20f	NA	TCGA-09-1667-01	NA	TCGA-09-1667-01C-01D-0536-05	NA	NA	NA	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	TCGA-09-1667-01C-01D-0533-01	TCGA-09-1667-01	NA	NA	TCGA-09-1667-01C-01D-0533-01	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	NA	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	NA	TCGA-09-1667-01	TCGA-09-1667-01	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	NA	TCGA-09-1667-01C-01R-0540-07	
TCGA-09-1668-01	0	TCGA-09-1668-01	1684	0	days	Squamous	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-09-1668	NA	NA	days	1684	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Right	TCGA-09-1668-F24300	TCGA-09-1668	TCGA-09-1668-01B	Stage IIIC	-20972	NA	NA	0	1684	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.7	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-1668.7740b3ec-1d81-4408-be9e-45ccd7e91b3a.pdf	1668	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	09	NA	Ovary	NO	B	LIVING	2004	TCGA-09-1668-01	TCGA-09-1668-01	NA	fe849a8b-cfb0-44a3-a264-75ccef069be3	NA	TCGA-09-1668-01	NA	TCGA-09-1668-01B-01D-0536-05	NA	NA	NA	66894abe-8af5-4fd9-9a59-cf24e57fc07f	TCGA-09-1668-01B-01D-0533-01	TCGA-09-1668-01	NA	NA	TCGA-09-1668-01B-01D-0533-01	66894abe-8af5-4fd9-9a59-cf24e57fc07f	NA	66894abe-8af5-4fd9-9a59-cf24e57fc07f	NA	TCGA-09-1668-01	TCGA-09-1668-01	66894abe-8af5-4fd9-9a59-cf24e57fc07f	NA	TCGA-09-1668-01B-01R-0540-07	
TCGA-09-1669-01	0	TCGA-09-1669-01	928	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1669	NA	NA	days	928	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Right	TCGA-09-1669-F24305	TCGA-09-1669	TCGA-09-1669-01A	Stage IIIA	-20052	NA	NA	0	928	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.9	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-1669.7870b5a7-a96c-4e55-b56f-8eca45918251.pdf	1669	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	09	No Macroscopic disease	Ovary	NO	A	LIVING	2004	TCGA-09-1669-01	TCGA-09-1669-01	TCGA-09-1669-01A-01W-0615-10	01119e56-c4b0-4d4f-876c-fd34e4185af3	NA	TCGA-09-1669-01	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01A-01D-0536-05	NA	NA	NA	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	TCGA-09-1669-01A-01D-0533-01	TCGA-09-1669-01	NA	NA	TCGA-09-1669-01A-01D-0533-01	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	NA	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	NA	TCGA-09-1669-01	TCGA-09-1669-01	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01A-01R-0540-07	
TCGA-09-1670-01	0	TCGA-09-1670-01	547	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-09-1670	NA	NA	days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-09-1670-F24309	TCGA-09-1670	TCGA-09-1670-01A	Stage IIIA	-21147	NA	NA	0	547	NA	547	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.6	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-09-1670.5cc85cd9-99c4-4087-bdc5-8039b0369538.pdf	1670	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	09	No Macroscopic disease	Ovary	NO	A	LIVING	2005	TCGA-09-1670-01	TCGA-09-1670-01	NA	99b305e7-c4d7-4174-955d-7618d91f84d0	NA	TCGA-09-1670-01	NA	TCGA-09-1670-01A-01D-0563-05	NA	TCGA-09-1670-01A-21-1558-20	TCGA-09-1670-01A-01W-0633-09	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	TCGA-09-1670-01A-01D-0559-01	TCGA-09-1670-01	950ea36f-87d6-4730-b11d-e8eae3e0fe79	NA	TCGA-09-1670-01A-01D-0559-01	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	NA	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	NA	TCGA-09-1670-01	TCGA-09-1670-01	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	NA	TCGA-09-1670-01A-01R-0566-07	
TCGA-09-1672-01	0	TCGA-09-1672-01	178	0	days	BRCA-LUAD+	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-09-1672	NA	NA	days	178	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Right	TCGA-09-1672-F24314	TCGA-09-1672	TCGA-09-1672-01A	Stage IIIC	-28556	NA	NA	0	178	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G1	NA	NA	NA	NA	NA	TCGA-09-1672.103ad514-77dc-42fd-8cf2-31e9de128a74.pdf	1672	NA	TUMOR FREE	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	09	NA	Ovary	YES	A	LIVING	2008	NA	NA	NA	67029a85-41d6-41a6-844e-cecf63941f3e	NA	NA	NA	TCGA-09-1672-01A-01D-0563-05	NA	NA	TCGA-09-1672-01A-01W-0633-09	NA	TCGA-09-1672-01A-01D-0559-01	TCGA-09-1672-01	NA	NA	TCGA-09-1672-01A-01D-0559-01	NA	NA	NA	NA	TCGA-09-1672-01	NA	NA	NA	TCGA-09-1672-01A-01R-0566-07	
TCGA-09-1673-01	0	TCGA-09-1673-01	92	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-09-1673	NA	NA	days	92	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-09-1673-F24318	TCGA-09-1673	TCGA-09-1673-01A	Stage IV	-18599	NA	NA	0	92	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	3	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450.pdf	1673	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	09	>20 mm	Ovary	YES	A	LIVING	2008	TCGA-09-1673-01	TCGA-09-1673-01	NA	f45664bd-409f-4819-bb3f-b16ce74e7d9c	NA	TCGA-09-1673-01	NA	TCGA-09-1673-01A-01D-0563-05	NA	TCGA-09-1673-01A-21-1558-20	TCGA-09-1673-01A-01W-0633-09	37037dcf-fa69-4cd3-b83d-e474d69059b4	TCGA-09-1673-01A-01D-0559-01	TCGA-09-1673-01	ca0ee85f-6e38-447b-b232-49812c6e2a97	NA	TCGA-09-1673-01A-01D-0559-01	37037dcf-fa69-4cd3-b83d-e474d69059b4	NA	37037dcf-fa69-4cd3-b83d-e474d69059b4	NA	TCGA-09-1673-01	TCGA-09-1673-01	37037dcf-fa69-4cd3-b83d-e474d69059b4	NA	TCGA-09-1673-01A-01R-0566-07	
TCGA-09-1674-01	0	TCGA-09-1674-01	260	0	days	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-09-1674	NA	NA	days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	79	Bilateral	TCGA-09-1674-F24322	TCGA-09-1674	TCGA-09-1674-01A	Stage IIIC	-28878	NA	NA	0	260	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2.1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e.pdf	1674	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	09	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-09-1674-01	TCGA-09-1674-01	NA	995f3a5f-4e3d-4e69-a473-4b53da943923	NA	TCGA-09-1674-01	NA	TCGA-09-1674-01A-01D-0563-05	NA	TCGA-09-1674-01A-21-1558-20	TCGA-09-1674-01A-01W-0633-09	3a81f083-56dc-48a5-be8d-b69a146db93b	TCGA-09-1674-01A-01D-0559-01	TCGA-09-1674-01	872b7aec-febf-4104-8269-bfb0c72fbeec	NA	TCGA-09-1674-01A-01D-0559-01	3a81f083-56dc-48a5-be8d-b69a146db93b	NA	3a81f083-56dc-48a5-be8d-b69a146db93b	NA	TCGA-09-1674-01	TCGA-09-1674-01	3a81f083-56dc-48a5-be8d-b69a146db93b	NA	TCGA-09-1674-01A-01R-0566-07	
TCGA-09-1675-01	0	TCGA-09-1675-01	2967	0	days	Squamous	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-09-1675	NA	NA	days	2967	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Left	TCGA-09-1675-F24326	TCGA-09-1675	TCGA-09-1675-01B	Stage IC	-18596	NA	NA	0	2967	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1.1	NA	NO	G2	NA	NA	NA	NA	NA	TCGA-09-1675.f981f103-fc2d-4f41-9f71-015f194391f5.pdf	1675	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	09	No Macroscopic disease	Ovary	NO	B	LIVING	2001	NA	NA	NA	690beb52-7ca9-448a-a134-7317be4f8289	NA	NA	NA	TCGA-09-1675-01B-01D-0563-05	NA	NA	TCGA-09-1675-01B-01W-0633-09	NA	TCGA-09-1675-01B-01D-0559-01	TCGA-09-1675-01	NA	NA	TCGA-09-1675-01B-01D-0559-01	NA	NA	NA	NA	TCGA-09-1675-01	NA	NA	NA	TCGA-09-1675-01B-01R-0566-07	
TCGA-09-2043-01	0	TCGA-09-2043-01	188	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-09-2043	NA	NA	days	188	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	69	Left	TCGA-09-2043-F24332	TCGA-09-2043	TCGA-09-2043-01A	Stage IC	-25480	NA	NA	0	188	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-2043.1fa4e0b8-344f-4ebb-b150-c3ace0ec4a00.pdf	2043	NA	TUMOR FREE	NO	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	09	No Macroscopic disease	Ovary	NO	A	LIVING	2009	NA	NA	NA	dec0d15f-9489-4987-83ff-3613cf21c379	NA	NA	NA	TCGA-09-2043-01A-01D-0708-05	NA	TCGA-09-2043-01A-21-1560-20	NA	NA	TCGA-09-2043-01A-01D-0704-01	TCGA-09-2043-01	066f35fb-d0a8-4968-acf1-1da9ec81748e	NA	TCGA-09-2043-01A-01D-0704-01	NA	NA	NA	NA	TCGA-09-2043-01	NA	NA	NA	TCGA-09-2043-01A-01R-0711-07	
TCGA-09-2044-01	0	TCGA-09-2044-01	186	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-09-2044	NA	NA	days	186	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	77	Right	TCGA-09-2044-F24334	TCGA-09-2044	TCGA-09-2044-01B	Stage IIB	-28231	NA	NA	0	186	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.8	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-2044.42d7c4ad-b379-4dc0-ba67-16aa6ead89d9.pdf	2044	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	09	No Macroscopic disease	Ovary	NO	B	LIVING	2009	TCGA-09-2044-01	TCGA-09-2044-01	NA	0b4c7448-2729-45db-b1b2-0fba79016c76	NA	TCGA-09-2044-01	NA	TCGA-09-2044-01B-01D-0708-05	NA	TCGA-09-2044-01B-21-1560-20	NA	658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01D-0704-01	TCGA-09-2044-01	32c1a264-b1dd-4307-ab4d-f710ea9692cc	NA	TCGA-09-2044-01B-01D-0704-01	658b4847-33bc-414c-a2bb-ce9379ef57bd	NA	658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01W-0799-08	TCGA-09-2044-01	TCGA-09-2044-01	658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01W-0799-08	TCGA-09-2044-01B-01R-0711-07	
TCGA-09-2045-01	1	TCGA-09-2045-01	1069	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-09-2045	NA	NA	days	1069	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-09-2045-F24338	TCGA-09-2045	TCGA-09-2045-01A	Stage IV	-18285	NA	1069	0	NA	NA	631	NA	NA	NA	2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NA	YES	G2	Recurrence	NA	NA	NA	NA	TCGA-09-2045.6c826e9d-b1aa-4c84-b294-c8fb41818da1.pdf	2045	NA	WITH TUMOR	YES	Stable Disease	Physical Examination	NO	NA	Primary Tumor	01	0.4	NA	NA	09	1-10 mm	Ovary	YES	A	DECEASED	1996	TCGA-09-2045-01	TCGA-09-2045-01	NA	4456d296-bac1-461d-bda9-d3c52aba590c	NA	TCGA-09-2045-01	NA	TCGA-09-2045-01A-01D-0708-05	NA	TCGA-09-2045-01A-21-1560-20	NA	7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01D-0704-01	TCGA-09-2045-01	51c5bf06-26be-471c-927c-1cb07bf10a2b	NA	TCGA-09-2045-01A-01D-0704-01	7b412fd9-4414-440f-b768-70666037c768	NA	7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01W-0799-08	TCGA-09-2045-01	TCGA-09-2045-01	7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01W-0799-08	TCGA-09-2045-01A-01R-0711-07	
TCGA-09-2048-01	1	TCGA-09-2048-01	138	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-09-2048	NA	NA	days	138	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-09-2048-F24351	TCGA-09-2048	TCGA-09-2048-01A	Stage IIIC	-23043	NA	138	0	NA	NA	NA	NA	NA	NA	2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-09-2048.0755D708-ADF5-4219-ABC6-BCD9C2BCA089.pdf	2048	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	09	1-10 mm	Ovary	YES	A	DECEASED	1999	TCGA-09-2048-01	TCGA-09-2048-01	NA	8d5f3a67-69eb-49b0-a1bc-f626eb70c76f	NA	TCGA-09-2048-01	NA	TCGA-09-2048-01A-01D-0708-05	NA	NA	NA	d3220bce-1bf3-47c4-951f-937dac7581be	TCGA-09-2048-01A-01D-0704-01	TCGA-09-2048-01	NA	NA	TCGA-09-2048-01A-01D-0704-01	d3220bce-1bf3-47c4-951f-937dac7581be	NA	d3220bce-1bf3-47c4-951f-937dac7581be	NA	TCGA-09-2048-01	TCGA-09-2048-01	d3220bce-1bf3-47c4-951f-937dac7581be	NA	TCGA-09-2048-01A-01R-0711-07	
TCGA-09-2049-01	0	TCGA-09-2049-01	3419	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	NA	NA	mutation cluster 8	TCGA-09-2049	NA	NA	days	3419	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-09-2049-F24354	TCGA-09-2049	TCGA-09-2049-01D	Stage IIIC	-23410	NA	NA	0	3419	NA	953	NA	NA	NA	2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-09-2049.17564604-ce57-4087-887a-f97a5b280b26.pdf	2049	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	09	>20 mm	Ovary	NO	D	LIVING	1999	NA	NA	NA	870e7182-fd31-4863-b19b-001fb9a2a11d	NA	NA	NA	TCGA-09-2049-01D-01D-0708-05	NA	TCGA-09-2049-01D-21-1560-20	NA	NA	TCGA-09-2049-01D-01D-0704-01	TCGA-09-2049-01	ccaa932c-805b-4a2c-825f-d742a9fddb2c	NA	TCGA-09-2049-01D-01D-0704-01	NA	NA	NA	TCGA-09-2049-01D-01W-0799-08	TCGA-09-2049-01	NA	NA	TCGA-09-2049-01D-01W-0799-08	TCGA-09-2049-01D-01R-0711-07	
TCGA-09-2050-01	0	TCGA-09-2050-01	2163	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2050	NA	NA	days	2163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	Bilateral	TCGA-09-2050-F24367	TCGA-09-2050	TCGA-09-2050-01A	Stage IIA	-23987	NA	NA	0	2163	NA	NA	NA	NA	NA	2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.6	NA	NO	G2	NA	NA	NA	NA	NA	TCGA-09-2050.fb343129-010d-430b-aae4-f7beb7122279.pdf	2050	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	09	No Macroscopic disease	Ovary	NO	A	LIVING	2003	NA	TCGA-09-2050-01	NA	968defb5-7701-4ec8-9c4f-7b73a13b0411	NA	TCGA-09-2050-01	NA	TCGA-09-2050-01A-01D-0708-05	NA	NA	NA	NA	TCGA-09-2050-01A-01D-0704-01	TCGA-09-2050-01	NA	NA	TCGA-09-2050-01A-01D-0704-01	NA	NA	NA	TCGA-09-2050-01A-01W-0799-08	TCGA-09-2050-01	NA	NA	TCGA-09-2050-01A-01W-0799-08	TCGA-09-2050-01A-01R-0711-07	
TCGA-09-2051-01	0	TCGA-09-2051-01	1919	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2051	NA	NA	days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-09-2051-F24373	TCGA-09-2051	TCGA-09-2051-01A	Stage IIIC	-15650	NA	NA	0	1919	NA	583	NA	NA	NA	2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-09-2051.242a1ff3-05ad-4623-b5aa-9bb556e2cfa9.pdf	2051	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	09	No Macroscopic disease	Ovary	YES	A	LIVING	2004	TCGA-09-2051-01	TCGA-09-2051-01	NA	34b0a38d-33f0-436f-a30b-4c730a37e27c	NA	TCGA-09-2051-01	NA	TCGA-09-2051-01A-01D-0708-05	NA	TCGA-09-2051-01A-21-1560-20	NA	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01D-0704-01	TCGA-09-2051-01	5bcc9755-b429-47c1-9a00-af84edd803aa	NA	TCGA-09-2051-01A-01D-0704-01	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	NA	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01W-0799-08	TCGA-09-2051-01	TCGA-09-2051-01	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01W-0799-08	TCGA-09-2051-01A-01R-0711-07	
TCGA-09-2053-01	0	TCGA-09-2053-01	1209	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-2053	NA	NA	days	1209	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	72	Left	TCGA-09-2053-F24384	TCGA-09-2053	TCGA-09-2053-01C	Stage IIIC	-26433	NA	NA	0	1209	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.7	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-2053.0d28e549-3ed0-4a22-bac7-9cbe24e44f53.pdf	2053	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	09	No Macroscopic disease	Ovary	NO	C	LIVING	2005	NA	TCGA-09-2053-01	NA	00fdb098-d819-43f1-995d-a43f2499afe7	NA	TCGA-09-2053-01	NA	TCGA-09-2053-01C-01D-0667-05	NA	NA	NA	NA	TCGA-09-2053-01C-01D-0663-01	TCGA-09-2053-01	NA	NA	TCGA-09-2053-01C-01D-0663-01	NA	NA	NA	TCGA-09-2053-01C-01W-0722-08	TCGA-09-2053-01	NA	NA	TCGA-09-2053-01C-01W-0722-08	TCGA-09-2053-01C-01R-0670-07	
TCGA-09-2054-01	1	TCGA-09-2054-01	637	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3	NA	TCGA-09-2054	NA	NA	days	637	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-09-2054-F24388	TCGA-09-2054	TCGA-09-2054-01A	Stage IIIC	-21285	NA	637	0	637	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-09-2054.4f0eb2a1-996c-4816-a956-835ce5085438.pdf	2054	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	09	1-10 mm	Ovary	YES	A	DECEASED	2005	TCGA-09-2054-01	TCGA-09-2054-01	NA	f6aa28c5-b1f6-4552-82a7-a6a170814534	NA	TCGA-09-2054-01	NA	TCGA-09-2054-01A-01D-0667-05	NA	TCGA-09-2054-01A-21-1560-20	NA	5cd7faa0-323a-4ea3-a658-859d0336e0ac	TCGA-09-2054-01A-01D-0663-01	TCGA-09-2054-01	3b31fec3-6dd6-4ef7-bcb4-8c67007f6937	NA	TCGA-09-2054-01A-01D-0663-01	5cd7faa0-323a-4ea3-a658-859d0336e0ac	NA	5cd7faa0-323a-4ea3-a658-859d0336e0ac	NA	TCGA-09-2054-01	TCGA-09-2054-01	5cd7faa0-323a-4ea3-a658-859d0336e0ac	NA	TCGA-09-2054-01A-01R-0670-07	
TCGA-09-2055-01	0	TCGA-09-2055-01	819	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-09-2055	NA	NA	days	819	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Left	TCGA-09-2055-F24395	TCGA-09-2055	TCGA-09-2055-01B	Stage IC	-17545	NA	NA	0	819	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.8	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-2055.4cff882a-1ce5-4586-a808-a7f00e319743.pdf	2055	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	09	No Macroscopic disease	Ovary	NO	B	LIVING	2007	NA	NA	NA	7c240854-d066-4ecd-905d-1f6dea67d509	NA	NA	NA	TCGA-09-2055-01B-01D-0708-05	NA	TCGA-09-2055-01A-11-1563-20	NA	NA	TCGA-09-2055-01B-01D-0704-01	TCGA-09-2055-01	b02ef957-7893-4222-983a-3784ee59dfdd	NA	TCGA-09-2055-01B-01D-0704-01	NA	NA	NA	NA	TCGA-09-2055-01	NA	NA	NA	TCGA-09-2055-01B-01R-0711-07	
TCGA-09-2056-01	0	TCGA-09-2056-01	379	0	days	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-09-2056	NA	NA	days	379	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-09-2056-F24399	TCGA-09-2056	TCGA-09-2056-01B	Stage IIIC	-22864	NA	NA	0	379	NA	NA	NA	NA	NA	2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.6	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-09-2056.67bdb457-cfb8-4052-bd33-bff86c736910.pdf	2056	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	09	No Macroscopic disease	Ovary	NO	B	LIVING	2008	TCGA-09-2056-01	NA	NA	6c194f10-5bf3-4331-b035-f50e93536dda	NA	NA	NA	TCGA-09-2056-01B-01D-0667-05	NA	TCGA-09-2056-01B-21-1560-20	NA	67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01D-0663-01	TCGA-09-2056-01	568718ea-3d9d-4d09-b155-0b8467a10bbe	NA	TCGA-09-2056-01B-01D-0663-01	67670628-ad07-41ef-8977-890080616900	NA	67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01W-0722-08	TCGA-09-2056-01	TCGA-09-2056-01	67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01W-0722-08	TCGA-09-2056-01B-01R-0670-07	
TCGA-10-0925-01	1	TCGA-10-0925-01	1652	1	days	BRCA-LUAD+	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-10-0925	NA	NA	days	1652	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-10-0925-F24403	TCGA-10-0925	TCGA-10-0925-01B	Stage IIIB	-21498	NA	1652	0	1652	NA	558	NA	NA	NA	2010-2-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	80	0.7	NA	NA	G1	Recurrence	NA	NA	NA	NA	TCGA-10-0925.96f0f453-84f9-401a-9fd0-0a8712a87be5.pdf	0925	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	10	1-10 mm	Ovary	NA	B	DECEASED	2000	NA	NA	NA	54016305-6747-489d-b09b-8db5be8409dc	NA	NA	NA	TCGA-10-0925-01B-01D-0652-05	NA	TCGA-10-0925-01A-11-20	NA	NA	TCGA-10-0925-01B-01D-0648-01	TCGA-10-0925-01	ee2bb61b-4b7c-4cb4-b9e8-381285ad51f7	NA	TCGA-10-0925-01B-01D-0648-01	NA	NA	NA	NA	TCGA-10-0925-01	NA	NA	NA	TCGA-10-0925-01B-01R-0655-07	
TCGA-10-0926-01	1	TCGA-10-0926-01	788	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0926	NA	NA	days	788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-10-0926-F24413	TCGA-10-0926	TCGA-10-0926-01A	Stage IIIC	-23307	NA	788	0	788	NA	287	NA	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	80	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-10-0926.b940b1b3-8278-400e-b43a-e7897e0361b7.pdf	0926	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	YES	NA	Primary Tumor	01	0.6	NA	NA	10	11-20 mm	Ovary	NO	A	DECEASED	2000	NA	NA	NA	892ce3d6-a97f-480f-85fb-5491e5ab9afa	NA	NA	NA	TCGA-10-0926-01A-01D-0402-05	NA	TCGA-10-0926-01A-21-20	NA	NA	TCGA-10-0926-01A-01D-0399-01	TCGA-10-0926-01	fb5e42c3-de28-4dc9-8e33-c56685b72e5e	NA	TCGA-10-0926-01A-01D-0399-01	NA	NA	NA	TCGA-10-0926-01A-01W-0420-08	TCGA-10-0926-01	NA	NA	TCGA-10-0926-01A-01W-0420-08	TCGA-10-0926-01A-01R-0406-07	
TCGA-10-0927-01	1	TCGA-10-0927-01	2490	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-10-0927	NA	NA	days	2490	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-10-0927-F24420	TCGA-10-0927	NA	Stage IIIC	-23982	NA	2490	0	2478	NA	1001	NA	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	0927	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	10	1-10 mm	Ovary	NA	NA	DECEASED	2000	NA	TCGA-10-0927-01	TCGA-10-0927-01A-02W-0419-10	c4ec4774-a95e-4097-bd99-7b0862020450	NA	TCGA-10-0927-01	TCGA-10-0927-01A-02W-0419-10	TCGA-10-0927-01A-02D-0402-05	NA	NA	NA	NA	TCGA-10-0927-01A-02D-0399-01	TCGA-10-0927-01	NA	NA	TCGA-10-0927-01A-02D-0399-01	NA	NA	NA	NA	TCGA-10-0927-01	NA	NA	TCGA-10-0927-01	TCGA-10-0927-01A-02R-0406-07	
TCGA-10-0928-01	1	TCGA-10-0928-01	563	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-10-0928	NA	NA	days	563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Bilateral	TCGA-10-0928-F24430	TCGA-10-0928	TCGA-10-0928-01A	Stage IIIC	-26066	NA	563	0	563	NA	NA	0	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-10-0928.859b2662-493a-4ead-9ac7-0aa8d0a7a3d8.pdf	0928	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	10	1-10 mm	Ovary	NO	A	DECEASED	2000	TCGA-10-0928-01	TCGA-10-0928-01	TCGA-10-0928-01A-02W-0419-10	3534ce20-56e1-409a-a438-50513c622602	NA	TCGA-10-0928-01	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01A-02D-0402-05	NA	NA	NA	9aa3ae15-1033-46f1-a304-993f5d41cd50	TCGA-10-0928-01A-02D-0399-01	TCGA-10-0928-01	NA	NA	TCGA-10-0928-01A-02D-0399-01	9aa3ae15-1033-46f1-a304-993f5d41cd50	NA	9aa3ae15-1033-46f1-a304-993f5d41cd50	NA	TCGA-10-0928-01	TCGA-10-0928-01	9aa3ae15-1033-46f1-a304-993f5d41cd50	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01A-02R-0406-07	
TCGA-10-0930-01	1	TCGA-10-0930-01	1040	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0930	NA	NA	days	1040	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Left	TCGA-10-0930-F24432	TCGA-10-0930	TCGA-10-0930-01A	Stage IIIC	-25737	NA	1040	0	1011	NA	680	NA	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-10-0930.89034658-e10d-47d3-9ad8-d79aa51cf234.pdf	0930	NA	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.3	NA	NA	10	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-10-0930-01	NA	36457b1f-1ee7-4bdc-82f4-75f3fccceb66	NA	TCGA-10-0930-01	NA	TCGA-10-0930-01A-02D-0402-05	TCGA-10-0930-01A-02W-0421-09	NA	TCGA-10-0930-01A-02W-0421-09	NA	TCGA-10-0930-01A-02D-0399-01	TCGA-10-0930-01	NA	NA	TCGA-10-0930-01A-02D-0399-01	NA	NA	NA	NA	TCGA-10-0930-01	NA	NA	TCGA-10-0930-01A-02W-0421-09	TCGA-10-0930-01A-02R-0406-07	
TCGA-10-0931-01	1	TCGA-10-0931-01	1000	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0931	NA	NA	days	1000	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-10-0931-F24440	TCGA-10-0931	TCGA-10-0931-01A	Stage IIIC	-16262	NA	1000	0	982	NA	300	1	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-10-0931.45d8f828-6dfb-4e68-8282-f2ee74671461.pdf	0931	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	10	1-10 mm	Ovary	NO	A	DECEASED	2002	NA	TCGA-10-0931-01	NA	3d021366-16ec-4c18-8ce6-17beebce1e9c	NA	TCGA-10-0931-01	NA	TCGA-10-0931-01A-01D-0402-05	NA	TCGA-10-0931-01A-21-20	NA	NA	TCGA-10-0931-01A-01D-0399-01	TCGA-10-0931-01	25a69746-6f70-41eb-9805-6299ea0a4728	NA	TCGA-10-0931-01A-01D-0399-01	NA	NA	NA	TCGA-10-0931-01A-01W-0420-08	TCGA-10-0931-01	NA	NA	TCGA-10-0931-01A-01W-0420-08	TCGA-10-0931-01A-01R-0406-07	
TCGA-10-0933-01	1	TCGA-10-0933-01	446	1	days	High	C9-OV	UCEC Serous c4	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0933	NA	NA	days	446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-10-0933-F24454	TCGA-10-0933	TCGA-10-0933-01A	Stage IIIC	-28433	NA	446	0	356	NA	356	1	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-10-0933.f973309d-55dd-489b-a7ca-9348666a9129.pdf	0933	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	10	No Macroscopic disease	Ovary	NA	A	DECEASED	2003	NA	TCGA-10-0933-01	NA	99221367-1f21-45c5-944f-f734178e1468	NA	TCGA-10-0933-01	NA	TCGA-10-0933-01A-01D-0402-05	TCGA-10-0933-01A-01W-0421-09	TCGA-10-0933-01A-21-20	TCGA-10-0933-01A-01W-0421-09	NA	TCGA-10-0933-01A-01D-0399-01	TCGA-10-0933-01	7c7459b2-2a24-4866-a4fc-e960ef606d39	NA	TCGA-10-0933-01A-01D-0399-01	NA	NA	NA	NA	TCGA-10-0933-01	NA	NA	TCGA-10-0933-01A-01W-0421-09	TCGA-10-0933-01A-01R-0406-07	
TCGA-10-0934-01	1	TCGA-10-0934-01	204	1	days	High	NA	UCEC non-CIMP c3	NA	NA	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-10-0934	NA	NA	days	204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-10-0934-F24458	TCGA-10-0934	NA	Stage IIIC	-18602	NA	204	0	119	NA	111	NA	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	NA	0934	NA	WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO	NA	Primary Tumor	01	NA	NA	NA	10	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	NA	NA	cb990c79-c1bf-45d1-88ff-04a916bf3a16	NA	NA	NA	TCGA-10-0934-01A-02D-0402-05	NA	NA	NA	NA	TCGA-10-0934-01A-02D-0399-01	TCGA-10-0934-01	NA	NA	TCGA-10-0934-01A-02D-0399-01	NA	NA	NA	TCGA-10-0934-01A-02W-0420-08	TCGA-10-0934-01	NA	NA	TCGA-10-0934-01A-02W-0420-08	TCGA-10-0934-01A-02R-0406-07	
TCGA-10-0935-01	1	TCGA-10-0935-01	1078	1	days	BRCA-LUAD+	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 5	TCGA-10-0935	NA	NA	days	1078	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	68	Bilateral	TCGA-10-0935-F24462	TCGA-10-0935	NA	Stage IIIC	-25098	NA	1078	0	1078	NA	NA	NA	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	0935	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	10	1-10 mm	Ovary	YES	NA	DECEASED	2003	NA	NA	NA	da4b7cf0-830b-42de-9bd5-fa065c331362	NA	NA	NA	TCGA-10-0935-01A-03D-0402-05	TCGA-10-0935-01A-03W-0421-09	NA	TCGA-10-0935-01A-03W-0421-09	NA	TCGA-10-0935-01A-03D-0399-01	TCGA-10-0935-01	NA	NA	TCGA-10-0935-01A-03D-0399-01	NA	NA	NA	NA	TCGA-10-0935-01	NA	NA	TCGA-10-0935-01A-03W-0421-09	TCGA-10-0935-01A-02R-0406-07	
TCGA-10-0936-01	1	TCGA-10-0936-01	1123	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 2	NA	TCGA-10-0936	NA	NA	days	1123	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	69	Bilateral	TCGA-10-0936-F24466	TCGA-10-0936	TCGA-10-0936-01A	Stage IIIC	-25454	NA	1123	0	1089	NA	NA	0	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-10-0936.6b9a13e4-760e-476f-a0a7-fb42ab7c63c5.pdf	0936	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	10	>20 mm	Ovary	NA	A	DECEASED	2005	TCGA-10-0936-01	TCGA-10-0936-01	NA	8492ae5a-2139-4159-8b99-133e01b12568	NA	TCGA-10-0936-01	NA	TCGA-10-0936-01A-01D-0402-05	NA	TCGA-10-0936-01A-21-20	NA	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	TCGA-10-0936-01A-01D-0399-01	TCGA-10-0936-01	5e8ac787-50cc-45ea-9fc4-efe67b6d05ff	NA	TCGA-10-0936-01A-01D-0399-01	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	NA	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	NA	TCGA-10-0936-01	TCGA-10-0936-01	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	NA	TCGA-10-0936-01A-01R-0406-07	
TCGA-10-0937-01	1	TCGA-10-0937-01	608	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0937	NA	NA	days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-10-0937-F24476	TCGA-10-0937	NA	Stage IIIC	-16222	NA	608	0	460	NA	235	0	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0937	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	10	1-10 mm	Ovary	NA	NA	DECEASED	2005	NA	NA	TCGA-10-0937-01A-02W-0419-10	a104dfcb-8b29-4ab3-99ad-9ccbac4b2d4d	NA	NA	TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01A-02D-0402-05	NA	NA	NA	NA	TCGA-10-0937-01A-02D-0399-01	TCGA-10-0937-01	NA	NA	TCGA-10-0937-01A-02D-0399-01	NA	NA	NA	NA	TCGA-10-0937-01	NA	NA	TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01A-02R-0406-07	
TCGA-10-0938-01	1	TCGA-10-0938-01	636	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0938	NA	NA	days	636	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	80	Bilateral	TCGA-10-0938-F24483	TCGA-10-0938	TCGA-10-0938-01A	Stage IIIC	-29558	NA	636	0	604	NA	362	2	NA	NA	2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	0.6	NO	NA	1	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92.pdf	0938	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	10	>20 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-10-0938-01	TCGA-10-0938-01A-02W-0419-10	02e1cf40-826f-451a-bb3c-a3c7c94e8104	NA	TCGA-10-0938-01	TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01A-02D-0402-05	NA	NA	NA	NA	TCGA-10-0938-01A-02D-0399-01	TCGA-10-0938-01	NA	NA	TCGA-10-0938-01A-02D-0399-01	NA	NA	NA	NA	TCGA-10-0938-01	NA	NA	TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01A-02R-0406-07	
TCGA-13-0714-01	1	TCGA-13-0714-01	189	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0714	NA	NA	days	189	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-0714-F24489	TCGA-13-0714	TCGA-13-0714-01A	Stage IV	-20109	NA	189	0	189	NA	110	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	80	1.2	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-13-0714.96EB4BD1-CE3B-44D8-8095-076712A3E082.pdf	0714	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2000	NA	TCGA-13-0714-01	TCGA-13-0714-01A-01W-0370-10	408156df-a8fa-4068-9b87-f92bd60ca873	NA	TCGA-13-0714-01	TCGA-13-0714-01A-01W-0370-10	TCGA-13-0714-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0714-01A-01D-0356-01	TCGA-13-0714-01	NA	NA	TCGA-13-0714-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0714-01	NA	NA	TCGA-13-0714-01A-01W-0370-10	NA	TCGA-13-0714-01A-01R-0363-07
TCGA-13-0717-01	1	TCGA-13-0717-01	748	1	days	High	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 8	TCGA-13-0717	NA	NA	days	748	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-13-0717-F24494	TCGA-13-0717	NA	Stage IIIC	-20042	NA	748	0	748	NA	294	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0717	NA	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	NA	NA	NA	13	>20 mm	Ovary	NA	NA	DECEASED	2000	NA	NA	TCGA-13-0717-01A-01W-0370-10	d6012831-3668-402e-8be1-849c011767a6	NA	NA	TCGA-13-0717-01A-01W-0370-10	TCGA-13-0717-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0717-01A-01D-0356-01	TCGA-13-0717-01	NA	NA	TCGA-13-0717-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0717-01	NA	NA	TCGA-13-0717-01A-01W-0370-10	NA	TCGA-13-0717-01A-01R-0363-07
TCGA-13-0720-01	1	TCGA-13-0720-01	1355	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-13-0720	NA	NA	days	1355	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-0720-F24498	TCGA-13-0720	TCGA-13-0720-01A	Stage IIIC	-17799	NA	1355	0	1355	NA	292	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	80	8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0720.0A196866-A083-40AC-90E3-5ECA3B141645.pdf	0720	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-13-0720-01	TCGA-13-0720-01A-01W-0370-10	595dacaa-2763-4482-998c-eb748907f146	NA	TCGA-13-0720-01	TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01A-01D-0359-05	NA	TCGA-13-0720-01A-21-20	NA	NA	TCGA-13-0720-01A-01D-0356-01	TCGA-13-0720-01	5864cd1e-a0da-4553-b12b-75f8941ecbab	NA	TCGA-13-0720-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0720-01	NA	NA	TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01A-01R-0363-07	
TCGA-13-0723-01	1	TCGA-13-0723-01	1204	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-0723	NA	NA	days	1204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	63	Bilateral	TCGA-13-0723-F24503	TCGA-13-0723	TCGA-13-0723-01A	Stage IIIC	-23094	NA	1204	0	1204	NA	210	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.3	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-13-0723.0A628FDD-EDDF-48BA-A083-8E2676DD9B5C.pdf	0723	NA	WITH TUMOR	YES	Progressive Disease	Molecular Markers	NO	NA	Primary Tumor	01	0.3	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-0723-01	NA	95906f3c-8c5d-4eb9-8183-a444efde2a18	NA	TCGA-13-0723-01	NA	TCGA-13-0723-01A-02D-0359-05	TCGA-13-0723-01A-02W-0372-09	NA	TCGA-13-0723-01A-02W-0372-09	NA	TCGA-13-0723-01A-02D-0356-01	TCGA-13-0723-01	NA	NA	TCGA-13-0723-01A-02D-0356-01	NA	NA	NA	NA	TCGA-13-0723-01	NA	NA	TCGA-13-0723-01A-02W-0372-09	NA	TCGA-13-0723-01A-02R-0363-07
TCGA-13-0724-01	1	TCGA-13-0724-01	83	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0724	NA	NA	days	83	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Right	TCGA-13-0724-F24507	TCGA-13-0724	NA	Stage IV	-26342	NA	83	0	83	NA	83	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	NA	NA	80	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	0724	Preoperative	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2002	NA	TCGA-13-0724-01	NA	fb6ffde7-3b9f-4f28-845c-e2bb245db90b	NA	TCGA-13-0724-01	NA	TCGA-13-0724-01A-01D-0359-05	TCGA-13-0724-01A-01W-0372-09	NA	TCGA-13-0724-01A-01W-0372-09	NA	TCGA-13-0724-01A-01D-0356-01	TCGA-13-0724-01	NA	NA	TCGA-13-0724-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0724-01	NA	NA	TCGA-13-0724-01A-01W-0372-09	NA	TCGA-13-0724-01A-01R-0363-07
TCGA-13-0725-01	1	TCGA-13-0725-01	377	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	NA	TCGA-13-0725	NA	NA	days	377	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-13-0725-F24510	TCGA-13-0725	TCGA-13-0725-01A	Stage IIIC	-16086	NA	377	0	377	NA	190	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0725.A6CD74F2-47A0-4790-BB81-6C636DA16ADC.pdf	0725	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-0725-01	NA	c030245e-982a-40d5-a03d-c7896105b062	NA	TCGA-13-0725-01	NA	TCGA-13-0725-01A-01D-0359-05	NA	TCGA-13-0725-01A-21-20	NA	NA	TCGA-13-0725-01A-01D-0356-01	TCGA-13-0725-01	6701705e-cbfb-4af1-b1ab-898298de7c02	NA	TCGA-13-0725-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0725-01	NA	NA	NA	NA	TCGA-13-0725-01A-01R-0363-07
TCGA-13-0726-01	1	TCGA-13-0726-01	949	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0726	NA	NA	days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-0726-F24515	TCGA-13-0726	NA	Stage IIIC	-20134	NA	949	0	946	NA	392	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	GX	Recurrence	NA	NA	NA	NA	NA	0726	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2002	NA	TCGA-13-0726-01	NA	ec64c4e0-8c79-4161-bc31-56abd101de2c	NA	TCGA-13-0726-01	NA	TCGA-13-0726-01A-01D-0359-05	TCGA-13-0726-01A-01W-0372-09	NA	TCGA-13-0726-01A-01W-0372-09	NA	TCGA-13-0726-01A-01D-0356-01	TCGA-13-0726-01	NA	NA	TCGA-13-0726-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0726-01	NA	NA	TCGA-13-0726-01A-01W-0372-09	NA	TCGA-13-0726-01A-01R-0363-07
TCGA-13-0727-01	1	TCGA-13-0727-01	462	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-13-0727	NA	NA	days	462	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-0727-F24519	TCGA-13-0727	NA	Stage IIIC	-26185	NA	462	0	462	NA	253	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0727	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-13-0727-01	TCGA-13-0727-01A-01W-0370-10	ccf2280b-6308-40ad-bf39-f222aa67a91b	NA	TCGA-13-0727-01	TCGA-13-0727-01A-01W-0370-10	TCGA-13-0727-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0727-01A-01D-0356-01	TCGA-13-0727-01	NA	NA	TCGA-13-0727-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0727-01	NA	NA	TCGA-13-0727-01A-01W-0370-10	NA	TCGA-13-0727-01A-01R-0363-07
TCGA-13-0730-01	1	TCGA-13-0730-01	542	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0730	NA	NA	days	542	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Bilateral	TCGA-13-0730-F60695	TCGA-13-0730	TCGA-13-0730-01A	Stage IIIC	-26086	NA	542	0	NA	NA	NA	NA	Scheduled Follow-up Submission	NA	2014-6-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	0.6	NO	NA	1.1	NO	NA	G3	NA	NA	NA	NA	NA	TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf	0730	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2003	TCGA-13-0730-01	TCGA-13-0730-01	TCGA-13-0730-01A-01W-0370-10	1bd423e8-af33-4277-8ded-7d8c3f675f4b	NA	TCGA-13-0730-01	TCGA-13-0730-01A-01W-0370-10	TCGA-13-0730-01A-01D-0359-05	NA	NA	NA	754dfe07-22f4-4070-bbcb-10bfbb649def	TCGA-13-0730-01A-01D-0356-01	TCGA-13-0730-01	NA	NA	TCGA-13-0730-01A-01D-0356-01	754dfe07-22f4-4070-bbcb-10bfbb649def	NA	754dfe07-22f4-4070-bbcb-10bfbb649def	NA	TCGA-13-0730-01	TCGA-13-0730-01	754dfe07-22f4-4070-bbcb-10bfbb649def	TCGA-13-0730-01A-01W-0370-10	NA	TCGA-13-0730-01A-01R-0363-07
TCGA-13-0751-01	1	TCGA-13-0751-01	1678	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0751	NA	NA	days	1678	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-13-0751-F24525	TCGA-13-0751	TCGA-13-0751-01A	Stage IIIC	-16304	NA	1678	0	1678	NA	653	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	GX	Recurrence	NA	NA	NA	NA	TCGA-13-0751.61280768-69DF-4601-BED6-E78C1F82E5BC.pdf	0751	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	1999	NA	TCGA-13-0751-01	NA	625f1703-3f6c-4434-b30d-8bf174c438d7	NA	TCGA-13-0751-01	NA	TCGA-13-0751-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0751-01A-01D-0356-01	TCGA-13-0751-01	NA	NA	TCGA-13-0751-01A-01D-0356-01	NA	NA	NA	TCGA-13-0751-01A-01D-0446-08	TCGA-13-0751-01	NA	NA	TCGA-13-0751-01	TCGA-13-0751-01A-01R-0363-07	
TCGA-13-0755-01	1	TCGA-13-0755-01	76	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-0755	NA	NA	days	76	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	75	Bilateral	TCGA-13-0755-F24531	TCGA-13-0755	NA	Stage IV	-27438	NA	76	0	76	NA	34	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	40	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	0755	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-13-0755-01	NA	b14fdd08-b406-4db3-ac74-d1fdb6b213a2	NA	TCGA-13-0755-01	NA	TCGA-13-0755-01A-01D-0359-05	TCGA-13-0755-01A-01W-0372-09	NA	TCGA-13-0755-01A-01W-0372-09	NA	TCGA-13-0755-01A-01D-0356-01	TCGA-13-0755-01	NA	NA	TCGA-13-0755-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0755-01	NA	NA	TCGA-13-0755-01A-01W-0372-09	TCGA-13-0755-01A-01R-0363-07	
TCGA-13-0757-01	1	TCGA-13-0757-01	340	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-13-0757	NA	NA	days	340	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-0757-F24534	TCGA-13-0757	TCGA-13-0757-01A	Stage IIIC	-25999	NA	340	0	340	NA	293	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	60	0.9	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0757.81F1B0FB-CEB7-4313-AA0D-71DA495AEABE.pdf	0757	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2005	NA	TCGA-13-0757-01	NA	69337aad-1fe3-4b0e-943e-ca5ac6dc6076	NA	TCGA-13-0757-01	NA	TCGA-13-0757-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0757-01A-01D-0356-01	TCGA-13-0757-01	NA	NA	TCGA-13-0757-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0757-01	NA	NA	NA	NA	TCGA-13-0757-01A-01R-0363-07
TCGA-13-0758-01	1	TCGA-13-0758-01	346	1	days	Squamous	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-13-0758	NA	NA	days	346	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-13-0758-F24539	TCGA-13-0758	TCGA-13-0758-01A	Stage IV	-22088	NA	346	0	346	NA	212	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	60	1.3	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-13-0758.37B557BB-D2C4-42A9-B224-F1DFFC9B8FE3.pdf	0758	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2005	NA	NA	NA	4d8ca9f7-21f4-49d8-b985-53a096e48428	NA	NA	NA	TCGA-13-0758-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0758-01A-01D-0356-01	TCGA-13-0758-01	NA	NA	TCGA-13-0758-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0758-01	NA	NA	NA	NA	TCGA-13-0758-01A-01R-0363-07
TCGA-13-0760-01	1	TCGA-13-0760-01	351	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0760	NA	NA	days	351	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-13-0760-F24543	TCGA-13-0760	NA	Stage IV	-23036	NA	351	0	351	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	0760	Pre-Adjuvant Therapy	NA	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	NA	DECEASED	2006	NA	TCGA-13-0760-01	NA	NA	NA	TCGA-13-0760-01	NA	TCGA-13-0760-01A-01D-0359-05	TCGA-13-0760-01A-01W-0372-09	NA	TCGA-13-0760-01A-01W-0372-09	NA	TCGA-13-0760-01A-01D-0356-01	TCGA-13-0760-01	NA	NA	TCGA-13-0760-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0760-01	NA	NA	TCGA-13-0760-01A-01W-0372-09	NA	TCGA-13-0760-01A-01R-0363-07
TCGA-13-0761-01	1	TCGA-13-0761-01	1156	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-13-0761	424	1	days	1156	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-13-0761-F72596	TCGA-13-0761	TCGA-13-0761-01A	Stage IV	-18697	NA	1156	0	1036	NA	424	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0761.9609319A-2534-4753-9C71-3F59BFD20F15.pdf	0761	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-0761-01	TCGA-13-0761-01A-01W-0370-10	31361f65-a9de-4272-9de7-d884d15db3f0	NA	TCGA-13-0761-01	TCGA-13-0761-01A-01W-0370-10	TCGA-13-0761-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0761-01A-01D-0356-01	TCGA-13-0761-01	NA	NA	TCGA-13-0761-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0761-01	NA	NA	TCGA-13-0761-01A-01W-0370-10	NA	TCGA-13-0761-01A-01R-0363-07
TCGA-13-0762-01	0	TCGA-13-0762-01	3400	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-13-0762	1003	1	days	3400	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	Bilateral	TCGA-13-0762-F72597	TCGA-13-0762	NA	Stage IIIC	-23960	NA	NA	0	3400	NA	1003	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	0762	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	NA	LIVING	2006	NA	TCGA-13-0762-01	TCGA-13-0762-01A-01W-0370-10	f33f5749-bed4-403d-b311-176f59fb32bc	NA	TCGA-13-0762-01	TCGA-13-0762-01A-01W-0370-10	TCGA-13-0762-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0762-01A-01D-0356-01	TCGA-13-0762-01	NA	NA	TCGA-13-0762-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0762-01	NA	NA	TCGA-13-0762-01A-01W-0370-10	NA	TCGA-13-0762-01A-01R-0363-07
TCGA-13-0764-01	1	TCGA-13-0764-01	1881	1	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-13-0764	272	1	days	1881	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-13-0764-F72599	TCGA-13-0764	NA	Stage IV	-22965	NA	1881	0	944	NA	272	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	0764	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2006	NA	NA	NA	b72f0610-8aaa-48ac-afed-333e5f4159cd	NA	NA	NA	TCGA-13-0764-01A-03D-0359-05	NA	NA	NA	NA	TCGA-13-0764-01A-03D-0356-01	TCGA-13-0764-01	NA	NA	TCGA-13-0764-01A-03D-0356-01	NA	NA	NA	NA	TCGA-13-0764-01	NA	NA	NA	NA	TCGA-13-0764-01A-03R-0363-07
TCGA-13-0765-01	1	TCGA-13-0765-01	1389	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0765	668	1	days	1389	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-13-0765-F72600	TCGA-13-0765	TCGA-13-0765-01A	Stage IIIC	-18574	NA	1389	0	869	NA	668	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0765.96588189-C273-4095-88C5-9E22368813C0.pdf	0765	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-0765-01	NA	17962695-e9c2-45f2-b4a2-00b7bfd1ffd6	NA	TCGA-13-0765-01	NA	TCGA-13-0765-01A-01D-0359-05	TCGA-13-0765-01A-01W-0372-09	NA	TCGA-13-0765-01A-01W-0372-09	NA	NA	TCGA-13-0765-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-0765-01A-01W-0372-09	TCGA-13-0765-01A-01R-0363-07	
TCGA-13-0766-01	1	TCGA-13-0766-01	1725	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-13-0766	628	1	days	1725	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	42	Bilateral	TCGA-13-0766-F72601	TCGA-13-0766	TCGA-13-0766-01A	Stage IIIC	-15571	NA	1725	0	651	NA	628	NA	NA	NA	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.7	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0766.7F283E4B-70F9-4834-866C-B91024C74EA3.pdf	0766	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-0766-01	NA	2b1e48b5-b8f4-4f57-8089-8293f470f466	NA	TCGA-13-0766-01	NA	TCGA-13-0766-01A-02D-0359-05	NA	NA	NA	NA	TCGA-13-0766-01A-02D-0356-01	TCGA-13-0766-01	NA	NA	TCGA-13-0766-01A-02D-0356-01	NA	NA	NA	NA	TCGA-13-0766-01	NA	NA	NA	TCGA-13-0766-01A-02R-0363-07	
TCGA-13-0768-01	1	TCGA-13-0768-01	1784	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 3	cluster 5	NA	TCGA-13-0768	398	1	days	1784	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-13-0768-F72603	TCGA-13-0768	TCGA-13-0768-01A	Stage IIIC	-26999	NA	1784	0	257	NA	398	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	60	0.8	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0768.7D67D0D3-105C-4A00-B104-106BE26FEE2D.pdf	0768	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-0768-01	NA	282e4c72-a430-4a70-9393-c259a90d9ee3	NA	TCGA-13-0768-01	NA	TCGA-13-0768-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0768-01A-01D-0356-01	TCGA-13-0768-01	NA	NA	TCGA-13-0768-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0768-01	NA	NA	NA	NA	TCGA-13-0768-01A-01R-0363-07
TCGA-13-0791-01	1	TCGA-13-0791-01	1224	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0791	281	1	days	1224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-0791-F72604	TCGA-13-0791	TCGA-13-0791-01A	Stage IIIC	-21380	NA	1224	0	1184	NA	281	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	80	1.8	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0791.BDF98098-6E0F-4387-9C2C-30CF1812073A.pdf	0791	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2005	NA	TCGA-13-0791-01	NA	7290ea9e-baf6-4777-b512-ab1da9bf62cd	NA	TCGA-13-0791-01	NA	TCGA-13-0791-01A-01D-0359-05	TCGA-13-0791-01A-01W-0372-09	NA	TCGA-13-0791-01A-01W-0372-09	NA	TCGA-13-0791-01A-01D-0356-01	TCGA-13-0791-01	NA	NA	TCGA-13-0791-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0791-01	NA	NA	TCGA-13-0791-01A-01W-0372-09	NA	TCGA-13-0791-01A-01R-0363-07
TCGA-13-0791-02	1	TCGA-13-0791-02	1224	1	days	NA	NA	OV-like c1	NA	NA	miRNA cluster 2	NA	mutation cluster 5	TCGA-13-0791	281	1	days	1224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-0791-F72604	TCGA-13-0791	TCGA-13-0791-02A	Stage IIIC	-21380	NA	1224	0	1184	NA	281	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	80	1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0791.60B0A7B2-179E-47CE-908C-A1360EA6BB6B.pdf	0791	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Recurrent Tumor	02	0.1	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2005	NA	TCGA-13-0791-02	NA	3038dbe5-a4fd-4ebf-b582-503b3041822b	NA	TCGA-13-0791-02	NA	TCGA-13-0791-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-0791-02A-01R-0810-07	
TCGA-13-0792-01	0	TCGA-13-0792-01	3602	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0792	816	1	days	3602	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	40	Bilateral	TCGA-13-0792-F72605	TCGA-13-0792	TCGA-13-0792-01A	Stage IIIC	-14729	NA	NA	0	3602	NA	816	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	80	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0792.3FBB8BEC-64D0-4AC8-9E15-C8FA9627E451.pdf	0792	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2005	NA	TCGA-13-0792-01	TCGA-13-0792-01A-01W-0370-10	3a6c89bc-5db4-4816-b7f4-d77cf1d8eb0b	NA	TCGA-13-0792-01	TCGA-13-0792-01A-01W-0370-10	TCGA-13-0792-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0792-01A-01D-0356-01	TCGA-13-0792-01	NA	NA	TCGA-13-0792-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0792-01	NA	NA	TCGA-13-0792-01A-01W-0370-10	NA	TCGA-13-0792-01A-01R-0363-07
TCGA-13-0793-01	0	TCGA-13-0793-01	3263	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0793	351	1	days	3263	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	40	Left	TCGA-13-0793-F72606	TCGA-13-0793	TCGA-13-0793-01A	Stage IV	-14708	NA	NA	0	3263	NA	351	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	80	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0793.43781B94-0865-4824-94B9-1476AC2F8677.pdf	0793	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2006	NA	TCGA-13-0793-01	TCGA-13-0793-01A-01W-0370-10	447c38c0-ac42-4a58-ad55-c1c68258cdf4	NA	TCGA-13-0793-01	TCGA-13-0793-01A-01W-0370-10	TCGA-13-0793-01A-01D-0359-05	NA	TCGA-13-0793-01A-03-20	NA	NA	TCGA-13-0793-01A-01D-0356-01	TCGA-13-0793-01	7a9e7c44-9e41-4f1c-bf87-3faa086b0306	NA	TCGA-13-0793-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0793-01	NA	NA	TCGA-13-0793-01A-01W-0370-10	NA	TCGA-13-0793-01A-01R-0363-07
TCGA-13-0794-01	1	TCGA-13-0794-01	1919	1	days	BRCA-LUAD+	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	NA	TCGA-13-0794	845	1	days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-13-0794-F72607	TCGA-13-0794	NA	Stage IIIC	-21945	NA	1919	0	923	NA	845	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	60	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	0794	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2006	NA	TCGA-13-0794-01	NA	c9dd6b81-e436-410c-abe3-aefea5b82103	NA	TCGA-13-0794-01	NA	TCGA-13-0794-01A-01D-0359-05	NA	TCGA-13-0794-01A-03-20	NA	NA	TCGA-13-0794-01A-01D-0356-01	TCGA-13-0794-01	fde6d311-beb0-4efa-92af-36b426444dd4	NA	TCGA-13-0794-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0794-01	NA	NA	NA	NA	TCGA-13-0794-01A-01R-0363-07
TCGA-13-0795-01	1	TCGA-13-0795-01	619	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-0795	325	1	days	619	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Bilateral	TCGA-13-0795-F72608	TCGA-13-0795	TCGA-13-0795-01A	Stage IIIC	-24403	NA	619	0	596	NA	325	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	0.9	NO	80	1.4	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0795.B98206EC-73D1-404F-B497-BAD6C817D9B7.pdf	0795	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2007	NA	TCGA-13-0795-01	NA	8a90ef9c-f444-4bff-92df-7356ec1c07ad	NA	TCGA-13-0795-01	NA	TCGA-13-0795-01A-01D-0359-05	TCGA-13-0795-01A-01W-0372-09	NA	TCGA-13-0795-01A-01W-0372-09	NA	TCGA-13-0795-01A-01D-0356-01	TCGA-13-0795-01	NA	NA	TCGA-13-0795-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0795-01	NA	NA	TCGA-13-0795-01A-01W-0372-09	NA	TCGA-13-0795-01A-01R-0363-07
TCGA-13-0797-01	0	TCGA-13-0797-01	2121	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	NA	TCGA-13-0797	525	1	days	2121	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-13-0797-F72609	TCGA-13-0797	TCGA-13-0797-01A	Stage IIIC	-18051	NA	NA	0	2121	NA	525	NA	NA	Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	80	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0797.84ED21CA-E018-44C5-86E4-57927ABBCC9A.pdf	0797	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-13-0797-01	NA	9efea7f4-e521-4520-8abb-c764fa2a6a8c	NA	TCGA-13-0797-01	NA	TCGA-13-0797-01A-01D-0359-05	NA	TCGA-13-0797-01A-03-20	NA	NA	TCGA-13-0797-01A-01D-0356-01	TCGA-13-0797-01	0a64d08c-7d28-4c74-ab75-2ff02f1a4de0	NA	TCGA-13-0797-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0797-01	NA	NA	NA	TCGA-13-0797-01A-01R-0363-07	
TCGA-13-0799-01	0	TCGA-13-0799-01	2535	0	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-13-0799	1262	1	days	2535	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	44	Bilateral	TCGA-13-0799-F72611	TCGA-13-0799	TCGA-13-0799-01A	Stage IIIC	-16171	NA	NA	0	2535	NA	1262	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	80	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0799.CBB83CF3-9846-409B-858B-C8A7E74CDFF1.pdf	0799	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2008	TCGA-13-0799-01	TCGA-13-0799-01	NA	1197c1db-5ef3-475a-bbdb-c81da71b6ccf	NA	TCGA-13-0799-01	NA	TCGA-13-0799-01A-01D-0359-05	NA	TCGA-13-0799-01A-03-1562-20	NA	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	TCGA-13-0799-01A-01D-0356-01	TCGA-13-0799-01	c91f1247-0579-4c10-8da1-2d62d276e58e	NA	TCGA-13-0799-01A-01D-0356-01	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	NA	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	NA	TCGA-13-0799-01	TCGA-13-0799-01	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	NA	TCGA-13-0799-01A-01R-0363-07	
TCGA-13-0800-01	0	TCGA-13-0800-01	2661	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 3	TCGA-13-0800	1396	1	days	2661	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-13-0800-F72612	TCGA-13-0800	TCGA-13-0800-01A	Stage IIIC	-19087	NA	NA	0	2661	NA	1396	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0800.E3206F00-3BC6-44B4-848E-F2ED70E094BD.pdf	0800	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2008	TCGA-13-0800-01	TCGA-13-0800-01	NA	b637c4e1-2685-4843-9d5f-f63db155b468	NA	TCGA-13-0800-01	NA	TCGA-13-0800-01A-01D-0359-05	TCGA-13-0800-01A-01W-0372-09	TCGA-13-0800-01A-03-1562-20	TCGA-13-0800-01A-01W-0372-09	cd93531b-4d92-4be3-95e5-032636dd1ad8	TCGA-13-0800-01A-01D-0356-01	TCGA-13-0800-01	81737798-92c9-46d7-a85c-751fc5b102e8	NA	TCGA-13-0800-01A-01D-0356-01	cd93531b-4d92-4be3-95e5-032636dd1ad8	NA	cd93531b-4d92-4be3-95e5-032636dd1ad8	NA	TCGA-13-0800-01	TCGA-13-0800-01	cd93531b-4d92-4be3-95e5-032636dd1ad8	TCGA-13-0800-01A-01W-0372-09	NA	TCGA-13-0800-01A-01R-0363-07
TCGA-13-0801-01	1	TCGA-13-0801-01	1399	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-13-0801	345	1	days	1399	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Bilateral	TCGA-13-0801-F72613	TCGA-13-0801	TCGA-13-0801-01A	Stage IIIC	-16812	NA	1399	0	252	NA	345	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	80	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0801.FA63535E-7499-41E3-AFB1-98EB18DA7371.pdf	0801	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2008	TCGA-13-0801-01	TCGA-13-0801-01	TCGA-13-0801-01A-01W-0370-10	98d97019-658a-4493-bea0-5c571e196889	NA	TCGA-13-0801-01	TCGA-13-0801-01A-01W-0370-10	TCGA-13-0801-01A-01D-0359-05	NA	TCGA-13-0801-01A-03-20	NA	c51dee3c-5047-4dde-b454-2474de5cf025	TCGA-13-0801-01A-01D-0356-01	TCGA-13-0801-01	1c4d4161-a528-4601-b512-eb2d5ed8d992	NA	TCGA-13-0801-01A-01D-0356-01	c51dee3c-5047-4dde-b454-2474de5cf025	NA	c51dee3c-5047-4dde-b454-2474de5cf025	NA	TCGA-13-0801-01	TCGA-13-0801-01	c51dee3c-5047-4dde-b454-2474de5cf025	NA	NA	TCGA-13-0801-01A-01R-0363-07
TCGA-13-0802-01	1	TCGA-13-0802-01	1552	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	NA	TCGA-13-0802	510	1	days	1552	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	79	Bilateral	TCGA-13-0802-F72615	TCGA-13-0802	NA	Stage IIIC	-29075	NA	1552	0	249	NA	510	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	60	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	0802	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	NA	DECEASED	2008	NA	TCGA-13-0802-01	TCGA-13-0802-01A-01W-0370-10	eb96b8fd-6402-434d-9b98-bfa40b4be522	NA	TCGA-13-0802-01	TCGA-13-0802-01A-01W-0370-10	TCGA-13-0802-01A-01D-0359-05	NA	TCGA-13-0802-01A-03-1562-20	NA	NA	TCGA-13-0802-01A-01D-0356-01	TCGA-13-0802-01	e8448d63-f837-4512-89bf-06201938b152	NA	TCGA-13-0802-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0802-01	NA	NA	NA	NA	TCGA-13-0802-01A-01R-0363-07
TCGA-13-0803-01	1	TCGA-13-0803-01	1334	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-13-0803	NA	NA	days	1334	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Bilateral	TCGA-13-0803-F24629	TCGA-13-0803	NA	Stage IIIC	-29685	NA	1334	0	1334	NA	337	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0803	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	NA	DECEASED	2001	NA	TCGA-13-0803-01	NA	f17806bc-e184-49dc-99aa-cd5547ebb032	NA	TCGA-13-0803-01	NA	TCGA-13-0803-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0803-01A-01D-0356-01	TCGA-13-0803-01	NA	NA	TCGA-13-0803-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0803-01	NA	NA	NA	NA	TCGA-13-0803-01A-01R-0363-07
TCGA-13-0804-01	1	TCGA-13-0804-01	1073	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0804	NA	NA	days	1073	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-13-0804-F24633	TCGA-13-0804	TCGA-13-0804-01A	Stage IIIC	-27021	NA	1073	0	1073	NA	329	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.3	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf	0804	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2003	NA	NA	NA	a7711b62-2471-4ee7-8461-279e9732e83b	NA	NA	NA	TCGA-13-0804-01A-01D-0359-05	TCGA-13-0804-01A-01W-0372-09	TCGA-13-0804-01A-03-20	TCGA-13-0804-01A-01W-0372-09	NA	TCGA-13-0804-01A-01D-0356-01	TCGA-13-0804-01	50ffbcf0-99c5-4528-bd60-8a054b3566a8	NA	TCGA-13-0804-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0804-01	NA	NA	TCGA-13-0804-01A-01W-0372-09	NA	TCGA-13-0804-01A-01R-0363-07
TCGA-13-0805-01	1	TCGA-13-0805-01	1074	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-13-0805	NA	NA	days	1074	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-13-0805-F24638	TCGA-13-0805	NA	Stage IIIC	-21014	NA	1074	0	1073	NA	177	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	0805	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2005	NA	TCGA-13-0805-01	NA	fbd0a639-044c-453b-a29c-3d914f431bd9	NA	TCGA-13-0805-01	NA	TCGA-13-0805-01A-01D-0359-05	NA	NA	NA	NA	TCGA-13-0805-01A-01D-0356-01	TCGA-13-0805-01	NA	NA	TCGA-13-0805-01A-01D-0356-01	NA	NA	NA	NA	TCGA-13-0805-01	NA	NA	NA	NA	TCGA-13-0805-01A-01R-0363-07
TCGA-13-0807-01	1	TCGA-13-0807-01	414	1	days	Squamous	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 5	TCGA-13-0807	NA	NA	days	414	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	NA	TCGA-13-0807-F24642	TCGA-13-0807	TCGA-13-0807-01B	Stage IIIC	-19890	NA	414	0	414	NA	NA	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-13-0807.E28B5574-1AC3-4E5E-BDD5-5B548E450F28.pdf	0807	NA	NA	YES	NA	NA	NO	R1	Primary Tumor	01	NA	NA	NA	13	>20 mm	Ovary	NA	B	DECEASED	2005	NA	NA	NA	8fee0dca-afdb-46a8-b7b3-e16ed7ba4e32	NA	NA	NA	TCGA-13-0807-01B-02D-0402-05	TCGA-13-0807-01B-02W-0421-09	NA	TCGA-13-0807-01B-02W-0421-09	NA	TCGA-13-0807-01B-02D-0399-01	TCGA-13-0807-01	NA	NA	TCGA-13-0807-01B-02D-0399-01	NA	NA	NA	NA	TCGA-13-0807-01	NA	NA	TCGA-13-0807-01B-02W-0421-09	TCGA-13-0807-01B-01R-0406-07	
TCGA-13-0883-01	1	TCGA-13-0883-01	2097	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0883	NA	NA	days	2097	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-13-0883-F24646	TCGA-13-0883	TCGA-13-0883-01A	Stage IIIC	-22395	NA	2097	0	2097	NA	819	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.1	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0883.7AC6471C-1BA0-4AA5-9A2E-70413C9768F8.pdf	0883	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-0883-01	NA	8b92a7da-e2b2-41c4-9ea2-8c3f87c2f5e9	NA	TCGA-13-0883-01	NA	TCGA-13-0883-01A-02D-0402-05	NA	NA	NA	NA	TCGA-13-0883-01A-02D-0399-01	TCGA-13-0883-01	NA	NA	TCGA-13-0883-01A-02D-0399-01	NA	NA	NA	TCGA-13-0883-01A-02W-0420-08	TCGA-13-0883-01	NA	NA	TCGA-13-0883-01A-02W-0420-08	TCGA-13-0883-01A-02R-0406-07	
TCGA-13-0884-01	1	TCGA-13-0884-01	3260	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0884	NA	NA	days	3260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	39	Bilateral	TCGA-13-0884-F24651	TCGA-13-0884	TCGA-13-0884-01B	Stage IIIC	-14538	NA	3260	0	3260	NA	1251	NA	NA	NA	2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.7	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0884.D15552F3-1407-4C01-9B59-DFAC5D4EF095.pdf	0884	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	B	DECEASED	1999	NA	TCGA-13-0884-01	NA	3b4e9ec5-9001-40af-8397-8802341611ad	NA	TCGA-13-0884-01	NA	TCGA-13-0884-01B-01D-0460-05	TCGA-13-0884-01B-01W-0494-09	TCGA-13-0884-01B-21-1562-20	TCGA-13-0884-01B-01W-0494-09	NA	TCGA-13-0884-01B-01D-0452-01	TCGA-13-0884-01	2185ae8b-2257-4cc5-b08d-cf91dffa760d	NA	TCGA-13-0884-01B-01D-0452-01	NA	NA	NA	NA	TCGA-13-0884-01	NA	NA	TCGA-13-0884-01B-01W-0494-09	TCGA-13-0884-01B-01R-0456-07	
TCGA-13-0885-01	0	TCGA-13-0885-01	3388	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0885	NA	NA	days	3388	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	70	Left	TCGA-13-0885-F72616	TCGA-13-0885	TCGA-13-0885-01A	Stage IIIC	-25763	NA	NA	0	3388	NA	NA	NA	NA	NA	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	80	1.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-13-0885.81DFFD49-45F0-4A20-AC27-B8316B2E0289.pdf	0885	Pre-Adjuvant Therapy	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	11-20 mm	Ovary	NA	A	LIVING	2000	NA	TCGA-13-0885-01	NA	22d268ea-7e43-46f4-8d1c-7a557d2f1664	NA	TCGA-13-0885-01	NA	TCGA-13-0885-01A-02D-0402-05	TCGA-13-0885-01A-02W-0421-09	NA	TCGA-13-0885-01A-02W-0421-09	NA	TCGA-13-0885-01A-02D-0399-01	TCGA-13-0885-01	NA	NA	TCGA-13-0885-01A-02D-0399-01	NA	NA	NA	NA	TCGA-13-0885-01	NA	NA	TCGA-13-0885-01A-02W-0421-09	TCGA-13-0885-01A-02R-0406-07	
TCGA-13-0886-01	0	TCGA-13-0886-01	4665	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0886	4665	0	days	4665	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-13-0886-F72617	TCGA-13-0886	TCGA-13-0886-01A	Stage IIIC	-24724	NA	NA	0	4665	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0886.2FB5824C-F30B-4E0B-B787-CBF93A6A48AE.pdf	0886	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2002	NA	TCGA-13-0886-01	NA	de22b463-bc0e-4f81-9a06-0e55353b1412	NA	TCGA-13-0886-01	NA	TCGA-13-0886-01A-01D-0402-05	NA	TCGA-13-0886-01A-21-20	NA	NA	TCGA-13-0886-01A-01D-0399-01	TCGA-13-0886-01	97f40569-5280-4c67-831d-dc8fa952e0f8	NA	TCGA-13-0886-01A-01D-0399-01	NA	NA	NA	TCGA-13-0886-01A-01W-0420-08	TCGA-13-0886-01	NA	NA	TCGA-13-0886-01A-01W-0420-08	TCGA-13-0886-01A-01R-0406-07	
TCGA-13-0887-01	1	TCGA-13-0887-01	2028	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0887	NA	NA	days	2028	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-13-0887-F24668	TCGA-13-0887	TCGA-13-0887-01A	Stage IIIC	-15669	NA	2028	0	2028	NA	514	NA	NA	NA	2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	80	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf	0887	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-0887-01	NA	3bc498df-2e02-4182-87f5-381fbde2f225	NA	TCGA-13-0887-01	NA	TCGA-13-0887-01A-01D-0402-05	TCGA-13-0887-01A-01W-0421-09	TCGA-13-0887-01A-21-20	TCGA-13-0887-01A-01W-0421-09	NA	TCGA-13-0887-01A-01D-0399-01	TCGA-13-0887-01	0226becf-0ff4-4457-a446-0ed079324b0d	NA	TCGA-13-0887-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0887-01	NA	NA	TCGA-13-0887-01A-01W-0421-09	TCGA-13-0887-01A-01R-0406-07	
TCGA-13-0888-01	1	TCGA-13-0888-01	2811	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	NA	TCGA-13-0888	2811	0	days	2811	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Right	TCGA-13-0888-F72618	TCGA-13-0888	TCGA-13-0888-01A	Stage IIIC	-28498	NA	2811	0	2141	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	80	1.2	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0888.DFDEBDE5-C16E-4B29-9986-8EB557648AC5.pdf	0888	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2003	NA	TCGA-13-0888-01	NA	2b24ddb3-3774-46ac-aa6f-48abfec30a81	NA	TCGA-13-0888-01	NA	TCGA-13-0888-01A-01D-0402-05	NA	TCGA-13-0888-01A-21-20	NA	NA	TCGA-13-0888-01A-01D-0399-01	TCGA-13-0888-01	bb0f85fb-5126-4934-89bc-39e1044dee03	NA	TCGA-13-0888-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0888-01	NA	NA	NA	TCGA-13-0888-01A-01R-0406-07	
TCGA-13-0889-01	1	TCGA-13-0889-01	2894	1	days	Squamous	NA	UCEC Serous c4	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0889	NA	NA	days	2894	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	75	Right	TCGA-13-0889-F72619	TCGA-13-0889	TCGA-13-0889-01A	Stage IV	-27674	NA	2894	0	1881	NA	NA	NA	NA	NA	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.5	NO	60	1.5	NA	NA	GX	NA	NA	NA	NA	NA	TCGA-13-0889.262B6A57-D2DF-47E3-BDB2-1FB956D8ABE9.pdf	0889	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2003	NA	TCGA-13-0889-01	TCGA-13-0889-01A-01W-0419-10	8f64648c-7481-4814-865a-c392da1968bd	NA	TCGA-13-0889-01	TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01A-01D-0402-05	NA	NA	NA	NA	TCGA-13-0889-01A-01D-0399-01	TCGA-13-0889-01	NA	NA	TCGA-13-0889-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0889-01	NA	NA	TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01A-01R-0406-07	
TCGA-13-0890-01	0	TCGA-13-0890-01	4424	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0890	4424	0	days	4424	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	Bilateral	TCGA-13-0890-F72620	TCGA-13-0890	TCGA-13-0890-01A	Stage IIIC	-20770	NA	NA	0	4424	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	1.5	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0890.78888517-0ADC-4A78-B7FA-9ACE201795AB.pdf	0890	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2003	TCGA-13-0890-01	TCGA-13-0890-01	NA	9b5c97b8-eba5-431b-96cc-c60f5ee91a62	NA	TCGA-13-0890-01	NA	TCGA-13-0890-01A-01D-0402-05	TCGA-13-0890-01A-01W-0421-09	NA	TCGA-13-0890-01A-01W-0421-09	65cc3a15-cfa9-48fb-b9e4-801398b073b8	TCGA-13-0890-01A-01D-0399-01	TCGA-13-0890-01	NA	NA	TCGA-13-0890-01A-01D-0399-01	65cc3a15-cfa9-48fb-b9e4-801398b073b8	NA	65cc3a15-cfa9-48fb-b9e4-801398b073b8	NA	TCGA-13-0890-01	TCGA-13-0890-01	65cc3a15-cfa9-48fb-b9e4-801398b073b8	TCGA-13-0890-01A-01W-0421-09	TCGA-13-0890-01A-01R-0406-07	
TCGA-13-0891-01	1	TCGA-13-0891-01	3128	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0891	762	1	days	3128	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-13-0891-F72621	TCGA-13-0891	TCGA-13-0891-01A	Stage IV	-26886	NA	3128	0	2099	NA	762	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1.2	NO	80	1.4	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0891.7DF79B3C-8CD7-446D-A13A-BBB69DFE2394.pdf	0891	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2003	NA	TCGA-13-0891-01	NA	7d27ea62-19e6-4032-9e7f-799be4d3eaef	NA	TCGA-13-0891-01	NA	TCGA-13-0891-01A-01D-0402-05	NA	TCGA-13-0891-01A-21-20	NA	NA	TCGA-13-0891-01A-01D-0399-01	TCGA-13-0891-01	f305890a-3b48-4e7b-8f31-f2653a5582b8	NA	TCGA-13-0891-01A-01D-0399-01	NA	NA	NA	TCGA-13-0891-01A-01W-0420-08	TCGA-13-0891-01	NA	NA	TCGA-13-0891-01A-01W-0420-08	TCGA-13-0891-01A-01R-0406-07	
TCGA-13-0893-01	1	TCGA-13-0893-01	1319	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-0893	NA	NA	days	1319	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-0893-F24690	TCGA-13-0893	TCGA-13-0893-01B	Stage IIIC	-17573	NA	1319	0	1319	NA	461	NA	NA	NA	2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E.pdf	0893	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	11-20 mm	Ovary	NA	B	DECEASED	2003	TCGA-13-0893-01	TCGA-13-0893-01	NA	901a306b-6a5b-4f94-aac0-6eb7c767bb2e	NA	TCGA-13-0893-01	NA	TCGA-13-0893-01B-01D-0460-05	TCGA-13-0893-01B-01W-0494-09	NA	TCGA-13-0893-01B-01W-0494-09	2b2d5fc7-b109-4d11-a632-db8016268840	TCGA-13-0893-01B-01D-0452-01	TCGA-13-0893-01	NA	NA	TCGA-13-0893-01B-01D-0452-01	2b2d5fc7-b109-4d11-a632-db8016268840	NA	2b2d5fc7-b109-4d11-a632-db8016268840	NA	TCGA-13-0893-01	TCGA-13-0893-01	2b2d5fc7-b109-4d11-a632-db8016268840	TCGA-13-0893-01B-01W-0494-09	TCGA-13-0893-01B-01R-0456-07	
TCGA-13-0894-01	1	TCGA-13-0894-01	1509	1	days	High	C9-OV	Low purity c2	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0894	NA	NA	days	1509	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-13-0894-F24695	TCGA-13-0894	TCGA-13-0894-01B	Stage IIIC	-19466	NA	1509	0	1509	NA	565	NA	NA	NA	2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.1	NO	80	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0894.305FFF39-3453-49A4-8ED6-0532C9119AF0.pdf	0894	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	B	DECEASED	2003	NA	TCGA-13-0894-01	NA	2f62cd27-7bac-44c6-baa8-7e8593962402	NA	TCGA-13-0894-01	NA	TCGA-13-0894-01B-01D-0460-05	TCGA-13-0894-01B-01W-0494-09	TCGA-13-0894-01B-03-1562-20	TCGA-13-0894-01B-01W-0494-09	NA	NA	TCGA-13-0894-01	7e63800a-f2db-4a2a-82ab-2867707caf14	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-0894-01B-01W-0494-09	TCGA-13-0894-01B-01R-0456-07	
TCGA-13-0897-01	1	TCGA-13-0897-01	2182	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0897	554	1	days	2182	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Right	TCGA-13-0897-F72622	TCGA-13-0897	TCGA-13-0897-01A	Stage IIIC	-19894	NA	2182	0	1748	NA	554	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.5	NO	80	1.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0897.058A5354-D36C-4398-AC2C-12447FDB0966.pdf	0897	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-13-0897-01	TCGA-13-0897-01	NA	5ae3b33e-162f-4784-b007-cce51fdcfa5e	NA	TCGA-13-0897-01	NA	TCGA-13-0897-01A-01D-0402-05	TCGA-13-0897-01A-01W-0421-09	TCGA-13-0897-01A-21-20	TCGA-13-0897-01A-01W-0421-09	479b74bf-5003-45e1-9505-687146a5fc45	TCGA-13-0897-01A-01D-0399-01	TCGA-13-0897-01	7a6431cb-6461-4534-89e9-fc15b639bfac	NA	TCGA-13-0897-01A-01D-0399-01	479b74bf-5003-45e1-9505-687146a5fc45	NA	479b74bf-5003-45e1-9505-687146a5fc45	NA	TCGA-13-0897-01	TCGA-13-0897-01	479b74bf-5003-45e1-9505-687146a5fc45	TCGA-13-0897-01A-01W-0421-09	TCGA-13-0897-01A-01R-0406-07	
TCGA-13-0899-01	1	TCGA-13-0899-01	2012	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0899	547	1	days	2012	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-13-0899-F72623	TCGA-13-0899	TCGA-13-0899-01A	Stage IIIC	-22031	NA	2012	0	1708	NA	547	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0899.AB15D325-CCD6-452F-8662-158E3153AFC4.pdf	0899	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-13-0899-01	TCGA-13-0899-01	NA	f5878d06-b37c-49fd-8a70-aaaaa270a14c	NA	TCGA-13-0899-01	NA	TCGA-13-0899-01A-01D-0402-05	NA	TCGA-13-0899-01A-21-20	NA	605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01D-0399-01	TCGA-13-0899-01	eacc42b9-bd6e-468c-8560-6d699ae97737	NA	TCGA-13-0899-01A-01D-0399-01	605d0aed-4637-4a09-82dd-eedd1aa76ca0	NA	605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01W-0420-08	TCGA-13-0899-01	TCGA-13-0899-01	605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01W-0420-08	TCGA-13-0899-01A-01R-0406-07	
TCGA-13-0900-01	0	TCGA-13-0900-01	4077	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 11	TCGA-13-0900	4077	0	days	4077	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-13-0900-F72637	TCGA-13-0900	TCGA-13-0900-01B	Stage IIIC	-21698	NA	NA	0	4077	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	60	1.5	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0900.27A4B579-9123-431C-95B6-FBC5CB5142C9.pdf	0900	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	13	NA	Ovary	NA	B	LIVING	2004	NA	TCGA-13-0900-01	TCGA-13-0900-01B-01W-0490-10	443f369f-d9cf-433a-a115-7934c20bf98a	NA	TCGA-13-0900-01	TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01B-01D-0460-05	NA	NA	NA	NA	TCGA-13-0900-01B-01D-0452-01	TCGA-13-0900-01	NA	NA	TCGA-13-0900-01B-01D-0452-01	NA	NA	NA	NA	TCGA-13-0900-01	NA	NA	TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01B-01R-0456-07	
TCGA-13-0901-01	0	TCGA-13-0901-01	589	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	NA	TCGA-13-0901	NA	NA	days	589	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Bilateral	TCGA-13-0901-F24712	TCGA-13-0901	TCGA-13-0901-01A	Stage IIIC	-15333	NA	NA	0	589	NA	390	NA	NA	NA	2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	80	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-0901.5613318C-D3D4-436D-B22F-BE8FC36D9686.pdf	0901	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	LIVING	2004	NA	TCGA-13-0901-01	TCGA-13-0901-01B-01W-0490-10	9a07f778-ddd0-4290-af0b-9cf85da4b123	NA	TCGA-13-0901-01	TCGA-13-0901-01B-01W-0490-10	TCGA-13-0901-01B-01D-0460-05	NA	TCGA-13-0901-01A-21-20	NA	NA	TCGA-13-0901-01B-01D-0452-01	TCGA-13-0901-01	0f0ae870-f5a7-4572-998d-d39403507fbe	NA	TCGA-13-0901-01B-01D-0452-01	NA	NA	NA	NA	TCGA-13-0901-01	NA	NA	NA	TCGA-13-0901-01B-01R-0456-07	
TCGA-13-0903-01	0	TCGA-13-0903-01	3887	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0903	3887	0	days	3887	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	42	Bilateral	TCGA-13-0903-F72624	TCGA-13-0903	TCGA-13-0903-01A	Stage IV	-15705	NA	NA	0	3887	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	80	1	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0903.A0EC0825-B2E7-40A0-868C-8C93A5D01AD8.pdf	0903	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2004	NA	TCGA-13-0903-01	NA	0931f0af-d4ff-4d49-9671-44f7f972ad49	NA	TCGA-13-0903-01	NA	TCGA-13-0903-01A-01D-0402-05	TCGA-13-0903-01A-01W-0421-09	TCGA-13-0903-01A-21-20	TCGA-13-0903-01A-01W-0421-09	NA	TCGA-13-0903-01A-01D-0399-01	TCGA-13-0903-01	1eb38ad5-a108-4461-8d9c-2246c4e5174c	NA	TCGA-13-0903-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0903-01	NA	NA	TCGA-13-0903-01A-01W-0421-09	TCGA-13-0903-01A-01R-0406-07	
TCGA-13-0904-01	1	TCGA-13-0904-01	1532	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-13-0904	330	1	days	1532	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-13-0904-F72625	TCGA-13-0904	TCGA-13-0904-01A	Stage IIIC	-23278	NA	1532	0	1470	NA	330	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	0.7	NO	80	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0904.4355BCD7-7A04-4F75-9415-83D3D6E18A24.pdf	0904	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2004	NA	TCGA-13-0904-01	NA	8db1ce50-4f8c-40a6-a56b-8266f0a16d28	NA	TCGA-13-0904-01	NA	TCGA-13-0904-01A-02D-0402-05	NA	NA	NA	NA	TCGA-13-0904-01A-02D-0399-01	TCGA-13-0904-01	NA	NA	TCGA-13-0904-01A-02D-0399-01	NA	NA	NA	TCGA-13-0904-01A-02W-0420-08	TCGA-13-0904-01	NA	NA	TCGA-13-0904-01A-02W-0420-08	TCGA-13-0904-01A-02R-0406-07	
TCGA-13-0905-01	0	TCGA-13-0905-01	3746	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0905	1535	1	days	3746	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Left	TCGA-13-0905-F72638	TCGA-13-0905	TCGA-13-0905-01B	Stage IIIC	-18757	NA	NA	0	3746	NA	1535	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	80	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0905.4EC6E47F-60BD-413E-9371-D70E1E89D0CA.pdf	0905	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	NA	Ovary	NA	B	LIVING	2005	NA	TCGA-13-0905-01	NA	05762312-1eb7-48bd-b497-97e2f94a86ff	NA	TCGA-13-0905-01	NA	TCGA-13-0905-01B-01D-0460-05	NA	NA	NA	NA	TCGA-13-0905-01B-01D-0452-01	TCGA-13-0905-01	NA	NA	TCGA-13-0905-01B-01D-0452-01	NA	NA	NA	TCGA-13-0905-01B-01W-0492-08	TCGA-13-0905-01	NA	NA	TCGA-13-0905-01B-01W-0492-08	TCGA-13-0905-01B-01R-0456-07	
TCGA-13-0906-01	0	TCGA-13-0906-01	3619	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0906	3619	0	days	3619	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-13-0906-F72626	TCGA-13-0906	TCGA-13-0906-01A	Stage IIIC	-18383	NA	NA	0	3619	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	60	1.1	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0906.D75790B2-C93F-4723-B691-84EE94656FF1.pdf	0906	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2005	NA	TCGA-13-0906-01	TCGA-13-0906-01A-01W-0419-10	8cba78d8-365d-4f21-9024-b1c65e7aebd9	NA	TCGA-13-0906-01	TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01A-01D-0402-05	NA	TCGA-13-0906-01A-21-20	NA	NA	TCGA-13-0906-01A-01D-0399-01	TCGA-13-0906-01	80aaf315-cf54-47e5-b82a-1343e25938ca	NA	TCGA-13-0906-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0906-01	NA	NA	TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01A-01R-0406-07	
TCGA-13-0908-01	1	TCGA-13-0908-01	1843	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 6	NA	TCGA-13-0908	552	1	days	1843	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-0908-F72639	TCGA-13-0908	TCGA-13-0908-01B	Stage IV	-21422	NA	1843	0	1364	NA	552	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.3	NO	NA	1.4	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0908.AE735D44-31EA-4345-9B3E-E92C7F236569.pdf	0908	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	B	DECEASED	2005	NA	TCGA-13-0908-01	NA	1a0d9712-cc09-46fa-a588-2d9db23c751b	NA	TCGA-13-0908-01	NA	TCGA-13-0908-01B-01D-0460-05	NA	NA	NA	NA	TCGA-13-0908-01B-01D-0452-01	TCGA-13-0908-01	NA	NA	TCGA-13-0908-01B-01D-0452-01	NA	NA	NA	NA	TCGA-13-0908-01	NA	NA	NA	TCGA-13-0908-01B-01R-0456-07	
TCGA-13-0910-01	0	TCGA-13-0910-01	3548	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0910	1212	1	days	3548	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-0910-F72627	TCGA-13-0910	NA	Stage IIIC	-21473	NA	NA	0	3548	NA	1212	NA	NA	Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	60	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	0910	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	LIVING	2005	NA	TCGA-13-0910-01	NA	c86a6b6b-046a-46c9-a89d-d365adafedd7	NA	TCGA-13-0910-01	NA	TCGA-13-0910-01A-01D-0402-05	TCGA-13-0910-01A-01W-0421-09	TCGA-13-0910-01A-21-20	TCGA-13-0910-01A-01W-0421-09	NA	TCGA-13-0910-01A-01D-0399-01	TCGA-13-0910-01	a7d2bac8-709d-455d-8613-e87b8fd8fe19	NA	TCGA-13-0910-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0910-01	NA	NA	TCGA-13-0910-01A-01W-0421-09	TCGA-13-0910-01A-01R-0406-07	
TCGA-13-0911-01	1	TCGA-13-0911-01	1355	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0911	279	1	days	1355	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Bilateral	TCGA-13-0911-F72628	TCGA-13-0911	TCGA-13-0911-01A	Stage IV	-20276	NA	1355	0	843	NA	279	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	80	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0911.0DE80BC5-8AA8-423A-B99B-9CD9883F27C2.pdf	0911	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	R1	Primary Tumor	01	0.8	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2005	NA	TCGA-13-0911-01	NA	68069103-49df-4246-8858-31d6b3571145	NA	TCGA-13-0911-01	NA	TCGA-13-0911-01A-01D-0402-05	NA	TCGA-13-0911-01A-21-20	NA	NA	TCGA-13-0911-01A-01D-0399-01	TCGA-13-0911-01	c2fbc465-c862-412d-8966-d88e0e414316	NA	TCGA-13-0911-01A-01D-0399-01	NA	NA	NA	TCGA-13-0911-01A-01W-0420-08	TCGA-13-0911-01	NA	NA	TCGA-13-0911-01A-01W-0420-08	TCGA-13-0911-01A-01R-0406-07	
TCGA-13-0912-01	1	TCGA-13-0912-01	1145	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0912	469	1	days	1145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-0912-F72629	TCGA-13-0912	TCGA-13-0912-01A	Stage IIIC	-21427	NA	1145	0	1036	NA	469	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	80	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0912.E6BF50DE-3E1D-447C-88B6-497B3C4C835F.pdf	0912	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-0912-01	NA	1daa5008-c4db-41ea-8e40-e551632f8bec	NA	TCGA-13-0912-01	NA	TCGA-13-0912-01A-01D-0402-05	TCGA-13-0912-01A-01W-0421-09	NA	TCGA-13-0912-01A-01W-0421-09	NA	TCGA-13-0912-01A-01D-0399-01	TCGA-13-0912-01	NA	NA	TCGA-13-0912-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0912-01	NA	NA	TCGA-13-0912-01A-01W-0421-09	TCGA-13-0912-01A-01R-0406-07	
TCGA-13-0913-01	0	TCGA-13-0913-01	3325	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0913	871	1	days	3325	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	53	Bilateral	TCGA-13-0913-F72630	TCGA-13-0913	TCGA-13-0913-01A	Stage IIIC	-19573	NA	NA	0	3325	NA	871	NA	NA	Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	80	1.3	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0913.E8FB6EA9-586A-452F-B6A6-0746F16B51DB.pdf	0913	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2006	TCGA-13-0913-01	TCGA-13-0913-01	NA	e993c6b2-05c7-4404-b8d8-a4e3ce8a8253	NA	TCGA-13-0913-01	NA	TCGA-13-0913-01A-01D-0402-05	NA	TCGA-13-0913-01A-21-20	NA	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01D-0399-01	TCGA-13-0913-01	8887c7f4-1bc4-4ec6-874f-453c17e1646e,0c76e11e-e654-49d5-9469-aec43bc8eb96	NA	TCGA-13-0913-01A-01D-0399-01	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	NA	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01W-0420-08	TCGA-13-0913-01	TCGA-13-0913-01	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01W-0420-08	TCGA-13-0913-01A-01R-0406-07	
TCGA-13-0913-02	0	TCGA-13-0913-02	3325	0	days	NA	C9-OV	OV-like c1	NA	NA	miRNA cluster 2	NA	mutation cluster 5	TCGA-13-0913	871	1	days	3325	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	53	Bilateral	TCGA-13-0913-F72630	TCGA-13-0913	TCGA-13-0913-02A	Stage IIIC	-19573	NA	NA	0	3325	NA	871	NA	NA	Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	80	1.4	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0913.61FBF10C-A508-4D83-971D-5A48BA81F08A.pdf	0913	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Recurrent Tumor	02	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2006	NA	TCGA-13-0913-02	NA	b9367a1a-2b4b-4beb-a02f-743f826bf85d	NA	TCGA-13-0913-02	NA	TCGA-13-0913-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	8c5c67e0-0a80-43b4-b35f-ddd51163b452	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-0913-02A-01R-0810-07	
TCGA-13-0916-01	0	TCGA-13-0916-01	1785	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0916	1785	0	days	1785	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-13-0916-F72631	TCGA-13-0916	TCGA-13-0916-01A	Stage IIIC	-18189	NA	NA	0	1785	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-0916.28A2A65C-70A2-40D2-A03A-F68884457C14.pdf	0916	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.6	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2006	TCGA-13-0916-01	TCGA-13-0916-01	NA	468b249e-69a0-4728-a0a3-cbe7fad18499	NA	TCGA-13-0916-01	NA	TCGA-13-0916-01A-01D-0402-05	NA	TCGA-13-0916-01A-21-20	NA	63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01D-0399-01	TCGA-13-0916-01	3a88bad5-3325-409f-8023-5e2df3ba1bf4	NA	TCGA-13-0916-01A-01D-0399-01	63c52e46-68cf-4dac-9bd7-37081daa4474	NA	63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01W-0420-08	TCGA-13-0916-01	TCGA-13-0916-01	63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01W-0420-08	TCGA-13-0916-01A-01R-0406-07	
TCGA-13-0919-01	0	TCGA-13-0919-01	2571	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-0919	2571	0	days	2571	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-13-0919-F72632	TCGA-13-0919	NA	Stage IIIC	-19337	NA	NA	0	2571	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	NO	NA	NA	NA	0919	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	NA	LIVING	2007	NA	TCGA-13-0919-01	TCGA-13-0919-01A-01W-0419-10	f00f1225-2b6a-4d61-a3e1-909fd595b624	NA	TCGA-13-0919-01	TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01A-01D-0402-05	NA	NA	NA	NA	TCGA-13-0919-01A-01D-0399-01	TCGA-13-0919-01	NA	NA	TCGA-13-0919-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0919-01	NA	NA	TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01A-01R-0406-07	
TCGA-13-0920-01	1	TCGA-13-0920-01	1484	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0920	297	1	days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	Bilateral	TCGA-13-0920-F72633	TCGA-13-0920	TCGA-13-0920-01A	Stage IIIC	-24064	NA	1484	0	420	NA	297	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0920.6880B406-08B2-43CE-9274-5826B1BE9114.pdf	0920	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2007	TCGA-13-0920-01	TCGA-13-0920-01	NA	f109f013-990a-4e2d-9bce-b3dce60e5b0f	NA	TCGA-13-0920-01	NA	TCGA-13-0920-01A-01D-0402-05	TCGA-13-0920-01A-01W-0421-09	TCGA-13-0920-01A-21-20	TCGA-13-0920-01A-01W-0421-09	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	TCGA-13-0920-01A-01D-0399-01	TCGA-13-0920-01	1aaaee17-5206-42cc-b678-f4a4e712ae54	NA	TCGA-13-0920-01A-01D-0399-01	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	NA	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	NA	TCGA-13-0920-01	TCGA-13-0920-01	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	TCGA-13-0920-01A-01W-0421-09	TCGA-13-0920-01A-01R-0406-07	
TCGA-13-0921-01	1	TCGA-13-0921-01	1483	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	NA	TCGA-13-0921	NA	NA	days	1483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	72	Bilateral	TCGA-13-0921-F72634	TCGA-13-0921	TCGA-13-0921-01A	Stage IIIC	-26606	NA	1483	0	141	NA	NA	NA	NA	NA	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-13-0921.307EC276-EE89-45D3-8B61-4F217C0F61C4.pdf	0921	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.2	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-0921-01	NA	d4b09b28-c890-406a-97d4-3354bb5484c6	NA	TCGA-13-0921-01	NA	TCGA-13-0921-01A-01D-0402-05	NA	TCGA-13-0921-01A-21-20	NA	NA	TCGA-13-0921-01A-01D-0399-01	TCGA-13-0921-01	56e2b31e-e133-45fa-a38c-9f1c8825194c	NA	TCGA-13-0921-01A-01D-0399-01	NA	NA	NA	NA	TCGA-13-0921-01	NA	NA	NA	TCGA-13-0921-01A-01R-0406-07	
TCGA-13-0923-01	0	TCGA-13-0923-01	2547	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0923	1719	1	days	2547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Right	TCGA-13-0923-F72635	TCGA-13-0923	TCGA-13-0923-01A	Stage IIIC	-27081	NA	NA	0	2547	NA	1719	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0923.06AB5B8C-7B57-43B0-8376-7A05C58AFC1A.pdf	0923	NA	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	TCGA-13-0923-01	NA	5e88feda-6485-4934-9c79-2c5c88e908de	NA	TCGA-13-0923-01	NA	TCGA-13-0923-01A-01D-0402-05	NA	NA	NA	NA	TCGA-13-0923-01A-01D-0399-01	TCGA-13-0923-01	NA	NA	TCGA-13-0923-01A-01D-0399-01	NA	NA	NA	TCGA-13-0923-01A-01W-0420-08	TCGA-13-0923-01	NA	NA	TCGA-13-0923-01A-01W-0420-08	TCGA-13-0923-01A-01R-0406-07	
TCGA-13-0924-01	0	TCGA-13-0924-01	2614	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0924	962	1	days	2614	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-13-0924-F72636	TCGA-13-0924	TCGA-13-0924-01A	Stage IV	-16670	NA	NA	0	2614	NA	962	NA	NA	Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NO	NA	NA	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-0924.2EA17F21-1594-430A-97E3-29C5F49CB3BC.pdf	0924	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-13-0924-01	TCGA-13-0924-01	NA	b0dae9c4-1401-4b88-94cb-bef931901b94	NA	TCGA-13-0924-01	NA	TCGA-13-0924-01A-01D-0402-05	TCGA-13-0924-01A-01W-0421-09	NA	TCGA-13-0924-01A-01W-0421-09	85a4c41b-9829-48f8-9c7a-a9de870332b6	TCGA-13-0924-01A-01D-0399-01	TCGA-13-0924-01	NA	NA	TCGA-13-0924-01A-01D-0399-01	85a4c41b-9829-48f8-9c7a-a9de870332b6	NA	85a4c41b-9829-48f8-9c7a-a9de870332b6	NA	TCGA-13-0924-01	TCGA-13-0924-01	85a4c41b-9829-48f8-9c7a-a9de870332b6	TCGA-13-0924-01A-01W-0421-09	TCGA-13-0924-01A-01R-0406-07	
TCGA-13-1403-01	1	TCGA-13-1403-01	2345	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1403	418	1	days	2345	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Left	TCGA-13-1403-F72653	TCGA-13-1403	TCGA-13-1403-01A	Stage IIIC	-17697	NA	2345	0	331	NA	418	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.9	NO	NA	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1403.435619AB-01F5-4AC3-8D28-A8CC0054699F.pdf	1403	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	NA	Ovary	NA	A	DECEASED	2008	TCGA-13-1403-01	TCGA-13-1403-01	NA	88424970-6ba5-4c0f-ac01-f06513be5b42	NA	TCGA-13-1403-01	NA	TCGA-13-1403-01A-01D-0460-05	TCGA-13-1403-01A-01W-0494-09	NA	TCGA-13-1403-01A-01W-0494-09	3217dd54-d41c-4c63-8bab-ff2c4baaee10	TCGA-13-1403-01A-01D-0452-01	TCGA-13-1403-01	NA	NA	TCGA-13-1403-01A-01D-0452-01	3217dd54-d41c-4c63-8bab-ff2c4baaee10	NA	3217dd54-d41c-4c63-8bab-ff2c4baaee10	NA	TCGA-13-1403-01	TCGA-13-1403-01	3217dd54-d41c-4c63-8bab-ff2c4baaee10	TCGA-13-1403-01A-01W-0494-09	TCGA-13-1403-01A-01R-0456-07	
TCGA-13-1404-01	0	TCGA-13-1404-01	2469	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1404	1581	1	days	2469	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Bilateral	TCGA-13-1404-F72655	TCGA-13-1404	TCGA-13-1404-01A	Stage IIIC	-17784	NA	NA	0	2469	NA	1581	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	60	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1404.39B73962-A374-4521-BFBB-F10D117979F9.pdf	1404	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-13-1404-01	NA	454548ae-a10c-4811-a88b-5e893ffe1caa	NA	TCGA-13-1404-01	NA	TCGA-13-1404-01A-01D-0460-05	TCGA-13-1404-01A-01W-0494-09	TCGA-13-1404-01A-21-1562-20	TCGA-13-1404-01A-01W-0494-09	NA	TCGA-13-1404-01A-01D-0452-01	TCGA-13-1404-01	b9dd3b0f-e45a-400a-8078-5d421d257726	NA	TCGA-13-1404-01A-01D-0452-01	NA	NA	NA	NA	TCGA-13-1404-01	NA	NA	TCGA-13-1404-01A-01W-0494-09	TCGA-13-1404-01A-01R-0456-07	
TCGA-13-1405-01	1	TCGA-13-1405-01	868	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1405	228	1	days	868	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-13-1405-F72656	TCGA-13-1405	TCGA-13-1405-01A	Stage IV	-18218	NA	868	0	224	NA	228	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.3	NO	80	1.3	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1405.DFB9F8B2-986C-4963-B2D2-837E54174CF0.pdf	1405	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2008	TCGA-13-1405-01	TCGA-13-1405-01	NA	04d8cf12-0689-4e2d-a8e9-771920563560	NA	TCGA-13-1405-01	NA	TCGA-13-1405-01A-01D-0460-05	TCGA-13-1405-01A-01W-0494-09	TCGA-13-1405-01A-21-1562-20	TCGA-13-1405-01A-01W-0494-09	044d949f-0eb4-44c9-8327-90226936fc7c	TCGA-13-1405-01A-01D-0452-01	TCGA-13-1405-01	79cd114a-31d2-468d-92e6-5ea925e61918	NA	TCGA-13-1405-01A-01D-0452-01	044d949f-0eb4-44c9-8327-90226936fc7c	NA	044d949f-0eb4-44c9-8327-90226936fc7c	NA	TCGA-13-1405-01	TCGA-13-1405-01	044d949f-0eb4-44c9-8327-90226936fc7c	TCGA-13-1405-01A-01W-0494-09	TCGA-13-1405-01A-01R-0456-07	
TCGA-13-1407-01	0	TCGA-13-1407-01	2534	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-1407	1333	1	days	2534	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-13-1407-F72657	TCGA-13-1407	NA	Stage IIIC	-18896	NA	NA	0	2534	NA	1333	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	1407	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	NA	Ovary	NA	NA	LIVING	2008	NA	TCGA-13-1407-01	TCGA-13-1407-01A-01W-0490-10	ba5b2281-2b96-47e8-92b9-0221c434b4e9	NA	TCGA-13-1407-01	TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01A-01D-0460-05	NA	NA	NA	NA	TCGA-13-1407-01A-01D-0452-01	TCGA-13-1407-01	NA	NA	TCGA-13-1407-01A-01D-0452-01	NA	NA	NA	NA	TCGA-13-1407-01	NA	NA	TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01A-01R-0456-07	
TCGA-13-1408-01	1	TCGA-13-1408-01	1680	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation cluster 14	TCGA-13-1408	765	1	days	1680	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	NA	TCGA-13-1408-F72659	TCGA-13-1408	TCGA-13-1408-01A	Stage IIIC	-21635	NA	1680	0	180	NA	765	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.8	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1408.39435FCB-699F-4A2F-9005-E67C9A41C766.pdf	1408	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-1408-01	TCGA-13-1408-01A-01W-0490-10	3f056922-bdb4-4a8f-8a4d-9116cae32ae8	NA	TCGA-13-1408-01	TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01A-01D-0460-05	NA	TCGA-13-1408-01A-21-1562-20	NA	NA	TCGA-13-1408-01A-01D-0452-01	TCGA-13-1408-01	c9dc89ec-e887-4acc-90a5-6fd20f4a1483	NA	TCGA-13-1408-01A-01D-0452-01	NA	NA	NA	NA	TCGA-13-1408-01	NA	NA	TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01A-01R-0456-07	
TCGA-13-1409-01	1	TCGA-13-1409-01	1742	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1409	690	1	days	1742	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	NA	TCGA-13-1409-F72660	TCGA-13-1409	TCGA-13-1409-01A	Stage IIIC	-26836	NA	1742	0	208	NA	690	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	1	NO	60	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1409.3F18B612-EE50-4459-8CAF-61A12157DD8A.pdf	1409	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.6	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-1409-01	NA	c4293c0c-8d5d-40b4-9f84-42633383f950	NA	TCGA-13-1409-01	NA	TCGA-13-1409-01A-01D-0460-05	NA	TCGA-13-1409-01A-21-20	NA	NA	TCGA-13-1409-01A-01D-0452-01	TCGA-13-1409-01	8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25	NA	TCGA-13-1409-01A-01D-0452-01	NA	NA	NA	TCGA-13-1409-01A-01W-0492-08	TCGA-13-1409-01	NA	NA	TCGA-13-1409-01A-01W-0492-08	TCGA-13-1409-01A-01R-0456-07	
TCGA-13-1410-01	0	TCGA-13-1410-01	2464	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1410	319	1	days	2464	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Bilateral	TCGA-13-1410-F72661	TCGA-13-1410	TCGA-13-1410-01A	Stage IV	-20950	NA	NA	0	2464	NA	319	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	60	1.9	NA	NA	GX	NA	NA	YES	NA	NA	TCGA-13-1410.0F641D88-673B-48C4-97F5-730DA3FD343C.pdf	1410	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	NA	Ovary	NA	A	LIVING	2008	TCGA-13-1410-01	TCGA-13-1410-01	NA	e8da901b-05d8-4448-8e0c-52c558fe2ea8	NA	TCGA-13-1410-01	NA	TCGA-13-1410-01A-01D-0460-05	NA	TCGA-13-1410-01A-21-20	NA	fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01D-0452-01	TCGA-13-1410-01	3f2151ce-1e04-4a0e-8ded-e59696b705cb	NA	TCGA-13-1410-01A-01D-0452-01	fdda1428-ad6b-4337-a959-83bae1f9664b	NA	fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01W-0492-08	TCGA-13-1410-01	TCGA-13-1410-01	fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01W-0492-08	TCGA-13-1410-01A-01R-0456-07	
TCGA-13-1411-01	1	TCGA-13-1411-01	531	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-1411	238	1	days	531	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	81	NA	TCGA-13-1411-F72662	TCGA-13-1411	TCGA-13-1411-01A	Stage IIIC	-29874	NA	531	0	128	NA	238	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	1.7	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1411.F73F2D6F-3FD9-4457-921A-9EE0E47A6470.pdf	1411	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2008	TCGA-13-1411-01	TCGA-13-1411-01	NA	88a02ee5-0e09-4181-ad62-88ec7f877f45	NA	TCGA-13-1411-01	NA	TCGA-13-1411-01A-01D-0460-05	TCGA-13-1411-01A-01W-0494-09	TCGA-13-1411-01A-21-20	TCGA-13-1411-01A-01W-0494-09	0069c63d-f699-41d4-9798-9a109d1c09df	TCGA-13-1411-01A-01D-0452-01	TCGA-13-1411-01	438d9016-0b99-46f7-b8ad-21c125f4bedd	NA	TCGA-13-1411-01A-01D-0452-01	0069c63d-f699-41d4-9798-9a109d1c09df	NA	0069c63d-f699-41d4-9798-9a109d1c09df	NA	TCGA-13-1411-01	TCGA-13-1411-01	0069c63d-f699-41d4-9798-9a109d1c09df	TCGA-13-1411-01A-01W-0494-09	TCGA-13-1411-01A-01R-0456-07	
TCGA-13-1412-01	1	TCGA-13-1412-01	984	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1412	409	1	days	984	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	41	Bilateral	TCGA-13-1412-F72669	TCGA-13-1412	TCGA-13-1412-01A	Stage IV	-15119	NA	984	0	162	NA	409	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	80	1.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1412.D36FA0B4-9605-498F-B815-1BE4BF64E100.pdf	1412	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-1412-01	NA	54620fb3-d7d9-4d00-a77b-4d8dcfee4d55	NA	TCGA-13-1412-01	NA	TCGA-13-1412-01A-01D-0460-05	TCGA-13-1412-01A-01W-0494-09	TCGA-13-1412-01A-21-20	TCGA-13-1412-01A-01W-0494-09	NA	TCGA-13-1412-01A-01D-0452-01	TCGA-13-1412-01	b22eb00b-8fcc-4fd5-b396-1169f7f025fd	NA	TCGA-13-1412-01A-01D-0452-01	NA	NA	NA	NA	TCGA-13-1412-01	NA	NA	TCGA-13-1412-01A-01W-0494-09	TCGA-13-1412-01A-01R-0456-07	
TCGA-13-1477-01	1	TCGA-13-1477-01	1662	1	days	Iq	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-1477	NA	NA	days	1662	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	49	Bilateral	TCGA-13-1477-F24839	TCGA-13-1477	TCGA-13-1477-01A	Stage IV	-18111	NA	1662	0	1662	NA	235	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	1.3	NO	NA	1.3	NA	NA	G2	Progression of Disease	NA	NA	NA	NA	TCGA-13-1477.2507FA0F-9709-4B5D-9EC1-907637FB373A.pdf	1477	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2000	NA	TCGA-13-1477-01	NA	7bc1d947-f625-418c-b577-c66aea3e33c4	NA	TCGA-13-1477-01	NA	TCGA-13-1477-01A-01D-0475-05	NA	TCGA-13-1477-01A-21-1562-20	NA	NA	TCGA-13-1477-01A-01D-0472-01	TCGA-13-1477-01	fa473bf9-b927-4d17-ac77-ad0e52f01cac	NA	TCGA-13-1477-01A-01D-0472-01	NA	NA	NA	TCGA-13-1477-01A-01D-0472-08	TCGA-13-1477-01	NA	NA	TCGA-13-1477-01A-01D-0472-08	TCGA-13-1477-01A-01R-0479-07	
TCGA-13-1479-01	NA	TCGA-13-1479-01	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-1479	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-1479-01A-01D-0475-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-1479-01A-01R-0479-07	
TCGA-13-1481-01	1	TCGA-13-1481-01	2648	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1481	NA	NA	days	2648	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	76	Right	TCGA-13-1481-F24843	TCGA-13-1481	TCGA-13-1481-01A	Stage IIIC	-27898	NA	2648	0	2648	NA	NA	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.3	NO	NA	1.4	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-13-1481.4832CBA4-9482-4A2A-A9E1-4E8489B0F157.pdf	1481	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-13-1481-01	TCGA-13-1481-01	NA	2b0cdd7b-9556-4bd5-bf80-1daa495b38e3	NA	TCGA-13-1481-01	NA	TCGA-13-1481-01A-01D-0475-05	TCGA-13-1481-01A-01W-0549-09	TCGA-13-1481-01A-21-1562-20	TCGA-13-1481-01A-01W-0549-09	761f9668-304f-4e22-87cd-2005aa86152c	TCGA-13-1481-01A-01D-0472-01	TCGA-13-1481-01	8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a	NA	TCGA-13-1481-01A-01D-0472-01	761f9668-304f-4e22-87cd-2005aa86152c	NA	761f9668-304f-4e22-87cd-2005aa86152c	NA	TCGA-13-1481-01	TCGA-13-1481-01	761f9668-304f-4e22-87cd-2005aa86152c	TCGA-13-1481-01A-01W-0549-09	TCGA-13-1481-01A-01R-0479-07	
TCGA-13-1482-01	1	TCGA-13-1482-01	1877	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1482	NA	NA	days	1877	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	NA	TCGA-13-1482-F24848	TCGA-13-1482	NA	Stage IV	-19178	NA	1877	0	1877	NA	602	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	80	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1482	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	>20 mm	Ovary	NA	NA	DECEASED	2000	NA	TCGA-13-1482-01	NA	c2b1ef9b-a1b3-4fe9-b35f-841893a6092d	NA	TCGA-13-1482-01	NA	TCGA-13-1482-01A-01D-0475-05	TCGA-13-1482-01A-01W-0549-09	TCGA-13-1482-01A-21-1562-20	TCGA-13-1482-01A-01W-0549-09	NA	TCGA-13-1482-01A-01D-0472-01	TCGA-13-1482-01	db641a43-1973-4213-a4ed-42fa9ff8e8ec	NA	TCGA-13-1482-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1482-01	NA	NA	TCGA-13-1482-01A-01W-0549-09	TCGA-13-1482-01A-01R-0479-07	
TCGA-13-1483-01	1	TCGA-13-1483-01	895	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1483	NA	NA	days	895	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	NA	TCGA-13-1483-F24852	TCGA-13-1483	TCGA-13-1483-01A	Stage IIIC	-22342	NA	895	0	895	NA	297	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1.4	NO	60	1.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1483.c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db.pdf	1483	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2000	NA	TCGA-13-1483-01	NA	ba90cac1-6c52-4111-99f5-8cb3cb11faeb	NA	TCGA-13-1483-01	NA	TCGA-13-1483-01A-01D-0475-05	TCGA-13-1483-01A-01W-0549-09	TCGA-13-1483-01A-21-1562-20	TCGA-13-1483-01A-01W-0549-09	NA	TCGA-13-1483-01A-01D-0472-01	TCGA-13-1483-01	3ab7ed23-61b4-4c74-8668-25b7ee186bf7	NA	TCGA-13-1483-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1483-01	NA	NA	TCGA-13-1483-01A-01W-0549-09	TCGA-13-1483-01A-01R-0479-07	
TCGA-13-1484-01	1	TCGA-13-1484-01	3785	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	NA	miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-13-1484	497	1	days	3785	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	NA	TCGA-13-1484-F72640	TCGA-13-1484	TCGA-13-1484-01A	Stage IIIC	-22698	NA	3785	0	2982	NA	497	NA	NA	Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	0.6	NO	80	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1484.CF223E16-1613-4FAB-A4DA-86D5ECE7B55E.pdf	1484	Preoperative	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	NA	Ovary	NA	A	DECEASED	2000	NA	TCGA-13-1484-01	NA	53f117b0-5e33-4abf-9720-e3358f62ed9a	NA	TCGA-13-1484-01	NA	TCGA-13-1484-01A-01D-0475-05	NA	TCGA-13-1484-01A-21-1562-20	NA	NA	TCGA-13-1484-01A-01D-0472-01	TCGA-13-1484-01	d48335c8-f1dd-472d-a4d6-6ad7eb5d081d	NA	TCGA-13-1484-01A-01D-0472-01	NA	NA	NA	TCGA-13-1484-01A-01W-0545-08	TCGA-13-1484-01	NA	NA	TCGA-13-1484-01A-01W-0545-08	TCGA-13-1484-01A-01R-0479-07	
TCGA-13-1485-01	1	TCGA-13-1485-01	629	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 3	cluster 6	NA	TCGA-13-1485	NA	NA	days	629	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-1485-F24861	TCGA-13-1485	NA	Stage IV	-17642	NA	629	0	629	NA	170	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	NA	NA	80	NA	NA	NA	G2	Progression of Disease	NA	NA	NA	NA	NA	1485	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2001	NA	TCGA-13-1485-01	NA	a1378617-e3ff-4bfa-adef-03e4c07512fa	NA	TCGA-13-1485-01	NA	TCGA-13-1485-01A-02D-0475-05	NA	NA	NA	NA	TCGA-13-1485-01A-02D-0472-01	TCGA-13-1485-01	NA	NA	TCGA-13-1485-01A-02D-0472-01	NA	NA	NA	NA	TCGA-13-1485-01	NA	NA	NA	TCGA-13-1485-01A-02R-0479-07	
TCGA-13-1487-01	1	TCGA-13-1487-01	681	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1487	NA	NA	days	681	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	NA	TCGA-13-1487-F24865	TCGA-13-1487	NA	Stage IV	-27176	NA	681	0	681	NA	412	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	GX	Recurrence	NA	NA	NA	NA	NA	1487	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	13	NA	Ovary	NA	NA	DECEASED	2002	NA	TCGA-13-1487-01	NA	a7c48735-a4be-424a-a3cd-125cf2e2a274	NA	TCGA-13-1487-01	NA	TCGA-13-1487-01A-01D-0475-05	NA	TCGA-13-1487-01A-21-1562-20	NA	NA	TCGA-13-1487-01A-01D-0472-01	TCGA-13-1487-01	f10389e0-3564-4067-b82a-d0be5d5eec92	NA	TCGA-13-1487-01A-01D-0472-01	NA	NA	NA	TCGA-13-1487-01A-01D-0472-08	TCGA-13-1487-01	NA	NA	TCGA-13-1487-01A-01D-0472-08	TCGA-13-1487-01A-01R-0479-07	
TCGA-13-1488-01	1	TCGA-13-1488-01	2154	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1488	NA	NA	days	2154	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-13-1488-F24871	TCGA-13-1488	TCGA-13-1488-01A	Stage IV	-21726	NA	2154	0	2154	NA	351	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	80	2.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1488.79A91E41-0B59-4328-B7BB-2B4EEAD46A89.pdf	1488	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	13	11-20 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-1488-01	NA	6b1d30b6-321c-4d55-bf9f-dfb4be92210b	NA	TCGA-13-1488-01	NA	TCGA-13-1488-01A-01D-0475-05	TCGA-13-1488-01A-01W-0549-09	TCGA-13-1488-01A-21-1562-20	TCGA-13-1488-01A-01W-0549-09	NA	TCGA-13-1488-01A-01D-0472-01	TCGA-13-1488-01	1ec3bf38-f06e-4789-a298-cde202cf3649	NA	TCGA-13-1488-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1488-01	NA	NA	TCGA-13-1488-01A-01W-0549-09	TCGA-13-1488-01A-01R-0479-07	
TCGA-13-1489-01	1	TCGA-13-1489-01	2553	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-13-1489	806	1	days	2553	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	70	Bilateral	TCGA-13-1489-F72641	TCGA-13-1489	NA	Stage IIIC	-25768	NA	2553	0	2521	NA	806	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	80	NA	NA	NA	G2	NA	NA	YES	NA	NA	NA	1489	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	NA	Ovary	NA	NA	DECEASED	2002	NA	TCGA-13-1489-01	NA	aeb47cad-0087-4bf3-aa09-3751a6dcb269	NA	TCGA-13-1489-01	NA	TCGA-13-1489-01A-01D-0475-05	TCGA-13-1489-01A-01W-0549-09	TCGA-13-1489-01A-21-1562-20	TCGA-13-1489-01A-01W-0549-09	NA	TCGA-13-1489-01A-01D-0472-01	TCGA-13-1489-01	f99befac-a46e-43a1-91b7-e4a492dae82f,c35fe897-f2eb-4dcb-a571-89f2c27ffa6a	NA	TCGA-13-1489-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1489-01	NA	NA	TCGA-13-1489-01A-01W-0549-09	TCGA-13-1489-01A-01R-0479-07	
TCGA-13-1489-02	1	TCGA-13-1489-02	2553	1	days	NA	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 3	NA	mutation cluster 5	TCGA-13-1489	806	1	days	2553	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	70	Bilateral	TCGA-13-1489-F72641	TCGA-13-1489	TCGA-13-1489-02A	Stage IIIC	-25768	NA	2553	0	2521	NA	806	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	80	1	NA	NA	G2	NA	NA	YES	NA	NA	TCGA-13-1489.639712E8-5C63-433C-8F23-4C78FF37D8FC.pdf	1489	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Recurrent Tumor	02	0.4	NA	NA	13	NA	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-1489-02	NA	141d2716-c6c3-4495-b30f-12dc204d77a3	NA	TCGA-13-1489-02	NA	TCGA-13-1489-02A-01D-0807-05	NA	NA	NA	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	NA	NA	d95612da-1768-4b34-bb28-607208c05c38	NA	NA	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	NA	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	NA	NA	NA	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	NA	TCGA-13-1489-02A-01R-0810-07	
TCGA-13-1491-01	1	TCGA-13-1491-01	1595	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1491	NA	NA	days	1595	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-1491-F24884	TCGA-13-1491	TCGA-13-1491-01A	Stage IIIC	-20262	NA	1595	0	1595	NA	508	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	0.6	NO	60	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1491.051EAB19-C9CF-407E-A0C3-19CB76368C22.pdf	1491	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	13	NA	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-1491-01	NA	7ae5754b-5508-416e-96ec-fe3221d6e2ff	NA	TCGA-13-1491-01	NA	TCGA-13-1491-01A-01D-0475-05	TCGA-13-1491-01A-01W-0549-09	TCGA-13-1491-01A-21-1562-20	TCGA-13-1491-01A-01W-0549-09	NA	TCGA-13-1491-01A-01D-0472-01	TCGA-13-1491-01	a2142ff2-fb53-4517-b0d5-9f25ba91ea1a	NA	TCGA-13-1491-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1491-01	NA	NA	TCGA-13-1491-01A-01W-0549-09	TCGA-13-1491-01A-01R-0479-07	
TCGA-13-1492-01	1	TCGA-13-1492-01	3819	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1492	3819	0	days	3819	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	NA	TCGA-13-1492-F72643	TCGA-13-1492	TCGA-13-1492-01A	Stage IIIC	-24332	NA	3819	0	2237	NA	NA	NA	NA	Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1.2	NO	80	2.5	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-1492.566BE185-8A2E-43C4-9762-65216AB9AC44.pdf	1492	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	NA	Ovary	NA	A	DECEASED	2002	NA	TCGA-13-1492-01	NA	c37d0090-3b9a-4832-934a-299d8a7f6a2d	NA	TCGA-13-1492-01	NA	TCGA-13-1492-01A-01D-0475-05	NA	TCGA-13-1492-01A-21-1562-20	NA	NA	TCGA-13-1492-01A-01D-0472-01	TCGA-13-1492-01	943e741f-3371-4167-99e0-fd795663874c	NA	TCGA-13-1492-01A-01D-0472-01	NA	NA	NA	TCGA-13-1492-01A-01D-0472-08	TCGA-13-1492-01	NA	NA	TCGA-13-1492-01A-01D-0472-08	TCGA-13-1492-01A-01R-0479-07	
TCGA-13-1494-01	1	TCGA-13-1494-01	2856	1	days	Squamous	C9-OV	OV-like c1	KIRC-like c1	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1494	693	1	days	2856	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	43	Bilateral	TCGA-13-1494-F72644	TCGA-13-1494	NA	Stage IV	-15993	NA	2856	0	1162	NA	693	NA	NA	NA	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	1494	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	NA	Ovary	NA	NA	DECEASED	2004	NA	TCGA-13-1494-01	NA	d8a57388-6e4e-4865-a68f-7485dec8304f	NA	TCGA-13-1494-01	NA	TCGA-13-1494-01A-01D-0475-05	NA	TCGA-13-1494-01A-21-1562-20	NA	NA	TCGA-13-1494-01A-01D-0472-01	TCGA-13-1494-01	af9b3f69-ef63-4303-85c6-8f6936dc6b6e	NA	TCGA-13-1494-01A-01D-0472-01	NA	NA	NA	TCGA-13-1494-01A-01W-0545-08	TCGA-13-1494-01	NA	NA	TCGA-13-1494-01A-01W-0545-08	TCGA-13-1494-01A-01R-0479-07	
TCGA-13-1495-01	1	TCGA-13-1495-01	2749	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-1495	977	1	days	2749	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-13-1495-F72645	TCGA-13-1495	TCGA-13-1495-01A	Stage IIIC	-22046	NA	2749	0	1498	NA	977	NA	NA	NA	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.5	NO	80	2.1	NA	NA	G2	NA	NA	YES	NA	NA	TCGA-13-1495.51F0A8BF-0E86-402D-BE9F-D41771ED98A3.pdf	1495	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	TCGA-13-1495-01	NA	2476b238-9e59-49ae-ac0d-456ad4fe4ffc	NA	TCGA-13-1495-01	NA	TCGA-13-1495-01A-01D-0475-05	NA	TCGA-13-1495-01A-21-1562-20	NA	NA	TCGA-13-1495-01A-01D-0472-01	TCGA-13-1495-01	15443f5b-51c9-496d-bf7a-99693ca3b943	NA	TCGA-13-1495-01A-01D-0472-01	NA	NA	NA	TCGA-13-1495-01A-01W-0545-08	TCGA-13-1495-01	NA	NA	TCGA-13-1495-01A-01W-0545-08	TCGA-13-1495-01A-01R-0479-07	
TCGA-13-1496-01	1	TCGA-13-1496-01	129	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1496	NA	NA	days	129	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	Bilateral	TCGA-13-1496-F24904	TCGA-13-1496	TCGA-13-1496-01A	Stage IIIC	-23993	NA	129	0	129	NA	NA	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-13-1496.BCDD1BDE-689B-455D-81A7-C2522417E055.pdf	1496	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2004	NA	TCGA-13-1496-01	NA	e75a75ac-204d-48b0-891e-c3d6e979d4d4	NA	TCGA-13-1496-01	NA	TCGA-13-1496-01A-01D-0475-05	NA	TCGA-13-1496-01A-21-1562-20	NA	NA	TCGA-13-1496-01A-01D-0472-01	TCGA-13-1496-01	35781069-501d-45c3-b3f0-7292b0186211	NA	TCGA-13-1496-01A-01D-0472-01	NA	NA	NA	TCGA-13-1496-01A-01W-0545-08	TCGA-13-1496-01	NA	NA	TCGA-13-1496-01A-01W-0545-08	TCGA-13-1496-01A-01R-0479-07	
TCGA-13-1497-01	0	TCGA-13-1497-01	3871	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1497	813	1	days	3871	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	47	NA	TCGA-13-1497-F72646	TCGA-13-1497	NA	Stage IIIC	-17528	NA	NA	0	3871	NA	813	NA	NA	Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	1497	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	NA	Ovary	NA	NA	LIVING	2004	TCGA-13-1497-01	TCGA-13-1497-01	NA	d53c30c7-126f-40ec-9e02-4a1d2a3e2681	NA	TCGA-13-1497-01	NA	TCGA-13-1497-01A-01D-0475-05	TCGA-13-1497-01A-01W-0549-09	NA	TCGA-13-1497-01A-01W-0549-09	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	TCGA-13-1497-01A-01D-0472-01	TCGA-13-1497-01	NA	NA	TCGA-13-1497-01A-01D-0472-01	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	NA	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	NA	TCGA-13-1497-01	TCGA-13-1497-01	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	TCGA-13-1497-01A-01W-0549-09	TCGA-13-1497-01A-01R-0479-07	
TCGA-13-1498-01	1	TCGA-13-1498-01	2012	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1498	534	1	days	2012	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	NA	TCGA-13-1498-F72647	TCGA-13-1498	TCGA-13-1498-01A	Stage IIIC	-26820	NA	2012	0	1144	NA	534	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	60	1.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1498.0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1.pdf	1498	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2006	TCGA-13-1498-01	TCGA-13-1498-01	NA	0fe423b7-115f-48a2-bc4a-9eec87f319e2	NA	TCGA-13-1498-01	NA	TCGA-13-1498-01A-01D-0475-05	TCGA-13-1498-01A-01W-0549-09	TCGA-13-1498-01A-21-1562-20	TCGA-13-1498-01A-01W-0549-09	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	TCGA-13-1498-01A-01D-0472-01	TCGA-13-1498-01	17dca857-f830-4be9-9f2b-5619ae7eb73f	NA	TCGA-13-1498-01A-01D-0472-01	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	NA	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	NA	TCGA-13-1498-01	TCGA-13-1498-01	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	TCGA-13-1498-01A-01W-0549-09	TCGA-13-1498-01A-01R-0479-07	
TCGA-13-1499-01	0	TCGA-13-1499-01	3500	0	days	Squamous	C9-OV	Low purity c2	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1499	583	1	days	3500	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	NA	TCGA-13-1499-F72649	TCGA-13-1499	TCGA-13-1499-01A	Stage IIIC	-20668	NA	NA	0	3500	NA	583	NA	NA	Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	1.1	NO	80	2.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1499.3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0.pdf	1499	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	NA	Ovary	NA	A	LIVING	2005	NA	TCGA-13-1499-01	NA	f54b35ad-c934-4df9-ba57-089c4c9d5c1e	NA	TCGA-13-1499-01	NA	TCGA-13-1499-01A-01D-0475-05	TCGA-13-1499-01A-01W-0549-09	TCGA-13-1499-01A-21-1562-20	TCGA-13-1499-01A-01W-0549-09	NA	TCGA-13-1499-01A-01D-0472-01	TCGA-13-1499-01	21c833c6-d2bc-4308-a233-894c7a6636f1	NA	TCGA-13-1499-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1499-01	NA	NA	TCGA-13-1499-01A-01W-0549-09	TCGA-13-1499-01A-01R-0479-07	
TCGA-13-1500-01	1	TCGA-13-1500-01	425	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	NA	TCGA-13-1500	NA	NA	days	425	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-1500-F24926	TCGA-13-1500	TCGA-13-1500-01A	Stage IIIC	-26172	NA	425	0	425	NA	253	NA	NA	NA	2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.2	NO	80	1.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1500.BFC92139-677F-4AD6-93D4-B479B8121449.pdf	1500	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.4	NA	NA	13	11-20 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-1500-01	NA	6bd685eb-c19d-404d-bb70-0d7590034653	NA	TCGA-13-1500-01	NA	TCGA-13-1500-01A-01D-0475-05	NA	TCGA-13-1500-01A-21-1562-20	NA	NA	TCGA-13-1500-01A-01D-0472-01	TCGA-13-1500-01	639afc90-9b92-45f2-a350-6b7e355bbcbc	NA	TCGA-13-1500-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1500-01	NA	NA	NA	TCGA-13-1500-01A-01R-0479-07	
TCGA-13-1501-01	1	TCGA-13-1501-01	1314	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1501	392	1	days	1314	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-13-1501-F72651	TCGA-13-1501	TCGA-13-1501-01A	Stage IV	-18393	NA	1314	0	999	NA	392	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.2	NO	80	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1501.7D27D441-D069-4674-A761-299E315D67C1.pdf	1501	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-13-1501-01	NA	cf8ec1d5-56c7-45b7-8208-58fc6f5d6aa6	NA	TCGA-13-1501-01	NA	TCGA-13-1501-01A-01D-0475-05	NA	TCGA-13-1501-01A-21-1562-20	NA	NA	TCGA-13-1501-01A-01D-0472-01	TCGA-13-1501-01	9f507427-22ed-408e-807f-39a90244bef4	NA	TCGA-13-1501-01A-01D-0472-01	NA	NA	NA	TCGA-13-1501-01A-01W-0545-08	TCGA-13-1501-01	NA	NA	TCGA-13-1501-01A-01W-0545-08	TCGA-13-1501-01A-01R-0479-07	
TCGA-13-1504-01	1	TCGA-13-1504-01	1059	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1504	548	1	days	1059	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	68	Bilateral	TCGA-13-1504-F72652	TCGA-13-1504	TCGA-13-1504-01A	Stage IIIC	-25008	NA	1059	0	504	NA	548	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	60	1.6	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1504.DB8A8258-9893-4968-A91B-5D9D319D0585.pdf	1504	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	NA	Ovary	NA	A	DECEASED	2007	NA	TCGA-13-1504-01	NA	6ad70118-653d-4476-b26c-4e276f556aaf	NA	TCGA-13-1504-01	NA	TCGA-13-1504-01A-01D-0475-05	NA	TCGA-13-1504-01A-21-1562-20	NA	NA	TCGA-13-1504-01A-01D-0472-01	TCGA-13-1504-01	f1e3f6ff-3c3d-4045-9ab3-bf5803828428	NA	TCGA-13-1504-01A-01D-0472-01	NA	NA	NA	TCGA-13-1504-01A-01W-0545-08	TCGA-13-1504-01	NA	NA	TCGA-13-1504-01A-01W-0545-08	TCGA-13-1504-01A-01R-0479-07	
TCGA-13-1505-01	0	TCGA-13-1505-01	1998	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1505	1561	1	days	1998	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-13-1505-F72674	TCGA-13-1505	TCGA-13-1505-01A	Stage IIIC	-23238	NA	NA	0	1998	NA	1561	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1505.ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF.pdf	1505	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-13-1505-01	TCGA-13-1505-01	NA	3237c7be-aa7d-47d1-8c46-8d6b4ce5d1c4	NA	TCGA-13-1505-01	NA	TCGA-13-1505-01A-01D-0475-05	NA	TCGA-13-1505-01A-21-1562-20	NA	7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-01	TCGA-13-1505-01	d15e55f3-d7f1-4276-9fe1-17cc18dc2515	NA	TCGA-13-1505-01A-01D-0472-01	7774b7d4-2935-4b9b-bf76-312a625629e1	NA	7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-08	TCGA-13-1505-01	TCGA-13-1505-01	7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-08	TCGA-13-1505-01A-01R-0479-07	
TCGA-13-1506-01	1	TCGA-13-1506-01	1039	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1506	666	1	days	1039	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-13-1506-F72675	TCGA-13-1506	TCGA-13-1506-01A	Stage IIIC	-16734	NA	1039	0	134	NA	666	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	80	1.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1506.88E423FF-4070-4F01-A0B0-41B45443E762.pdf	1506	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.2	NA	NA	13	NA	Ovary	NA	A	DECEASED	2008	TCGA-13-1506-01	TCGA-13-1506-01	NA	e9c25372-66bb-4c51-9b0f-8fb53262f48b	NA	TCGA-13-1506-01	NA	TCGA-13-1506-01A-01D-0475-05	TCGA-13-1506-01A-01W-0549-09	TCGA-13-1506-01A-21-1562-20	TCGA-13-1506-01A-01W-0549-09	927c7b6d-3997-453b-81b1-b947341d5819	TCGA-13-1506-01A-01D-0472-01	TCGA-13-1506-01	6bdc5656-6cff-48e4-9625-e953d683aed5	NA	TCGA-13-1506-01A-01D-0472-01	927c7b6d-3997-453b-81b1-b947341d5819	NA	927c7b6d-3997-453b-81b1-b947341d5819	NA	TCGA-13-1506-01	TCGA-13-1506-01	927c7b6d-3997-453b-81b1-b947341d5819	TCGA-13-1506-01A-01W-0549-09	TCGA-13-1506-01A-01R-0479-07	
TCGA-13-1507-01	1	TCGA-13-1507-01	1993	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1507	324	1	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	77	Bilateral	TCGA-13-1507-F72677	TCGA-13-1507	TCGA-13-1507-01A	Stage IIIC	-28445	NA	1993	0	145	NA	324	1	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.1	NO	60	2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1507.0B6D1513-8119-459C-8D5A-8942B8C31179.pdf	1507	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2008	TCGA-13-1507-01	TCGA-13-1507-01	NA	c374d509-5dff-45a7-bb49-b7e273b6f229	NA	TCGA-13-1507-01	NA	TCGA-13-1507-01A-01D-0475-05	TCGA-13-1507-01A-01W-0549-09	TCGA-13-1507-01A-21-1562-20	TCGA-13-1507-01A-01W-0549-09	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	TCGA-13-1507-01A-01D-0472-01	TCGA-13-1507-01	307d0834-99b0-416a-aafb-60d7ec74406f	NA	TCGA-13-1507-01A-01D-0472-01	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	NA	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	NA	TCGA-13-1507-01	TCGA-13-1507-01	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	TCGA-13-1507-01A-01W-0549-09	TCGA-13-1507-01A-01R-0479-07	
TCGA-13-1509-01	0	TCGA-13-1509-01	2438	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1509	578	1	days	2438	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Bilateral	TCGA-13-1509-F72678	TCGA-13-1509	TCGA-13-1509-01A	Stage IV	-23481	NA	NA	0	2438	NA	578	NA	NA	Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.5	NO	40	1.7	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1509.5FB47FA9-299B-4466-A324-20D44C788F8B.pdf	1509	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-13-1509-01	NA	36181328-ff8f-4ad6-9521-7020c689acfe	NA	TCGA-13-1509-01	NA	TCGA-13-1509-01A-01D-0475-05	TCGA-13-1509-01A-01W-0549-09	TCGA-13-1509-01A-21-1562-20	TCGA-13-1509-01A-01W-0549-09	NA	TCGA-13-1509-01A-01D-0472-01	TCGA-13-1509-01	a35cc137-a072-4287-8248-dbc4df213144	NA	TCGA-13-1509-01A-01D-0472-01	NA	NA	NA	NA	TCGA-13-1509-01	NA	NA	TCGA-13-1509-01A-01W-0549-09	TCGA-13-1509-01A-01R-0479-07	
TCGA-13-1510-01	1	TCGA-13-1510-01	1359	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1510	1189	1	days	1359	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Left	TCGA-13-1510-F72679	TCGA-13-1510	TCGA-13-1510-01A	Stage IIIC	-22708	NA	1359	0	78	NA	1189	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1510.D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D.pdf	1510	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2008	NA	TCGA-13-1510-01	NA	614859a5-6f16-4f6b-8c26-60646708c1ba	NA	TCGA-13-1510-01	NA	TCGA-13-1510-01A-02D-0475-05	NA	NA	NA	NA	TCGA-13-1510-01A-02D-0472-01	TCGA-13-1510-01	NA	NA	TCGA-13-1510-01A-02D-0472-01	NA	NA	NA	TCGA-13-1510-01A-02D-0472-08	TCGA-13-1510-01	NA	NA	TCGA-13-1510-01A-02D-0472-08	TCGA-13-1510-01A-02R-0479-07	
TCGA-13-1511-01	1	TCGA-13-1511-01	1650	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-13-1511	459	1	days	1650	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-13-1511-F72680	TCGA-13-1511	TCGA-13-1511-01A	Stage IV	-19258	NA	1650	0	119	NA	459	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.6	NO	60	2.2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1511.CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0.pdf	1511	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2008	TCGA-13-1511-01	TCGA-13-1511-01	NA	96a8f10e-4b72-4262-9ad7-3ba062ce7f85	NA	TCGA-13-1511-01	NA	TCGA-13-1511-01A-01D-0475-05	NA	TCGA-13-1511-01A-21-1562-20	NA	ccd83080-7a51-4952-b4af-d13e9c182bc0	TCGA-13-1511-01A-01D-0472-01	TCGA-13-1511-01	a5d23561-577b-4b73-979e-8908b15b223e	NA	TCGA-13-1511-01A-01D-0472-01	ccd83080-7a51-4952-b4af-d13e9c182bc0	NA	ccd83080-7a51-4952-b4af-d13e9c182bc0	NA	TCGA-13-1511-01	TCGA-13-1511-01	ccd83080-7a51-4952-b4af-d13e9c182bc0	NA	TCGA-13-1511-01A-01R-0479-07	
TCGA-13-1512-01	0	TCGA-13-1512-01	442	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-1512	427	1	days	442	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-13-1512-F72681	TCGA-13-1512	TCGA-13-1512-01A	Stage IIIC	-18134	NA	NA	0	442	NA	427	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1.4	NO	60	2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1512.66DC098E-9ADD-4446-AB6D-FEA35D5FD33B.pdf	1512	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2008	TCGA-13-1512-01	TCGA-13-1512-01	NA	59b113ee-0571-4e46-b437-9c48e04697eb	NA	TCGA-13-1512-01	NA	TCGA-13-1512-01A-01D-0475-05	NA	TCGA-13-1512-01A-21-1558-20	NA	67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01D-0472-01	TCGA-13-1512-01	70bd95ea-f6ca-4b5a-b744-e174576d1063	NA	TCGA-13-1512-01A-01D-0472-01	67e85198-4b8c-45db-b433-683b1899f3ea	NA	67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01W-0545-08	TCGA-13-1512-01	TCGA-13-1512-01	67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01W-0545-08	TCGA-13-1512-01A-01R-0479-07	
TCGA-13-1817-01	1	TCGA-13-1817-01	1024	1	days	High	NA	Cluster 6	OV-like c4	NA	NA	NA	NA	TCGA-13-1817	NA	NA	days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-13-1817-F24974	TCGA-13-1817	TCGA-13-1817-01A	Stage IIIC	-20771	NA	1024	0	1024	NA	541	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1817.76F55E61-714E-4C20-A9BD-2ECF28E5444F.pdf	1817	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2001	NA	NA	NA	aad798d8-5b4a-4f23-8ebe-fb68cb37fd51	NA	NA	NA	TCGA-13-1817-01A-01D-0807-05	NA	TCGA-13-1817-01A-21-1559-20	NA	NA	TCGA-13-1817-01A-01D-2069-01	TCGA-13-1817-01	82a5bb6f-81aa-4ba2-9a74-c0a7ea48cabc,cfa86d7b-f1c9-42b9-8d0e-dc7366aec542	NA	TCGA-13-1817-01A-01D-2069-01	NA	NA	NA	NA	TCGA-13-1817-01	NA	NA	NA	TCGA-13-1817-01A-01R-0810-07	
TCGA-13-1817-02	1	TCGA-13-1817-02	1024	1	days	NA	NA	Cluster 6	NA	NA	NA	NA	NA	TCGA-13-1817	NA	NA	days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-13-1817-F24974	TCGA-13-1817	TCGA-13-1817-02A	Stage IIIC	-20771	NA	1024	0	1024	NA	541	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-13-1817.AF88642C-B18E-4C22-A8B7-C6B2D259B4E9.pdf	1817	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.4	NA	NA	13	>20 mm	Ovary	NA	A	DECEASED	2001	NA	NA	NA	29cf6928-081b-4498-89b3-89bd24b61608	NA	NA	NA	TCGA-13-1817-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	5823971e-18e2-4fec-8872-a309b1a6914f	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-1817-02A-01R-0810-07	
TCGA-13-1819-01	1	TCGA-13-1819-01	2025	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-13-1819	429	1	days	2025	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Right	TCGA-13-1819-F72642	TCGA-13-1819	TCGA-13-1819-01A	Stage IIC	-21635	NA	2025	0	1946	NA	429	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1819.27225767-34C2-48F2-A347-867FDDC907E9.pdf	1819	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	NA	NA	NA	3816ef10-585d-4480-bee6-d3d3fe9cbef5	NA	NA	NA	TCGA-13-1819-01A-01D-0807-05	NA	TCGA-13-1819-01A-21-1559-20	NA	NA	TCGA-13-1819-01A-01D-2069-01	TCGA-13-1819-01	249b311f-42e8-4ae2-88a1-11e80c3c02f9,6b5c65d5-0279-43ca-80fb-ef142bf820b7	NA	TCGA-13-1819-01A-01D-2069-01	NA	NA	NA	NA	TCGA-13-1819-01	NA	NA	NA	TCGA-13-1819-01A-01R-0810-07	
TCGA-13-1819-02	1	TCGA-13-1819-02	2025	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-13-1819	429	1	days	2025	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Right	TCGA-13-1819-F72642	TCGA-13-1819	TCGA-13-1819-02A	Stage IIC	-21635	NA	2025	0	1946	NA	429	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2.1	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-1819.EABB4610-CCE8-4DC5-A416-0FABFA634056.pdf	1819	NA	WITH TUMOR	NA	NA	NA	NA	NA	Recurrent Tumor	02	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	NA	NA	NA	71492b0a-c202-4688-bb17-1828ed1d9d97	NA	NA	NA	TCGA-13-1819-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	f3945f2a-3281-446e-b8b9-d65ac2c770a9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-1819-02A-01R-0810-07	
TCGA-13-2057-01	0	TCGA-13-2057-01	2434	0	days	High	NA	UCEC Serous c4	NA	NA	NA	NA	NA	TCGA-13-2057	897	1	days	2434	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-13-2057-F72682	TCGA-13-2057	TCGA-13-2057-01A	Stage IIIC	-21554	NA	NA	0	2434	NA	897	NA	NA	Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	1.5	NO	60	3	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-2057.112EC7A2-A410-4D98-A974-BD6BF75E156F.pdf	2057	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	NA	NA	0b1c95cf-0eb2-4297-956e-85702b3bbbc3	NA	NA	NA	TCGA-13-2057-01A-02D-1047-05	NA	NA	TCGA-13-2057-01A-02D-1526-09	NA	TCGA-13-2057-01A-02D-1043-01	TCGA-13-2057-01	NA	NA	TCGA-13-2057-01A-02D-1043-01	NA	NA	NA	NA	TCGA-13-2057-01	NA	NA	NA	TCGA-13-2057-01A-02R-1050-07	
TCGA-13-2059-01	0	TCGA-13-2059-01	2387	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-13-2059	1005	1	days	2387	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-13-2059-F72684	TCGA-13-2059	TCGA-13-2059-01A	Stage IIIC	-18449	NA	NA	0	2387	NA	1005	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	80	2	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-2059.E3673116-F004-4011-A609-D8E1693DBA62.pdf	2059	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	96ef4c4d-9292-4281-b23d-8e29fe47119f	NA	NA	NA	TCGA-13-2059-01A-01D-1047-05	NA	TCGA-13-2059-01A-03-1563-20	TCGA-13-2059-01A-01D-1526-09	NA	TCGA-13-2059-01A-01D-1043-01	TCGA-13-2059-01	6af82345-1327-40dc-bbe3-1a4b5feb1da5	NA	TCGA-13-2059-01A-01D-1043-01	NA	NA	NA	NA	TCGA-13-2059-01	NA	NA	NA	TCGA-13-2059-01A-01R-1050-07	
TCGA-13-2060-01	0	TCGA-13-2060-01	2369	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-2060	1475	1	days	2369	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-13-2060-F72683	TCGA-13-2060	TCGA-13-2060-01A	Stage IV	-18635	NA	NA	0	2369	NA	1475	NA	NA	Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.5	NO	80	2.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-2060.F6986C14-4627-424E-81C5-74E1CE38D52D.pdf	2060	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-13-2060-01	TCGA-13-2060-01	NA	60beab4b-53c5-4c97-af8f-21f4076b4850	NA	TCGA-13-2060-01	NA	TCGA-13-2060-01A-01D-0708-05	NA	TCGA-13-2060-01A-21-1560-20	NA	32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01D-0704-01	TCGA-13-2060-01	19465a94-b5e9-4700-8f19-0724f72dd3a4	NA	TCGA-13-2060-01A-01D-0704-01	32de1e4d-198a-4616-8227-4d633c80124b	NA	32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01W-0799-08	TCGA-13-2060-01	TCGA-13-2060-01	32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01W-0799-08	TCGA-13-2060-01A-01R-0711-07	
TCGA-13-2061-01	0	TCGA-13-2061-01	2339	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-13-2061	2339	0	days	2339	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-13-2061-F72686	TCGA-13-2061	TCGA-13-2061-01A	Stage IIIC	-21543	NA	NA	0	2339	NA	NA	NA	NA	Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.5	NO	80	1.9	NA	NA	G3	NA	NA	NO	NA	NA	TCGA-13-2061.57D9D913-A6F9-4406-BF4D-0770004131D5.pdf	2061	Pre-Adjuvant Therapy	TUMOR FREE	NA	NA	NA	NA	NA	Primary Tumor	01	0.5	NA	NA	13	No Macroscopic disease	Ovary	NA	A	LIVING	2009	NA	NA	NA	7183ed35-46c8-49c5-b247-09d01df7f6de	NA	NA	NA	TCGA-13-2061-01A-01D-1047-05	NA	TCGA-13-2061-01A-03-1563-20	TCGA-13-2061-01A-01D-1526-09	NA	TCGA-13-2061-01A-01D-1043-01	TCGA-13-2061-01	7fd07232-c71d-43b3-8f05-8855c8028871	NA	TCGA-13-2061-01A-01D-1043-01	NA	NA	NA	NA	TCGA-13-2061-01	NA	NA	NA	TCGA-13-2061-01A-01R-1050-07	
TCGA-13-2065-01	0	TCGA-13-2065-01	1993	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-13-2065	946	1	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Bilateral	TCGA-13-2065-F72688	TCGA-13-2065	NA	Stage IIIC	-25973	NA	NA	0	1993	NA	946	NA	NA	Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	2065	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	LIVING	2009	NA	NA	NA	d020829d-93e8-4b1d-9b6e-006efc029547	NA	NA	NA	TCGA-13-2065-01A-01D-1047-05	NA	TCGA-13-2065-01A-03-1563-20	TCGA-13-2065-01A-01D-1526-09	NA	TCGA-13-2065-01A-01D-1043-01	TCGA-13-2065-01	c8f40939-b3f0-4392-bad8-38608d23f320	NA	TCGA-13-2065-01A-01D-1043-01	NA	NA	NA	NA	TCGA-13-2065-01	NA	NA	NA	TCGA-13-2065-01A-01R-1050-07	
TCGA-13-2066-01	1	TCGA-13-2066-01	2133	1	days	NA	NA	OV-like c1	UCEC-like c5	NA	NA	NA	NA	TCGA-13-2066	1028	1	days	2133	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-13-2066-F72687	TCGA-13-2066	NA	Stage IV	-18170	NA	2133	0	295	NA	1028	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	80	NA	NA	NA	G3	NA	NA	YES	NA	NA	NA	2066	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	NA	NA	NA	13	1-10 mm	Ovary	NA	NA	DECEASED	2009	NA	NA	NA	bfe15bbc-6ec4-4c49-b86d-4b01aa23093a	NA	NA	NA	TCGA-13-2066-01A-01D-1047-05	NA	TCGA-13-2066-01A-03-1562-20	TCGA-13-2066-01A-01D-1526-09	NA	NA	TCGA-13-2066-01	f2fa59a1-7ceb-4483-9925-3b2707f18d51	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-2066-01A-01R-1050-07	
TCGA-13-2071-01	1	TCGA-13-2071-01	773	1	days	Squamous	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-13-2071	322	1	days	773	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-13-2071-F72689	TCGA-13-2071	TCGA-13-2071-01A	Stage IV	-23367	NA	773	0	191	NA	322	NA	NA	Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	2	NO	80	2.5	NA	NA	G3	NA	NA	YES	NA	NA	TCGA-13-2071.882BE278-9263-466C-BF61-E30543690FD7.pdf	2071	Pre-Adjuvant Therapy	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.6	NA	NA	13	1-10 mm	Ovary	NA	A	DECEASED	2009	NA	NA	NA	97c72a04-f6a3-4f0e-89ca-8b6a47ee6d25	NA	NA	NA	TCGA-13-2071-01A-02D-1047-05	NA	NA	TCGA-13-2071-01A-02D-1526-09	NA	TCGA-13-2071-01A-02D-1043-01	TCGA-13-2071-01	NA	NA	TCGA-13-2071-01A-02D-1043-01	NA	NA	NA	NA	TCGA-13-2071-01	NA	NA	NA	TCGA-13-2071-01A-02R-1050-07	
TCGA-13-A5FT-01	0	TCGA-13-A5FT-01	2143	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-A5FT	2143	0	days	2143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-13-A5FT-F72595	TCGA-13-A5FT	TCGA-13-A5FT-01A	Stage IIIC	-24743	1211	NA	0	2143	NA	NA	NA	NA	Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	230	NA	NO	70	NA	NA	NA	G3	NA	NA	NO	true	No	TCGA-13-A5FT.B67517DE-A483-4563-8698-51CB95DC5CF1.pdf	A5FT	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	RX	Primary Tumor	01	NA	NO	YES	13	No Macroscopic disease	Ovary	NA	A	LIVING	2009	TCGA-13-A5FT-01	TCGA-13-A5FT-01	NA	NA	TCGA-13-A5FT-01A-11D-A409-05	TCGA-13-A5FT-01	NA	NA	NA	NA	NA	819ce36b-9256-4ea0-947f-694029850c9d	TCGA-13-A5FT-01A-11D-A402-01	NA	2066E3C1-00C3-4264-AA5A-A441AA209F55	TCGA-13-A5FT-01A-11R-A406-31	TCGA-13-A5FT-01A-11D-A402-01	819ce36b-9256-4ea0-947f-694029850c9d	TCGA-13-A5FT-01A-11R-A406-31	819ce36b-9256-4ea0-947f-694029850c9d	NA	NA	TCGA-13-A5FT-01	819ce36b-9256-4ea0-947f-694029850c9d	NA	NA	
TCGA-13-A5FU-01	1	TCGA-13-A5FU-01	256	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-13-A5FU	256	0	days	256	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	NA	TCGA-13-A5FU	TCGA-13-A5FU-01A	Stage IV	-22256	1151	256	0	NA	NA	NA	NA	NA	NA	2013-5-26	FEMALE	Serous Cystadenocarcinoma	No	C48.0	8441/3	C48.0	YES	Tumor resection	210	NA	NO	50	NA	NA	NA	G3	NA	NA	NO	true	No	TCGA-13-A5FU.81DED60F-76BC-47E8-A15C-4488C6FDA1A5.pdf	A5FU	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NA	NO	R2	Primary Tumor	01	NA	NO	YES	13	1-10 mm	Ovary	NA	A	DECEASED	2009	NA	TCGA-13-A5FU-01	NA	NA	TCGA-13-A5FU-01A-11D-A409-05	TCGA-13-A5FU-01	NA	NA	NA	NA	NA	NA	TCGA-13-A5FU-01A-11D-A402-01	NA	71773ABF-D6B1-46D1-BE6D-95F3B01E04A4	NA	TCGA-13-A5FU-01A-11D-A402-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-20-0987-01	1	TCGA-20-0987-01	701	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0987	NA	NA	days	701	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-20-0987-F25518	TCGA-20-0987	NA	Stage IIIC	-22287	NA	701	0	NA	NA	442	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0987	NA	WITH TUMOR	YES	NA	Physical Examination	NO	NA	Primary Tumor	01	NA	NA	NA	20	1-10 mm	Ovary	NA	NA	DECEASED	2004	NA	NA	NA	e770e1d2-f6bc-4fc0-87c5-15f0939a189b	NA	NA	NA	TCGA-20-0987-01A-02D-0432-05	NA	NA	NA	NA	TCGA-20-0987-01A-02D-0428-01	TCGA-20-0987-01	NA	NA	TCGA-20-0987-01A-02D-0428-01	NA	NA	NA	TCGA-20-0987-01A-02W-0486-08	TCGA-20-0987-01	NA	NA	TCGA-20-0987-01A-02W-0486-08	TCGA-20-0987-01A-02R-0436-07	
TCGA-20-0990-01	0	TCGA-20-0990-01	789	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0990	NA	NA	days	789	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-20-0990-F25523	TCGA-20-0990	TCGA-20-0990-01A	Stage IIIC	-27170	NA	NA	0	789	NA	871	1	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	0.6	NO	NA	0.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-20-0990.2380A6A4-8F10-40BE-BEE6-DCC116803763.pdf	0990	Post-Adjuvant Therapy	WITH TUMOR	YES	NA	Molecular Markers	NO	NA	Primary Tumor	01	0.3	NA	NA	20	NA	Ovary	NA	A	LIVING	2005	NA	TCGA-20-0990-01	NA	8179bb45-deba-42a6-9306-73030e4aa5d8	NA	TCGA-20-0990-01	NA	TCGA-20-0990-01A-01D-0432-05	NA	NA	NA	NA	TCGA-20-0990-01A-01D-0428-01	TCGA-20-0990-01	NA	NA	TCGA-20-0990-01A-01D-0428-01	NA	NA	NA	TCGA-20-0990-01A-01W-0486-08	TCGA-20-0990-01	NA	NA	TCGA-20-0990-01A-01W-0486-08	TCGA-20-0990-01A-01R-0436-07	
TCGA-20-0991-01	0	TCGA-20-0991-01	797	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-20-0991	NA	NA	days	797	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Right	TCGA-20-0991-F25530	TCGA-20-0991	NA	Stage IIB	-28694	NA	NA	0	797	NA	NA	0	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	0991	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	20	No Macroscopic disease	Ovary	NA	NA	LIVING	2006	NA	TCGA-20-0991-01	NA	bc5c2691-a35b-4548-99ed-7a3e6e95153f	NA	TCGA-20-0991-01	NA	TCGA-20-0991-01A-03D-0432-05	NA	NA	NA	NA	TCGA-20-0991-01A-03D-0428-01	TCGA-20-0991-01	NA	NA	TCGA-20-0991-01A-03D-0428-01	NA	NA	NA	TCGA-20-0991-01A-03D-0428-08	TCGA-20-0991-01	NA	NA	TCGA-20-0991-01A-03D-0428-08	TCGA-20-0991-01A-01R-0436-07	
TCGA-20-0996-01	0	TCGA-20-0996-01	2196	0	days	Kirc+	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-20-0996	NA	NA	days	2196	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-20-0996-F25533	TCGA-20-0996	NA	Stage IIIC	-21572	NA	NA	0	2196	NA	NA	0	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G2	NA	NA	NA	NA	NA	NA	0996	Post-Adjuvant Therapy	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	20	1-10 mm	Ovary	NA	NA	LIVING	2001	NA	NA	NA	c1396756-4582-49ae-ac88-857ff11b377d	NA	NA	NA	TCGA-20-0996-01A-03D-0432-05	NA	NA	NA	NA	TCGA-20-0996-01A-03D-0428-01	TCGA-20-0996-01	NA	NA	TCGA-20-0996-01A-03D-0428-01	NA	NA	NA	NA	TCGA-20-0996-01	NA	NA	NA	TCGA-20-0996-01A-02R-0436-07	
TCGA-20-1682-01	0	TCGA-20-1682-01	837	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-20-1682	NA	NA	days	837	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	Bilateral	TCGA-20-1682-F25540	TCGA-20-1682	TCGA-20-1682-01A	Stage IIIC	-20583	NA	NA	0	837	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1	NA	YES	GX	NA	NA	NA	NA	NA	TCGA-20-1682.cf49ea4d-478c-469d-ace2-7ef52b66a332.pdf	1682	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	20	11-20 mm	Ovary	YES	A	LIVING	2007	TCGA-20-1682-01	TCGA-20-1682-01	NA	3feadfdb-a932-4ead-8a20-59698a0655ae	NA	TCGA-20-1682-01	NA	TCGA-20-1682-01A-01D-0563-05	NA	TCGA-20-1682-01A-21-1558-20	TCGA-20-1682-01A-01W-0633-09	f03d023b-cba8-413d-a88d-0378ee7b7748	TCGA-20-1682-01A-01D-0559-01	TCGA-20-1682-01	a999220b-fed5-446d-8bba-c4c59428d473	NA	TCGA-20-1682-01A-01D-0559-01	f03d023b-cba8-413d-a88d-0378ee7b7748	NA	f03d023b-cba8-413d-a88d-0378ee7b7748	NA	TCGA-20-1682-01	TCGA-20-1682-01	f03d023b-cba8-413d-a88d-0378ee7b7748	NA	TCGA-20-1682-01A-01R-0566-07	
TCGA-20-1683-01	0	TCGA-20-1683-01	772	0	days	High	C9-OV	Cluster 6	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	NA	TCGA-20-1683	NA	NA	days	772	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-20-1683-F25544	TCGA-20-1683	TCGA-20-1683-01A	Stage IIIC	-24006	NA	NA	0	772	NA	618	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-20-1683.5a83e4b3-8be2-4628-bd4b-93d040b43856.pdf	1683	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease	Molecular Markers	NO	NA	Primary Tumor	01	0.4	NA	NA	20	No Macroscopic disease	Ovary	NA	A	LIVING	2007	TCGA-20-1683-01	TCGA-20-1683-01	NA	f44d8a5e-bb22-4961-bfa5-be4ba92c8729	NA	TCGA-20-1683-01	NA	TCGA-20-1683-01A-01D-0563-05	NA	TCGA-20-1683-01A-21-1558-20	TCGA-20-1683-01A-01W-0633-09	e78c6cd7-67f2-4ac8-9dd9-c46392459835	TCGA-20-1683-01A-01D-0559-01	TCGA-20-1683-01	78abd251-6a19-4b51-bd1d-7c8dba5f324e	NA	TCGA-20-1683-01A-01D-0559-01	e78c6cd7-67f2-4ac8-9dd9-c46392459835	NA	e78c6cd7-67f2-4ac8-9dd9-c46392459835	NA	TCGA-20-1683-01	TCGA-20-1683-01	e78c6cd7-67f2-4ac8-9dd9-c46392459835	NA	TCGA-20-1683-01A-01R-0566-07	
TCGA-20-1684-01	0	TCGA-20-1684-01	581	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-20-1684	NA	NA	days	581	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-20-1684-F25549	TCGA-20-1684	TCGA-20-1684-01A	Stage IIIC	-18755	NA	NA	0	581	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-20-1684.3ce61823-9e89-424f-9ce2-a8987420b2a9.pdf	1684	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	20	1-10 mm	Ovary	NO	A	LIVING	2007	TCGA-20-1684-01	TCGA-20-1684-01	NA	c0d9b7e3-7c05-4db3-a77e-ae8a6a4ab4e7	NA	TCGA-20-1684-01	NA	TCGA-20-1684-01A-01D-0563-05	NA	TCGA-20-1684-01A-21-1558-20	TCGA-20-1684-01A-01W-0633-09	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	TCGA-20-1684-01A-01D-0559-01	TCGA-20-1684-01	8ba9a6e5-3dc8-4e7b-80ca-17470663b495	NA	TCGA-20-1684-01A-01D-0559-01	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	NA	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	NA	TCGA-20-1684-01	TCGA-20-1684-01	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	NA	TCGA-20-1684-01A-01R-0566-07	
TCGA-20-1685-01	0	TCGA-20-1685-01	508	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-20-1685	NA	NA	days	508	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-20-1685-F25554	TCGA-20-1685	TCGA-20-1685-01A	Stage IIIC	-16745	NA	NA	0	508	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-20-1685.09b7c163-7ad3-42a2-bc06-32bd55f80327.pdf	1685	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	20	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-20-1685-01	TCGA-20-1685-01	NA	923bc90c-b380-4710-b062-5c3deb27de44	NA	TCGA-20-1685-01	NA	TCGA-20-1685-01A-01D-0563-05	NA	TCGA-20-1685-01A-21-1558-20	TCGA-20-1685-01A-01W-0633-09	9f6dd4ad-0130-46fe-9c49-72f378a753fe	TCGA-20-1685-01A-01D-0559-01	TCGA-20-1685-01	b1b57151-ff27-4b55-bf89-6e25a61f1060	NA	TCGA-20-1685-01A-01D-0559-01	9f6dd4ad-0130-46fe-9c49-72f378a753fe	NA	9f6dd4ad-0130-46fe-9c49-72f378a753fe	NA	TCGA-20-1685-01	TCGA-20-1685-01	9f6dd4ad-0130-46fe-9c49-72f378a753fe	NA	TCGA-20-1685-01A-01R-0566-07	
TCGA-20-1686-01	0	TCGA-20-1686-01	89	0	days	High	NA	OV-like c1	BRCA basal-like c6	NA	miRNA cluster 2	cluster 2	NA	TCGA-20-1686	NA	NA	days	89	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	75	Bilateral	TCGA-20-1686-F25559	TCGA-20-1686	TCGA-20-1686-01A	Stage IIIC	-27588	NA	NA	0	89	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.8	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-20-1686.c87ff195-1793-455a-bb19-e495a915befe.pdf	1686	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	20	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	TCGA-20-1686-01	NA	91fb24d3-6a1d-4fd1-9bf3-d891ab25017c	NA	TCGA-20-1686-01	NA	TCGA-20-1686-01A-01D-0563-05	NA	TCGA-20-1686-01A-21-1558-20	TCGA-20-1686-01A-01W-0633-09	NA	TCGA-20-1686-01A-01D-0559-01	TCGA-20-1686-01	92c3ac1c-3e84-4448-8587-8c95329d0549	NA	TCGA-20-1686-01A-01D-0559-01	NA	NA	NA	NA	TCGA-20-1686-01	NA	NA	NA	TCGA-20-1686-01A-01R-0566-07	
TCGA-20-1687-01	0	TCGA-20-1687-01	81	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-20-1687	NA	NA	days	81	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Bilateral	TCGA-20-1687-F25563	TCGA-20-1687	TCGA-20-1687-01A	Stage IV	-16961	NA	NA	0	81	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-20-1687.e966d90f-0e5f-42e6-b487-1f10fbef204f.pdf	1687	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	20	No Macroscopic disease	Ovary	NA	A	LIVING	2008	TCGA-20-1687-01	TCGA-20-1687-01	NA	7221f0cf-2235-4717-938b-425c949730e3	NA	TCGA-20-1687-01	NA	TCGA-20-1687-01A-01D-0563-05	NA	TCGA-20-1687-01A-21-1558-20	TCGA-20-1687-01A-01W-0633-09	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	TCGA-20-1687-01A-01D-0559-01	TCGA-20-1687-01	a3332b9e-1a9c-4a7e-81c0-e19de968609b	NA	TCGA-20-1687-01A-01D-0559-01	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	NA	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	NA	TCGA-20-1687-01	TCGA-20-1687-01	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	NA	TCGA-20-1687-01A-01R-0566-07	
TCGA-23-1021-01	1	TCGA-23-1021-01	1446	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1021	NA	NA	days	1446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Right	TCGA-23-1021-F25567	TCGA-23-1021	NA	Stage IV	-16484	NA	1446	0	1446	1181	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Locoregional Disease	YES	NA	NA	NA	NA	1021	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	>20 mm	Ovary	YES	NA	DECEASED	2004	NA	TCGA-23-1021-01	NA	eb55cb66-59d1-4b7c-a99e-3dd5e38cca85	NA	TCGA-23-1021-01	NA	TCGA-23-1021-01B-01D-0432-05	TCGA-23-1021-01B-01W-0488-09	NA	TCGA-23-1021-01B-01W-0488-09	NA	TCGA-23-1021-01B-01D-0428-01	TCGA-23-1021-01	NA	NA	TCGA-23-1021-01B-01D-0428-01	NA	NA	NA	NA	TCGA-23-1021-01	NA	NA	TCGA-23-1021-01B-01W-0488-09	TCGA-23-1021-01B-01R-0436-07	
TCGA-23-1022-01	1	TCGA-23-1022-01	1511	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1022	NA	NA	days	1511	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Left	TCGA-23-1022-F25576	TCGA-23-1022	TCGA-23-1022-01A	Stage IIIC	-24798	NA	1511	0	NA	NA	450	NA	NA	NA	2009-2-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.7	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1022.1A674838-E992-4E9B-82AE-FAFA0AD3BF56.pdf	1022	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	23	1-10 mm	Ovary	YES	A	DECEASED	2003	NA	TCGA-23-1022-01	NA	430ab09f-2d3f-4a3d-9aac-d6c678e983db	NA	TCGA-23-1022-01	NA	TCGA-23-1022-01A-02D-0432-05	TCGA-23-1022-01A-02W-0488-09	NA	TCGA-23-1022-01A-02W-0488-09	NA	TCGA-23-1022-01A-02D-0428-01	TCGA-23-1022-01	NA	NA	TCGA-23-1022-01A-02D-0428-01	NA	NA	NA	NA	TCGA-23-1022-01	NA	NA	TCGA-23-1022-01A-02W-0488-09	TCGA-23-1022-01A-01R-0436-07	
TCGA-23-1023-01	0	TCGA-23-1023-01	1233	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-23-1023	NA	NA	days	1233	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-23-1023-F25587	TCGA-23-1023	TCGA-23-1023-01R	Stage IIIC	-23826	NA	NA	0	1233	NA	490	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1023.98EBC356-C54E-4C1E-9726-BA61397DDA38.pdf	1023	NA	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	NA	Recurrent Tumor	02	0.3	NA	NA	23	1-10 mm	Ovary	YES	R	LIVING	2005	TCGA-23-1023-01	TCGA-23-1023-01	TCGA-23-1023-01A-03W-0484-10	fcd199f1-6a2a-4b56-977a-6e0959335ca9,d00090cb-c5e2-427f-bdee-5602808ec406	NA	TCGA-23-1023-01	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01A-03D-0432-05,TCGA-23-1023-01R-01D-0807-05	NA	NA	NA	1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf	TCGA-23-1023-01A-03D-0428-01	TCGA-23-1023-01	NA	NA	TCGA-23-1023-01A-03D-0428-01	1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf	NA	1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf	NA	TCGA-23-1023-01	TCGA-23-1023-01	69bec2db-02c3-46ca-b17b-60eae9a1e0bf,1c88dde8-4fe6-49e9-8d76-40668ed783ff	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01R-01R-0810-07,TCGA-23-1023-01A-02R-0436-07	
TCGA-23-1024-01	0	TCGA-23-1024-01	468	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1024	NA	NA	days	468	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Right	TCGA-23-1024-F25604	TCGA-23-1024	TCGA-23-1024-01A	Stage IV	-19052	NA	NA	0	468	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-23-1024.1CCE5978-6A4D-427A-9875-47617F6A4258.pdf	1024	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	23	1-10 mm	Ovary	NA	A	LIVING	2007	NA	TCGA-23-1024-01	TCGA-23-1024-01A-02W-0484-10	15e969ea-df91-4ade-9f5f-91f317ac7573	NA	TCGA-23-1024-01	TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01A-02D-0432-05	NA	NA	NA	NA	TCGA-23-1024-01A-02D-0428-01	TCGA-23-1024-01	NA	NA	TCGA-23-1024-01A-02D-0428-01	NA	NA	NA	NA	TCGA-23-1024-01	NA	NA	TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01A-02R-0436-07	
TCGA-23-1026-01	0	TCGA-23-1026-01	816	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-23-1026	NA	NA	days	816	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Left	TCGA-23-1026-F25610	TCGA-23-1026	TCGA-23-1026-01B	Stage IIIC	-16442	NA	NA	0	816	NA	797	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1026.E41E1018-422B-4B4A-8732-C9389847830D.pdf	1026	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	23	1-10 mm	Ovary	NA	B	LIVING	2004	TCGA-23-1026-01	TCGA-23-1026-01	TCGA-23-1026-01B-01W-0484-10	fca7646c-094b-4720-a550-f3e066f24431	NA	TCGA-23-1026-01	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01B-01D-0432-05	NA	NA	NA	973907c7-f259-4d1a-b9df-68db1837af91	TCGA-23-1026-01B-01D-0428-01	TCGA-23-1026-01	NA	NA	TCGA-23-1026-01B-01D-0428-01	973907c7-f259-4d1a-b9df-68db1837af91	NA	973907c7-f259-4d1a-b9df-68db1837af91	NA	TCGA-23-1026-01	TCGA-23-1026-01	973907c7-f259-4d1a-b9df-68db1837af91	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01B-01R-0436-07	
TCGA-23-1027-01	1	TCGA-23-1027-01	976	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1027	NA	NA	days	976	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Right	TCGA-23-1027-F25616	TCGA-23-1027	NA	Stage IIIC	-17588	NA	976	0	966	NA	114	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1027	NA	NA	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	YES	NA	DECEASED	2005	TCGA-23-1027-01	TCGA-23-1027-01	NA	acb73086-38dd-4ed6-9d1c-d14dcd155936	NA	TCGA-23-1027-01	NA	TCGA-23-1027-01A-02D-0432-05	NA	NA	NA	edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02D-0428-01	TCGA-23-1027-01	NA	NA	TCGA-23-1027-01A-02D-0428-01	edbc81a6-2593-45c5-8131-3c4615d1807f	NA	edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02W-0486-08	TCGA-23-1027-01	TCGA-23-1027-01	edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02W-0486-08	TCGA-23-1027-01A-02R-0436-07	
TCGA-23-1028-01	0	TCGA-23-1028-01	1503	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1028	NA	NA	days	1503	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	43	Left	TCGA-23-1028-F25624	TCGA-23-1028	TCGA-23-1028-01A	Stage IIIC	-16018	NA	NA	0	1503	NA	133	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.8	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1028.CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2.pdf	1028	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	23	1-10 mm	Ovary	YES	A	LIVING	2004	NA	TCGA-23-1028-01	TCGA-23-1028-01A-01W-0484-10	511adb99-1cae-481e-8da7-f4cdc4d5f385	NA	TCGA-23-1028-01	TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01A-01D-0432-05	NA	NA	NA	NA	TCGA-23-1028-01A-01D-0428-01	TCGA-23-1028-01	NA	NA	TCGA-23-1028-01A-01D-0428-01	NA	NA	NA	NA	TCGA-23-1028-01	NA	NA	TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01A-01R-0436-07	
TCGA-23-1029-01	0	TCGA-23-1029-01	268	0	days	Squamous	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-23-1029	NA	NA	days	268	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Right	TCGA-23-1029-F25639	TCGA-23-1029	TCGA-23-1029-01B	Stage IIIC	-16889	NA	NA	0	268	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-23-1029.89E1F403-12CB-442A-9588-CF5C0AC0E0A6.pdf	1029	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	23	1-10 mm	Ovary	NA	B	LIVING	2007	TCGA-23-1029-01	TCGA-23-1029-01	NA	fcd48515-450a-4a24-b92d-8fb4eb4890b3	NA	TCGA-23-1029-01	NA	TCGA-23-1029-01B-01D-0581-05	NA	NA	TCGA-23-1029-01B-01W-0639-09	9a54d0fe-f998-4866-bb1f-92be472d843a	TCGA-23-1029-01B-01D-0577-01	TCGA-23-1029-01	NA	NA	TCGA-23-1029-01B-01D-0577-01	9a54d0fe-f998-4866-bb1f-92be472d843a	NA	9a54d0fe-f998-4866-bb1f-92be472d843a	NA	TCGA-23-1029-01	TCGA-23-1029-01	9a54d0fe-f998-4866-bb1f-92be472d843a	NA	TCGA-23-1029-01B-01R-0584-07	
TCGA-23-1030-01	0	TCGA-23-1030-01	886	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1030	NA	NA	days	886	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-23-1030-F25643	TCGA-23-1030	NA	Stage IIIC	-23416	NA	NA	0	886	NA	544	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1030	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	YES	NA	LIVING	2006	NA	TCGA-23-1030-01	NA	b1f62bf0-8681-4b6d-ab78-a7c5757770a4	NA	TCGA-23-1030-01	NA	TCGA-23-1030-01A-02D-0432-05	NA	NA	NA	NA	TCGA-23-1030-01A-02D-0428-01	TCGA-23-1030-01	NA	NA	TCGA-23-1030-01A-02D-0428-01	NA	NA	NA	TCGA-23-1030-01A-02W-0486-08	TCGA-23-1030-01	NA	NA	TCGA-23-1030-01A-02W-0486-08	TCGA-23-1030-01A-02R-0436-07	
TCGA-23-1031-01	1	TCGA-23-1031-01	575	1	days	High	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 5	TCGA-23-1031	NA	NA	days	575	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Left	TCGA-23-1031-F25649	TCGA-23-1031	NA	Stage IV	-22225	NA	575	0	575	NA	NA	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1031	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	NA	NA	c85b3936-20a5-41cb-ad0d-d184c2c1f6d9	NA	NA	NA	TCGA-23-1031-01A-01D-0432-05	NA	NA	NA	NA	TCGA-23-1031-01A-01D-0428-01	TCGA-23-1031-01	NA	NA	TCGA-23-1031-01A-01D-0428-01	NA	NA	NA	TCGA-23-1031-01A-01W-0486-08	TCGA-23-1031-01	NA	NA	TCGA-23-1031-01A-01W-0486-08	TCGA-23-1031-01A-01R-0436-07	
TCGA-23-1032-01	1	TCGA-23-1032-01	84	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1032	NA	NA	days	84	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Right	TCGA-23-1032-F25659	TCGA-23-1032	TCGA-23-1032-01A	Stage IV	-26715	NA	84	0	68	NA	NA	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50.pdf	1032	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-23-1032-01	NA	986863dd-b61b-48c2-a37c-af21fed7e778	NA	TCGA-23-1032-01	NA	TCGA-23-1032-01A-02D-0432-05	NA	NA	NA	NA	TCGA-23-1032-01A-02D-0428-01	TCGA-23-1032-01	NA	NA	TCGA-23-1032-01A-02D-0428-01	NA	NA	NA	TCGA-23-1032-01A-02W-0486-08	TCGA-23-1032-01	NA	NA	TCGA-23-1032-01A-02W-0486-08	TCGA-23-1032-01A-02R-0436-07	
TCGA-23-1107-01	1	TCGA-23-1107-01	9	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-23-1107	NA	NA	days	9	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Left	TCGA-23-1107-F25661	TCGA-23-1107	TCGA-23-1107-01A	Stage IV	-21561	NA	9	0	9	NA	NA	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-23-1107.700802e6-8058-4485-8210-3e5b8f10bbf3.pdf	1107	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	>20 mm	Ovary	NA	A	DECEASED	1999	NA	TCGA-23-1107-01	TCGA-23-1107-01A-01W-0484-10	7f426322-5acf-4d04-8bd6-93ec56bffd0f	NA	TCGA-23-1107-01	TCGA-23-1107-01A-01W-0484-10	TCGA-23-1107-01A-01D-0432-05	NA	NA	NA	NA	NA	TCGA-23-1107-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-23-1107-01A-01R-0436-07	
TCGA-23-1109-01	1	TCGA-23-1109-01	1562	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	NA	TCGA-23-1109	NA	NA	days	1562	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	62	Right	TCGA-23-1109-F25663	TCGA-23-1109	NA	Stage IIIC	-23002	NA	1562	0	1562	NA	987	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1109	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	NA	NA	DECEASED	1999	TCGA-23-1109-01	TCGA-23-1109-01	TCGA-23-1109-01A-01W-0484-10	ef6ecfd8-badc-4863-a3d5-fc20161f09dc	NA	TCGA-23-1109-01	TCGA-23-1109-01A-01W-0484-10	TCGA-23-1109-01A-01D-0432-05	NA	TCGA-23-1109-01A-21-1562-20	NA	d47e074a-f78e-40c5-8af4-f737ce010041	TCGA-23-1109-01A-01D-0428-01	TCGA-23-1109-01	b8d71b4b-6d11-47da-b15d-a3eac835a9a9	NA	TCGA-23-1109-01A-01D-0428-01	d47e074a-f78e-40c5-8af4-f737ce010041	NA	d47e074a-f78e-40c5-8af4-f737ce010041	NA	TCGA-23-1109-01	TCGA-23-1109-01	d47e074a-f78e-40c5-8af4-f737ce010041	NA	TCGA-23-1109-01A-01R-0436-07	
TCGA-23-1110-01	0	TCGA-23-1110-01	1658	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-23-1110	NA	NA	days	1658	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Right	TCGA-23-1110-F25666	TCGA-23-1110	TCGA-23-1110-01A	Stage IIIC	-15383	NA	NA	0	1658	NA	326	NA	NA	NA	2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1110.07361efd-0b7d-4dcb-afe3-464200f59ac0.pdf	1110	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	23	No Macroscopic disease	Ovary	YES	A	LIVING	2003	NA	TCGA-23-1110-01	NA	811e848e-6289-4821-8640-c645e2b3f57e	NA	TCGA-23-1110-01	NA	TCGA-23-1110-01A-01D-0432-05	NA	TCGA-23-1110-01A-11-1562-20	NA	NA	TCGA-23-1110-01A-01D-0428-01	TCGA-23-1110-01	e36ba512-a711-4e42-80ce-94edb0be836e	NA	TCGA-23-1110-01A-01D-0428-01	NA	NA	NA	TCGA-23-1110-01A-01D-0428-08	TCGA-23-1110-01	NA	NA	TCGA-23-1110-01A-01D-0428-08	TCGA-23-1110-01A-01R-0436-07	
TCGA-23-1111-01	0	TCGA-23-1111-01	98	0	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-23-1111	NA	NA	days	98	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Right	TCGA-23-1111-F25672	TCGA-23-1111	TCGA-23-1111-01A	Stage IIIC	-23171	NA	NA	0	98	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	0.9	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-1111.ba3ae03c-74d4-4b5f-849f-71466bae7c0e.pdf	1111	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	23	>20 mm	Ovary	NA	A	LIVING	2008	TCGA-23-1111-01	TCGA-23-1111-01	NA	190f5d18-230f-417f-b10c-992c28dcf418	NA	TCGA-23-1111-01	NA	TCGA-23-1111-01A-01D-0581-05	NA	TCGA-23-1111-01A-21-20	TCGA-23-1111-01A-01W-0639-09	f38e46dc-67b9-448a-8d24-507291e55bca	TCGA-23-1111-01A-01D-0577-01	TCGA-23-1111-01	8e14b0f8-af54-486f-9ecc-8b62eb434ad4	NA	TCGA-23-1111-01A-01D-0577-01	f38e46dc-67b9-448a-8d24-507291e55bca	NA	f38e46dc-67b9-448a-8d24-507291e55bca	NA	TCGA-23-1111-01	TCGA-23-1111-01	f38e46dc-67b9-448a-8d24-507291e55bca	NA	TCGA-23-1111-01A-01R-0584-07	
TCGA-23-1113-01	1	TCGA-23-1113-01	949	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-23-1113	NA	NA	days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Left	TCGA-23-1113-F25677	TCGA-23-1113	NA	Stage IV	-17791	NA	949	0	NA	NA	NA	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	1113	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	NA	NA	DECEASED	2002	NA	TCGA-23-1113-01	NA	a418120d-175f-4f72-b81f-02528d563418	NA	TCGA-23-1113-01	NA	TCGA-23-1113-01A-01D-0432-05	NA	NA	NA	NA	TCGA-23-1113-01A-01D-0428-01	TCGA-23-1113-01	NA	NA	TCGA-23-1113-01A-01D-0428-01	NA	NA	NA	NA	TCGA-23-1113-01	NA	NA	NA	TCGA-23-1113-01A-01R-0436-07	
TCGA-23-1114-01	1	TCGA-23-1114-01	2089	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-23-1114	NA	NA	days	2089	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Left	TCGA-23-1114-F25685	TCGA-23-1114	TCGA-23-1114-01B	Stage IIIC	-20409	NA	2089	0	2089	NA	634	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1114.d5c00586-d7e4-4909-be2b-ffc4f9ef2e82.pdf	1114	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	23	No Macroscopic disease	Ovary	NA	B	DECEASED	2000	TCGA-23-1114-01	TCGA-23-1114-01	NA	7ee203ae-339a-4534-9e72-0dd723890ad1	NA	TCGA-23-1114-01	NA	TCGA-23-1114-01B-01D-0563-05	NA	NA	TCGA-23-1114-01B-01W-0633-09	7cfe1419-65be-4860-9f99-75f4a139d9ac	TCGA-23-1114-01B-01D-0559-01	TCGA-23-1114-01	NA	NA	TCGA-23-1114-01B-01D-0559-01	7cfe1419-65be-4860-9f99-75f4a139d9ac	NA	7cfe1419-65be-4860-9f99-75f4a139d9ac	NA	TCGA-23-1114-01	TCGA-23-1114-01	7cfe1419-65be-4860-9f99-75f4a139d9ac	NA	TCGA-23-1114-01B-01R-0566-07	
TCGA-23-1116-01	1	TCGA-23-1116-01	592	1	days	High	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 8	TCGA-23-1116	286	1	days	592	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	83	Left	TCGA-23-1116-F72416	TCGA-23-1116	NA	Stage IIIC	-30464	NA	592	0	139	NA	286	NA	Additional New Tumor Event	Progressive Disease	2015-6-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NO	YES	G3	Recurrence	NA	YES	NA	NA	NA	1116	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	>20 mm	Ovary	YES	NA	DECEASED	2008	NA	NA	NA	e7a2e1cf-9175-4d4b-9f6a-ccace71a5267	NA	NA	NA	TCGA-23-1116-01A-01D-0432-05	NA	NA	NA	NA	TCGA-23-1116-01A-01D-0428-01	TCGA-23-1116-01	NA	NA	TCGA-23-1116-01A-01D-0428-01	NA	NA	NA	TCGA-23-1116-01A-01W-0486-08	TCGA-23-1116-01	NA	NA	TCGA-23-1116-01A-01W-0486-08	TCGA-23-1116-01A-01R-0436-07	
TCGA-23-1117-01	1	TCGA-23-1117-01	1013	1	days	High	NA	OV-like c1	NA	NA	NA	NA	mutation cluster 8	TCGA-23-1117	NA	NA	days	1013	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Left	TCGA-23-1117-F25699	TCGA-23-1117	TCGA-23-1117-01A	Stage IIIC	-15690	NA	1013	0	NA	NA	418	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.7	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1117.abc636a1-677d-49e5-9259-5b5b828a575e.pdf	1117	NA	WITH TUMOR	NO	Complete Remission/Response	Other Method	YES	NA	Primary Tumor	01	0.4	NA	NA	23	1-10 mm	Ovary	YES	A	DECEASED	1998	NA	NA	NA	7cf2b05a-4475-44db-af64-1889f8073941	NA	NA	NA	TCGA-23-1117-01A-02D-0432-05	TCGA-23-1117-01A-02W-0488-09	NA	TCGA-23-1117-01A-02W-0488-09	NA	TCGA-23-1117-01A-02D-0428-01	TCGA-23-1117-01	NA	NA	TCGA-23-1117-01A-02D-0428-01	NA	NA	NA	NA	TCGA-23-1117-01	NA	NA	TCGA-23-1117-01A-02W-0488-09	TCGA-23-1117-01A-02R-0436-07	
TCGA-23-1118-01	0	TCGA-23-1118-01	2616	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1118	NA	NA	days	2616	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Left	TCGA-23-1118-F25708	TCGA-23-1118	NA	Stage IIIC	-16471	NA	NA	0	2616	NA	NA	NA	NA	NA	2009-2-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	1118	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	>20 mm	Ovary	YES	NA	LIVING	2001	NA	TCGA-23-1118-01	NA	cbd86cfc-faa7-40dd-a544-3c0dba5849aa	NA	TCGA-23-1118-01	NA	TCGA-23-1118-01A-01D-0432-05	TCGA-23-1118-01A-01W-0488-09	NA	TCGA-23-1118-01A-01W-0488-09	NA	TCGA-23-1118-01A-01D-0428-01	TCGA-23-1118-01	NA	NA	TCGA-23-1118-01A-01D-0428-01	NA	NA	NA	NA	TCGA-23-1118-01	NA	NA	TCGA-23-1118-01A-01W-0488-09	TCGA-23-1118-01A-01R-0436-07	
TCGA-23-1119-01	0	TCGA-23-1119-01	3953	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	NA	TCGA-23-1119	NA	NA	days	3953	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-23-1119-F25711	TCGA-23-1119	TCGA-23-1119-01A	Stage IIIC	-23686	NA	NA	0	3953	NA	3378	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1119.86389912-6945-49e6-9255-e7a41fde197a.pdf	1119	NA	TUMOR FREE	YES	Complete Remission/Response	Other Method	NO	NA	Primary Tumor	01	0.6	NA	NA	23	1-10 mm	Ovary	YES	A	LIVING	1997	NA	TCGA-23-1119-01	TCGA-23-1119-01A-02W-0484-10	14dd1630-da1d-47ca-bae2-457903a26761	NA	TCGA-23-1119-01	TCGA-23-1119-01A-02W-0484-10	TCGA-23-1119-01A-02D-0432-05	NA	NA	NA	NA	TCGA-23-1119-01A-02D-0428-01	TCGA-23-1119-01	NA	NA	TCGA-23-1119-01A-02D-0428-01	NA	NA	NA	NA	TCGA-23-1119-01	NA	NA	NA	TCGA-23-1119-01A-02R-0436-07	
TCGA-23-1120-01	0	TCGA-23-1120-01	130	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 2	TCGA-23-1120	NA	NA	days	130	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Right	TCGA-23-1120-F25715	TCGA-23-1120	TCGA-23-1120-01A	Stage IIIC	-22148	NA	NA	0	130	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.8	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-23-1120.e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37.pdf	1120	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-23-1120-01	TCGA-23-1120-01	TCGA-23-1120-01A-02W-0484-10	0486be96-3c9f-41a7-9115-295646258378	NA	TCGA-23-1120-01	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01A-02D-0432-05	NA	NA	NA	9b64998e-eed9-428b-97ac-4de398caaf81	TCGA-23-1120-01A-02D-0428-01	TCGA-23-1120-01	NA	NA	TCGA-23-1120-01A-02D-0428-01	9b64998e-eed9-428b-97ac-4de398caaf81	NA	9b64998e-eed9-428b-97ac-4de398caaf81	NA	TCGA-23-1120-01	TCGA-23-1120-01	9b64998e-eed9-428b-97ac-4de398caaf81	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01A-02R-0436-07	
TCGA-23-1121-01	0	TCGA-23-1121-01	194	0	days	High	NA	Cluster 5	OV-like c4	NA	miRNA cluster 1	cluster 5	NA	TCGA-23-1121	NA	NA	days	194	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Left	TCGA-23-1121-F25719	TCGA-23-1121	TCGA-23-1121-01A	Stage IIIC	-18983	NA	NA	0	194	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-1121.ed14039c-9ecf-4e01-9a1c-7a227847b8a3.pdf	1121	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	>20 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-23-1121-01	NA	e3fca11d-248c-4852-ad4b-09867693fd39	NA	TCGA-23-1121-01	NA	TCGA-23-1121-01A-01D-0432-05	NA	TCGA-23-1121-01A-11-1562-20	NA	NA	TCGA-23-1121-01A-01D-0428-01	TCGA-23-1121-01	97eb2839-fc59-4c0a-a075-b5fd802799c6	NA	TCGA-23-1121-01A-01D-0428-01	NA	NA	NA	NA	TCGA-23-1121-01	NA	NA	NA	TCGA-23-1121-01A-01R-0436-07	
TCGA-23-1122-01	1	TCGA-23-1122-01	1189	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1122	NA	NA	days	1189	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Left	TCGA-23-1122-F25724	TCGA-23-1122	TCGA-23-1122-01A	Stage IIIC	-19537	NA	1189	0	NA	NA	447	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba.pdf	1122	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	23	1-10 mm	Ovary	NA	A	DECEASED	1998	TCGA-23-1122-01	TCGA-23-1122-01	NA	c619e051-c770-4ed9-957b-b27ec8784864	NA	TCGA-23-1122-01	NA	TCGA-23-1122-01A-01D-0432-05	NA	TCGA-23-1122-01A-11-1562-20	NA	54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01D-0428-01	TCGA-23-1122-01	2877f544-7459-4a43-9e89-a014008f6a58	NA	TCGA-23-1122-01A-01D-0428-01	54b75801-ad36-49a1-b0c2-edc0053b897e	NA	54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01W-0486-08	TCGA-23-1122-01	TCGA-23-1122-01	54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01W-0486-08	TCGA-23-1122-01A-01R-0436-07	
TCGA-23-1123-01	1	TCGA-23-1123-01	1018	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1123	NA	NA	days	1018	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Left	TCGA-23-1123-F25733	TCGA-23-1123	TCGA-23-1123-01A	Stage IIIC	-21552	NA	1018	0	NA	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-1123.28f9189b-24eb-4540-8551-4eaacc296c20.pdf	1123	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	11-20 mm	Ovary	NA	A	DECEASED	1998	TCGA-23-1123-01	TCGA-23-1123-01	NA	c7657407-5f4d-441a-a943-90315de8c660	NA	TCGA-23-1123-01	NA	TCGA-23-1123-01A-01D-0432-05	TCGA-23-1123-01A-01W-0488-09	TCGA-23-1123-01A-11-1562-20	TCGA-23-1123-01A-01W-0488-09	71543abc-9f15-48d9-994d-e7b963a4d8f3	TCGA-23-1123-01A-01D-0428-01	TCGA-23-1123-01	184da43f-2906-495a-a714-031b30a78cdb	NA	TCGA-23-1123-01A-01D-0428-01	71543abc-9f15-48d9-994d-e7b963a4d8f3	NA	71543abc-9f15-48d9-994d-e7b963a4d8f3	NA	TCGA-23-1123-01	TCGA-23-1123-01	71543abc-9f15-48d9-994d-e7b963a4d8f3	TCGA-23-1123-01A-01W-0488-09	TCGA-23-1123-01A-01R-0436-07	
TCGA-23-1124-01	1	TCGA-23-1124-01	1768	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-1124	NA	NA	days	1768	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Left	TCGA-23-1124-F25739	TCGA-23-1124	NA	Stage IIIC	-23005	NA	1768	0	NA	NA	641	NA	NA	NA	2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1124	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	NA	NA	NA	23	No Macroscopic disease	Ovary	YES	NA	DECEASED	1999	NA	TCGA-23-1124-01	NA	e707d0a2-6e26-48dc-9020-ae36b666321a	NA	TCGA-23-1124-01	NA	TCGA-23-1124-01A-01D-0432-05	TCGA-23-1124-01A-01W-0488-09	TCGA-23-1124-01A-11-1562-20	TCGA-23-1124-01A-01W-0488-09	NA	TCGA-23-1124-01A-01D-0428-01	TCGA-23-1124-01	fe87e0a2-b27c-402c-81d8-ec0d24e7ce81	NA	TCGA-23-1124-01A-01D-0428-01	NA	NA	NA	NA	TCGA-23-1124-01	NA	NA	TCGA-23-1124-01A-01W-0488-09	TCGA-23-1124-01A-01R-0436-07	
TCGA-23-1809-01	0	TCGA-23-1809-01	16	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-23-1809	NA	NA	days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Right	TCGA-23-1809-F25753	TCGA-23-1809	TCGA-23-1809-01A	Stage IIC	-23111	NA	NA	0	16	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.9	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-23-1809.f69b3aba-61df-4fd8-94d7-9bb80692464c.pdf	1809	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	23	1-10 mm	Ovary	NO	A	LIVING	2009	TCGA-23-1809-01	TCGA-23-1809-01	NA	2bf22a99-e464-4889-9c1c-0208d5df2f36	NA	TCGA-23-1809-01	NA	TCGA-23-1809-01A-01D-0563-05	NA	TCGA-23-1809-01A-21-1559-20	TCGA-23-1809-01A-01W-0633-09	ac764277-4d48-489a-8625-f27541b11258	TCGA-23-1809-01A-01D-0559-01	TCGA-23-1809-01	2341af5b-d30e-4ae0-9384-119f66a797ed	NA	TCGA-23-1809-01A-01D-0559-01	ac764277-4d48-489a-8625-f27541b11258	NA	ac764277-4d48-489a-8625-f27541b11258	NA	TCGA-23-1809-01	TCGA-23-1809-01	ac764277-4d48-489a-8625-f27541b11258	NA	TCGA-23-1809-01A-01R-0566-07	
TCGA-23-2072-01	1	TCGA-23-2072-01	759	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-2072	NA	NA	days	759	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-23-2072-F25757	TCGA-23-2072	TCGA-23-2072-01A	Stage IV	-21523	NA	759	0	NA	NA	476	NA	NA	NA	2009-11-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e.pdf	2072	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	23	>20 mm	Ovary	NA	A	DECEASED	2000	NA	TCGA-23-2072-01	NA	5ba9bc54-191b-4a8b-8571-24a780a2e7d5	NA	TCGA-23-2072-01	NA	TCGA-23-2072-01A-01D-0667-05	NA	NA	NA	NA	TCGA-23-2072-01A-01D-0663-01	TCGA-23-2072-01	NA	NA	TCGA-23-2072-01A-01D-0663-01	NA	NA	NA	TCGA-23-2072-01A-01W-0722-08	TCGA-23-2072-01	NA	NA	TCGA-23-2072-01A-01W-0722-08	TCGA-23-2072-01A-01R-0670-07	
TCGA-23-2077-01	0	TCGA-23-2077-01	3525	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-23-2077	NA	NA	days	3525	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Left	TCGA-23-2077-F25763	TCGA-23-2077	TCGA-23-2077-01A	Stage IIIC	-16552	NA	NA	0	3525	NA	1232	NA	NA	NA	2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-23-2077.55589297-f28e-422c-beee-6cb19a2350be.pdf	2077	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	23	No Macroscopic disease	Ovary	YES	A	LIVING	1999	TCGA-23-2077-01	TCGA-23-2077-01	NA	2db607b0-cd7f-4686-9f85-a119b089ed7f	NA	TCGA-23-2077-01	NA	TCGA-23-2077-01A-01D-0667-05	NA	TCGA-23-2077-01A-21-1560-20	NA	16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01D-0663-01	TCGA-23-2077-01	3848ccad-5f29-40f6-8407-05e548a3b8e5	NA	TCGA-23-2077-01A-01D-0663-01	16c61c5a-a9b3-4022-9b79-d593e3519794	NA	16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01W-0722-08	TCGA-23-2077-01	TCGA-23-2077-01	16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01W-0722-08	TCGA-23-2077-01A-01R-0670-07	
TCGA-23-2078-01	0	TCGA-23-2078-01	2661	0	days	Squamous	C9-OV	OV-like c1	KIRC-like c1	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-2078	NA	NA	days	2661	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Bilateral	TCGA-23-2078-F25771	TCGA-23-2078	TCGA-23-2078-01A	Stage IIIC	-24223	NA	NA	0	2661	NA	NA	NA	NA	NA	2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.9	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-2078.19ed5fbe-17e1-43f3-bfa0-32f474a00be8.pdf	2078	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	23	No Macroscopic disease	Ovary	YES	A	LIVING	2001	TCGA-23-2078-01	TCGA-23-2078-01	NA	ec2fe757-24f2-4ffc-bf20-f6d6632eb775	NA	TCGA-23-2078-01	NA	TCGA-23-2078-01A-01D-0667-05	NA	TCGA-23-2078-01A-21-1560-20	NA	9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01D-0663-01	TCGA-23-2078-01	5ea02416-3cd8-443c-8336-4ad367757f38	NA	TCGA-23-2078-01A-01D-0663-01	9f35075d-4d81-44f2-a672-12028d6231be	NA	9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01W-0722-08	TCGA-23-2078-01	TCGA-23-2078-01	9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01W-0722-08	TCGA-23-2078-01A-01R-0670-07	
TCGA-23-2079-01	0	TCGA-23-2079-01	2788	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-23-2079	NA	NA	days	2788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	46	Bilateral	TCGA-23-2079-F25775	TCGA-23-2079	TCGA-23-2079-01A	Stage IIIC	-17122	NA	NA	0	2788	NA	283	NA	NA	NA	2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-2079.66ace408-fc31-463b-a218-94fdef0afaaf.pdf	2079	NA	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	23	No Macroscopic disease	Ovary	YES	A	LIVING	2001	NA	TCGA-23-2079-01	NA	6bbbfad0-800f-4537-99f2-6d5f1e5bdab0	NA	TCGA-23-2079-01	NA	TCGA-23-2079-01A-01D-0667-05	NA	TCGA-23-2079-01A-21-1560-20	NA	NA	TCGA-23-2079-01A-01D-0663-01	TCGA-23-2079-01	527e6a80-10fe-4b9d-9169-63ea62681e4a	NA	TCGA-23-2079-01A-01D-0663-01	NA	NA	NA	TCGA-23-2079-01A-01W-0722-08	TCGA-23-2079-01	NA	NA	TCGA-23-2079-01A-01W-0722-08	TCGA-23-2079-01A-01R-0670-07	
TCGA-23-2081-01	1	TCGA-23-2081-01	2342	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-2081	NA	NA	days	2342	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-23-2081-F25781	TCGA-23-2081	TCGA-23-2081-01A	Stage IV	-18162	NA	2342	0	NA	250	NA	NA	NA	NA	2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	YES	G3	Locoregional Disease	YES	NA	NA	NA	TCGA-23-2081.05dc597f-052a-461e-a67c-27dac0d10972.pdf	2081	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	23	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-23-2081-01	TCGA-23-2081-01	NA	c5bdab9f-b9fc-4f96-bc7b-b5a65ec3cf68	NA	TCGA-23-2081-01	NA	TCGA-23-2081-01A-01D-0667-05	NA	TCGA-23-2081-01A-21-1560-20	NA	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01D-0663-01	TCGA-23-2081-01	330a8af7-1a12-46a0-8ede-ca4e244de117	NA	TCGA-23-2081-01A-01D-0663-01	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	NA	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01W-0722-08	TCGA-23-2081-01	TCGA-23-2081-01	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01W-0722-08	TCGA-23-2081-01A-01R-0670-07	
TCGA-23-2084-01	1	TCGA-23-2084-01	1516	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-23-2084	NA	NA	days	1516	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Right	TCGA-23-2084-F25795	TCGA-23-2084	TCGA-23-2084-01A	Stage IV	-16493	NA	1516	0	NA	NA	619	NA	NA	NA	2009-11-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.4	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc.pdf	2084	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	23	No Macroscopic disease	Ovary	YES	A	DECEASED	2000	TCGA-23-2084-01	TCGA-23-2084-01	NA	6c08e99a-bd74-4e72-8d22-4295edfe6225	NA	TCGA-23-2084-01	NA	TCGA-23-2084-01A-02D-0667-05	NA	NA	NA	858a382c-49dc-4990-8c0f-017fedd9a6db	TCGA-23-2084-01A-02D-0663-01	TCGA-23-2084-01	NA	NA	TCGA-23-2084-01A-02D-0663-01	858a382c-49dc-4990-8c0f-017fedd9a6db	NA	858a382c-49dc-4990-8c0f-017fedd9a6db	NA	TCGA-23-2084-01	TCGA-23-2084-01	858a382c-49dc-4990-8c0f-017fedd9a6db	NA	TCGA-23-2084-01A-02R-0670-07	
TCGA-23-2641-01	0	TCGA-23-2641-01	84	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-23-2641	NA	NA	days	84	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	85	Left	TCGA-23-2641-F25810	TCGA-23-2641	TCGA-23-2641-01A	Stage IIIC	-31232	NA	NA	0	84	NA	NA	NA	NA	NA	2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-2641.0b8f79ba-dbf1-4978-9661-bb0b0dcc8768.pdf	2641	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	23	1-10 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	c7559a8a-552e-44e1-97dd-d3a333a5e283	NA	NA	NA	TCGA-23-2641-01A-01D-1047-05	NA	TCGA-23-2641-01A-21-20	TCGA-23-2641-01A-01D-1526-09	NA	TCGA-23-2641-01A-01D-1043-01	TCGA-23-2641-01	42dc7e58-4deb-4a79-8b08-67295835b807	NA	TCGA-23-2641-01A-01D-1043-01	NA	NA	NA	NA	TCGA-23-2641-01	NA	NA	NA	TCGA-23-2641-01A-01R-1050-07	
TCGA-23-2643-01	0	TCGA-23-2643-01	143	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-23-2643	NA	NA	days	143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Right	TCGA-23-2643-F25812	TCGA-23-2643	TCGA-23-2643-01A	Stage IIIC	-27093	NA	NA	0	143	NA	NA	NA	NA	NA	2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-23-2643.8481bd3e-147d-4a67-acdd-08fea5be431a.pdf	2643	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	23	1-10 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	02d0fc82-4de5-4543-88e1-b069652b6c4b	NA	NA	NA	TCGA-23-2643-01A-01D-1047-05	NA	TCGA-23-2643-01A-21-20	TCGA-23-2643-01A-01D-1526-09	NA	TCGA-23-2643-01A-01D-1043-01	TCGA-23-2643-01	061c8e23-337c-49f7-84bb-9289b1e71595	NA	TCGA-23-2643-01A-01D-1043-01	NA	NA	NA	NA	TCGA-23-2643-01	NA	NA	NA	TCGA-23-2643-01A-01R-1050-07	
TCGA-23-2645-01	0	TCGA-23-2645-01	137	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-23-2645	NA	NA	days	137	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Right	TCGA-23-2645-F25818	TCGA-23-2645	TCGA-23-2645-01A	Stage IIIC	-19758	NA	NA	0	137	NA	NA	NA	NA	NA	2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-2645.e1651bbc-ed16-4e45-b6f8-283459d72568.pdf	2645	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	23	No Macroscopic disease	Ovary	NA	A	LIVING	2009	NA	NA	NA	f6880438-40e9-4c78-ac4b-fbdf71637a68	NA	NA	NA	TCGA-23-2645-01A-01D-1047-05	NA	TCGA-23-2645-01A-21-20	TCGA-23-2645-01A-01W-1091-09	NA	TCGA-23-2645-01A-01D-1043-01	TCGA-23-2645-01	7326a637-b5db-47d8-a114-030db3a91417	NA	TCGA-23-2645-01A-01D-1043-01	NA	NA	NA	NA	TCGA-23-2645-01	NA	NA	NA	TCGA-23-2645-01A-01R-1050-07	
TCGA-23-2647-01	0	TCGA-23-2647-01	135	0	days	NA	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-23-2647	NA	NA	days	135	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-23-2647-F25820	TCGA-23-2647	NA	Stage IIIC	-18205	NA	NA	0	135	NA	NA	NA	NA	NA	2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	2647	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	23	1-10 mm	Ovary	YES	NA	LIVING	2009	NA	NA	NA	f50b14e1-8106-4823-9bbd-68cf5f17189b	NA	NA	NA	TCGA-23-2647-01A-01D-1047-05	NA	TCGA-23-2647-01A-21-20	TCGA-23-2647-01A-01D-1526-09	NA	NA	TCGA-23-2647-01	eeaa45e2-a17d-475c-b9a9-fbec7fa7ecd1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-23-2647-01A-01R-1050-07	
TCGA-23-2649-01	0	TCGA-23-2649-01	116	0	days	NA	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-23-2649	NA	NA	days	116	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Left	TCGA-23-2649-F25822	TCGA-23-2649	TCGA-23-2649-01A	Stage IIIC	-22210	NA	NA	0	116	NA	NA	NA	NA	NA	2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.3	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-23-2649.7a0bd8e4-1c7b-4bbc-bddc-e06902fc4db5.pdf	2649	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	23	1-10 mm	Ovary	YES	A	LIVING	2009	NA	NA	NA	408178f3-62ee-4c5d-a160-355deedc69c8	NA	NA	NA	TCGA-23-2649-01A-01D-1047-05	NA	TCGA-23-2649-01A-21-20	TCGA-23-2649-01A-01D-1526-09	NA	NA	TCGA-23-2649-01	2d3ae942-c1d4-4e80-a0e1-4b7fbc15952a	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-23-2649-01A-01R-1050-07	
TCGA-24-0966-01	0	TCGA-24-0966-01	232	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	mutation cluster 2	TCGA-24-0966	NA	NA	days	232	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Bilateral	TCGA-24-0966-F25875	TCGA-24-0966	TCGA-24-0966-01A	Stage IIIC	-28529	NA	NA	0	232	NA	NA	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.3	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-0966.99D5CA9E-3E3F-4037-96B9-9D4A34C614B3.pdf	0966	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	24	>20 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-24-0966-01	NA	5f1ed5e0-4a91-404f-a3b9-e855ff3ac303	NA	TCGA-24-0966-01	NA	TCGA-24-0966-01A-01D-0402-05	TCGA-24-0966-01A-01W-0977-09	TCGA-24-0966-01A-21-1562-20	TCGA-24-0966-01A-01W-0977-09	NA	TCGA-24-0966-01A-01D-0399-01	TCGA-24-0966-01	02ebd198-faca-4fb3-ba5a-531389b4fffa	NA	TCGA-24-0966-01A-01D-0399-01	NA	NA	NA	NA	TCGA-24-0966-01	NA	NA	TCGA-24-0966-01A-01W-0977-09	TCGA-24-0966-01A-01R-0406-07	
TCGA-24-0968-01	NA	TCGA-24-0968-01	NA	NA	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-0968	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Left	TCGA-24-0968-F25880	TCGA-24-0968	NA	Stage IIIC	-21664	NA	NA	0	598	NA	NA	NA	NA	NA	2009-3-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	0968	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	DECEASED	2005	NA	TCGA-24-0968-01	TCGA-24-0968-01A-01W-0484-10	e6f5bb0e-aab8-4243-b233-e07b2e5811f4	NA	TCGA-24-0968-01	TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01A-01D-0432-05	NA	NA	NA	NA	TCGA-24-0968-01A-01D-0428-01	TCGA-24-0968-01	NA	NA	TCGA-24-0968-01A-01D-0428-01	NA	NA	NA	NA	TCGA-24-0968-01	NA	NA	TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01A-01R-0436-07	
TCGA-24-0970-01	1	TCGA-24-0970-01	354	1	days	High	C9-OV	Low purity c2	OV-like c4	NA	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-0970	NA	NA	days	354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-24-0970-F25870	TCGA-24-0970	TCGA-24-0970-01B	Stage IIIC	-23276	NA	354	0	354	NA	280	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	0.8	NO	NA	2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-0970.50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F.pdf	0970	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.8	NA	NA	24	>20 mm	Ovary	NA	B	DECEASED	2005	NA	TCGA-24-0970-01	NA	ec3d35b4-27f6-4dd6-a6f2-596eed1a6547	NA	TCGA-24-0970-01	NA	TCGA-24-0970-01B-01D-0432-05	NA	TCGA-24-0970-01B-11-1562-20	NA	NA	TCGA-24-0970-01B-01D-0428-01	TCGA-24-0970-01	02d6074d-90c9-472f-a355-c799e2c96f4a	NA	TCGA-24-0970-01B-01D-0428-01	NA	NA	NA	TCGA-24-0970-01B-01W-0486-08	TCGA-24-0970-01	NA	NA	TCGA-24-0970-01B-01W-0486-08	TCGA-24-0970-01B-01R-0436-07	
TCGA-24-0975-01	1	TCGA-24-0975-01	663	1	days	High	C9-OV	Low purity c2	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-0975	NA	NA	days	663	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-24-0975-F25861	TCGA-24-0975	TCGA-24-0975-01A	Stage IIIC	-21417	NA	663	0	663	NA	NA	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-0975.8AA65DCA-E057-486F-AEFA-D8A3485416EC.pdf	0975	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-24-0975-01	TCGA-24-0975-01	NA	9f531d00-af98-4a8e-9614-74c063fa2f15	NA	TCGA-24-0975-01	NA	TCGA-24-0975-01B-02D-0432-05	NA	NA	NA	a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02D-0428-01	TCGA-24-0975-01	NA	NA	TCGA-24-0975-01B-02D-0428-01	a16723c4-d5b1-40a0-9890-570351738879	NA	a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02W-0486-08	TCGA-24-0975-01	TCGA-24-0975-01	a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02W-0486-08	TCGA-24-0975-01A-02R-0436-07	
TCGA-24-0979-01	1	TCGA-24-0979-01	1264	1	days	High	C9-OV	Low purity c2	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-0979	NA	NA	days	1264	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Bilateral	TCGA-24-0979-F25891	TCGA-24-0979	TCGA-24-0979-01A	Stage IV	-19595	NA	1264	0	1264	NA	428	NA	NA	NA	2009-5-11	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	0.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-0979.3385E5B4-EBD4-4317-8805-EE6EA47A2E4A.pdf	0979	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	2003	NA	TCGA-24-0979-01	NA	3a1401ac-2bfc-4baa-9018-bb71de5cfb51	NA	TCGA-24-0979-01	NA	TCGA-24-0979-01A-01D-0432-05	NA	TCGA-24-0979-01A-21-20	NA	NA	TCGA-24-0979-01A-01D-0428-01	TCGA-24-0979-01	1c5c8013-17c7-4be1-888c-ab0da1e3afdd	NA	TCGA-24-0979-01A-01D-0428-01	NA	NA	NA	TCGA-24-0979-01A-01W-0486-08	TCGA-24-0979-01	NA	NA	TCGA-24-0979-01A-01W-0486-08	TCGA-24-0979-01A-01R-0436-07	
TCGA-24-0980-01	1	TCGA-24-0980-01	233	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	NA	NA	mutation cluster 5	TCGA-24-0980	NA	NA	days	233	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-0980-F25896	TCGA-24-0980	NA	Stage IIIC	-19579	NA	233	0	233	NA	145	NA	NA	NA	2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	0980	NA	WITH TUMOR	YES	Progressive Disease	Other Method	NO	NA	Primary Tumor	01	NA	NA	NA	24	>20 mm	Ovary	NA	NA	DECEASED	2003	NA	NA	NA	eed170f8-eef5-4e58-8dda-64324bf900e2	NA	NA	NA	TCGA-24-0980-01A-01D-0402-05	TCGA-24-0980-01A-01W-0421-09	TCGA-24-0980-01A-21-20	TCGA-24-0980-01A-01W-0421-09	NA	TCGA-24-0980-01A-01D-0399-01	TCGA-24-0980-01	e09cff37-f92b-48f7-a2d6-e72b68d0a8b4	NA	TCGA-24-0980-01A-01D-0399-01	NA	NA	NA	NA	TCGA-24-0980-01	NA	NA	TCGA-24-0980-01A-01W-0421-09	TCGA-24-0980-01A-01R-0406-07	
TCGA-24-0981-01	NA	TCGA-24-0981-01	NA	NA	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-24-0981	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-24-0981-01A-01D-0432-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-24-0981-01A-01R-0436-07	
TCGA-24-0982-01	1	TCGA-24-0982-01	679	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-0982	NA	NA	days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-24-0982-F25900	TCGA-24-0982	NA	Stage IIIC	-28201	NA	679	0	679	NA	153	NA	NA	NA	2009-3-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	0982	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-24-0982-01	NA	fc2dbc4a-dd8a-4174-a186-15ceaaaac881	NA	TCGA-24-0982-01	NA	TCGA-24-0982-01A-01D-0432-05	TCGA-24-0982-01A-01W-0488-09	TCGA-24-0982-01A-21-20	TCGA-24-0982-01A-01W-0488-09	NA	TCGA-24-0982-01A-01D-0428-01	TCGA-24-0982-01	d712585f-3d02-4e1a-a11a-4ffac7295711	NA	TCGA-24-0982-01A-01D-0428-01	NA	NA	NA	NA	TCGA-24-0982-01	NA	NA	TCGA-24-0982-01A-01W-0488-09	TCGA-24-0982-01A-01R-0436-07	
TCGA-24-1103-01	1	TCGA-24-1103-01	1646	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1103	NA	NA	days	1646	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-24-1103-F25824	TCGA-24-1103	TCGA-24-1103-01A	Stage IIIC	-18583	NA	1646	0	1646	NA	678	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1103.B9628222-5530-4A82-9F13-2773173A0C95.pdf	1103	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-24-1103-01	TCGA-24-1103-01	NA	77d9fb44-1cbe-41aa-8abe-e66fa774a33e	NA	TCGA-24-1103-01	NA	TCGA-24-1103-01A-01D-0432-05	TCGA-24-1103-01A-01W-0488-09	TCGA-24-1103-01A-11-1562-20	TCGA-24-1103-01A-01W-0488-09	202abe19-20e0-4ea9-8653-bf5145da351c	TCGA-24-1103-01A-01D-0428-01	TCGA-24-1103-01	6f0a19c3-b3d6-44da-8962-79cd723f0fab	NA	TCGA-24-1103-01A-01D-0428-01	202abe19-20e0-4ea9-8653-bf5145da351c	NA	202abe19-20e0-4ea9-8653-bf5145da351c	NA	TCGA-24-1103-01	TCGA-24-1103-01	202abe19-20e0-4ea9-8653-bf5145da351c	TCGA-24-1103-01A-01W-0488-09	TCGA-24-1103-01A-01R-0436-07	
TCGA-24-1104-01	1	TCGA-24-1104-01	1933	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-1104	NA	NA	days	1933	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	56	Left	TCGA-24-1104-F25834	TCGA-24-1104	TCGA-24-1104-01A	Stage IV	-20527	NA	1933	0	1933	NA	959	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41.pdf	1104	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-24-1104-01	NA	14fde2bb-46b6-410f-89c6-f32a6f084668	NA	TCGA-24-1104-01	NA	TCGA-24-1104-01A-01D-0432-05	TCGA-24-1104-01A-01W-0488-09	TCGA-24-1104-01A-21-1562-20	TCGA-24-1104-01A-01W-0488-09	NA	TCGA-24-1104-01A-01D-0428-01	TCGA-24-1104-01	14177a50-0360-47ce-b24b-3468b4a2b75f	NA	TCGA-24-1104-01A-01D-0428-01	NA	NA	NA	NA	TCGA-24-1104-01	NA	NA	TCGA-24-1104-01A-01W-0488-09	TCGA-24-1104-01A-01R-0436-07	
TCGA-24-1105-01	1	TCGA-24-1105-01	1442	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1105	NA	NA	days	1442	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	36	Bilateral	TCGA-24-1105-F25844	TCGA-24-1105	TCGA-24-1105-01A	Stage IIIC	-13187	NA	1442	0	1442	NA	470	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1105.DE593AFC-BC21-4183-94A6-B8BA9931B70F.pdf	1105	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.8	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-24-1105-01	TCGA-24-1105-01A-01W-0484-10	9840b4a9-5f2f-4263-905f-e395092e2cea	NA	TCGA-24-1105-01	TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01A-01D-0432-05	NA	TCGA-24-1105-01A-21-1562-20	NA	NA	TCGA-24-1105-01A-01D-0428-01	TCGA-24-1105-01	ea5d304a-364c-4633-860b-f2e7be2ca00e	NA	TCGA-24-1105-01A-01D-0428-01	NA	NA	NA	NA	TCGA-24-1105-01	NA	NA	TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01A-01R-0436-07	
TCGA-24-1413-01	0	TCGA-24-1413-01	192	0	days	BRCA-LUAD+	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1413	NA	NA	days	192	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-24-1413-F25910	TCGA-24-1413	TCGA-24-1413-01A	Stage IIIC	-18846	NA	NA	0	192	NA	NA	NA	NA	NA	2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1413.2ca18d08-e930-4244-a0d5-316dfbca0fb4.pdf	1413	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1413-01	TCGA-24-1413-01	NA	78f0e50d-6dc9-4c74-8674-3cb6800ea7a6	NA	TCGA-24-1413-01	NA	TCGA-24-1413-01A-01D-0460-05	TCGA-24-1413-01A-01W-0494-09	NA	TCGA-24-1413-01A-01W-0494-09	545867ef-1299-410d-bbbf-d6c189344b0f	TCGA-24-1413-01A-01D-0452-01	TCGA-24-1413-01	NA	NA	TCGA-24-1413-01A-01D-0452-01	545867ef-1299-410d-bbbf-d6c189344b0f	NA	545867ef-1299-410d-bbbf-d6c189344b0f	NA	TCGA-24-1413-01	TCGA-24-1413-01	545867ef-1299-410d-bbbf-d6c189344b0f	TCGA-24-1413-01A-01W-0494-09	TCGA-24-1413-01A-01R-0456-07	
TCGA-24-1416-01	0	TCGA-24-1416-01	194	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 3	TCGA-24-1416	NA	NA	days	194	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	34	Bilateral	TCGA-24-1416-F25914	TCGA-24-1416	TCGA-24-1416-01A	Stage IV	-12772	NA	NA	0	194	NA	NA	NA	NA	NA	2009-4-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1416.c5a7b8b5-65b5-47d0-84dc-882024042a6f.pdf	1416	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1416-01	TCGA-24-1416-01	NA	f46fbaaf-21ba-40c3-9e27-db0febe3b250	NA	TCGA-24-1416-01	NA	TCGA-24-1416-01A-01D-0475-05	TCGA-24-1416-01A-01W-0549-09	TCGA-24-1416-01A-21-20	TCGA-24-1416-01A-01W-0549-09	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	TCGA-24-1416-01A-01D-0472-01	TCGA-24-1416-01	0eda7c90-97fe-4184-b8ad-73e7820c3b7e	NA	TCGA-24-1416-01A-01D-0472-01	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	NA	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	NA	TCGA-24-1416-01	TCGA-24-1416-01	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	TCGA-24-1416-01A-01W-0549-09	TCGA-24-1416-01A-01R-0479-07	
TCGA-24-1417-01	0	TCGA-24-1417-01	238	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1417	NA	NA	days	238	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Left	TCGA-24-1417-F25920	TCGA-24-1417	TCGA-24-1417-01A	Stage IV	-19775	NA	NA	0	238	NA	NA	NA	NA	NA	2009-4-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1417.4058a172-a0f6-4c91-9c79-aab63525340f.pdf	1417	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1417-01	TCGA-24-1417-01	NA	68f0717d-5edc-43f0-bbde-606574f02b4f	NA	TCGA-24-1417-01	NA	TCGA-24-1417-01A-01D-0475-05	TCGA-24-1417-01A-01W-0549-09	TCGA-24-1417-01A-21-20	TCGA-24-1417-01A-01W-0549-09	e76a7745-3193-4650-9a7a-c96329690be3	TCGA-24-1417-01A-01D-0472-01	TCGA-24-1417-01	4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a	NA	TCGA-24-1417-01A-01D-0472-01	e76a7745-3193-4650-9a7a-c96329690be3	NA	e76a7745-3193-4650-9a7a-c96329690be3	NA	TCGA-24-1417-01	TCGA-24-1417-01	e76a7745-3193-4650-9a7a-c96329690be3	TCGA-24-1417-01A-01W-0549-09	TCGA-24-1417-01A-01R-0479-07	
TCGA-24-1418-01	0	TCGA-24-1418-01	243	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1418	NA	NA	days	243	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	68	Bilateral	TCGA-24-1418-F25924	TCGA-24-1418	TCGA-24-1418-01A	Stage IIIC	-24842	NA	NA	0	243	NA	NA	0	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1.2	NO	NA	1.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1418.14fdb291-ba79-4852-9242-02dc191ca8c5.pdf	1418	Other	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	>20 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1418-01	TCGA-24-1418-01	NA	8302128a-2f41-42d9-8ebc-ceedb67f2919	NA	TCGA-24-1418-01	NA	TCGA-24-1418-01A-01D-0475-05	TCGA-24-1418-01A-01W-0549-09	NA	TCGA-24-1418-01A-01W-0549-09	4e701e9f-9127-4d61-8a72-7e440b969fbe	TCGA-24-1418-01A-01D-0472-01	TCGA-24-1418-01	NA	NA	TCGA-24-1418-01A-01D-0472-01	4e701e9f-9127-4d61-8a72-7e440b969fbe	NA	4e701e9f-9127-4d61-8a72-7e440b969fbe	NA	TCGA-24-1418-01	TCGA-24-1418-01	4e701e9f-9127-4d61-8a72-7e440b969fbe	TCGA-24-1418-01A-01W-0549-09	TCGA-24-1418-01A-01R-0479-07	
TCGA-24-1419-01	0	TCGA-24-1419-01	239	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1419	NA	NA	days	239	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-24-1419-F25929	TCGA-24-1419	TCGA-24-1419-01A	Stage IIIC	-22659	NA	NA	0	239	NA	NA	NA	NA	NA	2009-4-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1419.0a8c75aa-8031-4f1d-9dba-9029b009d677.pdf	1419	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	11-20 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1419-01	TCGA-24-1419-01	NA	8edd134e-95e4-47d2-9a2a-b68b0ca427ea	NA	TCGA-24-1419-01	NA	TCGA-24-1419-01A-01D-0475-05	NA	TCGA-24-1419-01A-21-20	NA	7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01D-0472-01	TCGA-24-1419-01	e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc	NA	TCGA-24-1419-01A-01D-0472-01	7bf43d51-2714-419e-a52f-863ca54c90e5	NA	7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01W-0545-08	TCGA-24-1419-01	TCGA-24-1419-01	7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01W-0545-08	TCGA-24-1419-01A-01R-0479-07	
TCGA-24-1422-01	1	TCGA-24-1422-01	23	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1422	NA	NA	days	23	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	82	Bilateral	TCGA-24-1422-F25934	TCGA-24-1422	TCGA-24-1422-01A	Stage IIIC	-30234	NA	23	0	23	NA	NA	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f.pdf	1422	NA	NA	NO	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2008	NA	TCGA-24-1422-01	NA	48e00661-f995-42b5-9400-3391914a90d9	NA	TCGA-24-1422-01	NA	TCGA-24-1422-01A-01D-0475-05	NA	TCGA-24-1422-01A-21-1562-20	NA	NA	TCGA-24-1422-01A-01D-0472-01	TCGA-24-1422-01	52fbe264-2840-4bae-86a9-17f09ebe5053	NA	TCGA-24-1422-01A-01D-0472-01	NA	NA	NA	TCGA-24-1422-01A-01W-0545-08	TCGA-24-1422-01	NA	NA	TCGA-24-1422-01A-01W-0545-08	TCGA-24-1422-01A-01R-0479-07	
TCGA-24-1423-01	0	TCGA-24-1423-01	190	0	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1423	NA	NA	days	190	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	61	Bilateral	TCGA-24-1423-F25936	TCGA-24-1423	TCGA-24-1423-01A	Stage IIIC	-22281	NA	NA	0	190	NA	NA	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1423.47331163-68e9-44fd-8b80-b9f70058957f.pdf	1423	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1423-01	TCGA-24-1423-01	NA	670fe1e4-f612-4797-a926-41cd2da84843	NA	TCGA-24-1423-01	NA	TCGA-24-1423-01A-01D-0475-05	NA	TCGA-24-1423-01A-21-1562-20	NA	b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01D-0472-01	TCGA-24-1423-01	5a0afbd0-e504-46d6-b268-2b04d7f8be98	NA	TCGA-24-1423-01A-01D-0472-01	b493df11-1929-4e35-ac44-49057cdbd86b	NA	b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01W-0545-08	TCGA-24-1423-01	TCGA-24-1423-01	b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01W-0545-08	TCGA-24-1423-01A-01R-0479-07	
TCGA-24-1424-01	0	TCGA-24-1424-01	183	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1424	NA	NA	days	183	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-24-1424-F25941	TCGA-24-1424	NA	Stage IIIC	-24545	NA	NA	0	183	NA	NA	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1424	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	LIVING	2008	TCGA-24-1424-01	TCGA-24-1424-01	NA	fdda2c0b-816d-4e49-83e8-2e40d4444f0c	NA	TCGA-24-1424-01	NA	TCGA-24-1424-01A-01D-0475-05	TCGA-24-1424-01A-01W-0549-09	TCGA-24-1424-01A-21-1562-20	TCGA-24-1424-01A-01W-0549-09	d3fbcdaa-11af-4233-9700-57c6e1628c4b	TCGA-24-1424-01A-01D-0472-01	TCGA-24-1424-01	b64c050d-b09e-4fbb-a906-b5d5e3904149	NA	TCGA-24-1424-01A-01D-0472-01	d3fbcdaa-11af-4233-9700-57c6e1628c4b	NA	d3fbcdaa-11af-4233-9700-57c6e1628c4b	NA	TCGA-24-1424-01	TCGA-24-1424-01	d3fbcdaa-11af-4233-9700-57c6e1628c4b	TCGA-24-1424-01A-01W-0549-09	TCGA-24-1424-01A-01R-0479-07	
TCGA-24-1425-01	0	TCGA-24-1425-01	181	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-24-1425	NA	NA	days	181	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-24-1425-F25946	TCGA-24-1425	NA	Stage IIIC	-16764	NA	NA	0	181	NA	NA	0	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1425	Other	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	LIVING	2008	TCGA-24-1425-01	TCGA-24-1425-01	NA	f112ed71-765e-48bc-a5ab-196f42740078	NA	TCGA-24-1425-01	NA	TCGA-24-1425-01A-02D-0501-05	TCGA-24-1425-01A-02W-0553-09	NA	TCGA-24-1425-01A-02W-0553-09	f580e84b-b405-43dc-9dae-4588cedf435f	TCGA-24-1425-01A-02D-0497-01	TCGA-24-1425-01	NA	NA	TCGA-24-1425-01A-02D-0497-01	f580e84b-b405-43dc-9dae-4588cedf435f	NA	f580e84b-b405-43dc-9dae-4588cedf435f	NA	TCGA-24-1425-01	TCGA-24-1425-01	f580e84b-b405-43dc-9dae-4588cedf435f	TCGA-24-1425-01A-02W-0553-09	TCGA-24-1425-01A-02R-0504-07	
TCGA-24-1426-01	0	TCGA-24-1426-01	163	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1426	NA	NA	days	163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	43	Bilateral	TCGA-24-1426-F25951	TCGA-24-1426	TCGA-24-1426-01A	Stage IIIC	-15949	NA	NA	0	163	NA	NA	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1.2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb.pdf	1426	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-24-1426-01	NA	8395c4e0-d327-472d-a7e6-3af3e2cbb0be	NA	TCGA-24-1426-01	NA	TCGA-24-1426-01A-01D-0475-05	TCGA-24-1426-01A-01W-0549-09	NA	TCGA-24-1426-01A-01W-0549-09	NA	TCGA-24-1426-01A-01D-0472-01	TCGA-24-1426-01	NA	NA	TCGA-24-1426-01A-01D-0472-01	NA	NA	NA	NA	TCGA-24-1426-01	NA	NA	TCGA-24-1426-01A-01W-0549-09	TCGA-24-1426-01A-01R-0479-07	
TCGA-24-1427-01	0	TCGA-24-1427-01	147	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1427	NA	NA	days	147	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Bilateral	TCGA-24-1427-F25956	TCGA-24-1427	TCGA-24-1427-01A	Stage IIIC	-21423	NA	NA	0	147	NA	NA	NA	NA	NA	2009-4-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.7	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1427.af63c4e2-2f77-4311-bfe2-ee45cfd200bb.pdf	1427	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	24	>20 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1427-01	TCGA-24-1427-01	NA	5beadb09-fe3f-44aa-8c20-fdf66e0a68ca	NA	TCGA-24-1427-01	NA	TCGA-24-1427-01A-01D-0475-05	TCGA-24-1427-01A-01W-0549-09	TCGA-24-1427-01A-21-1562-20	TCGA-24-1427-01A-01W-0549-09	5a505632-422c-4083-b867-82a7a503b314	TCGA-24-1427-01A-01D-0472-01	TCGA-24-1427-01	87a8658e-3143-4074-9988-b0fed3d25f8b	NA	TCGA-24-1427-01A-01D-0472-01	5a505632-422c-4083-b867-82a7a503b314	NA	5a505632-422c-4083-b867-82a7a503b314	NA	TCGA-24-1427-01	TCGA-24-1427-01	5a505632-422c-4083-b867-82a7a503b314	TCGA-24-1427-01A-01W-0549-09	TCGA-24-1427-01A-01R-0479-07	
TCGA-24-1428-01	0	TCGA-24-1428-01	529	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1428	NA	NA	days	529	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Left	TCGA-24-1428-F25960	TCGA-24-1428	TCGA-24-1428-01A	Stage IIIC	-18306	NA	NA	0	529	NA	448	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1428.9fcdd584-25e6-4a5a-ae15-f2956de32822.pdf	1428	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1428-01	TCGA-24-1428-01	NA	c9eb8b63-8b8a-47eb-8fb1-11b089bf4a00	NA	TCGA-24-1428-01	NA	TCGA-24-1428-01A-01D-0475-05	TCGA-24-1428-01A-01W-0549-09	TCGA-24-1428-01A-21-1562-20	TCGA-24-1428-01A-01W-0549-09	30b9b778-1422-4842-ae99-658b8b1d7605	TCGA-24-1428-01A-01D-0472-01	TCGA-24-1428-01	66bafc53-dafe-493e-8ede-22866b714a76	NA	TCGA-24-1428-01A-01D-0472-01	30b9b778-1422-4842-ae99-658b8b1d7605	NA	30b9b778-1422-4842-ae99-658b8b1d7605	NA	TCGA-24-1428-01	TCGA-24-1428-01	30b9b778-1422-4842-ae99-658b8b1d7605	TCGA-24-1428-01A-01W-0549-09	TCGA-24-1428-01A-01R-0479-07	
TCGA-24-1430-01	1	TCGA-24-1430-01	863	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-24-1430	NA	NA	days	863	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-24-1430-F25966	TCGA-24-1430	TCGA-24-1430-01A	Stage IIIC	-24939	NA	863	0	863	NA	449	1	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.7	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1430.d0f95ced-e33f-4796-a6a4-3030f8e21761.pdf	1430	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.8	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1430-01	TCGA-24-1430-01	NA	0bad8ba4-8a10-49d9-a2f6-5e833fb9f2da	NA	TCGA-24-1430-01	NA	TCGA-24-1430-01A-01D-0475-05	NA	TCGA-24-1430-01A-21-1562-20	NA	4c19d12e-0160-4d01-b621-65335156488b	TCGA-24-1430-01A-01D-0472-01	TCGA-24-1430-01	7dbdc93e-9d1d-48fe-92eb-9615eac2adb6	NA	TCGA-24-1430-01A-01D-0472-01	4c19d12e-0160-4d01-b621-65335156488b	NA	4c19d12e-0160-4d01-b621-65335156488b	NA	TCGA-24-1430-01	TCGA-24-1430-01	4c19d12e-0160-4d01-b621-65335156488b	NA	TCGA-24-1430-01A-01R-0479-07	
TCGA-24-1431-01	1	TCGA-24-1431-01	567	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1431	NA	NA	days	567	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-1431-F25977	TCGA-24-1431	NA	Stage IIIC	-24758	NA	567	0	583	NA	199	NA	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1431	NA	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	DECEASED	1999	NA	TCGA-24-1431-01	NA	e5aed4a1-b8f1-44bd-957c-94acfca519a7	NA	TCGA-24-1431-01	NA	TCGA-24-1431-01A-01D-0475-05	NA	TCGA-24-1431-01A-21-1562-20	NA	NA	TCGA-24-1431-01A-01D-0472-01	TCGA-24-1431-01	a2ff2d82-073d-4ea0-b407-5a68de79f622	NA	TCGA-24-1431-01A-01D-0472-01	NA	NA	NA	TCGA-24-1431-01A-01D-0472-08	TCGA-24-1431-01	NA	NA	TCGA-24-1431-01A-01D-0472-08	TCGA-24-1431-01A-01R-0479-07	
TCGA-24-1434-01	1	TCGA-24-1434-01	568	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1434	NA	NA	days	568	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-24-1434-F25984	TCGA-24-1434	TCGA-24-1434-01A	Stage IIIC	-21810	NA	568	0	568	NA	337	NA	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961.pdf	1434	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1434-01	TCGA-24-1434-01	NA	a6c7ca3f-b07b-46d5-a1ba-f1c88a358229	NA	TCGA-24-1434-01	NA	TCGA-24-1434-01A-01D-0475-05	NA	TCGA-24-1434-01A-21-1562-20	NA	368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01D-0472-01	TCGA-24-1434-01	0106e887-2791-4c17-9260-07bd927e5d9b	NA	TCGA-24-1434-01A-01D-0472-01	368f21cd-dd07-440d-89f5-5874e37fe63b	NA	368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01W-0545-08	TCGA-24-1434-01	TCGA-24-1434-01	368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01W-0545-08	TCGA-24-1434-01A-01R-0479-07	
TCGA-24-1435-01	1	TCGA-24-1435-01	1324	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-24-1435	NA	NA	days	1324	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-24-1435-F25993	TCGA-24-1435	TCGA-24-1435-01A	Stage IIIC	-21107	NA	1324	0	1324	NA	505	NA	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1435.d1574b6c-6cc1-45bc-86d0-97585d8a5c93.pdf	1435	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1435-01	TCGA-24-1435-01	NA	ac8a9858-933c-4d44-ae0c-e8b964344d0c	NA	TCGA-24-1435-01	NA	TCGA-24-1435-01A-01D-0475-05	TCGA-24-1435-01A-01W-0549-09	TCGA-24-1435-01A-21-1562-20	TCGA-24-1435-01A-01W-0549-09	c20ba763-e310-448a-9c85-0b4f680e6196	TCGA-24-1435-01A-01D-0472-01	TCGA-24-1435-01	591cd2fa-3920-42e9-a1ed-d76898930e6f	NA	TCGA-24-1435-01A-01D-0472-01	c20ba763-e310-448a-9c85-0b4f680e6196	NA	c20ba763-e310-448a-9c85-0b4f680e6196	NA	TCGA-24-1435-01	TCGA-24-1435-01	c20ba763-e310-448a-9c85-0b4f680e6196	TCGA-24-1435-01A-01W-0549-09	TCGA-24-1435-01A-01R-0479-07	
TCGA-24-1436-01	1	TCGA-24-1436-01	260	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1436	NA	NA	days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Right	TCGA-24-1436-F26004	TCGA-24-1436	TCGA-24-1436-01A	Stage IIIC	-20881	NA	260	0	260	NA	NA	NA	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12.pdf	1436	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1436-01	TCGA-24-1436-01	NA	432c75c7-ece9-49a3-8f6e-ceb61c30ca10	NA	TCGA-24-1436-01	NA	TCGA-24-1436-01A-01D-0475-05	TCGA-24-1436-01A-01W-0549-09	TCGA-24-1436-01A-21-1563-20	TCGA-24-1436-01A-01W-0549-09	45ff767a-721a-4d89-b5e9-0c6e7eba476d	TCGA-24-1436-01A-01D-0472-01	TCGA-24-1436-01	d6aaae43-70fd-461e-b240-8ba220221828	NA	TCGA-24-1436-01A-01D-0472-01	45ff767a-721a-4d89-b5e9-0c6e7eba476d	NA	45ff767a-721a-4d89-b5e9-0c6e7eba476d	NA	TCGA-24-1436-01	TCGA-24-1436-01	45ff767a-721a-4d89-b5e9-0c6e7eba476d	TCGA-24-1436-01A-01W-0549-09	TCGA-24-1436-01A-01R-0479-07	
TCGA-24-1463-01	1	TCGA-24-1463-01	2218	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 2	mutation cluster 2	TCGA-24-1463	NA	NA	days	2218	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-24-1463-F26009	TCGA-24-1463	TCGA-24-1463-01A	Stage IIIC	-25734	NA	2218	0	2218	NA	971	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1463.864CB084-569A-47F0-A83D-F3FA649A6B00.pdf	1463	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1463-01	TCGA-24-1463-01	NA	28787351-5cbd-4d64-910c-e306e7f65d8e	NA	TCGA-24-1463-01	NA	TCGA-24-1463-01A-01D-0475-05	TCGA-24-1463-01A-01W-0549-09	TCGA-24-1463-01A-21-1562-20	TCGA-24-1463-01A-01W-0549-09	939d41b7-9ccb-4cf6-be16-f2792aece5eb	TCGA-24-1463-01A-01D-0472-01	TCGA-24-1463-01	62f0c11f-4f42-45f6-9916-f4470a096431	NA	TCGA-24-1463-01A-01D-0472-01	939d41b7-9ccb-4cf6-be16-f2792aece5eb	NA	939d41b7-9ccb-4cf6-be16-f2792aece5eb	NA	TCGA-24-1463-01	TCGA-24-1463-01	939d41b7-9ccb-4cf6-be16-f2792aece5eb	TCGA-24-1463-01A-01W-0549-09	TCGA-24-1463-01A-01R-0479-07	
TCGA-24-1464-01	1	TCGA-24-1464-01	379	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1464	NA	NA	days	379	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	70	Left	TCGA-24-1464-F26022	TCGA-24-1464	TCGA-24-1464-01A	Stage IIIC	-25874	NA	379	0	379	NA	323	1	NA	NA	2009-3-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E.pdf	1464	Post-Adjuvant Therapy	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1998	NA	TCGA-24-1464-01	NA	2ed4bcf3-8abb-454c-a19d-54101ccf222f	NA	TCGA-24-1464-01	NA	TCGA-24-1464-01A-01D-0475-05	TCGA-24-1464-01A-01W-0549-09	TCGA-24-1464-01A-21-1562-20	TCGA-24-1464-01A-01W-0549-09	NA	TCGA-24-1464-01A-01D-0472-01	TCGA-24-1464-01	eef306a8-dd2b-4d8e-90c2-cb05094fd5f2	NA	TCGA-24-1464-01A-01D-0472-01	NA	NA	NA	NA	TCGA-24-1464-01	NA	NA	TCGA-24-1464-01A-01W-0549-09	TCGA-24-1464-01A-01R-0479-07	
TCGA-24-1466-01	1	TCGA-24-1466-01	1373	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-1466	NA	NA	days	1373	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-1466-F26028	TCGA-24-1466	TCGA-24-1466-01A	Stage IIIC	-27307	NA	1373	0	1373	NA	491	NA	NA	NA	2009-4-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1466.BA86880B-184B-4CB7-8BBF-100D5CBD76C0.pdf	1466	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1998	NA	TCGA-24-1466-01	NA	2f2c0eed-dd98-42f0-af6e-7c2290a12f37	NA	TCGA-24-1466-01	NA	TCGA-24-1466-01A-01D-0475-05	NA	TCGA-24-1466-01A-21-1562-20	NA	NA	TCGA-24-1466-01A-01D-0472-01	TCGA-24-1466-01	b5bd0882-705b-4f50-a748-8dc096d39717	NA	TCGA-24-1466-01A-01D-0472-01	NA	NA	NA	TCGA-24-1466-01A-01W-0545-08	TCGA-24-1466-01	NA	NA	TCGA-24-1466-01A-01W-0545-08	TCGA-24-1466-01A-01R-0479-07	
TCGA-24-1467-01	1	TCGA-24-1467-01	3224	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-24-1467	NA	NA	days	3224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Right	TCGA-24-1467-F26039	TCGA-24-1467	TCGA-24-1467-01A	Stage IIIC	-18652	NA	3224	0	3224	NA	1253	NA	NA	NA	2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.3	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1467.6949EFBE-C2EA-4767-B194-2343254F2752.pdf	1467	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.7	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1998	TCGA-24-1467-01	TCGA-24-1467-01	NA	f521b01e-14ea-4350-ad50-ce4dfa9594b6	NA	TCGA-24-1467-01	NA	TCGA-24-1467-01A-01D-0475-05	NA	TCGA-24-1467-01A-21-1562-20	NA	22902cdb-69f7-4bfc-a5c3-a56229ee501d	TCGA-24-1467-01A-01D-0472-01	TCGA-24-1467-01	efc7b16f-9e40-480e-b0ba-0a92cc54c0b9	NA	TCGA-24-1467-01A-01D-0472-01	22902cdb-69f7-4bfc-a5c3-a56229ee501d	NA	22902cdb-69f7-4bfc-a5c3-a56229ee501d	NA	TCGA-24-1467-01	TCGA-24-1467-01	22902cdb-69f7-4bfc-a5c3-a56229ee501d	NA	TCGA-24-1467-01A-01R-0479-07	
TCGA-24-1469-01	0	TCGA-24-1469-01	277	0	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-1469	NA	NA	days	277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Right	TCGA-24-1469-F26060	TCGA-24-1469	TCGA-24-1469-01A	Stage IIIC	-25937	NA	NA	0	277	NA	NA	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1469.8f0b80d0-cf56-477c-898b-bb92934f64d4.pdf	1469	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2008	TCGA-24-1469-01	TCGA-24-1469-01	NA	1a83a75d-e788-407c-afae-326d9a553604	NA	TCGA-24-1469-01	NA	TCGA-24-1469-01A-01D-0501-05	TCGA-24-1469-01A-01W-0553-09	TCGA-24-1469-01A-21-1562-20	TCGA-24-1469-01A-01W-0553-09	7b6fe6e3-145b-46e6-884e-fcec23514674	TCGA-24-1469-01A-01D-0497-01	TCGA-24-1469-01	6f95df6b-dcdc-4727-8cf5-76b30b6ae455	NA	TCGA-24-1469-01A-01D-0497-01	7b6fe6e3-145b-46e6-884e-fcec23514674	NA	7b6fe6e3-145b-46e6-884e-fcec23514674	NA	TCGA-24-1469-01	TCGA-24-1469-01	7b6fe6e3-145b-46e6-884e-fcec23514674	TCGA-24-1469-01A-01W-0553-09	TCGA-24-1469-01A-01R-0504-07	
TCGA-24-1470-01	0	TCGA-24-1470-01	105	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1470	NA	NA	days	105	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Bilateral	TCGA-24-1470-F26064	TCGA-24-1470	NA	Stage IIIB	-20007	NA	NA	0	105	NA	NA	1	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1470	Other	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	LIVING	2009	NA	TCGA-24-1470-01	NA	a10cd463-df96-48b7-a4cc-21268bce6eb0	NA	TCGA-24-1470-01	NA	TCGA-24-1470-01A-01D-0501-05	TCGA-24-1470-01A-01W-0553-09	TCGA-24-1470-01A-21-1562-20	TCGA-24-1470-01A-01W-0553-09	NA	TCGA-24-1470-01A-01D-0497-01	TCGA-24-1470-01	c9231718-6532-4ff2-b83f-4050d75b82fe	NA	TCGA-24-1470-01A-01D-0497-01	NA	NA	NA	NA	TCGA-24-1470-01	NA	NA	TCGA-24-1470-01A-01W-0553-09	TCGA-24-1470-01A-01R-0504-07	
TCGA-24-1471-01	0	TCGA-24-1471-01	36	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 13	TCGA-24-1471	NA	NA	days	36	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Left	TCGA-24-1471-F26069	TCGA-24-1471	TCGA-24-1471-01A	Stage IIIC	-22081	NA	NA	0	36	NA	NA	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1471.d20b8ed1-c74e-4ee8-9ae2-5512429810bc.pdf	1471	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	LIVING	2009	NA	TCGA-24-1471-01	NA	2434de17-87b9-44f4-85b9-e07932d062ae	NA	TCGA-24-1471-01	NA	TCGA-24-1471-01A-01D-0501-05	NA	TCGA-24-1471-01A-21-1562-20	NA	NA	TCGA-24-1471-01A-01D-0497-01	TCGA-24-1471-01	f9ddc125-66a3-4277-ac22-1b3b2acced36	NA	TCGA-24-1471-01A-01D-0497-01	NA	NA	NA	TCGA-24-1471-01A-01W-0551-08	TCGA-24-1471-01	NA	NA	TCGA-24-1471-01A-01W-0551-08	TCGA-24-1471-01A-01R-0504-07	
TCGA-24-1474-01	1	TCGA-24-1474-01	676	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1474	NA	NA	days	676	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Left	TCGA-24-1474-F26073	TCGA-24-1474	TCGA-24-1474-01A	Stage IIIC	-20902	NA	676	0	676	NA	332	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7.pdf	1474	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1474-01	TCGA-24-1474-01	NA	c6e04760-3285-42ad-b307-cb00ffbe2e9e	NA	TCGA-24-1474-01	NA	TCGA-24-1474-01A-01D-0501-05	NA	TCGA-24-1474-01A-21-1562-20	NA	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01D-0497-01	TCGA-24-1474-01	e5f26e9b-2fc8-4514-a028-cd97c5390b0a	NA	TCGA-24-1474-01A-01D-0497-01	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	NA	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01W-0551-08	TCGA-24-1474-01	TCGA-24-1474-01	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01W-0551-08	TCGA-24-1474-01A-01R-0504-07	
TCGA-24-1544-01	1	TCGA-24-1544-01	820	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation c1uster 9	TCGA-24-1544	NA	NA	days	820	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-24-1544-F26080	TCGA-24-1544	TCGA-24-1544-01A	Stage IIIC	-26141	NA	820	0	820	NA	643	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.4	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-24-1544.2fd78a14-cc3f-4920-9c50-6051579b6ad4.pdf	1544	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1544-01	TCGA-24-1544-01	TCGA-24-1544-01A-01W-0615-10	d403d7b8-d8d8-47ba-9821-a314704866bb	NA	TCGA-24-1544-01	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01A-01D-0536-05	NA	TCGA-24-1544-01A-21-1558-20	NA	83333a5a-de0b-4d72-b886-e5488c619827	TCGA-24-1544-01A-01D-0533-01	TCGA-24-1544-01	9653a9c6-37fa-4e38-9c7e-c48ae95933ec	NA	TCGA-24-1544-01A-01D-0533-01	83333a5a-de0b-4d72-b886-e5488c619827	NA	83333a5a-de0b-4d72-b886-e5488c619827	NA	TCGA-24-1544-01	TCGA-24-1544-01	83333a5a-de0b-4d72-b886-e5488c619827	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01A-01R-0540-07	
TCGA-24-1545-01	1	TCGA-24-1545-01	1746	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1545	NA	NA	days	1746	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-24-1545-F26088	TCGA-24-1545	TCGA-24-1545-01A	Stage IIIC	-25460	NA	1746	0	1746	NA	861	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1545.0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975.pdf	1545	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1545-01	TCGA-24-1545-01	TCGA-24-1545-01A-01W-0615-10	3ed80032-69ae-4f21-8e60-8f177787e9f0	NA	TCGA-24-1545-01	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01A-01D-0536-05	NA	TCGA-24-1545-01A-21-1558-20	NA	e2fcba09-755d-425d-ab4d-cede8ef86e48	TCGA-24-1545-01A-01D-0533-01	TCGA-24-1545-01	f3a3c3dc-4069-4c53-9017-c6dc610240e4	NA	TCGA-24-1545-01A-01D-0533-01	e2fcba09-755d-425d-ab4d-cede8ef86e48	NA	e2fcba09-755d-425d-ab4d-cede8ef86e48	NA	TCGA-24-1545-01	TCGA-24-1545-01	e2fcba09-755d-425d-ab4d-cede8ef86e48	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01A-01R-0540-07	
TCGA-24-1546-01	1	TCGA-24-1546-01	1955	1	days	High	NA	Low purity c2	OV-like c4	NA	miRNA cluster 3	cluster 6	NA	TCGA-24-1546	NA	NA	days	1955	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Bilateral	TCGA-24-1546-F26097	TCGA-24-1546	TCGA-24-1546-01A	Stage IIIC	-17130	NA	1955	0	1955	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1546.d6eec9a6-7bfd-40e2-891e-0a3cd7759ace.pdf	1546	NA	NA	YES	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1546-01	TCGA-24-1546-01	TCGA-24-1546-01A-01W-0615-10	67d70140-fcb4-4b5b-9821-498cbd5d53c2	NA	TCGA-24-1546-01	TCGA-24-1546-01A-01W-0615-10	TCGA-24-1546-01A-01D-0536-05	NA	TCGA-24-1546-01A-21-1563-20	NA	9984be2d-c37f-44cd-9eb8-61b65efcf8cb	TCGA-24-1546-01A-01D-0533-01	TCGA-24-1546-01	9cdbc7ad-cffd-4f34-b805-47e7c57d9978	NA	TCGA-24-1546-01A-01D-0533-01	9984be2d-c37f-44cd-9eb8-61b65efcf8cb	NA	9984be2d-c37f-44cd-9eb8-61b65efcf8cb	NA	TCGA-24-1546-01	TCGA-24-1546-01	9984be2d-c37f-44cd-9eb8-61b65efcf8cb	NA	TCGA-24-1546-01A-01R-0540-07	
TCGA-24-1548-01	1	TCGA-24-1548-01	493	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1548	NA	NA	days	493	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-24-1548-F26101	TCGA-24-1548	TCGA-24-1548-01A	Stage IIIC	-20945	NA	493	0	493	NA	207	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1548.d7b9bc71-e243-478f-a116-7e9371b87327.pdf	1548	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1548-01	TCGA-24-1548-01	TCGA-24-1548-01A-01W-0615-10	45cc6ed6-17ea-4291-8654-2b5b30c5a5e1	NA	TCGA-24-1548-01	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01A-01D-0536-05	NA	TCGA-24-1548-01A-21-1558-20	NA	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	TCGA-24-1548-01A-01D-0533-01	TCGA-24-1548-01	adc1690a-194c-44ea-8344-7bac461ab669	NA	TCGA-24-1548-01A-01D-0533-01	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	NA	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	NA	TCGA-24-1548-01	TCGA-24-1548-01	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01A-01R-0540-07	
TCGA-24-1549-01	1	TCGA-24-1549-01	1721	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1549	NA	NA	days	1721	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-24-1549-F26113	TCGA-24-1549	NA	Stage IIIB	-21432	NA	1721	0	1721	NA	1042	NA	NA	NA	2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1549	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	NA	Ovary	NA	NA	DECEASED	1997	TCGA-24-1549-01	TCGA-24-1549-01	NA	f0c19024-16a9-4bc1-af8a-5f55326a22d4	NA	TCGA-24-1549-01	NA	TCGA-24-1549-01A-01D-0501-05	TCGA-24-1549-01A-01W-0553-09	TCGA-24-1549-01A-21-1558-20	TCGA-24-1549-01A-01W-0553-09	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	TCGA-24-1549-01A-01D-0497-01	TCGA-24-1549-01	b18db100-89ea-409a-841a-e90e9e9b65b2	NA	TCGA-24-1549-01A-01D-0497-01	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	NA	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	NA	TCGA-24-1549-01	TCGA-24-1549-01	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	TCGA-24-1549-01A-01W-0553-09	TCGA-24-1549-01A-01R-0504-07	
TCGA-24-1550-01	1	TCGA-24-1550-01	1249	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-24-1550	NA	NA	days	1249	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Left	TCGA-24-1550-F26130	TCGA-24-1550	TCGA-24-1550-01A	Stage IIIC	-18049	NA	1249	0	1249	NA	892	1	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1550.7ebd8d19-0a81-4623-8127-f225ad650d46.pdf	1550	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1550-01	TCGA-24-1550-01	NA	d5e13008-a81c-4dc5-b621-6d11b492883b	NA	TCGA-24-1550-01	NA	TCGA-24-1550-01A-01D-0501-05	NA	TCGA-24-1550-01A-21-1558-20	NA	648cb96f-df1c-48c1-bb15-c37a2784a9db	TCGA-24-1550-01A-01D-0497-01	TCGA-24-1550-01	907ac822-b65b-45f3-87ea-fc78f06bab60	NA	TCGA-24-1550-01A-01D-0497-01	648cb96f-df1c-48c1-bb15-c37a2784a9db	NA	648cb96f-df1c-48c1-bb15-c37a2784a9db	NA	TCGA-24-1550-01	TCGA-24-1550-01	648cb96f-df1c-48c1-bb15-c37a2784a9db	NA	TCGA-24-1550-01A-01R-0504-07	
TCGA-24-1551-01	1	TCGA-24-1551-01	1579	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1551	NA	NA	days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1551-F26139	TCGA-24-1551	TCGA-24-1551-01A	Stage IIIC	-19661	NA	1579	0	1579	NA	764	1	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1551.474ac527-45a2-4258-bec4-0a48a3b80742.pdf	1551	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1551-01	TCGA-24-1551-01	NA	6e9136b5-6f84-4b3d-9586-257b42d3d8e2	NA	TCGA-24-1551-01	NA	TCGA-24-1551-01A-01D-0501-05	NA	TCGA-24-1551-01A-21-1558-20	NA	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01D-0497-01	TCGA-24-1551-01	48b26794-efa4-4e9a-b3c0-5a5391b17b03	NA	TCGA-24-1551-01A-01D-0497-01	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	NA	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01W-0551-08	TCGA-24-1551-01	TCGA-24-1551-01	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01W-0551-08	TCGA-24-1551-01A-01R-0504-07	
TCGA-24-1552-01	1	TCGA-24-1552-01	1259	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1552	NA	NA	days	1259	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Left	TCGA-24-1552-F26148	TCGA-24-1552	TCGA-24-1552-01A	Stage IIIC	-28129	NA	1259	0	1259	NA	403	0	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.9	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1552.FF7B6D0B-D13B-473E-A924-C63CB0B46511.pdf	1552	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.8	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1552-01	TCGA-24-1552-01	NA	62b27771-c8c0-41f8-852f-07b188f7b8e3	NA	TCGA-24-1552-01	NA	TCGA-24-1552-01A-01D-0501-05	NA	TCGA-24-1552-01A-21-1558-20	NA	990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01D-0497-01	TCGA-24-1552-01	ce833a2e-7c81-4720-baa7-49cf52f4f0bd	NA	TCGA-24-1552-01A-01D-0497-01	990bcb1f-7269-4020-8ea5-8ba338b390b8	NA	990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01W-0551-08	TCGA-24-1552-01	TCGA-24-1552-01	990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01W-0551-08	TCGA-24-1552-01A-01R-0504-07	
TCGA-24-1553-01	1	TCGA-24-1553-01	1767	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1553	NA	NA	days	1767	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1553-F26157	TCGA-24-1553	TCGA-24-1553-01A	Stage IIIB	-19393	NA	1767	0	1767	NA	553	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1553.5abe7782-ca53-4add-9a9a-01955859420b.pdf	1553	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1553-01	TCGA-24-1553-01	TCGA-24-1553-01A-01W-0552-10	6007eb37-11b8-4127-b498-f3ada326b0e1	NA	TCGA-24-1553-01	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01A-01D-0501-05	NA	TCGA-24-1553-01A-21-1558-20	NA	7c607e77-a353-4995-855b-36ccaaf3bde6	TCGA-24-1553-01A-01D-0497-01	TCGA-24-1553-01	64c63ba8-750c-4ac7-a0e9-57044507a0a4	NA	TCGA-24-1553-01A-01D-0497-01	7c607e77-a353-4995-855b-36ccaaf3bde6	NA	7c607e77-a353-4995-855b-36ccaaf3bde6	NA	TCGA-24-1553-01	TCGA-24-1553-01	7c607e77-a353-4995-855b-36ccaaf3bde6	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01A-01R-0504-07	
TCGA-24-1555-01	1	TCGA-24-1555-01	2692	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-24-1555	NA	NA	days	2692	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-24-1555-F26171	TCGA-24-1555	TCGA-24-1555-01A	Stage IIIC	-18404	NA	2692	0	2692	NA	1577	0	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1555.b7b2f370-207a-4849-b7a0-528789363a02.pdf	1555	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	NA	Ovary	NA	A	DECEASED	1997	TCGA-24-1555-01	TCGA-24-1555-01	TCGA-24-1555-01A-01W-0552-10	b3e00fd1-65a1-4254-ac59-1d56b879c253	NA	TCGA-24-1555-01	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01A-01D-0501-05	NA	TCGA-24-1555-01A-21-1558-20	NA	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	TCGA-24-1555-01A-01D-0497-01	TCGA-24-1555-01	10cb1259-03bf-4d9e-946e-bea05e4f23bd	NA	TCGA-24-1555-01A-01D-0497-01	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	NA	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	NA	TCGA-24-1555-01	TCGA-24-1555-01	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01A-01R-0504-07	
TCGA-24-1556-01	1	TCGA-24-1556-01	2148	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1556	NA	NA	days	2148	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	50	Left	TCGA-24-1556-F26184	TCGA-24-1556	TCGA-24-1556-01A	Stage IIB	-18517	NA	2148	0	2148	NA	539	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.9	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1556.75c91323-45a7-4629-b014-f7eda2f1075e.pdf	1556	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1556-01	TCGA-24-1556-01	TCGA-24-1556-01A-01W-0615-10	3602ad67-bdfb-48a8-8a58-8019bee04630	NA	TCGA-24-1556-01	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01A-01D-0536-05	NA	TCGA-24-1556-01A-21-1558-20	NA	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	TCGA-24-1556-01A-01D-0533-01	TCGA-24-1556-01	7c4dcb9c-346b-4b52-9b64-f835ebc85dba	NA	TCGA-24-1556-01A-01D-0533-01	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	NA	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	NA	TCGA-24-1556-01	TCGA-24-1556-01	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01A-01R-0540-07	
TCGA-24-1557-01	1	TCGA-24-1557-01	1213	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1557	NA	NA	days	1213	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-24-1557-F26194	TCGA-24-1557	NA	Stage IIIC	-17943	NA	1213	0	1213	NA	447	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	1557	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	>20 mm	Ovary	NA	NA	DECEASED	2000	TCGA-24-1557-01	TCGA-24-1557-01	TCGA-24-1557-01A-01W-0615-10	e9f05aba-2e25-44c7-b49f-9300cb5c61e1	NA	TCGA-24-1557-01	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01A-01D-0536-05	NA	TCGA-24-1557-01A-21-1558-20	NA	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	TCGA-24-1557-01A-01D-0533-01	TCGA-24-1557-01	d534bbdd-5827-426e-ad74-9346b06716f5	NA	TCGA-24-1557-01A-01D-0533-01	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	NA	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	NA	TCGA-24-1557-01	TCGA-24-1557-01	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01A-01R-0540-07	
TCGA-24-1558-01	1	TCGA-24-1558-01	594	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 2	TCGA-24-1558	NA	NA	days	594	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-24-1558-F26212	TCGA-24-1558	TCGA-24-1558-01A	Stage IIIC	-27004	NA	594	0	594	NA	273	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.9	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1558.62143e5f-4452-47ca-a67c-cd87036424b1.pdf	1558	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.9	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-1558-01	TCGA-24-1558-01	TCGA-24-1558-01A-01W-0615-10	beca71a6-9c32-4f27-9419-32d96cafed27	NA	TCGA-24-1558-01	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01A-01D-0536-05	NA	TCGA-24-1558-01A-21-1558-20	NA	1b8d5b5e-f671-419a-844a-6640fe5a896d	TCGA-24-1558-01A-01D-0533-01	TCGA-24-1558-01	b37713e8-e63a-4dba-b7fb-aebc5914676d	NA	TCGA-24-1558-01A-01D-0533-01	1b8d5b5e-f671-419a-844a-6640fe5a896d	NA	1b8d5b5e-f671-419a-844a-6640fe5a896d	NA	TCGA-24-1558-01	TCGA-24-1558-01	1b8d5b5e-f671-419a-844a-6640fe5a896d	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01A-01R-0540-07	
TCGA-24-1560-01	1	TCGA-24-1560-01	1341	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1560	NA	NA	days	1341	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Left	TCGA-24-1560-F26221	TCGA-24-1560	TCGA-24-1560-01A	Stage IIIC	-18671	NA	1341	0	1341	NA	143	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G4	Recurrence	NA	NA	NA	NA	TCGA-24-1560.464e1a20-b2d1-49c4-8da5-11b8c0f96b4e.pdf	1560	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1560-01	TCGA-24-1560-01	TCGA-24-1560-01A-01W-0615-10	5b6e5bbe-fe20-4613-b55c-2e544ea51a2b	NA	TCGA-24-1560-01	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01A-01D-0536-05	NA	TCGA-24-1560-01A-21-1558-20	NA	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	TCGA-24-1560-01A-01D-0533-01	TCGA-24-1560-01	15295f32-7794-43cb-a943-03a38d4b6016	NA	TCGA-24-1560-01A-01D-0533-01	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	NA	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	NA	TCGA-24-1560-01	TCGA-24-1560-01	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01A-01R-0540-07	
TCGA-24-1562-01	1	TCGA-24-1562-01	1384	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1562	NA	NA	days	1384	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-1562-F26237	TCGA-24-1562	TCGA-24-1562-01A	Stage IIIC	-24747	NA	1384	0	1384	NA	229	0	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a.pdf	1562	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1562-01	TCGA-24-1562-01	NA	f36d78a7-5e27-4a7a-8055-a7ca51b8c371	NA	TCGA-24-1562-01	NA	TCGA-24-1562-01A-01D-0501-05	TCGA-24-1562-01A-01W-0553-09	TCGA-24-1562-01A-21-1558-20	TCGA-24-1562-01A-01W-0553-09	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	TCGA-24-1562-01A-01D-0497-01	TCGA-24-1562-01	9082bc34-1aa2-4e77-bb64-22778ee28635	NA	TCGA-24-1562-01A-01D-0497-01	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	NA	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	NA	TCGA-24-1562-01	TCGA-24-1562-01	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	TCGA-24-1562-01A-01W-0553-09	TCGA-24-1562-01A-01R-0504-07	
TCGA-24-1563-01	1	TCGA-24-1563-01	1451	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1563	NA	NA	days	1451	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Left	TCGA-24-1563-F26248	TCGA-24-1563	TCGA-24-1563-01A	Stage IIIC	-24274	NA	1451	0	1451	NA	396	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba.pdf	1563	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1563-01	TCGA-24-1563-01	NA	70951f22-8982-42be-bf1e-15f24b415708	NA	TCGA-24-1563-01	NA	TCGA-24-1563-01A-01D-0501-05	TCGA-24-1563-01A-01W-0553-09	TCGA-24-1563-01A-21-1558-20	TCGA-24-1563-01A-01W-0553-09	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	TCGA-24-1563-01A-01D-0497-01	TCGA-24-1563-01	e52eaae7-ae99-43fe-a752-89045be81447	NA	TCGA-24-1563-01A-01D-0497-01	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	NA	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	NA	TCGA-24-1563-01	TCGA-24-1563-01	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	TCGA-24-1563-01A-01W-0553-09	TCGA-24-1563-01A-01R-0504-07	
TCGA-24-1564-01	1	TCGA-24-1564-01	787	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1564	NA	NA	days	787	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	67	Bilateral	TCGA-24-1564-F26260	TCGA-24-1564	TCGA-24-1564-01A	Stage IIIC	-24668	NA	787	0	787	NA	221	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1564.fa1c8286-2e55-4137-93ae-c19d470ce2e4.pdf	1564	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-1564-01	TCGA-24-1564-01	NA	3b4f61f1-616b-4995-bcb6-6eb2e11be681	NA	TCGA-24-1564-01	NA	TCGA-24-1564-01A-01D-0501-05	NA	TCGA-24-1564-01A-21-1558-20	NA	03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01D-0497-01	TCGA-24-1564-01	b6e7fde5-418d-4848-a99e-6fc8c943bd7b	NA	TCGA-24-1564-01A-01D-0497-01	03b8480f-d19e-43e4-8a09-f9230c525c1e	NA	03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01W-0551-08	TCGA-24-1564-01	TCGA-24-1564-01	03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01W-0551-08	TCGA-24-1564-01A-01R-0504-07	
TCGA-24-1565-01	1	TCGA-24-1565-01	312	1	days	Iq	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-24-1565	NA	NA	days	312	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-1565-F26274	TCGA-24-1565	TCGA-24-1565-01A	Stage IIIC	-27048	NA	312	0	312	NA	145	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1565.f424905e-3dc2-4e37-b6c4-8a77c7ce817b.pdf	1565	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	NA	TCGA-24-1565-01	NA	8c0e5f5a-fd1e-40de-9746-1b22572df7b8	NA	TCGA-24-1565-01	NA	TCGA-24-1565-01A-01D-0501-05	NA	TCGA-24-1565-01A-21-1558-20	NA	NA	TCGA-24-1565-01A-01D-0497-01	TCGA-24-1565-01	bd856415-5235-4086-a72f-9d0a65b8867b	NA	TCGA-24-1565-01A-01D-0497-01	NA	NA	NA	TCGA-24-1565-01A-01W-0551-08	TCGA-24-1565-01	NA	NA	TCGA-24-1565-01A-01W-0551-08	TCGA-24-1565-01A-01R-0504-07	
TCGA-24-1567-01	1	TCGA-24-1567-01	524	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1567	NA	NA	days	524	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-24-1567-F26279	TCGA-24-1567	TCGA-24-1567-01A	Stage IIIB	-19843	NA	524	0	524	NA	319	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.3	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1567.90910bbc-49e1-495b-9b06-11056ff401df.pdf	1567	NA	WITH TUMOR	YES	NA	Molecular Markers	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-1567-01	TCGA-24-1567-01	TCGA-24-1567-01A-01W-0615-10	b39f67ca-abb2-4f96-a0c4-79ea6cbe523e	NA	TCGA-24-1567-01	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01A-01D-0536-05	NA	TCGA-24-1567-01A-21-1558-20	NA	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	TCGA-24-1567-01A-01D-0533-01	TCGA-24-1567-01	e4b66de6-faab-41b2-af46-ad0f9f81bed7	NA	TCGA-24-1567-01A-01D-0533-01	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	NA	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	NA	TCGA-24-1567-01	TCGA-24-1567-01	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01A-01R-0540-07	
TCGA-24-1603-01	1	TCGA-24-1603-01	2742	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1603	NA	NA	days	2742	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1603-F26284	TCGA-24-1603	TCGA-24-1603-01A	Stage IIIB	-19681	NA	2742	0	2742	NA	992	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9.pdf	1603	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	24	NA	Ovary	NA	A	DECEASED	1996	TCGA-24-1603-01	TCGA-24-1603-01	NA	74a46153-942a-42e8-b6a0-ac066c006e5d	NA	TCGA-24-1603-01	NA	TCGA-24-1603-01A-01D-0501-05	NA	TCGA-24-1603-01A-21-1558-20	NA	f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01D-0497-01	TCGA-24-1603-01	eecacbb1-98ef-4194-957d-5a49f9548657	NA	TCGA-24-1603-01A-01D-0497-01	f4187f4f-9c52-4065-818b-c884183a5a70	NA	f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01W-0551-08	TCGA-24-1603-01	TCGA-24-1603-01	f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01W-0551-08	TCGA-24-1603-01A-01R-0504-07	
TCGA-24-1604-01	1	TCGA-24-1604-01	2688	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1604	NA	NA	days	2688	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Bilateral	TCGA-24-1604-F26299	TCGA-24-1604	TCGA-24-1604-01A	Stage IIIC	-24471	NA	2688	0	2688	NA	NA	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.4	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1604.de978a3d-92f9-4bd8-98f4-f8a3ec09b362.pdf	1604	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	24	NA	Ovary	NA	A	DECEASED	1996	TCGA-24-1604-01	TCGA-24-1604-01	TCGA-24-1604-01A-01W-0552-10	08109bba-5c11-4400-a968-c858329cbedf	NA	TCGA-24-1604-01	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01A-01D-0501-05	NA	TCGA-24-1604-01A-21-1558-20	NA	a658045c-93a6-4aac-abbb-1cd6093b7735	TCGA-24-1604-01A-01D-0497-01	TCGA-24-1604-01	2350016d-f638-4c02-a24b-76f1df75cb69	NA	TCGA-24-1604-01A-01D-0497-01	a658045c-93a6-4aac-abbb-1cd6093b7735	NA	a658045c-93a6-4aac-abbb-1cd6093b7735	NA	TCGA-24-1604-01	TCGA-24-1604-01	a658045c-93a6-4aac-abbb-1cd6093b7735	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01A-01R-0504-07	
TCGA-24-1614-01	1	TCGA-24-1614-01	1470	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1614	NA	NA	days	1470	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Right	TCGA-24-1614-F26306	TCGA-24-1614	TCGA-24-1614-01A	Stage IIIC	-20993	NA	1470	0	1470	NA	644	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	100	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1614.4e371c15-c0d1-454a-997d-dfbe98b02f7e.pdf	1614	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-24-1614-01	TCGA-24-1614-01A-01W-0552-10	a85349ef-886c-4d39-8c23-ff13b920059a	NA	TCGA-24-1614-01	TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01A-01D-0501-05	NA	TCGA-24-1614-01A-21-1558-20	NA	NA	TCGA-24-1614-01A-01D-0497-01	TCGA-24-1614-01	6ceece0c-56d0-41e6-93e9-12e2a4fdb4c4	NA	TCGA-24-1614-01A-01D-0497-01	NA	NA	NA	NA	TCGA-24-1614-01	NA	NA	TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01A-01R-0504-07	
TCGA-24-1616-01	1	TCGA-24-1616-01	1163	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1616	NA	NA	days	1163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-24-1616-F26315	TCGA-24-1616	TCGA-24-1616-01A	Stage IIIC	-20785	NA	1163	0	1163	NA	405	NA	NA	NA	2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.9	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1616.d8c764d9-0fe8-488e-8aa1-da73a8c10b01.pdf	1616	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-24-1616-01	TCGA-24-1616-01	NA	e40e646a-09da-49ad-bcca-1e56df395a36	NA	TCGA-24-1616-01	NA	TCGA-24-1616-01A-01D-0501-05	TCGA-24-1616-01A-01W-0553-09	TCGA-24-1616-01A-21-1558-20	TCGA-24-1616-01A-01W-0553-09	c334b353-0652-49fb-8cd6-5bcf8485e5d0	TCGA-24-1616-01A-01D-0497-01	TCGA-24-1616-01	3e449bae-1749-47d9-adc1-6e70b0c829dc	NA	TCGA-24-1616-01A-01D-0497-01	c334b353-0652-49fb-8cd6-5bcf8485e5d0	NA	c334b353-0652-49fb-8cd6-5bcf8485e5d0	NA	TCGA-24-1616-01	TCGA-24-1616-01	c334b353-0652-49fb-8cd6-5bcf8485e5d0	TCGA-24-1616-01A-01W-0553-09	TCGA-24-1616-01A-01R-0504-07	
TCGA-24-1842-01	0	TCGA-24-1842-01	253	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-1842	NA	NA	days	253	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-24-1842-F26325	TCGA-24-1842	TCGA-24-1842-01A	Stage IIIC	-18227	NA	NA	0	253	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1842.3465aae7-0664-44e5-a27f-c02fd73526a1.pdf	1842	Other	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1842-01	TCGA-24-1842-01	NA	af43832d-2996-4a7f-8e5c-6bd2ec938cfe	NA	TCGA-24-1842-01	NA	TCGA-24-1842-01A-01D-0581-05	NA	TCGA-24-1842-01A-21-1559-20	TCGA-24-1842-01A-01W-0639-09	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	TCGA-24-1842-01A-01D-0577-01	TCGA-24-1842-01	5dcf27b7-8966-4c46-a0f6-5a1450f60d1d	NA	TCGA-24-1842-01A-01D-0577-01	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	NA	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	NA	TCGA-24-1842-01	TCGA-24-1842-01	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	NA	TCGA-24-1842-01A-01R-0584-07	
TCGA-24-1843-01	0	TCGA-24-1843-01	106	0	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-1843	NA	NA	days	106	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Right	TCGA-24-1843-F26330	TCGA-24-1843	TCGA-24-1843-01A	Stage IIIC	-24469	NA	NA	0	106	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb.pdf	1843	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1843-01	TCGA-24-1843-01	NA	51ac296a-c599-47db-9a67-5aacf572efab	NA	TCGA-24-1843-01	NA	TCGA-24-1843-01A-01D-0581-05	NA	NA	TCGA-24-1843-01A-01W-0639-09	c50cf5af-3375-4748-9894-1f9521f746da	TCGA-24-1843-01A-01D-0577-01	TCGA-24-1843-01	NA	NA	TCGA-24-1843-01A-01D-0577-01	c50cf5af-3375-4748-9894-1f9521f746da	NA	c50cf5af-3375-4748-9894-1f9521f746da	NA	TCGA-24-1843-01	TCGA-24-1843-01	c50cf5af-3375-4748-9894-1f9521f746da	NA	TCGA-24-1843-01A-01R-0584-07	
TCGA-24-1844-01	0	TCGA-24-1844-01	113	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-1844	NA	NA	days	113	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Bilateral	TCGA-24-1844-F26335	TCGA-24-1844	TCGA-24-1844-01A	Stage IIIC	-23542	NA	NA	0	113	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1844.5fd30c3c-9734-40dd-b81e-ae3f364c8fa8.pdf	1844	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1844-01	TCGA-24-1844-01	NA	5f13ef2d-8e72-4552-8ace-f089597b1131	NA	TCGA-24-1844-01	NA	TCGA-24-1844-01A-01D-0581-05	NA	TCGA-24-1844-01A-21-1559-20	TCGA-24-1844-01A-01W-0639-09	53a60e9f-3541-4fe7-a7ea-87ee888c0446	TCGA-24-1844-01A-01D-0577-01	TCGA-24-1844-01	d95c8065-b35e-47b0-899a-305b14ed2a56	NA	TCGA-24-1844-01A-01D-0577-01	53a60e9f-3541-4fe7-a7ea-87ee888c0446	NA	53a60e9f-3541-4fe7-a7ea-87ee888c0446	NA	TCGA-24-1844-01	TCGA-24-1844-01	53a60e9f-3541-4fe7-a7ea-87ee888c0446	NA	TCGA-24-1844-01A-01R-0584-07	
TCGA-24-1845-01	0	TCGA-24-1845-01	116	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	NA	TCGA-24-1845	NA	NA	days	116	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	42	Bilateral	TCGA-24-1845-F26340	TCGA-24-1845	TCGA-24-1845-01A	Stage IIIC	-15599	NA	NA	0	116	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1845.1fda446a-e0d2-422a-a023-57ec5bfae62b.pdf	1845	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	NA	TCGA-24-1845-01	NA	24d1e3ea-44ad-4bb9-8aa7-cd448b8bec21	NA	TCGA-24-1845-01	NA	TCGA-24-1845-01A-01D-0581-05	NA	TCGA-24-1845-01A-21-1559-20	TCGA-24-1845-01A-01W-0639-09	NA	TCGA-24-1845-01A-01D-0577-01	TCGA-24-1845-01	cd017460-81cb-4e71-b352-42612cae745e	NA	TCGA-24-1845-01A-01D-0577-01	NA	NA	NA	NA	TCGA-24-1845-01	NA	NA	NA	TCGA-24-1845-01A-01R-0584-07	
TCGA-24-1846-01	0	TCGA-24-1846-01	133	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-1846	NA	NA	days	133	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-24-1846-F26346	TCGA-24-1846	TCGA-24-1846-01A	Stage IIIC	-16534	NA	NA	0	133	NA	NA	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1846.fb12e5b3-1529-4873-90fd-7ba0a78dd9f4.pdf	1846	Other	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1846-01	TCGA-24-1846-01	NA	50b9dcb5-0fb8-4be7-97ce-5cd477d6c351	NA	TCGA-24-1846-01	NA	TCGA-24-1846-01A-01D-0581-05	NA	TCGA-24-1846-01A-21-1559-20	TCGA-24-1846-01A-01W-0639-09	4b073708-9525-4340-90dc-ede08ee24977	TCGA-24-1846-01A-01D-0577-01	TCGA-24-1846-01	15134c0c-7253-481e-83e3-7d1c57bc521d	NA	TCGA-24-1846-01A-01D-0577-01	4b073708-9525-4340-90dc-ede08ee24977	NA	4b073708-9525-4340-90dc-ede08ee24977	NA	TCGA-24-1846-01	TCGA-24-1846-01	4b073708-9525-4340-90dc-ede08ee24977	NA	TCGA-24-1846-01A-01R-0584-07	
TCGA-24-1847-01	0	TCGA-24-1847-01	343	0	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-24-1847	NA	NA	days	343	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-24-1847-F26350	TCGA-24-1847	TCGA-24-1847-01A	Stage IV	-16529	NA	NA	0	343	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	0.9	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1847.20d96d45-40d3-44ad-a9e8-fdc7e545ed5d.pdf	1847	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1847-01	TCGA-24-1847-01	NA	74b939d6-c502-4edf-a412-df6dc9484eb6	NA	TCGA-24-1847-01	NA	TCGA-24-1847-01A-01D-0563-05	NA	NA	TCGA-24-1847-01A-01W-0633-09	83354694-078e-411e-89d2-029649708528	TCGA-24-1847-01A-01D-0559-01	TCGA-24-1847-01	NA	NA	TCGA-24-1847-01A-01D-0559-01	83354694-078e-411e-89d2-029649708528	NA	83354694-078e-411e-89d2-029649708528	NA	TCGA-24-1847-01	TCGA-24-1847-01	83354694-078e-411e-89d2-029649708528	NA	TCGA-24-1847-01A-01R-0566-07	
TCGA-24-1849-01	0	TCGA-24-1849-01	176	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	NA	TCGA-24-1849	NA	NA	days	176	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	80	Bilateral	TCGA-24-1849-F26355	TCGA-24-1849	TCGA-24-1849-01A	Stage IIIC	-29555	NA	NA	0	176	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1849.a2181913-086c-42a2-99fd-057b17025deb.pdf	1849	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1849-01	TCGA-24-1849-01	NA	36592a9b-a440-4741-95bc-51e700d14b52	NA	TCGA-24-1849-01	NA	TCGA-24-1849-01A-01D-0581-05	NA	TCGA-24-1849-01A-21-1562-20	TCGA-24-1849-01A-01W-0639-09	58f3764a-4651-4c26-a667-74aef5c5679c	TCGA-24-1849-01A-01D-0577-01	TCGA-24-1849-01	66dc2c60-9fa1-4fb7-8bd4-76da1e11229a	NA	TCGA-24-1849-01A-01D-0577-01	58f3764a-4651-4c26-a667-74aef5c5679c	NA	58f3764a-4651-4c26-a667-74aef5c5679c	NA	TCGA-24-1849-01	TCGA-24-1849-01	58f3764a-4651-4c26-a667-74aef5c5679c	NA	TCGA-24-1849-01A-01R-0584-07	
TCGA-24-1850-01	0	TCGA-24-1850-01	168	0	days	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-24-1850	NA	NA	days	168	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	72	Bilateral	TCGA-24-1850-F26359	TCGA-24-1850	TCGA-24-1850-01A	Stage IIIC	-26369	NA	NA	0	168	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-1850.a8c2f09f-6971-48e1-b890-f1d63611cdbd.pdf	1850	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-1850-01	TCGA-24-1850-01	NA	717a05a3-2930-4f69-a497-d884d493edaa	NA	TCGA-24-1850-01	NA	TCGA-24-1850-01A-01D-0581-05	NA	TCGA-24-1850-01A-21-1559-20	TCGA-24-1850-01A-01W-0639-09	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	TCGA-24-1850-01A-01D-0577-01	TCGA-24-1850-01	eacc0479-97ed-45f6-a4cb-9cca12252bd2	NA	TCGA-24-1850-01A-01D-0577-01	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	NA	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	NA	TCGA-24-1850-01	TCGA-24-1850-01	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	NA	TCGA-24-1850-01A-01R-0584-07	
TCGA-24-1852-01	1	TCGA-24-1852-01	2201	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-24-1852	NA	NA	days	2201	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-1852-F26363	TCGA-24-1852	TCGA-24-1852-01A	Stage IIIC	-20390	NA	2201	0	2201	NA	1009	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1852.FC6FD336-EB96-40CD-91FB-9371A305EF76.pdf	1852	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	NA	NA	NA	8bc4b5b7-b987-475b-90f7-28c8bd19a0fa	NA	NA	NA	TCGA-24-1852-01A-01D-0807-05	NA	TCGA-24-1852-01A-21-1559-20	NA	NA	TCGA-24-1852-01A-01D-0803-01	TCGA-24-1852-01	6800890d-adf7-4831-8a21-68fc3b583fe6,b2810bf7-eaed-4955-b0da-e6ea3c65a9a7	NA	TCGA-24-1852-01A-01D-0803-01	NA	NA	NA	NA	TCGA-24-1852-01	NA	NA	NA	TCGA-24-1852-01A-01R-0810-07	
TCGA-24-1852-02	1	TCGA-24-1852-02	2201	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-24-1852	NA	NA	days	2201	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-1852-F26363	TCGA-24-1852	TCGA-24-1852-02A	Stage IIIC	-20390	NA	2201	0	2201	NA	1009	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1852.FC644609-4B3F-41A5-9164-BC024C95DAB0.pdf	1852	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1997	NA	NA	NA	7c459b65-7eca-4081-83f0-ff67f0410a9b	NA	NA	NA	TCGA-24-1852-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	8e296930-ef86-4ff6-ac5c-11ef322d0dc2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-24-1852-02A-01R-0810-07	
TCGA-24-1920-01	0	TCGA-24-1920-01	298	0	days	High	NA	OV-like c1	BRCA basal-like c6	NA	miRNA cluster 1	cluster 3	NA	TCGA-24-1920	NA	NA	days	298	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Right	TCGA-24-1920-F26373	TCGA-24-1920	TCGA-24-1920-01A	Stage IIIC	-27042	NA	NA	0	298	NA	NA	0	NA	NA	2010-2-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-1920.292d7fe5-e949-458b-b7da-cc55009b1c06.pdf	1920	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	NA	TCGA-24-1920-01	NA	678cbaa5-cd2a-4cf5-a7e5-34b3db7281cc	NA	TCGA-24-1920-01	NA	TCGA-24-1920-01A-01D-0652-05	NA	TCGA-24-1920-01A-21-1559-20	NA	NA	TCGA-24-1920-01A-01D-0648-01	TCGA-24-1920-01	300fb12e-d372-4a03-ae7f-95d0cef8027a	NA	TCGA-24-1920-01A-01D-0648-01	NA	NA	NA	NA	TCGA-24-1920-01	NA	NA	NA	TCGA-24-1920-01A-01R-0655-07	
TCGA-24-1923-01	1	TCGA-24-1923-01	690	1	days	Squamous	NA	Low purity c2	OV-like c4	NA	miRNA cluster 3	cluster 6	NA	TCGA-24-1923	NA	NA	days	690	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-24-1923-F26379	TCGA-24-1923	TCGA-24-1923-01A	Stage IIIC	-18628	NA	690	0	690	NA	343	NA	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	0.6	NO	NA	1.3	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7.pdf	1923	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	NA	TCGA-24-1923-01	NA	fde22a7e-62c4-4c20-ac40-ac1b873edf9a	NA	TCGA-24-1923-01	NA	TCGA-24-1923-01A-01D-0652-05	NA	TCGA-24-1923-01A-21-1559-20	NA	NA	TCGA-24-1923-01A-01D-0648-01	TCGA-24-1923-01	9c88c21f-4bb9-41cc-b942-9c6e73a46511	NA	TCGA-24-1923-01A-01D-0648-01	NA	NA	NA	NA	TCGA-24-1923-01	NA	NA	NA	TCGA-24-1923-01A-01R-0655-07	
TCGA-24-1924-01	1	TCGA-24-1924-01	919	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-24-1924	NA	NA	days	919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-24-1924-F26386	TCGA-24-1924	TCGA-24-1924-01A	Stage IIIC	-23801	NA	919	0	919	NA	320	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1924.4199b57a-81f5-4d5f-9f4c-1e514dcd26dc.pdf	1924	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-24-1924-01	TCGA-24-1924-01	NA	16cd57f0-1334-447e-828e-989c2339c282	NA	TCGA-24-1924-01	NA	TCGA-24-1924-01A-01D-0652-05	NA	TCGA-24-1924-01A-21-1559-20	NA	2592f314-cc0a-4d00-bdcf-6376afd32bb7	TCGA-24-1924-01A-01D-0648-01	TCGA-24-1924-01	d4067ae4-665b-4539-938c-e86a08523d3f	NA	TCGA-24-1924-01A-01D-0648-01	2592f314-cc0a-4d00-bdcf-6376afd32bb7	NA	2592f314-cc0a-4d00-bdcf-6376afd32bb7	NA	TCGA-24-1924-01	TCGA-24-1924-01	2592f314-cc0a-4d00-bdcf-6376afd32bb7	NA	TCGA-24-1924-01A-01R-0655-07	
TCGA-24-1927-01	1	TCGA-24-1927-01	500	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-24-1927	NA	NA	days	500	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-24-1927-F26396	TCGA-24-1927	NA	Stage IIIC	-21719	NA	500	0	500	NA	290	NA	NA	NA	2010-3-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1927	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	DECEASED	1999	NA	NA	NA	NA	NA	NA	NA	TCGA-24-1927-01A-01D-0652-05	NA	TCGA-24-1927-01A-21-1559-20	NA	NA	TCGA-24-1927-01A-01D-0648-01	TCGA-24-1927-01	f9b9b275-8678-4ff8-95fe-dd804f20713d	NA	TCGA-24-1927-01A-01D-0648-01	NA	NA	NA	NA	TCGA-24-1927-01	NA	NA	NA	TCGA-24-1927-01A-01R-0655-07	
TCGA-24-1928-01	1	TCGA-24-1928-01	336	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 2	NA	TCGA-24-1928	NA	NA	days	336	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-24-1928-F26403	TCGA-24-1928	TCGA-24-1928-01A	Stage IIIC	-28126	NA	336	0	336	NA	70	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.5	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1928.dc4407fb-d15b-44d5-9c3b-129cca67d8f1.pdf	1928	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	24	11-20 mm	Ovary	NA	A	DECEASED	1998	TCGA-24-1928-01	TCGA-24-1928-01	NA	681d19fb-e521-4105-8d76-275624c1d3b0	NA	TCGA-24-1928-01	NA	TCGA-24-1928-01A-01D-0652-05	NA	NA	NA	433d642a-06fe-454f-a2bf-3e0afb3dd23b	TCGA-24-1928-01A-01D-0648-01	TCGA-24-1928-01	NA	NA	TCGA-24-1928-01A-01D-0648-01	433d642a-06fe-454f-a2bf-3e0afb3dd23b	NA	433d642a-06fe-454f-a2bf-3e0afb3dd23b	NA	TCGA-24-1928-01	TCGA-24-1928-01	433d642a-06fe-454f-a2bf-3e0afb3dd23b	NA	TCGA-24-1928-01A-01R-0655-07	
TCGA-24-1930-01	1	TCGA-24-1930-01	2467	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-24-1930	NA	NA	days	2467	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Bilateral	TCGA-24-1930-F26410	TCGA-24-1930	TCGA-24-1930-01A	Stage IIIC	-19387	NA	2467	0	2467	NA	544	0	NA	NA	2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	100	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c.pdf	1930	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1998	TCGA-24-1930-01	TCGA-24-1930-01	NA	3412c513-36c6-459c-9f66-3dd15d0d8e72	NA	TCGA-24-1930-01	NA	TCGA-24-1930-01A-01D-0652-05	NA	TCGA-24-1930-01A-21-1559-20	NA	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	TCGA-24-1930-01A-01D-0648-01	TCGA-24-1930-01	bf3c2d8b-6072-4f59-8f19-128cfff7314e	NA	TCGA-24-1930-01A-01D-0648-01	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	NA	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	NA	TCGA-24-1930-01	TCGA-24-1930-01	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	NA	TCGA-24-1930-01A-01R-0655-07	
TCGA-24-2019-01	0	TCGA-24-2019-01	148	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-2019	NA	NA	days	148	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Bilateral	TCGA-24-2019-F26429	TCGA-24-2019	TCGA-24-2019-01A	Stage IIIC	-17009	NA	NA	0	148	NA	NA	1	NA	NA	2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1.pdf	2019	Other	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-24-2019-01	TCGA-24-2019-01	NA	437a6ae6-ad96-446e-ad48-d2d8f608e915	NA	TCGA-24-2019-01	NA	TCGA-24-2019-01A-02D-0667-05	NA	NA	NA	52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02D-0663-01	TCGA-24-2019-01	NA	NA	TCGA-24-2019-01A-02D-0663-01	52908652-f29a-4517-8ff6-6f4cd31c691b	NA	52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02W-0722-08	TCGA-24-2019-01	TCGA-24-2019-01	52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02W-0722-08	TCGA-24-2019-01A-02R-0670-07	
TCGA-24-2020-01	1	TCGA-24-2020-01	4624	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-24-2020	NA	NA	days	4624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-2020-F26431	TCGA-24-2020	TCGA-24-2020-01A	Stage IIIC	-24682	NA	4624	0	4624	NA	723	NA	NA	NA	2010-3-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2020.4f529d42-acb0-4c02-bd0f-d4a650655df8.pdf	2020	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1994	TCGA-24-2020-01	TCGA-24-2020-01	NA	dfccfa2b-c85a-4ef7-815f-75d1042b5c6d	NA	TCGA-24-2020-01	NA	TCGA-24-2020-01A-01D-0652-05	NA	TCGA-24-2020-01A-21-1560-20	NA	19765b4f-458e-4f02-bf96-01498d80ac83	TCGA-24-2020-01A-01D-0648-01	TCGA-24-2020-01	809ac07d-5244-462e-a41e-531eeb193296	NA	TCGA-24-2020-01A-01D-0648-01	19765b4f-458e-4f02-bf96-01498d80ac83	NA	19765b4f-458e-4f02-bf96-01498d80ac83	NA	TCGA-24-2020-01	TCGA-24-2020-01	19765b4f-458e-4f02-bf96-01498d80ac83	NA	TCGA-24-2020-01A-01R-0655-07	
TCGA-24-2023-01	1	TCGA-24-2023-01	1364	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-24-2023	NA	NA	days	1364	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-24-2023-F26442	TCGA-24-2023	TCGA-24-2023-01A	Stage IIIA	-19901	NA	1364	0	1364	NA	1069	NA	NA	NA	2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2023.2a255fa6-65cd-4fb7-9d08-1b6aadd6682b.pdf	2023	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1994	TCGA-24-2023-01	TCGA-24-2023-01	NA	feeee3cc-2213-4b46-b985-4575d7dcbf23	NA	TCGA-24-2023-01	NA	TCGA-24-2023-01A-01D-0652-05	NA	TCGA-24-2023-01A-21-1560-20	NA	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	TCGA-24-2023-01A-01D-0648-01	TCGA-24-2023-01	53cd60af-85e4-468e-a6f8-f21be9631a23	NA	TCGA-24-2023-01A-01D-0648-01	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	NA	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	NA	TCGA-24-2023-01	TCGA-24-2023-01	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	NA	TCGA-24-2023-01A-01R-0655-07	
TCGA-24-2024-01	1	TCGA-24-2024-01	1769	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2024	NA	NA	days	1769	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Bilateral	TCGA-24-2024-F26450	TCGA-24-2024	TCGA-24-2024-01A	Stage IIIC	-26476	NA	1769	0	1769	NA	421	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061.pdf	2024	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1994	TCGA-24-2024-01	TCGA-24-2024-01	NA	3f66920b-c10b-4768-a706-c8a6cef1c149	NA	TCGA-24-2024-01	NA	TCGA-24-2024-01A-02D-0667-05	NA	TCGA-24-2024-01A-03-1563-20	NA	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02D-0663-01	TCGA-24-2024-01	c3771a58-897b-4427-8dbb-70214f74dc03	NA	TCGA-24-2024-01A-02D-0663-01	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	NA	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02W-0722-08	TCGA-24-2024-01	TCGA-24-2024-01	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02W-0722-08	TCGA-24-2024-01A-02R-0670-07	
TCGA-24-2026-01	1	TCGA-24-2026-01	1059	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-2026	NA	NA	days	1059	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	79	Bilateral	TCGA-24-2026-F26456	TCGA-24-2026	NA	Stage IIIC	-29050	NA	1059	0	1059	NA	NA	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	NA	NA	NA	NA	NA	NA	2026	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	24	>20 mm	Ovary	NA	NA	DECEASED	1995	TCGA-24-2026-01	TCGA-24-2026-01	NA	ccb2b163-3da6-4594-b55b-c63221fc8ad5	NA	TCGA-24-2026-01	NA	TCGA-24-2026-01A-01D-0652-05	NA	TCGA-24-2026-01A-21-1560-20	NA	ce0fd762-e18f-4cca-a4c4-c064dca62e60	TCGA-24-2026-01A-01D-0648-01	TCGA-24-2026-01	f68086f7-8d41-4631-9346-849088f1f577	NA	TCGA-24-2026-01A-01D-0648-01	ce0fd762-e18f-4cca-a4c4-c064dca62e60	NA	ce0fd762-e18f-4cca-a4c4-c064dca62e60	NA	TCGA-24-2026-01	TCGA-24-2026-01	ce0fd762-e18f-4cca-a4c4-c064dca62e60	NA	TCGA-24-2026-01A-01R-0655-07	
TCGA-24-2027-01	1	TCGA-24-2027-01	3337	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-24-2027	NA	NA	days	3337	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-24-2027-F26460	TCGA-24-2027	TCGA-24-2027-01A	Stage IV	-18835	NA	3337	0	3337	NA	617	0	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6.pdf	2027	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1995	TCGA-24-2027-01	TCGA-24-2027-01	NA	e9c0e81a-4be2-4ab2-a0fe-33ea200f4047	NA	TCGA-24-2027-01	NA	TCGA-24-2027-01A-01D-0652-05	NA	TCGA-24-2027-01A-21-1560-20	NA	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	TCGA-24-2027-01A-01D-0648-01	TCGA-24-2027-01	55afc19d-b001-47f3-9d3d-9bc9a8681031	NA	TCGA-24-2027-01A-01D-0648-01	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	NA	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	NA	TCGA-24-2027-01	TCGA-24-2027-01	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	NA	TCGA-24-2027-01A-01R-0655-07	
TCGA-24-2029-01	1	TCGA-24-2029-01	439	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	NA	TCGA-24-2029	NA	NA	days	439	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	75	Bilateral	TCGA-24-2029-F26476	TCGA-24-2029	NA	Stage IIIC	-27527	NA	439	0	439	NA	372	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	2029	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	>20 mm	Ovary	NA	NA	DECEASED	1995	NA	TCGA-24-2029-01	NA	fc252b6a-222d-4529-a609-012e71c0b436	NA	TCGA-24-2029-01	NA	TCGA-24-2029-01A-01D-0652-05	NA	TCGA-24-2029-01A-21-1560-20	NA	NA	TCGA-24-2029-01A-01D-0648-01	TCGA-24-2029-01	c10a5aef-aa73-4f20-acef-a5bd42e29fca	NA	TCGA-24-2029-01A-01D-0648-01	NA	NA	NA	NA	TCGA-24-2029-01	NA	NA	NA	TCGA-24-2029-01A-01R-0655-07	
TCGA-24-2030-01	1	TCGA-24-2030-01	1701	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-24-2030	NA	NA	days	1701	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Left	TCGA-24-2030-F26480	TCGA-24-2030	TCGA-24-2030-01A	Stage IIIC	-31900	NA	1701	0	1641	NA	646	NA	NA	NA	2010-2-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2030.bb1b63ab-1e13-4401-ab6a-0325da96b17f.pdf	2030	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1995	NA	TCGA-24-2030-01	NA	07894e29-8a70-415e-a10d-389d652f11a5	NA	TCGA-24-2030-01	NA	TCGA-24-2030-01A-01D-0667-05	NA	TCGA-24-2030-01A-21-1560-20	NA	NA	TCGA-24-2030-01A-01D-0663-01	TCGA-24-2030-01	827506c7-c89c-4301-971d-b42ace20769e	NA	TCGA-24-2030-01A-01D-0663-01	NA	NA	NA	TCGA-24-2030-01A-01W-0722-08	TCGA-24-2030-01	NA	NA	TCGA-24-2030-01A-01W-0722-08	TCGA-24-2030-01A-01R-0670-07	
TCGA-24-2033-01	1	TCGA-24-2033-01	562	1	days	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-24-2033	NA	NA	days	562	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Bilateral	TCGA-24-2033-F26490	TCGA-24-2033	NA	Stage IIIC	-31977	NA	562	0	562	NA	351	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	2033	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	NA	NA	NA	24	>20 mm	Ovary	NA	NA	DECEASED	1995	TCGA-24-2033-01	TCGA-24-2033-01	NA	a735c975-e05c-4389-a39d-80c25462dfe6	NA	TCGA-24-2033-01	NA	TCGA-24-2033-01A-01D-0667-05	NA	TCGA-24-2033-01A-21-1560-20	NA	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	TCGA-24-2033-01A-01D-0663-01	TCGA-24-2033-01	d671c1b8-d45e-4d50-bf32-458677874c49	NA	TCGA-24-2033-01A-01D-0663-01	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	NA	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	NA	TCGA-24-2033-01	TCGA-24-2033-01	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	NA	TCGA-24-2033-01A-01R-0670-07	
TCGA-24-2035-01	1	TCGA-24-2035-01	857	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2035	NA	NA	days	857	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Left	TCGA-24-2035-F26496	TCGA-24-2035	NA	Stage IIIC	-23855	NA	857	0	857	NA	287	0	NA	NA	2010-3-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	2035	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	24	1-10 mm	Ovary	NA	NA	DECEASED	1996	TCGA-24-2035-01	TCGA-24-2035-01	NA	ede49e4b-e555-4d20-99cb-e98ea98ddec2	NA	TCGA-24-2035-01	NA	TCGA-24-2035-01A-01D-0667-05	NA	NA	NA	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01D-0663-01	TCGA-24-2035-01	NA	NA	TCGA-24-2035-01A-01D-0663-01	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	NA	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01W-0722-08	TCGA-24-2035-01	TCGA-24-2035-01	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01W-0722-08	TCGA-24-2035-01A-01R-0670-07	
TCGA-24-2036-01	1	TCGA-24-2036-01	1947	1	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-24-2036	NA	NA	days	1947	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	50	NA	TCGA-24-2036-F26505	TCGA-24-2036	TCGA-24-2036-01A	Stage IIIA	-18582	NA	1947	0	1947	NA	914	0	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e.pdf	2036	Other	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1996	TCGA-24-2036-01	NA	NA	b7b09d06-e228-4549-b19a-99561867345b	NA	NA	NA	TCGA-24-2036-01A-01D-0667-05	NA	TCGA-24-2036-01A-21-1560-20	NA	788ade22-382b-49ca-b2b1-447a2072d0ea	TCGA-24-2036-01A-01D-0663-01	TCGA-24-2036-01	bcde7ed3-4bc7-41c7-99af-f132bda4a6ef	NA	TCGA-24-2036-01A-01D-0663-01	788ade22-382b-49ca-b2b1-447a2072d0ea	NA	788ade22-382b-49ca-b2b1-447a2072d0ea	NA	TCGA-24-2036-01	TCGA-24-2036-01	788ade22-382b-49ca-b2b1-447a2072d0ea	NA	TCGA-24-2036-01A-01R-0670-07	
TCGA-24-2038-01	1	TCGA-24-2038-01	1354	1	days	Iq	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 12	TCGA-24-2038	NA	NA	days	1354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Right	TCGA-24-2038-F26518	TCGA-24-2038	TCGA-24-2038-01A	Stage IIIA	-24957	NA	1354	0	1354	NA	1169	NA	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	GB	Recurrence	NA	NA	NA	NA	TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81.pdf	2038	NA	WITH TUMOR	NO	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-24-2038-01	TCGA-24-2038-01	NA	05783372-9fc0-426a-a1ea-203af160b5b6	NA	TCGA-24-2038-01	NA	TCGA-24-2038-01A-01D-0667-05	NA	TCGA-24-2038-01A-21-1560-20	NA	372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01D-0663-01	TCGA-24-2038-01	b9526a72-d01f-46bc-896d-4798319abebf	NA	TCGA-24-2038-01A-01D-0663-01	372a8471-dff3-44c0-9393-94ad511a7374	NA	372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01W-0722-08	TCGA-24-2038-01	TCGA-24-2038-01	372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01W-0722-08	TCGA-24-2038-01A-01R-0670-07	
TCGA-24-2254-01	1	TCGA-24-2254-01	1736	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 2	TCGA-24-2254	NA	NA	days	1736	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-24-2254-F26523	TCGA-24-2254	TCGA-24-2254-01A	Stage IIIC	-24407	NA	1736	0	1736	NA	606	0	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2254.3788629f-17da-4075-af61-cf124bdfb48e.pdf	2254	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	2003	TCGA-24-2254-01	TCGA-24-2254-01	NA	b8cac420-a963-4be2-9ecf-dd92700477e1	NA	TCGA-24-2254-01	NA	TCGA-24-2254-01A-01D-0667-05	NA	TCGA-24-2254-01A-21-1560-20	NA	e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01D-0663-01	TCGA-24-2254-01	9525da91-59ae-487e-b9cb-925f263dfcb6	NA	TCGA-24-2254-01A-01D-0663-01	e496319b-df71-44a0-bfa6-90f50ae54654	NA	e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01W-0722-08	TCGA-24-2254-01	TCGA-24-2254-01	e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01W-0722-08	TCGA-24-2254-01A-01R-0670-07	
TCGA-24-2260-01	1	TCGA-24-2260-01	1100	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2260	NA	NA	days	1100	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-2260-F26532	TCGA-24-2260	TCGA-24-2260-01A	Stage IIIB	-27112	NA	1100	0	1100	NA	667	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1	NO	NA	1.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8.pdf	2260	NA	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.5	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1992	NA	TCGA-24-2260-01	NA	0bfc4955-78bd-4883-b7b0-a262b6c1594f	NA	TCGA-24-2260-01	NA	TCGA-24-2260-01A-01D-0667-05	NA	TCGA-24-2260-01A-21-1560-20	NA	NA	TCGA-24-2260-01A-01D-0663-01	TCGA-24-2260-01	34ce0e32-d482-45e5-8663-edf50b16309a	NA	TCGA-24-2260-01A-01D-0663-01	NA	NA	NA	TCGA-24-2260-01A-01W-0722-08	TCGA-24-2260-01	NA	NA	TCGA-24-2260-01A-01W-0722-08	TCGA-24-2260-01A-01R-0670-07	
TCGA-24-2261-01	1	TCGA-24-2261-01	24	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-2261	NA	NA	days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	76	Left	TCGA-24-2261-F26540	TCGA-24-2261	TCGA-24-2261-01A	Stage IIIC	-27897	NA	24	0	24	NA	NA	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.7	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86.pdf	2261	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	24	11-20 mm	Ovary	NA	A	DECEASED	1992	TCGA-24-2261-01	TCGA-24-2261-01	NA	8c41ba6a-3315-4903-9cd5-ac3f82576008	NA	TCGA-24-2261-01	NA	TCGA-24-2261-01A-01D-0667-05	NA	TCGA-24-2261-01A-21-1560-20	NA	75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01D-0663-01	TCGA-24-2261-01	cbbb0190-5bfe-4a4f-aabe-63d68021b388	NA	TCGA-24-2261-01A-01D-0663-01	75e9506a-d007-4fb2-8bdd-7e7780653a63	NA	75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01W-0722-08	TCGA-24-2261-01	TCGA-24-2261-01	75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01W-0722-08	TCGA-24-2261-01A-01R-0670-07	
TCGA-24-2262-01	1	TCGA-24-2262-01	11	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2262	NA	NA	days	11	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Right	TCGA-24-2262-F26542	TCGA-24-2262	TCGA-24-2262-01A	Stage IIIC	-20861	NA	11	0	11	NA	NA	NA	NA	NA	2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff.pdf	2262	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	DECEASED	1992	TCGA-24-2262-01	TCGA-24-2262-01	NA	8462f214-6bf7-4018-b40b-f9a3f3847542	NA	TCGA-24-2262-01	NA	TCGA-24-2262-01A-01D-0708-05	NA	TCGA-24-2262-01A-21-1560-20	NA	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01D-0704-01	TCGA-24-2262-01	5d31db74-24ef-4322-9880-5189dee10ccb	NA	TCGA-24-2262-01A-01D-0704-01	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	NA	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01W-0799-08	TCGA-24-2262-01	TCGA-24-2262-01	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01W-0799-08	TCGA-24-2262-01A-01R-0711-07	
TCGA-24-2267-01	1	TCGA-24-2267-01	1446	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2267	NA	NA	days	1446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-24-2267-F26544	TCGA-24-2267	TCGA-24-2267-01A	Stage IIB	-21293	NA	1446	0	1446	NA	512	NA	NA	NA	2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2267.24844312-f32c-4366-945e-96d9a923f82a.pdf	2267	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	24	No Macroscopic disease	Ovary	NA	A	DECEASED	1993	TCGA-24-2267-01	TCGA-24-2267-01	NA	7d6e82dd-4715-42df-8325-444be465aa24	NA	TCGA-24-2267-01	NA	TCGA-24-2267-01A-01D-0708-05	NA	TCGA-24-2267-01A-21-1560-20	NA	9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01D-0704-01	TCGA-24-2267-01	25f1b635-6318-41d5-a0c8-37e8d263dddd	NA	TCGA-24-2267-01A-01D-0704-01	9ebb3535-6536-49fc-a88b-473235972378	NA	9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01W-0799-08	TCGA-24-2267-01	TCGA-24-2267-01	9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01W-0799-08	TCGA-24-2267-01A-01R-0711-07	
TCGA-24-2271-01	1	TCGA-24-2271-01	962	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2271	NA	NA	days	962	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-2271-F26557	TCGA-24-2271	TCGA-24-2271-01A	Stage IIIC	-20399	NA	962	0	962	NA	827	NA	NA	NA	2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.6	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2271.87d64a93-9b08-48a5-a26e-1cc4b5ac8bde.pdf	2271	NA	WITH TUMOR	YES	NA	Physical Examination	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	YES	A	DECEASED	1999	TCGA-24-2271-01	TCGA-24-2271-01	NA	3f1bd8a1-5a33-4c68-9d62-a65289c677dd	NA	TCGA-24-2271-01	NA	TCGA-24-2271-01A-01D-0708-05	NA	TCGA-24-2271-01A-21-1560-20	NA	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01D-0704-01	TCGA-24-2271-01	9651ae11-92cc-4085-b9f5-b141eff0fb99	NA	TCGA-24-2271-01A-01D-0704-01	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	NA	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01W-0799-08	TCGA-24-2271-01	TCGA-24-2271-01	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01W-0799-08	TCGA-24-2271-01A-01R-0711-07	
TCGA-24-2280-01	0	TCGA-24-2280-01	2143	0	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-2280	NA	NA	days	2143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-2280-F26561	TCGA-24-2280	TCGA-24-2280-01A	Stage IIIC	-27356	NA	NA	0	2143	NA	535	0	NA	NA	2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192.pdf	2280	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2004	NA	TCGA-24-2280-01	NA	964fcf21-982e-474f-ab2d-cfcb0bbd0e15	NA	TCGA-24-2280-01	NA	TCGA-24-2280-01A-01D-0708-05	NA	NA	NA	NA	TCGA-24-2280-01A-01D-0704-01	TCGA-24-2280-01	NA	NA	TCGA-24-2280-01A-01D-0704-01	NA	NA	NA	TCGA-24-2280-01A-01W-0799-08	TCGA-24-2280-01	NA	NA	TCGA-24-2280-01A-01W-0799-08	TCGA-24-2280-01A-01R-0711-07	
TCGA-24-2281-01	0	TCGA-24-2281-01	1357	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2281	NA	NA	days	1357	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	68	Bilateral	TCGA-24-2281-F26570	TCGA-24-2281	TCGA-24-2281-01A	Stage IIA	-25019	NA	NA	0	1357	NA	NA	0	NA	NA	2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8.pdf	2281	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	24	1-10 mm	Ovary	NA	A	LIVING	2006	TCGA-24-2281-01	TCGA-24-2281-01	NA	0ca4dc50-aee3-49e2-b327-b86ddfce658f	NA	TCGA-24-2281-01	NA	TCGA-24-2281-01A-01D-0708-05	NA	TCGA-24-2281-01A-21-1560-20	NA	44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01D-0704-01	TCGA-24-2281-01	e83257be-084b-405a-8098-b10055d1ad85	NA	TCGA-24-2281-01A-01D-0704-01	44948279-405d-42f6-ad29-465150ee6d85	NA	44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01W-0799-08	TCGA-24-2281-01	TCGA-24-2281-01	44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01W-0799-08	TCGA-24-2281-01A-01R-0711-07	
TCGA-24-2288-01	1	TCGA-24-2288-01	25	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-24-2288	NA	NA	days	25	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	70	Bilateral	TCGA-24-2288-F26574	TCGA-24-2288	TCGA-24-2288-01A	Stage IIIC	-25831	NA	25	0	25	NA	NA	NA	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45.pdf	2288	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1999	TCGA-24-2288-01	TCGA-24-2288-01	NA	bea203c5-e349-4941-aa28-d3b9372ad7a2	NA	TCGA-24-2288-01	NA	TCGA-24-2288-01A-01D-0708-05	NA	TCGA-24-2288-01A-21-1560-20	NA	dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01D-0704-01	TCGA-24-2288-01	7c143023-df5b-42cb-958b-962d6f607e92	NA	TCGA-24-2288-01A-01D-0704-01	dbc2cfac-df65-4750-af39-37760bad1057	NA	dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01W-0799-08	TCGA-24-2288-01	TCGA-24-2288-01	dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01W-0799-08	TCGA-24-2288-01A-01R-0711-07	
TCGA-24-2289-01	1	TCGA-24-2289-01	2049	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	mutation cluster 8	TCGA-24-2289	NA	NA	days	2049	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-24-2289-F26578	TCGA-24-2289	TCGA-24-2289-01A	Stage IV	-25191	NA	2049	0	2049	NA	568	NA	NA	NA	2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2289.3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d.pdf	2289	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	0.4	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1997	TCGA-24-2289-01	TCGA-24-2289-01	NA	9ef0fcf7-e7c3-4c19-ab2b-185392963182	NA	TCGA-24-2289-01	NA	TCGA-24-2289-01A-01D-0708-05	NA	TCGA-24-2289-01A-21-1560-20	NA	bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01D-0704-01	TCGA-24-2289-01	992227e4-86a6-4703-ac81-cae8ea4a5dac	NA	TCGA-24-2289-01A-01D-0704-01	bdc4400c-c552-450b-a806-2ae10f61cca8	NA	bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01W-0799-08	TCGA-24-2289-01	TCGA-24-2289-01	bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01W-0799-08	TCGA-24-2289-01A-01R-0711-07	
TCGA-24-2290-01	1	TCGA-24-2290-01	1102	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2290	NA	NA	days	1102	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	NA	TCGA-24-2290-F26583	TCGA-24-2290	TCGA-24-2290-01A	Stage IIIC	-20530	NA	1102	0	1102	NA	324	0	NA	NA	2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d.pdf	2290	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	24	1-10 mm	Omentum	NA	A	DECEASED	1997	TCGA-24-2290-01	TCGA-24-2290-01	NA	ad9e04b7-2000-411e-81bd-d1d22381d5c8	NA	TCGA-24-2290-01	NA	TCGA-24-2290-01A-01D-0708-05	NA	TCGA-24-2290-01A-21-1560-20	NA	a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01D-0704-01	TCGA-24-2290-01	7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9	NA	TCGA-24-2290-01A-01D-0704-01	a3173b33-aa16-48a2-b733-0345aad49755	NA	a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01W-0799-08	TCGA-24-2290-01	TCGA-24-2290-01	a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01W-0799-08	TCGA-24-2290-01A-01R-0711-07	
TCGA-24-2293-01	1	TCGA-24-2293-01	506	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	mutation c1uster 9	TCGA-24-2293	NA	NA	days	506	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	47	Right	TCGA-24-2293-F26598	TCGA-24-2293	TCGA-24-2293-01A	NA	-17235	NA	506	0	506	NA	NA	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection	NA	1.1	NO	NA	1.3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-2293.caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7.pdf	2293	NA	NA	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	>20 mm	Omentum	NA	A	DECEASED	1995	TCGA-24-2293-01	TCGA-24-2293-01	NA	87480009-8495-4826-9d10-dbe6dc6281f1	NA	TCGA-24-2293-01	NA	TCGA-24-2293-01A-01D-0708-05	NA	TCGA-24-2293-01A-21-1560-20	NA	d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01D-0704-01	TCGA-24-2293-01	a40fdeac-ebb6-4f9f-9f90-837deef5095e	NA	TCGA-24-2293-01A-01D-0704-01	d554a1f1-3e8a-4b8c-a458-36e6550905dd	NA	d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01W-0799-08	TCGA-24-2293-01	TCGA-24-2293-01	d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01W-0799-08	TCGA-24-2293-01A-01R-0711-07	
TCGA-24-2295-01	1	TCGA-24-2295-01	1007	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-24-2295	NA	NA	days	1007	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Right	TCGA-24-2295-F26605	TCGA-24-2295	TCGA-24-2295-01A	Stage IIIC	-25416	NA	1007	0	1007	NA	281	NA	NA	NA	2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2295.44d946e9-12ae-437b-9211-1be42b4d6439.pdf	2295	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.4	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1995	NA	NA	NA	8a525a38-29e3-457d-a665-e05297e6b07a	NA	NA	NA	TCGA-24-2295-01A-01D-0708-05	NA	TCGA-24-2295-01A-21-1560-20	NA	NA	TCGA-24-2295-01A-01D-0704-01	TCGA-24-2295-01	eb245ed7-60fc-47eb-9d75-4704c337b943	NA	TCGA-24-2295-01A-01D-0704-01	NA	NA	NA	NA	TCGA-24-2295-01	NA	NA	NA	TCGA-24-2295-01A-01R-0711-07	
TCGA-24-2297-01	1	TCGA-24-2297-01	1699	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-24-2297	NA	NA	days	1699	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	Bilateral	TCGA-24-2297-F26612	TCGA-24-2297	TCGA-24-2297-01A	Stage IIIC	-20487	NA	1699	0	1699	NA	NA	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-24-2297.12b02227-4050-4d02-bdb8-939d348a4c19.pdf	2297	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1993	TCGA-24-2297-01	TCGA-24-2297-01	NA	971a0b51-b807-436b-ac4c-ef9cc2e2038d	NA	TCGA-24-2297-01	NA	TCGA-24-2297-01A-01D-0708-05	NA	TCGA-24-2297-01A-21-1560-20	NA	2b0089bc-b493-4179-bf5c-e58550e1ee5b	TCGA-24-2297-01A-01D-0704-01	TCGA-24-2297-01	f700e3e2-462f-4889-82fa-ac614983d642	NA	TCGA-24-2297-01A-01D-0704-01	2b0089bc-b493-4179-bf5c-e58550e1ee5b	NA	2b0089bc-b493-4179-bf5c-e58550e1ee5b	NA	TCGA-24-2297-01	TCGA-24-2297-01	2b0089bc-b493-4179-bf5c-e58550e1ee5b	NA	TCGA-24-2297-01A-01R-0711-07	
TCGA-24-2298-01	1	TCGA-24-2298-01	1620	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2298	NA	NA	days	1620	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-2298-F26616	TCGA-24-2298	TCGA-24-2298-01A	Stage IIIC	-20453	NA	1620	0	1620	NA	469	NA	NA	NA	2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-24-2298.fe9d7bf4-a278-4842-b911-018d0127ef20.pdf	2298	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	24	>20 mm	Ovary	NA	A	DECEASED	1993	TCGA-24-2298-01	TCGA-24-2298-01	NA	9c71ce7f-4e80-46bc-b66c-c893614dd207	NA	TCGA-24-2298-01	NA	TCGA-24-2298-01A-01D-0708-05	NA	TCGA-24-2298-01A-21-1560-20	NA	7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01D-0704-01	TCGA-24-2298-01	a99356d2-7d94-4274-9720-3defe513159a	NA	TCGA-24-2298-01A-01D-0704-01	7b39cb0a-7152-4037-9989-57545a1df980	NA	7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01W-0799-08	TCGA-24-2298-01	TCGA-24-2298-01	7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01W-0799-08	TCGA-24-2298-01A-01R-0711-07	
TCGA-25-1312-01	1	TCGA-25-1312-01	31	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-25-1312	NA	NA	days	31	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	69	Left	TCGA-25-1312-F26626	TCGA-25-1312	TCGA-25-1312-01A	Stage IV	-25537	NA	31	0	31	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2.5	NO	NA	3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1312.9AD5ADDB-713E-4FF7-97F1-123FA771AC5B.pdf	1312	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	1	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1312-01	TCGA-25-1312-01	NA	c31a0d45-5e8c-4fcb-b773-1bd3744b5eea	NA	TCGA-25-1312-01	NA	TCGA-25-1312-01A-01D-0460-05	NA	TCGA-25-1312-01A-11-1562-20	NA	0d7561dc-7069-41df-ba49-8fcd4df52efb	TCGA-25-1312-01A-01D-0452-01	TCGA-25-1312-01	43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b	NA	TCGA-25-1312-01A-01D-0452-01	0d7561dc-7069-41df-ba49-8fcd4df52efb	NA	0d7561dc-7069-41df-ba49-8fcd4df52efb	NA	TCGA-25-1312-01	TCGA-25-1312-01	0d7561dc-7069-41df-ba49-8fcd4df52efb	NA	TCGA-25-1312-01A-01R-0456-07	
TCGA-25-1313-01	1	TCGA-25-1313-01	820	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-25-1313	NA	NA	days	820	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-25-1313-F26628	TCGA-25-1313	TCGA-25-1313-01A	Stage IV	-22982	NA	820	0	820	NA	394	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1313.3F5AAE21-3694-4AC2-8A18-4970090A08F4.pdf	1313	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NA	NA	Primary Tumor	01	1.5	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-25-1313-01	TCGA-25-1313-01	NA	5e71901f-ac21-4d6d-8705-ab20c65ec0f0	NA	TCGA-25-1313-01	NA	TCGA-25-1313-01A-01D-0460-05	NA	TCGA-25-1313-01A-21-1562-20	NA	ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01D-0452-01	TCGA-25-1313-01	291a8a6a-23e2-42c9-a260-8696b9795cf2	NA	TCGA-25-1313-01A-01D-0452-01	ab99683f-6116-463d-8bf6-5782809d4729	NA	ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01W-0492-08	TCGA-25-1313-01	TCGA-25-1313-01	ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01W-0492-08	TCGA-25-1313-01A-01R-0456-07	
TCGA-25-1314-01	1	TCGA-25-1314-01	1004	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-25-1314	NA	NA	days	1004	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-25-1314-F26633	TCGA-25-1314	NA	Stage IV	-15462	NA	1004	0	974	NA	274	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	1314	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	25	1-10 mm	Ovary	NA	NA	DECEASED	2000	TCGA-25-1314-01	TCGA-25-1314-01	NA	da862d11-c970-44ee-af78-1179902f9310	NA	TCGA-25-1314-01	NA	TCGA-25-1314-01A-01D-0460-05	NA	TCGA-25-1314-01A-21-1562-20	NA	b571f7cf-e9b8-493f-822b-a489f114420b	TCGA-25-1314-01A-01D-0452-01	TCGA-25-1314-01	b17945ba-39d6-400d-8e3e-e81123595c51	NA	TCGA-25-1314-01A-01D-0452-01	b571f7cf-e9b8-493f-822b-a489f114420b	NA	b571f7cf-e9b8-493f-822b-a489f114420b	NA	TCGA-25-1314-01	TCGA-25-1314-01	b571f7cf-e9b8-493f-822b-a489f114420b	NA	TCGA-25-1314-01A-01R-0456-07	
TCGA-25-1315-01	1	TCGA-25-1315-01	1583	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1315	NA	NA	days	1583	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-25-1315-F26639	TCGA-25-1315	TCGA-25-1315-01A	Stage IIIC	-18263	NA	1583	0	1553	NA	153	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	3.5	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-25-1315.486E22A0-A224-4471-BA52-9F52E021B131.pdf	1315	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.9	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-25-1315-01	TCGA-25-1315-01	NA	6f8cdfc3-aada-43e2-a9ce-9d8d437b9442	NA	TCGA-25-1315-01	NA	TCGA-25-1315-01A-01D-0460-05	TCGA-25-1315-01A-01W-0494-09	TCGA-25-1315-01A-21-1562-20	TCGA-25-1315-01A-01W-0494-09	b6908d33-80c8-4fc0-bd1d-829ec3161527	TCGA-25-1315-01A-01D-0452-01	TCGA-25-1315-01	1ecf4db0-2d32-4ad5-a14a-ce5065f7fb01	NA	TCGA-25-1315-01A-01D-0452-01	b6908d33-80c8-4fc0-bd1d-829ec3161527	NA	b6908d33-80c8-4fc0-bd1d-829ec3161527	NA	TCGA-25-1315-01	TCGA-25-1315-01	b6908d33-80c8-4fc0-bd1d-829ec3161527	TCGA-25-1315-01A-01W-0494-09	TCGA-25-1315-01A-01R-0456-07	
TCGA-25-1316-01	1	TCGA-25-1316-01	1279	1	days	BRCA-LUAD+	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 12	TCGA-25-1316	NA	NA	days	1279	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Right	TCGA-25-1316-F26646	TCGA-25-1316	TCGA-25-1316-01A	Stage IIIC	-20331	NA	1279	0	1126	NA	276	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2.5	NO	NA	3	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-25-1316.B766CB7E-C4EC-489C-AEF0-BE28132D5BA5.pdf	1316	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	1.5	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-25-1316-01	TCGA-25-1316-01	NA	5c167e3e-7757-4a02-b218-81c2ba107bfa	NA	TCGA-25-1316-01	NA	TCGA-25-1316-01A-01D-0460-05	TCGA-25-1316-01A-01W-0494-09	TCGA-25-1316-01A-21-20	TCGA-25-1316-01A-01W-0494-09	6cb5e275-1284-482b-a4e9-933acf9aad44	TCGA-25-1316-01A-01D-0452-01	TCGA-25-1316-01	4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4	NA	TCGA-25-1316-01A-01D-0452-01	6cb5e275-1284-482b-a4e9-933acf9aad44	NA	6cb5e275-1284-482b-a4e9-933acf9aad44	NA	TCGA-25-1316-01	TCGA-25-1316-01	6cb5e275-1284-482b-a4e9-933acf9aad44	TCGA-25-1316-01A-01W-0494-09	TCGA-25-1316-01A-01R-0456-07	
TCGA-25-1317-01	1	TCGA-25-1317-01	61	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1317	NA	NA	days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Bilateral	TCGA-25-1317-F26651	TCGA-25-1317	TCGA-25-1317-01A	Stage IIIC	-24199	NA	61	0	NA	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1317.5DC53520-0991-42B6-B10D-0D62C3F92BAD.pdf	1317	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	25	NA	Ovary	NA	A	DECEASED	2000	TCGA-25-1317-01	TCGA-25-1317-01	TCGA-25-1317-01A-01W-0490-10	5b49f5cc-28fd-4b1e-ae8e-6391f99ccb46	NA	TCGA-25-1317-01	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01A-01D-0460-05	NA	NA	NA	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	TCGA-25-1317-01A-01D-0452-01	TCGA-25-1317-01	NA	NA	TCGA-25-1317-01A-01D-0452-01	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	NA	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	NA	TCGA-25-1317-01	TCGA-25-1317-01	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01A-01R-0456-07	
TCGA-25-1318-01	1	TCGA-25-1318-01	1064	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1318	NA	NA	days	1064	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-25-1318-F26655	TCGA-25-1318	TCGA-25-1318-01A	Stage IIIC	-19755	NA	1064	0	1064	NA	185	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	4.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1318.D9B9F69A-265C-42F4-BCD2-4B136A7FE935.pdf	1318	NA	WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.8	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2000	TCGA-25-1318-01	TCGA-25-1318-01	TCGA-25-1318-01A-01W-0490-10	f912d9b2-2f49-4c3f-aed0-3edc0065d54b	NA	TCGA-25-1318-01	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01A-01D-0460-05	NA	TCGA-25-1318-01A-21-1562-20	NA	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	TCGA-25-1318-01A-01D-0452-01	TCGA-25-1318-01	2f954b2b-ab8d-4f81-8717-e85d500987ee	NA	TCGA-25-1318-01A-01D-0452-01	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	NA	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	NA	TCGA-25-1318-01	TCGA-25-1318-01	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01A-01R-0456-07	
TCGA-25-1319-01	1	TCGA-25-1319-01	1977	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1319	NA	NA	days	1977	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-25-1319-F26660	TCGA-25-1319	TCGA-25-1319-01A	Stage IIIC	-26786	NA	1977	0	1977	NA	730	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2.5	NO	NA	3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1319.62BFD64E-1C60-49A8-BAD0-B173DD22C951.pdf	1319	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	1	NA	NA	25	11-20 mm	Ovary	NA	A	DECEASED	2000	TCGA-25-1319-01	TCGA-25-1319-01	NA	7f028062-e863-4f7d-8ec6-8e91da60fc74	NA	TCGA-25-1319-01	NA	TCGA-25-1319-01A-01D-0460-05	NA	TCGA-25-1319-01A-21-1562-20	NA	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01D-0452-01	TCGA-25-1319-01	09ef1041-497f-409f-9892-b5a1631a647f	NA	TCGA-25-1319-01A-01D-0452-01	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	NA	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01W-0492-08	TCGA-25-1319-01	TCGA-25-1319-01	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01W-0492-08	TCGA-25-1319-01A-01R-0456-07	
TCGA-25-1320-01	1	TCGA-25-1320-01	1155	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1320	NA	NA	days	1155	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-25-1320-F26664	TCGA-25-1320	TCGA-25-1320-01A	Stage IIIC	-24018	NA	1155	0	1124	NA	424	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	3	NO	NA	3.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1320.AF68EF8D-A31D-453B-8083-CF6B9EE4E838.pdf	1320	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	1	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1320-01	TCGA-25-1320-01	NA	7a1cfa3d-a19e-42b1-91b5-485891ff2d34	NA	TCGA-25-1320-01	NA	TCGA-25-1320-01A-01D-0460-05	NA	TCGA-25-1320-01A-21-1562-20	NA	52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01D-0452-01	TCGA-25-1320-01	d1b3fd86-d1f2-4621-980a-19f3d9ee76f4	NA	TCGA-25-1320-01A-01D-0452-01	52697815-ede2-4ce3-a6d0-2680f6b9bb73	NA	52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01W-0492-08	TCGA-25-1320-01	TCGA-25-1320-01	52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01W-0492-08	TCGA-25-1320-01A-01R-0456-07	
TCGA-25-1321-01	1	TCGA-25-1321-01	1033	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1321	NA	NA	days	1033	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-25-1321-F26670	TCGA-25-1321	TCGA-25-1321-01A	Stage IIIC	-23987	NA	1033	0	1033	NA	454	0	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.6	NO	NA	3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1321.5D309784-AED1-4946-817D-37AC8969315C.pdf	1321	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.8	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2001	TCGA-25-1321-01	TCGA-25-1321-01	NA	8f9bea4f-6738-429b-8ebb-8ae8cf65d294	NA	TCGA-25-1321-01	NA	TCGA-25-1321-01A-01D-0460-05	NA	TCGA-25-1321-01A-21-1562-20	NA	74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01D-0452-01	TCGA-25-1321-01	9790631d-f673-415e-8644-5419b2b956b2	NA	TCGA-25-1321-01A-01D-0452-01	74ad9d3e-97a9-419d-8842-3fb37d3f099a	NA	74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01W-0492-08	TCGA-25-1321-01	TCGA-25-1321-01	74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01W-0492-08	TCGA-25-1321-01A-01R-0456-07	
TCGA-25-1322-01	1	TCGA-25-1322-01	91	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1322	NA	NA	days	91	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-25-1322-F26676	TCGA-25-1322	TCGA-25-1322-01A	Stage IV	-22646	NA	91	0	91	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.8	NO	NA	2.6	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1322.6EAF4358-51F9-4999-A219-39178418CC9C.pdf	1322	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.8	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1322-01	TCGA-25-1322-01	NA	34a7dcf3-fc87-4334-8ee0-77166a5398fa	NA	TCGA-25-1322-01	NA	TCGA-25-1322-01A-01D-0460-05	TCGA-25-1322-01A-01W-0494-09	TCGA-25-1322-01A-21-20	TCGA-25-1322-01A-01W-0494-09	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	TCGA-25-1322-01A-01D-0452-01	TCGA-25-1322-01	90cba3ae-e75e-4a1e-bc31-293ac260cf96	NA	TCGA-25-1322-01A-01D-0452-01	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	NA	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	NA	TCGA-25-1322-01	TCGA-25-1322-01	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	TCGA-25-1322-01A-01W-0494-09	TCGA-25-1322-01A-01R-0456-07	
TCGA-25-1323-01	1	TCGA-25-1323-01	395	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	NA	TCGA-25-1323	NA	NA	days	395	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Bilateral	TCGA-25-1323-F26680	TCGA-25-1323	TCGA-25-1323-01A	Stage IIIC	-26602	NA	395	0	365	NA	365	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2.5	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-25-1323.AFE55BB2-F0FC-4B39-A61A-2287B62354AD.pdf	1323	NA	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.6	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1323-01	TCGA-25-1323-01	NA	61b1bbe5-434f-4d88-aadb-a42344b0e0fb	NA	TCGA-25-1323-01	NA	TCGA-25-1323-01A-01D-0460-05	NA	TCGA-25-1323-01A-21-1562-20	NA	cd401b89-ae05-4775-94b0-6800f88652b0	TCGA-25-1323-01A-01D-0452-01	TCGA-25-1323-01	e89ce7f4-4c3f-4c48-a222-506d3806ad33	NA	TCGA-25-1323-01A-01D-0452-01	cd401b89-ae05-4775-94b0-6800f88652b0	NA	cd401b89-ae05-4775-94b0-6800f88652b0	NA	TCGA-25-1323-01	TCGA-25-1323-01	cd401b89-ae05-4775-94b0-6800f88652b0	NA	TCGA-25-1323-01A-01R-0456-07	
TCGA-25-1324-01	1	TCGA-25-1324-01	1035	1	days	NA	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 11	TCGA-25-1324	NA	NA	days	1035	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Bilateral	TCGA-25-1324-F26685	TCGA-25-1324	TCGA-25-1324-01A	Stage IIIC	-27090	NA	1035	0	1035	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1324.53AE406F-E6E6-4137-A7B3-01DAFAEDE783.pdf	1324	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.8	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1324-01	TCGA-25-1324-01	TCGA-25-1324-01A-01W-0490-10	dadc9a44-fbec-4109-b5e5-4a21ad28eb63	NA	TCGA-25-1324-01	TCGA-25-1324-01A-01W-0490-10	TCGA-25-1324-01A-01D-0460-05	NA	NA	NA	790c6d79-9f7d-4e9a-89db-43b26fe16816	NA	TCGA-25-1324-01	NA	NA	NA	790c6d79-9f7d-4e9a-89db-43b26fe16816	NA	790c6d79-9f7d-4e9a-89db-43b26fe16816	NA	NA	NA	790c6d79-9f7d-4e9a-89db-43b26fe16816	TCGA-25-1324-01A-01W-0490-10	TCGA-25-1324-01A-01R-0456-07	
TCGA-25-1325-01	1	TCGA-25-1325-01	976	1	days	NA	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	NA	TCGA-25-1325	NA	NA	days	976	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	77	Left	TCGA-25-1325-F26689	TCGA-25-1325	TCGA-25-1325-01A	Stage IV	-28183	NA	976	0	976	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1325.E9315413-584C-4F29-B05D-657DB9A0B4F5.pdf	1325	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	1.3	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-25-1325-01	TCGA-25-1325-01A-01W-0490-10	7d8ca51a-3995-47a6-89ad-63ffd81e32a0	NA	TCGA-25-1325-01	TCGA-25-1325-01A-01W-0490-10	TCGA-25-1325-01A-01D-0460-05	NA	TCGA-25-1325-01A-21-1562-20	NA	NA	NA	TCGA-25-1325-01	8896ef4e-3809-4ed8-befa-a014b7b81da1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-25-1325-01A-01R-0456-07	
TCGA-25-1326-01	1	TCGA-25-1326-01	1249	1	days	NA	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1326	NA	NA	days	1249	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-25-1326-F26691	TCGA-25-1326	TCGA-25-1326-01A	Stage IIIC	-22339	NA	1249	0	945	NA	396	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2.5	NO	NA	3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1326.B17E5B27-48DB-4E64-A1C3-CAE4921C14DF.pdf	1326	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	1.2	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1326-01	TCGA-25-1326-01	NA	f01d69dc-1d50-4afb-83de-8124b93685a9	NA	TCGA-25-1326-01	NA	TCGA-25-1326-01A-01D-0460-05	NA	TCGA-25-1326-01A-21-1562-20	NA	b29bd766-95b1-46fa-a070-d2206cd5722a	NA	TCGA-25-1326-01	6e7bb043-ec9a-4648-9acd-14526dca800e	NA	NA	b29bd766-95b1-46fa-a070-d2206cd5722a	NA	b29bd766-95b1-46fa-a070-d2206cd5722a	TCGA-25-1326-01A-01W-0492-08	NA	NA	b29bd766-95b1-46fa-a070-d2206cd5722a	TCGA-25-1326-01A-01W-0492-08	TCGA-25-1326-01A-01R-0456-07	
TCGA-25-1328-01	1	TCGA-25-1328-01	2009	1	days	NA	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-25-1328	NA	NA	days	2009	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-25-1328-F26698	TCGA-25-1328	TCGA-25-1328-01A	Stage IIIC	-13911	NA	2009	0	1979	NA	244	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.8	NO	NA	2.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1328.A2DA7EB3-8E42-4E86-9352-99673F51AEFF.pdf	1328	NA	WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	1	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2001	TCGA-25-1328-01	TCGA-25-1328-01	NA	73b10e0b-cb82-49ec-8bdd-07d79bc2b8d6	NA	TCGA-25-1328-01	NA	TCGA-25-1328-01A-01D-0460-05	NA	TCGA-25-1328-01A-21-1562-20	NA	9ba8d6bf-1541-4127-bc60-73091d2d81c7	NA	TCGA-25-1328-01	d064cdc4-ad95-4e85-b9b0-6871d9c2698d	NA	NA	9ba8d6bf-1541-4127-bc60-73091d2d81c7	NA	9ba8d6bf-1541-4127-bc60-73091d2d81c7	TCGA-25-1328-01A-01W-0492-08	NA	NA	9ba8d6bf-1541-4127-bc60-73091d2d81c7	TCGA-25-1328-01A-01W-0492-08	TCGA-25-1328-01A-01R-0456-07	
TCGA-25-1329-01	1	TCGA-25-1329-01	457	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1329	NA	NA	days	457	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	76	Bilateral	TCGA-25-1329-F26705	TCGA-25-1329	TCGA-25-1329-01A	Stage IIIC	-28093	NA	457	0	90	NA	NA	NA	NA	NA	2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2.6	NO	NA	3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1329.857409C6-75EC-4935-85BC-6D5F66AF4DB3.pdf	1329	NA	NA	YES	NA	NA	NA	NA	Primary Tumor	01	0.6	NA	NA	25	11-20 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1329-01	TCGA-25-1329-01	NA	3bd2e158-9743-44cd-a5c3-0ba7179b8660	NA	TCGA-25-1329-01	NA	TCGA-25-1329-01A-01D-0460-05	NA	TCGA-25-1329-01A-21-1562-20	NA	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01D-0452-01	TCGA-25-1329-01	299168d0-39ac-4d64-9345-88fe0f6746ee	NA	TCGA-25-1329-01A-01D-0452-01	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	NA	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01W-0492-08	TCGA-25-1329-01	TCGA-25-1329-01	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01W-0492-08	TCGA-25-1329-01A-01R-0456-07	
TCGA-25-1623-01	1	TCGA-25-1623-01	565	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1623	NA	NA	days	565	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-1623-F26707	TCGA-25-1623	TCGA-25-1623-01A	Stage IV	-26060	NA	565	0	565	NA	342	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.8	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1623.A57CB221-076A-4EE5-8C77-D1E33070597C.pdf	1623	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2006	TCGA-25-1623-01	TCGA-25-1623-01	TCGA-25-1623-01A-01W-0615-10	47640c72-6c10-4956-8a89-0c5f0b12cc49	NA	TCGA-25-1623-01	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01A-01D-0536-05	NA	TCGA-25-1623-01A-21-1558-20	NA	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	TCGA-25-1623-01A-01D-0533-01	TCGA-25-1623-01	ef62a625-cf2c-45d1-aa59-9d44e16a37fa	NA	TCGA-25-1623-01A-01D-0533-01	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	NA	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	NA	TCGA-25-1623-01	TCGA-25-1623-01	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01A-01R-0540-07	
TCGA-25-1625-01	1	TCGA-25-1625-01	840	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1625	NA	NA	days	840	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-25-1625-F26712	TCGA-25-1625	TCGA-25-1625-01A	Stage IIIC	-24298	NA	840	0	548	NA	526	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf	1625	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2006	TCGA-25-1625-01	TCGA-25-1625-01	TCGA-25-1625-01A-01W-0615-10	b176a30a-0977-46e6-b577-a421ca9bb340	NA	TCGA-25-1625-01	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01A-01D-0536-05	NA	TCGA-25-1625-01A-21-1558-20	NA	921fab94-5522-4c08-8e02-13fb6ea2d388	TCGA-25-1625-01A-01D-0533-01	TCGA-25-1625-01	ffb78d5c-46f5-4f3a-8572-55df5db80a1d	NA	TCGA-25-1625-01A-01D-0533-01	921fab94-5522-4c08-8e02-13fb6ea2d388	NA	921fab94-5522-4c08-8e02-13fb6ea2d388	NA	TCGA-25-1625-01	TCGA-25-1625-01	921fab94-5522-4c08-8e02-13fb6ea2d388	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01A-01R-0540-07	
TCGA-25-1626-01	1	TCGA-25-1626-01	518	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1626	NA	NA	days	518	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-25-1626-F26716	TCGA-25-1626	TCGA-25-1626-01A	Stage IIIC	-23932	NA	518	0	481	NA	318	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1626.4B54A1C9-6F08-435B-B85F-736D4278EA82.pdf	1626	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2006	TCGA-25-1626-01	TCGA-25-1626-01	TCGA-25-1626-01A-01W-0615-10	a1ed5a8a-8ac2-4d94-96e0-92bb4dcc8af6	NA	TCGA-25-1626-01	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01A-01D-0536-05	NA	TCGA-25-1626-01A-21-1558-20	NA	daaba89d-acd3-4670-a618-89e5973b03f4	TCGA-25-1626-01A-01D-0533-01	TCGA-25-1626-01	7a9090de-0e14-4fc3-a2d7-c42629b3afd7	NA	TCGA-25-1626-01A-01D-0533-01	daaba89d-acd3-4670-a618-89e5973b03f4	NA	daaba89d-acd3-4670-a618-89e5973b03f4	NA	TCGA-25-1626-01	TCGA-25-1626-01	daaba89d-acd3-4670-a618-89e5973b03f4	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01A-01R-0540-07	
TCGA-25-1627-01	1	TCGA-25-1627-01	394	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1627	NA	NA	days	394	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-25-1627-F26722	TCGA-25-1627	TCGA-25-1627-01A	Stage IIIC	-26784	NA	394	0	11	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1627.FB36B0F9-6519-4CF5-9A74-F7015FD405FF.pdf	1627	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2003	TCGA-25-1627-01	TCGA-25-1627-01	TCGA-25-1627-01A-01W-0615-10	d1eafd5b-5036-44dd-b902-92951e9d31c5	NA	TCGA-25-1627-01	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01A-01D-0536-05	NA	TCGA-25-1627-01A-21-1558-20	NA	0fc68715-c7fc-4481-a5bf-68a281f5ec64	TCGA-25-1627-01A-01D-0533-01	TCGA-25-1627-01	a2210172-a1e0-4bbf-a38a-363571251f90	NA	TCGA-25-1627-01A-01D-0533-01	0fc68715-c7fc-4481-a5bf-68a281f5ec64	NA	0fc68715-c7fc-4481-a5bf-68a281f5ec64	NA	TCGA-25-1627-01	TCGA-25-1627-01	0fc68715-c7fc-4481-a5bf-68a281f5ec64	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01A-01R-0540-07	
TCGA-25-1628-01	1	TCGA-25-1628-01	627	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1628	NA	NA	days	627	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	NA	TCGA-25-1628-F26724	TCGA-25-1628	TCGA-25-1628-01A	Stage IIIC	-24488	NA	627	0	627	NA	287	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1628.790D6E48-15D0-45F9-B6DD-182787298EBA.pdf	1628	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1628-01	TCGA-25-1628-01	TCGA-25-1628-01A-01W-0615-10	7db7c522-1983-4b98-b630-2ddbd5d4aefa	NA	TCGA-25-1628-01	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01A-01D-0536-05	NA	TCGA-25-1628-01A-21-1558-20	NA	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	TCGA-25-1628-01A-01D-0533-01	TCGA-25-1628-01	f7ac6f1b-7ee1-4536-84ae-48d20a61df99	NA	TCGA-25-1628-01A-01D-0533-01	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	NA	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	NA	TCGA-25-1628-01	TCGA-25-1628-01	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01A-01R-0540-07	
TCGA-25-1630-01	1	TCGA-25-1630-01	1162	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1630	NA	NA	days	1162	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-25-1630-F26729	TCGA-25-1630	NA	Stage IIIC	-27006	NA	1162	0	239	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	1630	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	25	1-10 mm	Ovary	NA	NA	DECEASED	2002	TCGA-25-1630-01	TCGA-25-1630-01	TCGA-25-1630-01A-01W-0615-10	f497f9fd-9a0e-446e-98fa-265e325e194e	NA	TCGA-25-1630-01	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01A-01D-0536-05	NA	TCGA-25-1630-01A-21-1558-20	NA	c5a82b6e-048d-4377-9b6c-4417ba1876fe	TCGA-25-1630-01A-01D-0533-01	TCGA-25-1630-01	c0b3ff41-c34a-4f86-b029-5a761ff85b2e	NA	TCGA-25-1630-01A-01D-0533-01	c5a82b6e-048d-4377-9b6c-4417ba1876fe	NA	c5a82b6e-048d-4377-9b6c-4417ba1876fe	NA	TCGA-25-1630-01	TCGA-25-1630-01	c5a82b6e-048d-4377-9b6c-4417ba1876fe	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01A-01R-0540-07	
TCGA-25-1631-01	1	TCGA-25-1631-01	9	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1631	NA	NA	days	9	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-25-1631-F26733	TCGA-25-1631	TCGA-25-1631-01A	Stage IIIC	-26687	NA	9	0	9	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-1631.1C74F61E-1131-4782-8117-20C59B86D845.pdf	1631	NA	TUMOR FREE	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1631-01	TCGA-25-1631-01	TCGA-25-1631-01A-01W-0615-10	2fab3946-dfac-449c-971a-9312801bbe51	NA	TCGA-25-1631-01	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01A-01D-0536-05	NA	TCGA-25-1631-01A-21-1558-20	NA	29c4cab9-c19e-4416-ad88-484cc02a980f	TCGA-25-1631-01A-01D-0533-01	TCGA-25-1631-01	51225525-5680-46ab-8e00-f35ed4df6470	NA	TCGA-25-1631-01A-01D-0533-01	29c4cab9-c19e-4416-ad88-484cc02a980f	NA	29c4cab9-c19e-4416-ad88-484cc02a980f	NA	TCGA-25-1631-01	TCGA-25-1631-01	29c4cab9-c19e-4416-ad88-484cc02a980f	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01A-01R-0540-07	
TCGA-25-1632-01	1	TCGA-25-1632-01	1799	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-25-1632	NA	NA	days	1799	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-25-1632-F26735	TCGA-25-1632	TCGA-25-1632-01A	Stage IV	-24993	NA	1799	0	1732	NA	537	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1632.F083C2B4-20DE-440F-B6A8-2F332346CECA.pdf	1632	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1632-01	TCGA-25-1632-01	TCGA-25-1632-01A-01W-0615-10	8736b37d-cdc1-4e9e-8215-edb675c8a072	NA	TCGA-25-1632-01	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01A-01D-0536-05	NA	TCGA-25-1632-01A-21-1558-20	NA	12c78d62-6045-4f77-bd84-9ab5a38f4635	TCGA-25-1632-01A-01D-0533-01	TCGA-25-1632-01	105464b7-4efd-4ed6-a906-2dab64b49ad0	NA	TCGA-25-1632-01A-01D-0533-01	12c78d62-6045-4f77-bd84-9ab5a38f4635	NA	12c78d62-6045-4f77-bd84-9ab5a38f4635	NA	TCGA-25-1632-01	TCGA-25-1632-01	12c78d62-6045-4f77-bd84-9ab5a38f4635	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01A-01R-0540-07	
TCGA-25-1633-01	1	TCGA-25-1633-01	1891	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1633	NA	NA	days	1891	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Bilateral	TCGA-25-1633-F26742	TCGA-25-1633	TCGA-25-1633-01A	Stage IIIC	-23407	NA	1891	0	1843	NA	616	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1633.B3B45EA2-B154-45DC-B49D-422500EA1D9C.pdf	1633	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1633-01	TCGA-25-1633-01	TCGA-25-1633-01A-01W-0615-10	9f229f84-97c9-4684-8eb7-f2af666e3399	NA	TCGA-25-1633-01	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01A-01D-0536-05	NA	TCGA-25-1633-01A-21-1558-20	NA	7517c446-401d-4501-bf27-916e0835deac	TCGA-25-1633-01A-01D-0533-01	TCGA-25-1633-01	a9062738-4ec8-464c-b5c9-abd82bf322bc	NA	TCGA-25-1633-01A-01D-0533-01	7517c446-401d-4501-bf27-916e0835deac	NA	7517c446-401d-4501-bf27-916e0835deac	NA	TCGA-25-1633-01	TCGA-25-1633-01	7517c446-401d-4501-bf27-916e0835deac	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01A-01R-0540-07	
TCGA-25-1634-01	1	TCGA-25-1634-01	1091	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-25-1634	NA	NA	days	1091	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Bilateral	TCGA-25-1634-F26749	TCGA-25-1634	NA	Stage IIIC	-27749	NA	1091	0	1081	NA	380	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1634	NA	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	NA	Primary Tumor	01	NA	NA	NA	25	No Macroscopic disease	Ovary	NA	NA	DECEASED	2002	TCGA-25-1634-01	TCGA-25-1634-01	TCGA-25-1634-01A-01W-0615-10	e3aae8d6-511b-40ce-8ade-6208c6fcdb9f	NA	TCGA-25-1634-01	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01A-01D-0536-05	NA	NA	NA	d10f0cee-d755-43cc-8d3d-8974cea0defb	TCGA-25-1634-01A-01D-0533-01	TCGA-25-1634-01	NA	NA	TCGA-25-1634-01A-01D-0533-01	d10f0cee-d755-43cc-8d3d-8974cea0defb	NA	d10f0cee-d755-43cc-8d3d-8974cea0defb	NA	TCGA-25-1634-01	TCGA-25-1634-01	d10f0cee-d755-43cc-8d3d-8974cea0defb	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01A-01R-0540-07	
TCGA-25-1635-01	1	TCGA-25-1635-01	1583	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1635	NA	NA	days	1583	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-1635-F26756	TCGA-25-1635	TCGA-25-1635-01A	Stage IIIC	-26200	NA	1583	0	1558	NA	614	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1635.28168C52-FD75-4B43-918B-C48CC8DA9C66.pdf	1635	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-25-1635-01	TCGA-25-1635-01	TCGA-25-1635-01A-01W-0615-10	2fc96f18-9f32-4d5f-b768-587981329254	NA	TCGA-25-1635-01	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01A-01D-0536-05	NA	TCGA-25-1635-01A-21-1558-20	NA	877d96a2-6e5c-472c-b190-59fcfd1febb4	TCGA-25-1635-01A-01D-0533-01	TCGA-25-1635-01	e22c9a04-50e5-40e2-9df0-66c86b6f3b38	NA	TCGA-25-1635-01A-01D-0533-01	877d96a2-6e5c-472c-b190-59fcfd1febb4	NA	877d96a2-6e5c-472c-b190-59fcfd1febb4	NA	TCGA-25-1635-01	TCGA-25-1635-01	877d96a2-6e5c-472c-b190-59fcfd1febb4	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01A-01R-0540-07	
TCGA-25-1870-01	1	TCGA-25-1870-01	455	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-25-1870	NA	NA	days	455	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-25-1870-F26763	TCGA-25-1870	NA	Stage IIIC	-21550	NA	455	0	455	NA	243	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1870	NA	WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	NA	NA	NA	25	11-20 mm	Ovary	NA	NA	DECEASED	1994	TCGA-25-1870-01	TCGA-25-1870-01	NA	fc0c9f6b-6603-4200-9190-25422af07078	NA	TCGA-25-1870-01	NA	TCGA-25-1870-01A-01D-0652-05	NA	NA	NA	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	TCGA-25-1870-01A-01D-0648-01	TCGA-25-1870-01	NA	NA	TCGA-25-1870-01A-01D-0648-01	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	NA	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	NA	TCGA-25-1870-01	TCGA-25-1870-01	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	NA	TCGA-25-1870-01A-01R-0655-07	
TCGA-25-1871-01	1	TCGA-25-1871-01	760	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-25-1871	NA	NA	days	760	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-25-1871-F26769	TCGA-25-1871	TCGA-25-1871-01A	Stage IIIC	-25627	NA	760	0	760	NA	230	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1871.737827A6-C99E-49BE-90AD-004FE8DF11F1.pdf	1871	NA	WITH TUMOR	YES	Progressive Disease	Physical Examination	NO	NA	Primary Tumor	01	0.1	NA	NA	25	11-20 mm	Ovary	NA	A	DECEASED	1993	TCGA-25-1871-01	TCGA-25-1871-01	NA	2ee780b4-d0ac-4d56-9120-fdf5e98b4249	NA	TCGA-25-1871-01	NA	TCGA-25-1871-01A-01D-0652-05	NA	NA	NA	efcc36b2-e351-4875-b743-df58480bc9fb	TCGA-25-1871-01A-01D-0648-01	TCGA-25-1871-01	NA	NA	TCGA-25-1871-01A-01D-0648-01	efcc36b2-e351-4875-b743-df58480bc9fb	NA	efcc36b2-e351-4875-b743-df58480bc9fb	NA	TCGA-25-1871-01	TCGA-25-1871-01	efcc36b2-e351-4875-b743-df58480bc9fb	NA	TCGA-25-1871-01A-01R-0655-07	
TCGA-25-1877-01	1	TCGA-25-1877-01	730	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	NA	TCGA-25-1877	NA	NA	days	730	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Left	TCGA-25-1877-F26774	TCGA-25-1877	TCGA-25-1877-01A	Stage IIIC	-29615	NA	730	0	549	NA	549	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-1877.D98B5A1F-DF34-43E7-826F-BCB45DEC582D.pdf	1877	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	1993	NA	TCGA-25-1877-01	NA	8918bbfe-a867-41ea-a137-46e704232e6d	NA	TCGA-25-1877-01	NA	TCGA-25-1877-01A-01D-0652-05	NA	NA	NA	NA	TCGA-25-1877-01A-01D-0648-01	TCGA-25-1877-01	NA	NA	TCGA-25-1877-01A-01D-0648-01	NA	NA	NA	NA	TCGA-25-1877-01	NA	NA	NA	TCGA-25-1877-01A-01R-0655-07	
TCGA-25-1878-01	1	TCGA-25-1878-01	2587	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-25-1878	NA	NA	days	2587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-25-1878-F26779	TCGA-25-1878	NA	Stage IIIC	-22035	NA	2587	0	2587	NA	971	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1878	NA	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	25	1-10 mm	Ovary	NA	NA	DECEASED	1994	NA	TCGA-25-1878-01	NA	f38efeef-0f8b-48f8-8ad9-caaaad82eecc	NA	TCGA-25-1878-01	NA	TCGA-25-1878-01A-01D-0652-05	NA	TCGA-25-1878-01A-21-1559-20	NA	NA	TCGA-25-1878-01A-01D-0648-01	TCGA-25-1878-01	c747a216-2d46-4b01-a34d-651fa616109a	NA	TCGA-25-1878-01A-01D-0648-01	NA	NA	NA	NA	TCGA-25-1878-01	NA	NA	NA	TCGA-25-1878-01A-01R-0655-07	
TCGA-25-2042-01	1	TCGA-25-2042-01	396	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-25-2042	NA	NA	days	396	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-25-2042-F26785	TCGA-25-2042	TCGA-25-2042-01A	Stage IIIC	-22127	NA	396	0	396	123	NA	NA	NA	NA	2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.4	NA	NA	G3	Metastatic	YES	NA	NA	NA	TCGA-25-2042.4D14A408-E3F6-47EB-A67C-0606450DB0C5.pdf	2042	NA	WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.3	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2006	TCGA-25-2042-01	TCGA-25-2042-01	NA	4873bfbf-079c-407d-9d8f-5bab18d1c3a0	NA	TCGA-25-2042-01	NA	TCGA-25-2042-01A-01D-0708-05	NA	TCGA-25-2042-01A-21-1560-20	NA	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01D-0704-01	TCGA-25-2042-01	59676524-6b40-4bcc-b488-120781e23d22	NA	TCGA-25-2042-01A-01D-0704-01	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	NA	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01W-0799-08	TCGA-25-2042-01	TCGA-25-2042-01	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01W-0799-08	TCGA-25-2042-01A-01R-0711-07	
TCGA-25-2390-01	NA	TCGA-25-2390-01	NA	NA	days	NA	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-25-2390	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	80	NA	NA	TCGA-25-2390	TCGA-25-2390-01A	NA	-29257	NA	NA	0	NA	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	NA	NA	0.6	NO	NA	1.6	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-25-2390.B57A7111-209E-4FD3-8E2E-868B70BFF806.pdf	2390	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.3	NA	NA	25	NA	Ovary	NA	A	NA	2003	NA	NA	NA	NA	NA	NA	NA	TCGA-25-2390-01A-01D-0708-05	NA	TCGA-25-2390-01A-21-1560-20	NA	NA	NA	NA	29f6e462-4410-445e-8777-3402fc8488be	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-25-2390-01A-01R-0711-07	
TCGA-25-2391-01	1	TCGA-25-2391-01	1492	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2391	NA	NA	days	1492	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Bilateral	TCGA-25-2391-F26796	TCGA-25-2391	TCGA-25-2391-01A	Stage IIIC	-20939	NA	1492	0	1492	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-2391.32AC761D-67A0-46C5-AB01-AE9BBE7307CA.pdf	2391	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2003	TCGA-25-2391-01	TCGA-25-2391-01	NA	bf367755-354c-4d12-a8a8-7a1373b8d397	NA	TCGA-25-2391-01	NA	TCGA-25-2391-01A-01D-0708-05	NA	TCGA-25-2391-01A-21-1560-20	NA	0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01D-0704-01	TCGA-25-2391-01	53220d7f-967c-4101-82ce-24495a3e2b9a	NA	TCGA-25-2391-01A-01D-0704-01	0ee0c708-77c4-4ac3-be13-0d08e6444003	NA	0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01W-0799-08	TCGA-25-2391-01	TCGA-25-2391-01	0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01W-0799-08	TCGA-25-2391-01A-01R-0711-07	
TCGA-25-2392-01	1	TCGA-25-2392-01	31	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 2	TCGA-25-2392	NA	NA	days	31	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	75	Bilateral	TCGA-25-2392-F26801	TCGA-25-2392	TCGA-25-2392-01A	Stage IV	-27667	NA	31	0	31	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-2392.C520D0D6-F104-492C-A4C2-844390F55570.pdf	2392	NA	NA	NO	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	25	11-20 mm	Ovary	NA	A	DECEASED	2003	TCGA-25-2392-01	TCGA-25-2392-01	NA	62414e51-fd9a-4ed8-bc34-c4d194fdc884	NA	TCGA-25-2392-01	NA	TCGA-25-2392-01A-01D-0708-05	NA	NA	NA	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01D-0704-01	TCGA-25-2392-01	NA	NA	TCGA-25-2392-01A-01D-0704-01	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	NA	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01W-0799-08	TCGA-25-2392-01	TCGA-25-2392-01	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01W-0799-08	TCGA-25-2392-01A-01R-0711-07	
TCGA-25-2393-01	1	TCGA-25-2393-01	1157	1	days	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2393	NA	NA	days	1157	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Left	TCGA-25-2393-F26803	TCGA-25-2393	TCGA-25-2393-01A	Stage IIIC	-29585	NA	1157	0	1157	NA	305	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2393.0B780E04-2DE3-4C56-9B93-1919F4BBE5D4.pdf	2393	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	25	11-20 mm	Ovary	NA	A	DECEASED	2003	TCGA-25-2393-01	TCGA-25-2393-01	NA	93d53663-d5fc-4a27-8844-d58f09f47c64	NA	TCGA-25-2393-01	NA	TCGA-25-2393-01A-01D-0708-05	NA	TCGA-25-2393-01A-21-1560-20	NA	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01D-0704-01	TCGA-25-2393-01	7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5	NA	TCGA-25-2393-01A-01D-0704-01	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	NA	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01W-0799-08	TCGA-25-2393-01	TCGA-25-2393-01	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01W-0799-08	TCGA-25-2393-01A-01R-0711-07	
TCGA-25-2396-01	1	TCGA-25-2396-01	92	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2396	NA	NA	days	92	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Bilateral	TCGA-25-2396-F26808	TCGA-25-2396	TCGA-25-2396-01A	Stage IIIC	-26145	NA	92	0	92	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-2396.5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF.pdf	2396	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	1	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	TCGA-25-2396-01	TCGA-25-2396-01	NA	5cbceba0-c820-45dc-926d-ee4893659503	NA	TCGA-25-2396-01	NA	TCGA-25-2396-01A-01D-0708-05	NA	TCGA-25-2396-01A-21-1560-20	NA	43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01D-0704-01	TCGA-25-2396-01	abf3ad2e-f8d1-4a58-a48b-eaf3b553e793	NA	TCGA-25-2396-01A-01D-0704-01	43352a4d-f866-4ed7-81f5-5dc478c10992	NA	43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01W-0799-08	TCGA-25-2396-01	TCGA-25-2396-01	43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01W-0799-08	TCGA-25-2396-01A-01R-0711-07	
TCGA-25-2397-01	1	TCGA-25-2397-01	365	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-25-2397	NA	NA	days	365	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-25-2397-F26810	TCGA-25-2397	TCGA-25-2397-01A	Stage IV	-21581	NA	365	0	365	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	2.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-2397.D67C4E1F-6A68-4EE6-B143-22038C05C926.pdf	2397	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	TCGA-25-2397-01	TCGA-25-2397-01	NA	3faab68c-41ef-4eef-8ed1-1d5c7c5b9a8b	NA	TCGA-25-2397-01	NA	TCGA-25-2397-01A-01D-0708-05	NA	TCGA-25-2397-01A-21-1560-20	NA	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	TCGA-25-2397-01A-01D-0704-01	TCGA-25-2397-01	eac7612a-49d6-4b40-84b7-c68db54e56c1	NA	TCGA-25-2397-01A-01D-0704-01	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	NA	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	NA	TCGA-25-2397-01	TCGA-25-2397-01	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	NA	TCGA-25-2397-01A-01R-0711-07	
TCGA-25-2398-01	1	TCGA-25-2398-01	1369	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2398	NA	NA	days	1369	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-2398-F26812	TCGA-25-2398	TCGA-25-2398-01A	Stage IIIC	-26267	NA	1369	0	1369	NA	577	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2398.CFF4E9E3-AC10-4A50-BE90-5A12822FEF42.pdf	2398	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.5	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-25-2398-01	TCGA-25-2398-01	NA	bcdd8efe-1f50-4bb6-904a-b8bdfd32dfbd	NA	TCGA-25-2398-01	NA	TCGA-25-2398-01A-01D-0708-05	NA	TCGA-25-2398-01A-21-1563-20	NA	3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01D-0704-01	TCGA-25-2398-01	b081cedd-6727-478d-9ebf-22ad78c34b27	NA	TCGA-25-2398-01A-01D-0704-01	3a080008-8266-4e2d-a143-adac14991b22	NA	3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01W-0799-08	TCGA-25-2398-01	TCGA-25-2398-01	3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01W-0799-08	TCGA-25-2398-01A-01R-0711-07	
TCGA-25-2399-01	1	TCGA-25-2399-01	608	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2399	NA	NA	days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	80	Bilateral	TCGA-25-2399-F26818	TCGA-25-2399	TCGA-25-2399-01A	Stage IIIC	-29373	NA	608	0	608	NA	243	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2399.38AEA3BF-A853-4719-B308-63884A6F8F13.pdf	2399	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	25	>20 mm	Ovary	NA	A	DECEASED	2004	TCGA-25-2399-01	TCGA-25-2399-01	NA	a05df1ef-35d1-4fe3-a944-ab5c6b52d468	NA	TCGA-25-2399-01	NA	TCGA-25-2399-01A-01D-0708-05	NA	TCGA-25-2399-01A-21-1560-20	NA	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01D-0704-01	TCGA-25-2399-01	27dde0e4-5be8-4045-910b-24c0535a4623	NA	TCGA-25-2399-01A-01D-0704-01	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	NA	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01W-0799-08	TCGA-25-2399-01	TCGA-25-2399-01	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01W-0799-08	TCGA-25-2399-01A-01R-0711-07	
TCGA-25-2400-01	1	TCGA-25-2400-01	1278	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2400	NA	NA	days	1278	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-25-2400-F26823	TCGA-25-2400	TCGA-25-2400-01A	Stage IIIC	-27789	NA	1278	0	1278	NA	577	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2400.0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C.pdf	2400	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	TCGA-25-2400-01	TCGA-25-2400-01	NA	1dab017a-bf35-4cec-9bef-f03b5c5b363c	NA	TCGA-25-2400-01	NA	TCGA-25-2400-01A-01D-0708-05	NA	TCGA-25-2400-01A-21-1560-20	NA	5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01D-0704-01	TCGA-25-2400-01	ab4e5114-ba2a-4706-8be1-a359c4e5b547	NA	TCGA-25-2400-01A-01D-0704-01	5c98c2c5-806f-4562-ad57-e152ea8388ab	NA	5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01W-0799-08	TCGA-25-2400-01	TCGA-25-2400-01	5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01W-0799-08	TCGA-25-2400-01A-01R-0711-07	
TCGA-25-2401-01	1	TCGA-25-2401-01	90	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-25-2401	NA	NA	days	90	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Bilateral	TCGA-25-2401-F26829	TCGA-25-2401	TCGA-25-2401-01A	Stage IIIC	-23711	NA	90	0	90	NA	NA	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-25-2401.5B192072-1F11-4316-AC39-81085F7E425D.pdf	2401	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-25-2401-01	TCGA-25-2401-01	NA	d34e80bb-5261-478c-9aa8-6732cc107f9f	NA	TCGA-25-2401-01	NA	TCGA-25-2401-01A-01D-0708-05	NA	TCGA-25-2401-01A-21-1560-20	NA	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01D-0704-01	TCGA-25-2401-01	8b55fa70-3074-4209-ab77-4634075aa0d1	NA	TCGA-25-2401-01A-01D-0704-01	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	NA	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01W-0799-08	TCGA-25-2401-01	TCGA-25-2401-01	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01W-0799-08	TCGA-25-2401-01A-01R-0711-07	
TCGA-25-2404-01	1	TCGA-25-2404-01	883	1	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2404	NA	NA	days	883	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-25-2404-F26831	TCGA-25-2404	TCGA-25-2404-01A	Stage IIIC	-14184	NA	883	0	883	NA	426	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2404.7B13E549-204D-47F8-93EB-D8C5C8D259FA.pdf	2404	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	25	No Macroscopic disease	Ovary	NA	A	DECEASED	2005	TCGA-25-2404-01	TCGA-25-2404-01	NA	df215206-d33b-40b7-94dc-86d5a3cfbc87	NA	TCGA-25-2404-01	NA	TCGA-25-2404-01A-01D-0708-05	NA	TCGA-25-2404-01A-21-1560-20	NA	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01D-0704-01	TCGA-25-2404-01	2300785c-d77b-4d40-94e5-7947b18f9c24	NA	TCGA-25-2404-01A-01D-0704-01	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	NA	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01W-0799-08	TCGA-25-2404-01	TCGA-25-2404-01	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01W-0799-08	TCGA-25-2404-01A-01R-0711-07	
TCGA-25-2408-01	1	TCGA-25-2408-01	943	1	days	Iq	C9-OV	Low purity c2	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-25-2408	NA	NA	days	943	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NO	37	Bilateral	TCGA-25-2408-F26837	TCGA-25-2408	TCGA-25-2408-01A	Stage IV	-13606	NA	943	0	943	NA	334	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-25-2408.2A91BE69-31C8-456E-8EBB-8AD08AAAB3A9.pdf	2408	NA	WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.3	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2005	NA	TCGA-25-2408-01	NA	a693a4be-bb91-4608-bacb-4ffa101e413a	NA	TCGA-25-2408-01	NA	TCGA-25-2408-01A-01D-0708-05	NA	TCGA-25-2408-01A-21-1562-20	NA	NA	TCGA-25-2408-01A-01D-0704-01	TCGA-25-2408-01	19590adb-d236-4acf-a78f-275de0e8f0e1	NA	TCGA-25-2408-01A-01D-0704-01	NA	NA	NA	TCGA-25-2408-01A-01W-0799-08	TCGA-25-2408-01	NA	NA	TCGA-25-2408-01A-01W-0799-08	TCGA-25-2408-01A-01R-0711-07	
TCGA-25-2409-01	1	TCGA-25-2409-01	821	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-2409	NA	NA	days	821	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-2409-F26841	TCGA-25-2409	TCGA-25-2409-01A	Stage IV	-26267	NA	821	0	821	NA	304	NA	NA	NA	2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-25-2409.89A631C6-5000-4A96-B752-879EAA7231CB.pdf	2409	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	25	1-10 mm	Ovary	NA	A	DECEASED	2005	TCGA-25-2409-01	TCGA-25-2409-01	NA	71b8d6ab-57cb-411e-89f3-9ea82e67abff	NA	TCGA-25-2409-01	NA	TCGA-25-2409-01A-01D-0708-05	NA	TCGA-25-2409-01A-21-1560-20	NA	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01D-0704-01	TCGA-25-2409-01	bfaa6831-b085-4b98-90a5-fef72266d642	NA	TCGA-25-2409-01A-01D-0704-01	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	NA	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01W-0799-08	TCGA-25-2409-01	TCGA-25-2409-01	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01W-0799-08	TCGA-25-2409-01A-01R-0711-07	
TCGA-29-1688-01	1	TCGA-29-1688-01	2400	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	NA	TCGA-29-1688	NA	NA	days	2400	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	39	Bilateral	TCGA-29-1688-F27124	TCGA-29-1688	TCGA-29-1688-01A	Stage IIIC	-14574	NA	2400	0	2400	NA	184	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3.pdf	1688	NA	WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.5	NA	NA	29	NA	Ovary	YES	A	DECEASED	1992	TCGA-29-1688-01	TCGA-29-1688-01	NA	065ec84d-9986-4b99-8c58-3d0a578cd8fb	NA	TCGA-29-1688-01	NA	TCGA-29-1688-01A-01D-0563-05	NA	TCGA-29-1688-01A-21-1558-20	TCGA-29-1688-01A-01W-0633-09	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	TCGA-29-1688-01A-01D-0559-01	TCGA-29-1688-01	46d8cea8-b5a2-4136-bfeb-4969e3ccbd85	NA	TCGA-29-1688-01A-01D-0559-01	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	NA	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	NA	TCGA-29-1688-01	TCGA-29-1688-01	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	NA	TCGA-29-1688-01A-01R-0566-07	
TCGA-29-1690-01	1	TCGA-29-1690-01	1448	1	days	Iq	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-29-1690	NA	NA	days	1448	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	66	Bilateral	TCGA-29-1690-F27142	TCGA-29-1690	TCGA-29-1690-01A	Stage IIIC	-24319	NA	1448	0	1360	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.3	NO	NA	1.4	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-29-1690.a44f0507-fc95-410a-a6b2-b66caacee30e.pdf	1690	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.7	NA	NA	29	11-20 mm	Ovary	NA	A	DECEASED	1993	TCGA-29-1690-01	TCGA-29-1690-01	NA	21ed8b03-3122-4467-8542-a90a261e9934	NA	TCGA-29-1690-01	NA	TCGA-29-1690-01A-01D-0563-05	NA	TCGA-29-1690-01A-21-1558-20	TCGA-29-1690-01A-01W-0633-09	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	TCGA-29-1690-01A-01D-0559-01	TCGA-29-1690-01	865fd9bb-d8c0-43d0-874c-ce6e69ce93be	NA	TCGA-29-1690-01A-01D-0559-01	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	NA	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	NA	TCGA-29-1690-01	TCGA-29-1690-01	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	NA	TCGA-29-1690-01A-01R-0566-07	
TCGA-29-1691-01	1	TCGA-29-1691-01	1470	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-29-1691	NA	NA	days	1470	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-29-1691-F27148	TCGA-29-1691	NA	Stage IIIC	-18664	NA	1470	0	1435	NA	613	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1691	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	29	1-10 mm	Ovary	NA	NA	DECEASED	1995	TCGA-29-1691-01	TCGA-29-1691-01	NA	cbacc51e-d8b4-4dab-8ba8-7e769d19c26a	NA	TCGA-29-1691-01	NA	TCGA-29-1691-01A-01D-0563-05	NA	TCGA-29-1691-01A-21-1558-20	TCGA-29-1691-01A-01W-0633-09	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	TCGA-29-1691-01A-01D-0559-01	TCGA-29-1691-01	e634e64b-7b5c-4d33-88f9-c5c83442fdc1	NA	TCGA-29-1691-01A-01D-0559-01	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	NA	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	NA	TCGA-29-1691-01	TCGA-29-1691-01	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	NA	TCGA-29-1691-01A-01R-0566-07	
TCGA-29-1692-01	1	TCGA-29-1692-01	2872	1	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-29-1692	NA	NA	days	2872	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-29-1692-F27159	TCGA-29-1692	TCGA-29-1692-01B	Stage IIIC	-21193	NA	2872	0	2872	NA	544	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.7	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1692.522E504C-7F53-4E91-A684-FD7B3C54CF06.pdf	1692	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NA	NO	R1	Primary Tumor	01	0.2	NA	NA	29	11-20 mm	Ovary	NA	B	DECEASED	1997	NA	NA	NA	2ecbe10e-1afc-4a38-91ee-cb0cc670f254	NA	NA	NA	TCGA-29-1692-01B-01D-0807-05	NA	NA	NA	NA	TCGA-29-1692-01B-01D-2069-01	TCGA-29-1692-01	NA	NA	TCGA-29-1692-01B-01D-2069-01	NA	NA	NA	NA	TCGA-29-1692-01	NA	NA	NA	TCGA-29-1692-01B-01R-0810-07	
TCGA-29-1692-02	1	TCGA-29-1692-02	2872	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-29-1692	NA	NA	days	2872	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-29-1692-F27159	TCGA-29-1692	TCGA-29-1692-02A	Stage IIIC	-21193	NA	2872	0	2872	NA	544	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1692.FF9EECFF-66C4-440F-91AB-42ACCEED0A3B.pdf	1692	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NA	NO	R1	Recurrent Tumor	02	0.6	NA	NA	29	11-20 mm	Ovary	NA	A	DECEASED	1997	NA	NA	NA	4001650f-30d3-46dd-8ba2-7f148afe4ba7	NA	NA	NA	TCGA-29-1692-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	fb710151-c817-4915-90d2-2997726ceccd	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-1692-02A-01R-0810-07	
TCGA-29-1693-01	0	TCGA-29-1693-01	3096	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1693	NA	NA	days	3096	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	72	Left	TCGA-29-1693-F27174	TCGA-29-1693	TCGA-29-1693-01A	Stage IIIC	-26300	NA	NA	0	3096	NA	694	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.7	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1693.90087244-634d-45eb-a877-ff7cc6bd2282.pdf	1693	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	YES	A	LIVING	2001	TCGA-29-1693-01	TCGA-29-1693-01	NA	111c7bf6-d79d-48e4-adf8-94bc0c538ab5	NA	TCGA-29-1693-01	NA	TCGA-29-1693-01A-01D-0563-05	NA	TCGA-29-1693-01A-21-1558-20	TCGA-29-1693-01A-01W-0633-09	7e5d2390-1e04-4e46-aa48-4b0131076007	TCGA-29-1693-01A-01D-0559-01	TCGA-29-1693-01	75dd78d6-cd26-476f-927f-ddb0d4a9c66f	NA	TCGA-29-1693-01A-01D-0559-01	7e5d2390-1e04-4e46-aa48-4b0131076007	NA	7e5d2390-1e04-4e46-aa48-4b0131076007	NA	TCGA-29-1693-01	TCGA-29-1693-01	7e5d2390-1e04-4e46-aa48-4b0131076007	NA	TCGA-29-1693-01A-01R-0566-07	
TCGA-29-1694-01	1	TCGA-29-1694-01	1187	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1694	NA	NA	days	1187	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	45	Bilateral	TCGA-29-1694-F27192	TCGA-29-1694	TCGA-29-1694-01A	Stage IIIC	-16523	NA	1187	0	[Discrepancy]	206	NA	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	GX	Locoregional Disease	YES	NA	NA	NA	TCGA-29-1694.ccfb9f1d-1779-4fae-a34f-c46a19d4b095.pdf	1694	Other	WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.3	NA	NA	29	11-20 mm	Ovary	NA	A	DECEASED	2002	TCGA-29-1694-01	TCGA-29-1694-01	NA	57cead11-58b6-4d8e-ab66-b742de63ae1d	NA	TCGA-29-1694-01	NA	TCGA-29-1694-01A-01D-0563-05	NA	TCGA-29-1694-01A-21-1558-20	TCGA-29-1694-01A-01W-0633-09	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	TCGA-29-1694-01A-01D-0559-01	TCGA-29-1694-01	463fec61-5758-4225-b43e-b77f36ece717	NA	TCGA-29-1694-01A-01D-0559-01	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	NA	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	NA	TCGA-29-1694-01	TCGA-29-1694-01	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	NA	TCGA-29-1694-01A-01R-0566-07	
TCGA-29-1695-01	1	TCGA-29-1695-01	1229	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-29-1695	NA	NA	days	1229	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Left	TCGA-29-1695-F27204	TCGA-29-1695	TCGA-29-1695-01A	Stage IIIC	-22895	NA	1229	0	24	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-29-1695.136a4380-2a2a-489f-8675-886e876f17f7.pdf	1695	NA	NA	NA	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2003	TCGA-29-1695-01	TCGA-29-1695-01	NA	43c657df-dd50-4c53-a5de-e73d3a5e1b0c	NA	TCGA-29-1695-01	NA	TCGA-29-1695-01A-01D-0563-05	NA	TCGA-29-1695-01A-21-1558-20	TCGA-29-1695-01A-01W-0633-09	33f1dda6-7601-48c6-b46d-f0ba759e4048	TCGA-29-1695-01A-01D-0559-01	TCGA-29-1695-01	997dba94-b0d4-4872-b93b-d561f71f6ba3	NA	TCGA-29-1695-01A-01D-0559-01	33f1dda6-7601-48c6-b46d-f0ba759e4048	NA	33f1dda6-7601-48c6-b46d-f0ba759e4048	NA	TCGA-29-1695-01	TCGA-29-1695-01	33f1dda6-7601-48c6-b46d-f0ba759e4048	NA	TCGA-29-1695-01A-01R-0566-07	
TCGA-29-1696-01	1	TCGA-29-1696-01	1032	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1696	NA	NA	days	1032	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	43	Right	TCGA-29-1696-F27206	TCGA-29-1696	TCGA-29-1696-01A	Stage IIIC	-15818	NA	1032	0	1025	NA	342	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	0.8	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1696.5e817943-3108-4838-bf8c-85c4507eb873.pdf	1696	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2003	TCGA-29-1696-01	TCGA-29-1696-01	NA	fea497c6-293b-49aa-9d5f-021f2f89913e	NA	TCGA-29-1696-01	NA	TCGA-29-1696-01A-01D-0563-05	NA	TCGA-29-1696-01A-21-1558-20	TCGA-29-1696-01A-01W-0633-09	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	TCGA-29-1696-01A-01D-0559-01	TCGA-29-1696-01	93ea52c3-dc03-4845-9493-f1ecdd9e9124	NA	TCGA-29-1696-01A-01D-0559-01	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	NA	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	NA	TCGA-29-1696-01	TCGA-29-1696-01	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	NA	TCGA-29-1696-01A-01R-0566-07	
TCGA-29-1697-01	1	TCGA-29-1697-01	949	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5	NA	TCGA-29-1697	NA	NA	days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-29-1697-F27216	TCGA-29-1697	TCGA-29-1697-01A	Stage IIIC	-22933	NA	949	0	949	NA	500	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.9	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1697.294ba09f-347a-4129-847d-211cdf73ca99.pdf	1697	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2003	TCGA-29-1697-01	TCGA-29-1697-01	NA	bd90331c-acc6-49f5-8943-065fbfb16519	NA	TCGA-29-1697-01	NA	TCGA-29-1697-01A-01D-0563-05	NA	TCGA-29-1697-01A-21-1558-20	TCGA-29-1697-01A-01W-0633-09	75435634-4311-49d8-8e42-ae1069c1e2ef	TCGA-29-1697-01A-01D-0559-01	TCGA-29-1697-01	9efe9dcc-44d7-47ae-b404-d324e821910e	NA	TCGA-29-1697-01A-01D-0559-01	75435634-4311-49d8-8e42-ae1069c1e2ef	NA	75435634-4311-49d8-8e42-ae1069c1e2ef	NA	TCGA-29-1697-01	TCGA-29-1697-01	75435634-4311-49d8-8e42-ae1069c1e2ef	NA	TCGA-29-1697-01A-01R-0566-07	
TCGA-29-1698-01	0	TCGA-29-1698-01	2078	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-29-1698	NA	NA	days	2078	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-29-1698-F27227	TCGA-29-1698	TCGA-29-1698-01A	Stage IIIC	-19611	NA	NA	0	2078	NA	181	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.4	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1698.133f2df5-6c22-4653-9d2e-f3d5971502b0.pdf	1698	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.3	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2004	TCGA-29-1698-01	TCGA-29-1698-01	NA	86e20816-f37a-4686-876b-3ef6f0be521a	NA	TCGA-29-1698-01	NA	TCGA-29-1698-01A-01D-0563-05	NA	TCGA-29-1698-01A-21-1558-20	TCGA-29-1698-01A-01W-0633-09	74970c45-4cc5-4952-9846-ce2d959437ea	TCGA-29-1698-01A-01D-0559-01	TCGA-29-1698-01	a40be7ea-f682-4d3e-a749-74aec6961b88	NA	TCGA-29-1698-01A-01D-0559-01	74970c45-4cc5-4952-9846-ce2d959437ea	NA	74970c45-4cc5-4952-9846-ce2d959437ea	NA	TCGA-29-1698-01	TCGA-29-1698-01	74970c45-4cc5-4952-9846-ce2d959437ea	NA	TCGA-29-1698-01A-01R-0566-07	
TCGA-29-1699-01	1	TCGA-29-1699-01	1106	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-29-1699	1106	0	days	1106	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Bilateral	TCGA-29-1699-F41729	TCGA-29-1699	TCGA-29-1699-01A	Stage IIIC	-21130	NA	1106	0	16	NA	NA	1	NA	Progressive Disease	2013-8-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.5	NA	YES	G3	NA	NA	NO	NA	NA	TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036.pdf	1699	Preoperative	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.6	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2004	TCGA-29-1699-01	TCGA-29-1699-01	NA	036b4d31-1291-4092-9442-9950564a6699	NA	TCGA-29-1699-01	NA	TCGA-29-1699-01A-01D-0563-05	NA	TCGA-29-1699-01A-21-1558-20	TCGA-29-1699-01A-01W-0633-09	6d1d8c8a-fea0-4a47-bd2a-124270561406	TCGA-29-1699-01A-01D-0559-01	TCGA-29-1699-01	21c96f53-087e-42c2-86ce-ea45cf876627	NA	TCGA-29-1699-01A-01D-0559-01	6d1d8c8a-fea0-4a47-bd2a-124270561406	NA	6d1d8c8a-fea0-4a47-bd2a-124270561406	NA	TCGA-29-1699-01	TCGA-29-1699-01	6d1d8c8a-fea0-4a47-bd2a-124270561406	NA	TCGA-29-1699-01A-01R-0566-07	
TCGA-29-1701-01	1	TCGA-29-1701-01	515	1	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-29-1701	NA	NA	days	515	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-29-1701-F27243	TCGA-29-1701	TCGA-29-1701-01A	Stage IIIC	-20737	NA	515	0	514	NA	298	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.3	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1701.f7568046-b77a-4654-9f94-8978bd3e22c4.pdf	1701	Post-Adjuvant Therapy	WITH TUMOR	NO	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.6	NA	NA	29	NA	Ovary	YES	A	DECEASED	2004	TCGA-29-1701-01	TCGA-29-1701-01	NA	9ffceda1-d2ab-4689-baee-eab0b133ded9	NA	TCGA-29-1701-01	NA	TCGA-29-1701-01A-01D-0563-05	NA	TCGA-29-1701-01A-21-1558-20	TCGA-29-1701-01A-01W-0633-09	e5e6f25b-d641-4598-8bb1-0850750ef048	TCGA-29-1701-01A-01D-0559-01	TCGA-29-1701-01	d770980a-b6ef-4e85-8ed6-a22702326573	NA	TCGA-29-1701-01A-01D-0559-01	e5e6f25b-d641-4598-8bb1-0850750ef048	NA	e5e6f25b-d641-4598-8bb1-0850750ef048	NA	TCGA-29-1701-01	TCGA-29-1701-01	e5e6f25b-d641-4598-8bb1-0850750ef048	NA	TCGA-29-1701-01A-01R-0566-07	
TCGA-29-1702-01	1	TCGA-29-1702-01	728	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-29-1702	NA	NA	days	728	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	84	Right	TCGA-29-1702-F27249	TCGA-29-1702	TCGA-29-1702-01A	Stage IIIC	-30910	NA	728	0	568	NA	286	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1702.f825bb6c-afc2-48ea-9286-09c09c7e9918.pdf	1702	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2005	TCGA-29-1702-01	TCGA-29-1702-01	NA	3a13cc49-5376-4695-9e64-45b457b9d36b	NA	TCGA-29-1702-01	NA	TCGA-29-1702-01A-01D-0563-05	NA	TCGA-29-1702-01A-21-1558-20	TCGA-29-1702-01A-01W-0633-09	c317689f-a405-4486-9a22-ff6eadd2d5b8	TCGA-29-1702-01A-01D-0559-01	TCGA-29-1702-01	0160cfab-a19a-415e-a418-5679ae8d6779	NA	TCGA-29-1702-01A-01D-0559-01	c317689f-a405-4486-9a22-ff6eadd2d5b8	NA	c317689f-a405-4486-9a22-ff6eadd2d5b8	NA	TCGA-29-1702-01	TCGA-29-1702-01	c317689f-a405-4486-9a22-ff6eadd2d5b8	NA	TCGA-29-1702-01A-01R-0566-07	
TCGA-29-1703-01	1	TCGA-29-1703-01	1815	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-29-1703	NA	NA	days	1815	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-29-1703-F27255	TCGA-29-1703	TCGA-29-1703-01A	Stage IIIC	-20622	NA	1815	0	1815	NA	324	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953.pdf	1703	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2005	TCGA-29-1703-01	TCGA-29-1703-01	NA	059bf2b5-7752-44aa-935c-8b9c482e29e2	NA	TCGA-29-1703-01	NA	TCGA-29-1703-01A-01D-0563-05	NA	TCGA-29-1703-01A-21-1558-20	TCGA-29-1703-01A-01W-0633-09	64e3f978-d213-45e2-bb52-e9b9a2032dc0	TCGA-29-1703-01A-01D-0559-01	TCGA-29-1703-01	13530c03-540d-4e0d-a760-c0f6946f0480	NA	TCGA-29-1703-01A-01D-0559-01	64e3f978-d213-45e2-bb52-e9b9a2032dc0	NA	64e3f978-d213-45e2-bb52-e9b9a2032dc0	NA	TCGA-29-1703-01	TCGA-29-1703-01	64e3f978-d213-45e2-bb52-e9b9a2032dc0	NA	TCGA-29-1703-01A-01R-0566-07	
TCGA-29-1704-01	0	TCGA-29-1704-01	1587	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-29-1704	NA	NA	days	1587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-29-1704-F27269	TCGA-29-1704	NA	Stage IIIC	-22511	NA	NA	0	1587	NA	568	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1704	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Primary Tumor	01	NA	NA	NA	29	11-20 mm	Ovary	NA	NA	LIVING	2005	NA	NA	NA	bbc42149-d2c4-44f9-a59f-bd9397bc96e8	NA	NA	NA	TCGA-29-1704-01B-01D-0807-05	NA	NA	NA	NA	TCGA-29-1704-01B-01D-0803-01	TCGA-29-1704-01	NA	NA	TCGA-29-1704-01B-01D-0803-01	NA	NA	NA	NA	TCGA-29-1704-01	NA	NA	NA	TCGA-29-1704-01B-01R-0810-07	
TCGA-29-1704-02	0	TCGA-29-1704-02	1587	0	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-29-1704	NA	NA	days	1587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-29-1704-F27269	TCGA-29-1704	TCGA-29-1704-02A	Stage IIIC	-22511	NA	NA	0	1587	NA	568	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1704.4C689C80-12E5-4E40-8A12-910D07C8C084.pdf	1704	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Recurrent Tumor	02	0.2	NA	NA	29	11-20 mm	Ovary	NA	A	LIVING	2005	NA	NA	NA	NA	NA	NA	NA	TCGA-29-1704-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-29-1705-01	1	TCGA-29-1705-01	555	1	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-29-1705	NA	NA	days	555	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-29-1705-F27279	TCGA-29-1705	TCGA-29-1705-01A	Stage IIIC	-17530	NA	555	0	555	NA	283	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.8	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1705.e7a899e9-2c61-4bda-874c-0f1b456e5dfc.pdf	1705	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.7	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2005	TCGA-29-1705-01	TCGA-29-1705-01	NA	3d4c3c05-1760-43b8-9a4d-e66ebfaf9533	NA	TCGA-29-1705-01	NA	TCGA-29-1705-01A-01D-0563-05	NA	TCGA-29-1705-01A-21-1558-20	TCGA-29-1705-01A-01W-0633-09	d1603029-2b45-4c5c-b313-8846d0ebdbdb	TCGA-29-1705-01A-01D-0559-01	TCGA-29-1705-01	94faea93-a4a5-45c7-9b05-b342bec4e176,daae8ca1-a6fd-43cc-a82e-32ffe02803c7	NA	TCGA-29-1705-01A-01D-0559-01	d1603029-2b45-4c5c-b313-8846d0ebdbdb	NA	d1603029-2b45-4c5c-b313-8846d0ebdbdb	NA	TCGA-29-1705-01	TCGA-29-1705-01	d1603029-2b45-4c5c-b313-8846d0ebdbdb	NA	TCGA-29-1705-01A-01R-0566-07	
TCGA-29-1705-02	1	TCGA-29-1705-02	555	1	days	NA	C9-OV	OV-like c1	NA	NA	miRNA cluster 3	NA	NA	TCGA-29-1705	NA	NA	days	555	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-29-1705-F27279	TCGA-29-1705	TCGA-29-1705-02A	Stage IIIC	-17530	NA	555	0	555	NA	283	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.3	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1705.EADA1E69-0CAB-4521-ABE4-035F73ABB54A.pdf	1705	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2005	NA	TCGA-29-1705-02	NA	83b8567f-7316-4c8b-877d-b5db5bf8c9da	NA	TCGA-29-1705-02	NA	TCGA-29-1705-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	032aec92-5009-4a62-94cf-7dca39023322	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-1705-02A-01R-0810-07	
TCGA-29-1707-01	0	TCGA-29-1707-01	1277	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-29-1707	NA	NA	days	1277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Left	TCGA-29-1707-F27288	TCGA-29-1707	TCGA-29-1707-01A	Stage IIC	-15017	NA	NA	0	1277	NA	1201	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1707.da725324-2b94-47d4-a35c-a5f2233a024f.pdf	1707	Post-Adjuvant Therapy	NA	YES	Complete Remission/Response	Other Method	NO	NA	Primary Tumor	01	0.5	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2006	NA	TCGA-29-1707-01	NA	5a0fb2e7-59de-4180-9b11-456580ad1d78	NA	TCGA-29-1707-01	NA	TCGA-29-1707-01A-01D-0563-05	NA	TCGA-29-1707-01A-21-1559-20	TCGA-29-1707-01A-01W-0633-09	NA	TCGA-29-1707-01A-01D-0559-01	TCGA-29-1707-01	c7511c99-d363-45ed-9d27-cff988927e46,26e9028d-8002-4408-82e8-68bf43f27fec	NA	TCGA-29-1707-01A-01D-0559-01	NA	NA	NA	NA	TCGA-29-1707-01	NA	NA	NA	TCGA-29-1707-01A-01R-0566-07	
TCGA-29-1707-02	0	TCGA-29-1707-02	1277	0	days	NA	NA	OV-like c1	NA	NA	miRNA cluster 1	NA	NA	TCGA-29-1707	NA	NA	days	1277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Left	TCGA-29-1707-F27288	TCGA-29-1707	TCGA-29-1707-02A	Stage IIC	-15017	NA	NA	0	1277	NA	1201	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1707.264DFD3E-7413-4DEA-A115-14887718139D.pdf	1707	Post-Adjuvant Therapy	NA	YES	Complete Remission/Response	Other Method	NO	NA	Recurrent Tumor	02	0.5	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2006	NA	TCGA-29-1707-02	NA	ef4e079b-c946-4598-a7dd-575e48a4a133	NA	TCGA-29-1707-02	NA	TCGA-29-1707-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	08fc3ec8-3c83-4ffc-bd91-67e6b162790b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-1707-02A-01R-0810-07	
TCGA-29-1710-01	1	TCGA-29-1710-01	951	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-29-1710	NA	NA	days	951	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1710-F27294	TCGA-29-1710	TCGA-29-1710-01A	Stage IIIC	-19969	NA	951	0	889	NA	315	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.8	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1710.52a0d2ae-7467-40f0-b8f3-59812cfac52a.pdf	1710	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2006	TCGA-29-1710-01	TCGA-29-1710-01	NA	31aaa27c-8eaf-4030-9067-d505d9abf983	NA	TCGA-29-1710-01	NA	TCGA-29-1710-01A-02D-0563-05	NA	NA	TCGA-29-1710-01A-02W-0633-09	3bf24456-4b70-4313-a04d-19aba239108d	TCGA-29-1710-01A-02D-0559-01	TCGA-29-1710-01	34b987ae-5e5a-435b-b1f3-0cf9623f1337	NA	TCGA-29-1710-01A-02D-0559-01	3bf24456-4b70-4313-a04d-19aba239108d	NA	3bf24456-4b70-4313-a04d-19aba239108d	NA	TCGA-29-1710-01	TCGA-29-1710-01	3bf24456-4b70-4313-a04d-19aba239108d	NA	TCGA-29-1710-01A-02R-0566-07	
TCGA-29-1710-02	1	TCGA-29-1710-02	951	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-29-1710	NA	NA	days	951	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1710-F27294	TCGA-29-1710	TCGA-29-1710-02A	Stage IIIC	-19969	NA	951	0	889	NA	315	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1710.4FD493D6-DAA8-497E-8EB2-ED2A97034B23.pdf	1710	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.3	NA	NA	29	1-10 mm	Ovary	NA	A	DECEASED	2006	NA	NA	NA	4a8f0084-d5a6-4f5b-bc46-8494a2bfe6b1	NA	NA	NA	TCGA-29-1710-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	8fdfe883-7ce3-46b5-a3c7-e34b59a5557c	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-1710-02A-01R-0810-07	
TCGA-29-1711-01	0	TCGA-29-1711-01	1053	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-29-1711	NA	NA	days	1053	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	45	Bilateral	TCGA-29-1711-F27307	TCGA-29-1711	TCGA-29-1711-01A	Stage IIIC	-16485	NA	NA	0	1053	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.2	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-29-1711.e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d.pdf	1711	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2006	TCGA-29-1711-01	TCGA-29-1711-01	NA	299a04e7-e90f-4a24-a211-7f0bd18b3ea0	NA	TCGA-29-1711-01	NA	TCGA-29-1711-01A-01D-0563-05	NA	TCGA-29-1711-01A-21-1559-20	TCGA-29-1711-01A-01W-0633-09	c512a6e3-8bc8-4188-b264-89b2fe02baa8	TCGA-29-1711-01A-01D-0559-01	TCGA-29-1711-01	8aedfe25-9010-4502-a25c-88ed899eeb22	NA	TCGA-29-1711-01A-01D-0559-01	c512a6e3-8bc8-4188-b264-89b2fe02baa8	NA	c512a6e3-8bc8-4188-b264-89b2fe02baa8	NA	TCGA-29-1711-01	TCGA-29-1711-01	c512a6e3-8bc8-4188-b264-89b2fe02baa8	NA	TCGA-29-1711-01A-01R-0566-07	
TCGA-29-1761-01	1	TCGA-29-1761-01	528	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1761	NA	NA	days	528	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	80	Bilateral	TCGA-29-1761-F27312	TCGA-29-1761	TCGA-29-1761-01A	Stage IIIC	-29337	NA	528	0	517	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.9	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854.pdf	1761	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	1998	TCGA-29-1761-01	TCGA-29-1761-01	NA	288d1cec-45f2-448c-8bf1-ce001420d126	NA	TCGA-29-1761-01	NA	TCGA-29-1761-01A-01D-0563-05	NA	TCGA-29-1761-01A-21-1559-20	TCGA-29-1761-01A-01W-0633-09	c4446f6f-fae9-414c-8bae-7c78bb894982	TCGA-29-1761-01A-01D-0559-01	TCGA-29-1761-01	1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8	NA	TCGA-29-1761-01A-01D-0559-01	c4446f6f-fae9-414c-8bae-7c78bb894982	NA	c4446f6f-fae9-414c-8bae-7c78bb894982	NA	TCGA-29-1761-01	TCGA-29-1761-01	c4446f6f-fae9-414c-8bae-7c78bb894982	NA	TCGA-29-1761-01A-01R-0566-07	
TCGA-29-1762-01	1	TCGA-29-1762-01	2634	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-29-1762	NA	NA	days	2634	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-29-1762-F27316	TCGA-29-1762	TCGA-29-1762-01A	Stage IV	-21879	NA	2634	0	2606	NA	1375	2	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	0.9	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e.pdf	1762	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	1998	TCGA-29-1762-01	TCGA-29-1762-01	NA	49c0d36f-14fc-49f0-90a0-57cfbd8ec25b	NA	TCGA-29-1762-01	NA	TCGA-29-1762-01A-01D-0563-05	NA	TCGA-29-1762-01A-21-1559-20	TCGA-29-1762-01A-01W-0633-09	c3559ae3-3355-4f38-9c07-e557e435fcbd	TCGA-29-1762-01A-01D-0559-01	TCGA-29-1762-01	a8bcbfb3-7a83-4170-8b2c-fa5447b5abce	NA	TCGA-29-1762-01A-01D-0559-01	c3559ae3-3355-4f38-9c07-e557e435fcbd	NA	c3559ae3-3355-4f38-9c07-e557e435fcbd	NA	TCGA-29-1762-01	TCGA-29-1762-01	c3559ae3-3355-4f38-9c07-e557e435fcbd	NA	TCGA-29-1762-01A-01R-0566-07	
TCGA-29-1763-01	0	TCGA-29-1763-01	2032	0	days	High	NA	Low purity c2	NA	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-29-1763	NA	NA	days	2032	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	43	Bilateral	TCGA-29-1763-F27325	TCGA-29-1763	NA	Stage IIC	-16021	NA	NA	0	2032	NA	428	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1763	Other	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	NA	Primary Tumor	01	NA	NA	NA	29	1-10 mm	Ovary	NA	NA	LIVING	2004	TCGA-29-1763-01	TCGA-29-1763-01	NA	afc40d40-daf1-4bb5-8813-017913722541	NA	TCGA-29-1763-01	NA	TCGA-29-1763-01A-02D-0563-05	NA	NA	TCGA-29-1763-01A-02W-0633-09	af63aa43-ab5f-44c5-85cf-01d84be261a3	TCGA-29-1763-01A-02D-0559-01	TCGA-29-1763-01	NA	NA	TCGA-29-1763-01A-02D-0559-01	af63aa43-ab5f-44c5-85cf-01d84be261a3	NA	af63aa43-ab5f-44c5-85cf-01d84be261a3	NA	TCGA-29-1763-01	TCGA-29-1763-01	af63aa43-ab5f-44c5-85cf-01d84be261a3	NA	TCGA-29-1763-01A-02R-0566-07	
TCGA-29-1764-01	0	TCGA-29-1764-01	1914	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-29-1764	NA	NA	days	1914	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-29-1764-F27338	TCGA-29-1764	TCGA-29-1764-01A	Stage IIIC	-18012	NA	NA	0	1914	NA	792	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.6	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17.pdf	1764	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2004	NA	TCGA-29-1764-01	NA	523d9b2a-4c0b-479c-917c-2086480c8558	NA	TCGA-29-1764-01	NA	TCGA-29-1764-01A-01D-0563-05	NA	TCGA-29-1764-01A-21-1559-20	TCGA-29-1764-01A-01W-0633-09	NA	TCGA-29-1764-01A-01D-0559-01	TCGA-29-1764-01	3c3a33be-9e62-4a32-946a-15f32661e2a1	NA	TCGA-29-1764-01A-01D-0559-01	NA	NA	NA	NA	TCGA-29-1764-01	NA	NA	NA	TCGA-29-1764-01A-01R-0566-07	
TCGA-29-1766-01	1	TCGA-29-1766-01	1199	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	NA	TCGA-29-1766	NA	NA	days	1199	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Right	TCGA-29-1766-F27350	TCGA-29-1766	NA	Stage IIIC	-27359	NA	1199	0	1190	NA	672	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1766	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	29	11-20 mm	Peritoneum ovary	NA	NA	DECEASED	2006	NA	TCGA-29-1766-01	NA	a7005558-9983-48f6-8252-943b8a9dd384	NA	TCGA-29-1766-01	NA	TCGA-29-1766-01A-01D-0563-05	NA	TCGA-29-1766-01A-21-1559-20	TCGA-29-1766-01A-01W-0633-09	NA	TCGA-29-1766-01A-01D-0559-01	TCGA-29-1766-01	dd8951d2-5b83-4b78-9b04-52d474639e2f	NA	TCGA-29-1766-01A-01D-0559-01	NA	NA	NA	NA	TCGA-29-1766-01	NA	NA	NA	TCGA-29-1766-01A-01R-0566-07	
TCGA-29-1768-01	1	TCGA-29-1768-01	952	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-29-1768	NA	NA	days	952	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-29-1768-F27358	TCGA-29-1768	TCGA-29-1768-01A	Stage IV	-18396	NA	952	0	950	NA	547	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1768.12d9b343-a52d-4a36-ba7b-31bfeb66da50.pdf	1768	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2006	NA	TCGA-29-1768-01	NA	83edce75-1b96-4e56-8042-76fc6e87f25f	NA	TCGA-29-1768-01	NA	TCGA-29-1768-01A-01D-0563-05	NA	TCGA-29-1768-01A-21-1559-20	TCGA-29-1768-01A-01W-0633-09	NA	TCGA-29-1768-01A-01D-0559-01	TCGA-29-1768-01	f70a1542-3bd5-4ebe-880a-e8f7c75faaba	NA	TCGA-29-1768-01A-01D-0559-01	NA	NA	NA	NA	TCGA-29-1768-01	NA	NA	NA	TCGA-29-1768-01A-01R-0566-07	
TCGA-29-1769-01	0	TCGA-29-1769-01	699	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	NA	TCGA-29-1769	NA	NA	days	699	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	40	Bilateral	TCGA-29-1769-F27366	TCGA-29-1769	TCGA-29-1769-01A	Stage IIIC	-14754	NA	NA	0	699	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-29-1769.67f144b3-c10b-4f96-a70b-6794d817170f.pdf	1769	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2007	NA	TCGA-29-1769-01	NA	8e7a34f7-d49b-46c8-8b74-374232c60b71	NA	TCGA-29-1769-01	NA	TCGA-29-1769-01A-01D-0581-05	NA	TCGA-29-1769-01A-21-1559-20	TCGA-29-1769-01A-01W-0639-09	NA	TCGA-29-1769-01A-01D-0577-01	TCGA-29-1769-01	161fd24e-ed8c-41ef-8f00-000b3554d9e8	NA	TCGA-29-1769-01A-01D-0577-01	NA	NA	NA	NA	TCGA-29-1769-01	NA	NA	NA	TCGA-29-1769-01A-01R-0584-07	
TCGA-29-1770-01	0	TCGA-29-1770-01	741	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-29-1770	NA	NA	days	741	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1770-F27373	TCGA-29-1770	TCGA-29-1770-01A	Stage IIIC	-20015	NA	NA	0	741	NA	377	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.2	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1770.05816aac-55d2-4604-9300-e268f73338fe.pdf	1770	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2007	TCGA-29-1770-01	TCGA-29-1770-01	NA	17024b36-bf59-4753-bcb3-7ddda14f1556	NA	TCGA-29-1770-01	NA	TCGA-29-1770-01A-01D-0563-05	NA	TCGA-29-1770-01A-21-1559-20	TCGA-29-1770-01A-01W-0633-09	5ba75bb8-6229-4d6a-80e5-9a79a548e167	TCGA-29-1770-01A-01D-0559-01	TCGA-29-1770-01	1577dc3d-937d-4fbb-b280-25f969e43f81	NA	TCGA-29-1770-01A-01D-0559-01	5ba75bb8-6229-4d6a-80e5-9a79a548e167	NA	5ba75bb8-6229-4d6a-80e5-9a79a548e167	NA	TCGA-29-1770-01	TCGA-29-1770-01	5ba75bb8-6229-4d6a-80e5-9a79a548e167	NA	TCGA-29-1770-01A-01R-0566-07	
TCGA-29-1770-02	0	TCGA-29-1770-02	741	0	days	NA	C9-OV	Low purity c2	NA	OV-like c16	miRNA cluster 3	NA	NA	TCGA-29-1770	NA	NA	days	741	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1770-F27373	TCGA-29-1770	TCGA-29-1770-02A	Stage IIIC	-20015	NA	NA	0	741	NA	377	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.4	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1770.49220236-FBFE-44AA-89BC-FC4E7CBC94FA.pdf	1770	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.2	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2007	NA	TCGA-29-1770-02	NA	4ccece6b-c6cf-4921-81e5-af3780afffbc	NA	TCGA-29-1770-02	NA	TCGA-29-1770-02A-01D-0807-05	NA	NA	NA	ea119111-5217-4b8a-88e0-36dc77782241	NA	NA	NA	NA	NA	ea119111-5217-4b8a-88e0-36dc77782241	NA	ea119111-5217-4b8a-88e0-36dc77782241	NA	NA	NA	ea119111-5217-4b8a-88e0-36dc77782241	NA	TCGA-29-1770-02A-01R-0810-07	
TCGA-29-1771-01	0	TCGA-29-1771-01	686	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-29-1771	NA	NA	days	686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-29-1771-F27383	TCGA-29-1771	NA	Stage IIIC	-28093	NA	NA	0	686	NA	595	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1771	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	29	>20 mm	Ovary	NA	NA	LIVING	2007	NA	TCGA-29-1771-01	NA	d95ccef1-6cfa-4bda-ab09-c931f8c7a344	NA	TCGA-29-1771-01	NA	TCGA-29-1771-01A-01D-0563-05	NA	TCGA-29-1771-01A-21-1559-20	TCGA-29-1771-01A-01W-0633-09	NA	TCGA-29-1771-01A-01D-0559-01	TCGA-29-1771-01	b69387b5-4b22-4ef1-8711-d1e406c1afdc	NA	TCGA-29-1771-01A-01D-0559-01	NA	NA	NA	NA	TCGA-29-1771-01	NA	NA	NA	TCGA-29-1771-01A-01R-0566-07	
TCGA-29-1774-01	0	TCGA-29-1774-01	527	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-29-1774	NA	NA	days	527	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	82	Bilateral	TCGA-29-1774-F27391	TCGA-29-1774	NA	Stage IIIC	-29991	NA	NA	0	527	NA	234	2	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1774	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	29	>20 mm	Ovary	NA	NA	LIVING	2008	NA	TCGA-29-1774-01	NA	d9a5abd2-9d18-48b7-a38a-c69c134e6086	NA	TCGA-29-1774-01	NA	TCGA-29-1774-01A-01D-0581-05	NA	TCGA-29-1774-01A-21-1559-20	TCGA-29-1774-01A-01W-0639-09	NA	TCGA-29-1774-01A-01D-0577-01	TCGA-29-1774-01	eed4cd8b-16bc-419f-8474-248270a93780	NA	TCGA-29-1774-01A-01D-0577-01	NA	NA	NA	NA	TCGA-29-1774-01	NA	NA	NA	TCGA-29-1774-01A-01R-0584-07	
TCGA-29-1775-01	0	TCGA-29-1775-01	376	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-29-1775	NA	NA	days	376	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-29-1775-F27398	TCGA-29-1775	TCGA-29-1775-01A	Stage IIIC	-18943	NA	NA	0	376	NA	341	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy	NA	0.7	NO	NA	1.1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-1775.8f5dd3e0-b6c8-443e-88d9-c9d02a531f60.pdf	1775	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.5	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2008	NA	NA	NA	8ead8627-a2d2-4952-9d59-cb15c2ae2021	NA	NA	NA	TCGA-29-1775-01A-01D-0581-05	NA	TCGA-29-1775-01A-21-1559-20	TCGA-29-1775-01A-01W-0639-09	NA	TCGA-29-1775-01A-01D-0577-01	TCGA-29-1775-01	8a55a793-3d3c-455f-a342-3c5cbd01f849	NA	TCGA-29-1775-01A-01D-0577-01	NA	NA	NA	NA	TCGA-29-1775-01	NA	NA	NA	TCGA-29-1775-01A-01R-0584-07	
TCGA-29-1776-01	0	TCGA-29-1776-01	360	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-29-1776	NA	NA	days	360	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-29-1776-F27409	TCGA-29-1776	TCGA-29-1776-01A	Stage IIIC	-23016	NA	NA	0	360	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.9	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-1776.eb6df66e-c6ee-4c63-889d-9f4b6ca170c7.pdf	1776	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2008	TCGA-29-1776-01	TCGA-29-1776-01	NA	1549eee5-f999-4053-b926-baae183792f1	NA	TCGA-29-1776-01	NA	TCGA-29-1776-01A-01D-0581-05	NA	TCGA-29-1776-01A-21-1559-20	TCGA-29-1776-01A-01W-0639-09	50867fed-2fda-4c45-aa08-042087e7daa9	TCGA-29-1776-01A-01D-0577-01	TCGA-29-1776-01	3da0c471-ede3-480f-b692-f94939ed8ac3	NA	TCGA-29-1776-01A-01D-0577-01	50867fed-2fda-4c45-aa08-042087e7daa9	NA	50867fed-2fda-4c45-aa08-042087e7daa9	NA	TCGA-29-1776-01	TCGA-29-1776-01	50867fed-2fda-4c45-aa08-042087e7daa9	NA	TCGA-29-1776-01A-01R-0584-07	
TCGA-29-1777-01	0	TCGA-29-1777-01	374	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	NA	TCGA-29-1777	NA	NA	days	374	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	47	Bilateral	TCGA-29-1777-F27415	TCGA-29-1777	TCGA-29-1777-01A	Stage IIIC	-17356	NA	NA	0	374	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.3	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-29-1777.bfd59906-509b-4ca3-9282-c881f9962e15.pdf	1777	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2008	NA	TCGA-29-1777-01	NA	79992944-6a6c-4f97-baf4-132689a69fff	NA	TCGA-29-1777-01	NA	TCGA-29-1777-01A-01D-0581-05	NA	TCGA-29-1777-01A-21-1559-20	TCGA-29-1777-01A-01W-0639-09	NA	TCGA-29-1777-01A-01D-0577-01	TCGA-29-1777-01	9b5e802b-56e7-4f93-8869-2db3170006bc	NA	TCGA-29-1777-01A-01D-0577-01	NA	NA	NA	NA	TCGA-29-1777-01	NA	NA	NA	TCGA-29-1777-01A-01R-0584-07	
TCGA-29-1778-01	0	TCGA-29-1778-01	454	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1778	NA	NA	days	454	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	77	Right	TCGA-29-1778-F27420	TCGA-29-1778	TCGA-29-1778-01A	Stage IIIC	-28147	NA	NA	0	454	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701.pdf	1778	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2008	TCGA-29-1778-01	TCGA-29-1778-01	NA	0654179f-2887-47e8-b4f4-051312a4907c	NA	TCGA-29-1778-01	NA	TCGA-29-1778-01A-01D-0581-05	NA	TCGA-29-1778-01A-21-1559-20	TCGA-29-1778-01A-01W-0639-09	7ecd0f7a-d186-422b-a2e1-833dfc400e39	TCGA-29-1778-01A-01D-0577-01	TCGA-29-1778-01	9a724a0a-6807-4995-889b-4b80a32e280d	NA	TCGA-29-1778-01A-01D-0577-01	7ecd0f7a-d186-422b-a2e1-833dfc400e39	NA	7ecd0f7a-d186-422b-a2e1-833dfc400e39	NA	TCGA-29-1778-01	TCGA-29-1778-01	7ecd0f7a-d186-422b-a2e1-833dfc400e39	NA	TCGA-29-1778-01A-01R-0584-07	
TCGA-29-1781-01	0	TCGA-29-1781-01	255	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	NA	TCGA-29-1781	NA	NA	days	255	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	69	Bilateral	TCGA-29-1781-F27427	TCGA-29-1781	TCGA-29-1781-01A	Stage IIIC	-25404	NA	NA	0	255	NA	NA	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-1781.959c11fe-f170-49bc-a1fe-73b799741b93.pdf	1781	Pre-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2009	TCGA-29-1781-01	TCGA-29-1781-01	NA	b87d2ec7-4fbf-4ecd-99fd-4983eb2fb7d8	NA	TCGA-29-1781-01	NA	TCGA-29-1781-01A-01D-0563-05	NA	TCGA-29-1781-01A-21-1559-20	TCGA-29-1781-01A-01W-0633-09	5fd66773-ed5a-438c-a7c1-d029f05798e5	TCGA-29-1781-01A-01D-0559-01	TCGA-29-1781-01	7b26743c-756e-45d0-8eaa-cffb1c11fef1	NA	TCGA-29-1781-01A-01D-0559-01	5fd66773-ed5a-438c-a7c1-d029f05798e5	NA	5fd66773-ed5a-438c-a7c1-d029f05798e5	NA	TCGA-29-1781-01	TCGA-29-1781-01	5fd66773-ed5a-438c-a7c1-d029f05798e5	NA	TCGA-29-1781-01A-01R-0566-07	
TCGA-29-1783-01	0	TCGA-29-1783-01	220	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1783	NA	NA	days	220	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Right	TCGA-29-1783-F27431	TCGA-29-1783	TCGA-29-1783-01A	Stage IIIC	-21284	NA	NA	0	220	NA	NA	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-1783.6ebf4763-bb2a-4ef5-ab22-23460980df1c.pdf	1783	Post-Adjuvant Therapy	TUMOR FREE	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2009	TCGA-29-1783-01	TCGA-29-1783-01	NA	2981b53e-f39a-4c5e-9254-dd1a6bf6c4e6	NA	TCGA-29-1783-01	NA	TCGA-29-1783-01A-01D-0563-05	NA	TCGA-29-1783-01A-21-1559-20	TCGA-29-1783-01A-01W-0633-09	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	TCGA-29-1783-01A-01D-0559-01	TCGA-29-1783-01	82dd8748-e0c5-4030-bf40-fe5d229adeae	NA	TCGA-29-1783-01A-01D-0559-01	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	NA	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	NA	TCGA-29-1783-01	TCGA-29-1783-01	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	NA	TCGA-29-1783-01A-01R-0566-07	
TCGA-29-1784-01	0	TCGA-29-1784-01	163	0	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1784	NA	NA	days	163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Right	TCGA-29-1784-F27436	TCGA-29-1784	TCGA-29-1784-01A	Stage IIIC	-20210	NA	NA	0	163	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-29-1784.e4614e5d-eb1f-4ac7-a17f-105936745e80.pdf	1784	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2009	TCGA-29-1784-01	TCGA-29-1784-01	NA	3720cc8a-5b9c-44cb-ba9d-5540f1ece950	NA	TCGA-29-1784-01	NA	TCGA-29-1784-01A-02D-0563-05	NA	NA	TCGA-29-1784-01A-02W-0633-09	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	TCGA-29-1784-01A-02D-0559-01	TCGA-29-1784-01	NA	NA	TCGA-29-1784-01A-02D-0559-01	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	NA	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	NA	TCGA-29-1784-01	TCGA-29-1784-01	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	NA	TCGA-29-1784-01A-02R-0566-07	
TCGA-29-1785-01	1	TCGA-29-1785-01	1104	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-29-1785	NA	NA	days	1104	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Right	TCGA-29-1785-F27442	TCGA-29-1785	TCGA-29-1785-01A	Stage IIIC	-20417	NA	1104	0	1053	NA	473	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-29-1785.b520ed75-17dd-420f-b444-4436bb03f40f.pdf	1785	Post-Adjuvant Therapy	NA	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2006	TCGA-29-1785-01	TCGA-29-1785-01	NA	89db2b71-04a7-42f7-8480-a8ba3f118bcc	NA	TCGA-29-1785-01	NA	TCGA-29-1785-01A-01D-0563-05	NA	TCGA-29-1785-01A-21-1559-20	TCGA-29-1785-01A-01W-0633-09	dcff1416-56fd-4d8e-a472-a40a00ef3066	TCGA-29-1785-01A-01D-0559-01	TCGA-29-1785-01	c7002a87-0a3e-4ffb-b976-b1d7f768dd30	NA	TCGA-29-1785-01A-01D-0559-01	dcff1416-56fd-4d8e-a472-a40a00ef3066	NA	dcff1416-56fd-4d8e-a472-a40a00ef3066	NA	TCGA-29-1785-01	TCGA-29-1785-01	dcff1416-56fd-4d8e-a472-a40a00ef3066	NA	TCGA-29-1785-01A-01R-0566-07	
TCGA-29-2414-01	1	TCGA-29-2414-01	2621	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-29-2414	NA	NA	days	2621	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Left	TCGA-29-2414-F27451	TCGA-29-2414	TCGA-29-2414-01A	Stage IIIC	-27417	NA	2621	0	2621	NA	552	NA	NA	NA	2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf	2414	NA	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Primary Tumor	01	0.5	NA	NA	29	11-20 mm	Ovary	NO	A	DECEASED	1998	TCGA-29-2414-01	TCGA-29-2414-01	NA	9d580db8-ad4f-4ecb-affd-e9ae032e8ebb	NA	TCGA-29-2414-01	NA	TCGA-29-2414-01A-02D-0708-05	NA	NA	NA	ecbadb01-01ec-4d9f-877c-75709d6f5914	TCGA-29-2414-01A-02D-2069-01	TCGA-29-2414-01	2433c714-344b-4fa6-91a4-2cab830a4485	NA	TCGA-29-2414-01A-02D-2069-01	ecbadb01-01ec-4d9f-877c-75709d6f5914	NA	ecbadb01-01ec-4d9f-877c-75709d6f5914	NA	TCGA-29-2414-01	TCGA-29-2414-01	ecbadb01-01ec-4d9f-877c-75709d6f5914	NA	TCGA-29-2414-01A-02R-0711-07	
TCGA-29-2414-02	1	TCGA-29-2414-02	2621	1	days	NA	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	NA	NA	TCGA-29-2414	NA	NA	days	2621	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Left	TCGA-29-2414-F27451	TCGA-29-2414	TCGA-29-2414-02A	Stage IIIC	-27417	NA	2621	0	2621	NA	552	NA	NA	NA	2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf	2414	NA	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Recurrent Tumor	02	0.3	NA	NA	29	11-20 mm	Ovary	NO	A	DECEASED	1998	NA	TCGA-29-2414-02	NA	4e488bb5-78b0-4a28-b276-109b203230d4	NA	TCGA-29-2414-02	NA	TCGA-29-2414-02A-01D-0807-05	NA	NA	NA	1558c0c4-6bd2-482d-9c4e-2430a402dacc	NA	NA	754eb22a-d0a5-4ea9-9fee-685e6d2cad7f	NA	NA	1558c0c4-6bd2-482d-9c4e-2430a402dacc	NA	1558c0c4-6bd2-482d-9c4e-2430a402dacc	NA	NA	NA	1558c0c4-6bd2-482d-9c4e-2430a402dacc	NA	TCGA-29-2414-02A-01R-0810-07	
TCGA-29-2425-01	0	TCGA-29-2425-01	1977	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-29-2425	NA	NA	days	1977	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	NA	TCGA-29-2425-F27462	TCGA-29-2425	TCGA-29-2425-01A	Stage IIIC	-22089	NA	NA	0	1977	NA	1577	0	NA	NA	2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	NO	G2	Progression of Disease	NA	NA	NA	NA	TCGA-29-2425.ec04e6ae-ae66-4fc2-b77b-485f77ce39bc.pdf	2425	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2004	TCGA-29-2425-01	TCGA-29-2425-01	NA	572ffa30-3fd6-49b7-a250-f8505555bde9	NA	TCGA-29-2425-01	NA	TCGA-29-2425-01A-01D-0708-05	NA	TCGA-29-2425-01A-21-1560-20	NA	3ce6b8c4-7020-447a-8eb8-5370eef05344	TCGA-29-2425-01A-01D-0704-01	TCGA-29-2425-01	8d87815d-6b5a-4713-9f0b-0ca8609996f2	NA	TCGA-29-2425-01A-01D-0704-01	3ce6b8c4-7020-447a-8eb8-5370eef05344	NA	3ce6b8c4-7020-447a-8eb8-5370eef05344	NA	TCGA-29-2425-01	TCGA-29-2425-01	3ce6b8c4-7020-447a-8eb8-5370eef05344	NA	TCGA-29-2425-01A-01R-0711-07	
TCGA-29-2427-01	0	TCGA-29-2427-01	1900	0	days	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-29-2427	NA	NA	days	1900	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Left	TCGA-29-2427-F27470	TCGA-29-2427	TCGA-29-2427-01A	Stage IIIC	-21940	NA	NA	0	1900	NA	1582	0	NA	NA	2010-2-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf	2427	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2004	TCGA-29-2427-01	TCGA-29-2427-01	NA	68e99d72-4df2-4d2d-9e24-b8fc81942a46	NA	TCGA-29-2427-01	NA	TCGA-29-2427-01A-01D-0708-05	NA	TCGA-29-2427-01A-21-1560-20	NA	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01D-0704-01	TCGA-29-2427-01	596d6d8e-d15c-442b-bcd4-ed2dec59aef2	NA	TCGA-29-2427-01A-01D-0704-01	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	NA	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01W-0799-08	TCGA-29-2427-01	TCGA-29-2427-01	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01W-0799-08	TCGA-29-2427-01A-01R-0711-07	
TCGA-29-2428-01	0	TCGA-29-2428-01	1372	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-29-2428	NA	NA	days	1372	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Left	TCGA-29-2428-F27478	TCGA-29-2428	TCGA-29-2428-01A	Stage IIIC	-21392	NA	NA	0	1372	NA	NA	0	NA	NA	2010-2-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.7	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb.pdf	2428	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R1	Primary Tumor	01	0.4	NA	NA	29	>20 mm	Ovary	NA	A	LIVING	2005	TCGA-29-2428-01	TCGA-29-2428-01	NA	b7c8f2a5-de96-4a38-bfa4-2a6c1b8ea1e2	NA	TCGA-29-2428-01	NA	TCGA-29-2428-01A-01D-0708-05	NA	TCGA-29-2428-01A-21-1560-20	NA	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	TCGA-29-2428-01A-01D-0704-01	TCGA-29-2428-01	364ced0b-2737-4f70-a7bb-a5a9171e4ef8	NA	TCGA-29-2428-01A-01D-0704-01	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	NA	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	NA	TCGA-29-2428-01	TCGA-29-2428-01	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	NA	TCGA-29-2428-01A-01R-0711-07	
TCGA-29-2429-01	1	TCGA-29-2429-01	421	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-29-2429	421	0	days	421	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	79	Right	TCGA-29-2429-F44633	TCGA-29-2429	TCGA-29-2429-01A	Stage IIIC	-29156	NA	421	0	NA	NA	NA	NA	NA	NA	2013-8-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.1	YES	NA	G3	NA	NA	NO	NA	NA	TCGA-29-2429.09804c6e-b6f3-482f-a23e-a4efa84f2ab7.pdf	2429	NA	WITH TUMOR	NA	NA	NA	NA	R1	Primary Tumor	01	0.3	NA	NA	29	>20 mm	Ovary	NA	A	DECEASED	2005	NA	NA	NA	1142b276-1e85-4021-8fa7-85e562b6c747	NA	NA	NA	TCGA-29-2429-01A-01D-1047-05	NA	TCGA-29-2429-01A-21-1560-20	TCGA-29-2429-01A-01D-1526-09	NA	TCGA-29-2429-01A-01D-1043-01	TCGA-29-2429-01	3ba731e2-2840-44c0-aa48-541f8f9e4d29	NA	TCGA-29-2429-01A-01D-1043-01	NA	NA	NA	NA	TCGA-29-2429-01	NA	NA	NA	TCGA-29-2429-01A-01R-1050-07	
TCGA-29-2431-01	0	TCGA-29-2431-01	1285	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-29-2431	NA	NA	days	1285	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-29-2431-F27485	TCGA-29-2431	TCGA-29-2431-01A	Stage IIIC	-21833	NA	NA	0	1285	NA	960	0	NA	NA	2010-6-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-29-2431.cbd3ddd8-b431-4852-b4db-b4be535115d6.pdf	2431	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R0	Primary Tumor	01	0.3	NA	NA	29	1-10 mm	Ovary	NA	A	LIVING	2006	NA	NA	NA	88be95fd-3aa9-4279-91ff-e705db3e187c	NA	NA	NA	TCGA-29-2431-01A-01D-1047-05	NA	TCGA-29-2431-01A-21-1560-20	TCGA-29-2431-01A-01D-1526-09	NA	TCGA-29-2431-01A-01D-1043-01	TCGA-29-2431-01	f02341bc-10e3-4bbf-98c8-0604616796ea	NA	TCGA-29-2431-01A-01D-1043-01	NA	NA	NA	NA	TCGA-29-2431-01	NA	NA	NA	TCGA-29-2431-01A-01R-1050-07	
TCGA-29-2432-01	1	TCGA-29-2432-01	653	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-29-2432	NA	NA	days	653	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-29-2432-F27492	TCGA-29-2432	TCGA-29-2432-01A	Stage IIIC	-22605	NA	653	0	360	NA	174	NA	NA	NA	2010-6-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f.pdf	2432	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	R1	Primary Tumor	01	0.5	NA	NA	29	11-20 mm	Ovary	NA	A	DECEASED	2008	NA	NA	NA	6fcda1cc-9224-452c-8fda-369e73f2f05e	NA	NA	NA	TCGA-29-2432-01A-01D-1047-05	NA	TCGA-29-2432-01A-21-1560-20	TCGA-29-2432-01A-01D-1526-09	NA	TCGA-29-2432-01A-01D-1043-01	TCGA-29-2432-01	a835eb6a-c37b-49de-bea5-9f9251f817a5	NA	TCGA-29-2432-01A-01D-1043-01	NA	NA	NA	NA	TCGA-29-2432-01	NA	NA	NA	TCGA-29-2432-01A-01R-1050-07	
TCGA-29-2434-01	0	TCGA-29-2434-01	349	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-29-2434	NA	NA	days	349	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Left	TCGA-29-2434-F27505	TCGA-29-2434	TCGA-29-2434-01A	Stage IIIC	-18997	NA	NA	0	349	NA	NA	NA	NA	NA	2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-2434.0891ac31-d9ed-4cb3-82ae-8499fb4c29ea.pdf	2434	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	0.4	NA	NA	29	No Macroscopic disease	Ovary	NA	A	LIVING	2009	NA	NA	NA	7b45cfcd-a37c-4f92-b35f-e75ac6b1d000	NA	NA	NA	TCGA-29-2434-01A-01D-1047-05	NA	TCGA-29-2434-01A-21-1560-20	TCGA-29-2434-01A-01D-1526-09	NA	TCGA-29-2434-01A-01D-1043-01	TCGA-29-2434-01	9eb175cd-3311-4f57-a37a-7a2463bc58fb	NA	TCGA-29-2434-01A-01D-1043-01	NA	NA	NA	NA	TCGA-29-2434-01	NA	NA	NA	TCGA-29-2434-01A-01R-1050-07	
TCGA-29-2435-01	0	TCGA-29-2435-01	34	0	days	NA	NA	NA	OV-like c4	NA	NA	NA	NA	TCGA-29-2435	NA	NA	days	34	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Left	TCGA-29-2435-F27510	TCGA-29-2435	TCGA-29-2435-01A	Stage IV	-28779	NA	NA	0	34	NA	NA	NA	NA	NA	2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-29-2435.6EF128AE-31B6-483A-B0DD-9626CEEC278E.pdf	2435	NA	NA	YES	NA	NA	NA	R1	Primary Tumor	01	0.3	NA	NA	29	11-20 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-2435-01A-21-1560-20	NA	NA	NA	NA	84e1540d-c756-414e-92c9-3e0d5f45cd48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-29-2436-01	0	TCGA-29-2436-01	297	0	days	COAD-READ	NA	Low purity c2	OV-like c4	NA	NA	NA	NA	TCGA-29-2436	NA	NA	days	297	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	36	Bilateral	TCGA-29-2436-F27514	TCGA-29-2436	TCGA-29-2436-01A	Stage IIIC	-13346	NA	NA	0	297	NA	NA	NA	NA	NA	2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.3	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-29-2436.0caa891b-3d47-44c1-bc75-0468afc11495.pdf	2436	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	0.4	NA	NA	29	1-10 mm	Ovary	YES	A	LIVING	2009	NA	NA	NA	e467e3e0-9311-48ff-8da8-f3b9118011e7	NA	NA	NA	TCGA-29-2436-01A-01D-1047-05	NA	TCGA-29-2436-01A-21-1560-20	TCGA-29-2436-01A-01D-1526-09	NA	TCGA-29-2436-01A-01D-1043-01	TCGA-29-2436-01	851a2dc8-da35-4a80-bcd1-1ed74ee459c7	NA	TCGA-29-2436-01A-01D-1043-01	NA	NA	NA	NA	TCGA-29-2436-01	NA	NA	NA	TCGA-29-2436-01A-01R-1050-07	
TCGA-29-A5NZ-01	0	TCGA-29-A5NZ-01	984	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-29-A5NZ	879	1	days	984	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	NA	TCGA-29-A5NZ-F59530	TCGA-29-A5NZ	TCGA-29-A5NZ-01A	Stage IIIC	-24161	515	1088	0	984	NA	879	NA	Additional New Tumor Event	NA	2014-5-14	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8460/3	C48.1	YES	NA	1040	NA	NO	NA	NA	NO	NA	G3	Progression of Disease	NA	YES	true	No	TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864.pdf	A5NZ	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	29	NA	Omentum	NA	A	LIVING	2011	TCGA-29-A5NZ-01	TCGA-29-A5NZ-01	NA	NA	TCGA-29-A5NZ-01A-11D-A409-05	TCGA-29-A5NZ-01	NA	NA	NA	NA	NA	ea715147-2b94-4bed-9531-ba91c13630fe	TCGA-29-A5NZ-01A-11D-A402-01	NA	8E54518A-2DD5-448F-AFA2-C23D91E0290D	TCGA-29-A5NZ-01A-11R-A406-31	TCGA-29-A5NZ-01A-11D-A402-01	ea715147-2b94-4bed-9531-ba91c13630fe	TCGA-29-A5NZ-01A-11R-A406-31	ea715147-2b94-4bed-9531-ba91c13630fe	NA	NA	TCGA-29-A5NZ-01	ea715147-2b94-4bed-9531-ba91c13630fe	NA	NA	
TCGA-30-1714-01	1	TCGA-30-1714-01	1158	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	NA	TCGA-30-1714	NA	NA	days	1158	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	68	Bilateral	TCGA-30-1714-F27518	TCGA-30-1714	TCGA-30-1714-01A	Stage IV	-25032	NA	1158	0	1158	NA	241	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.6	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1714.7bec7160-e40c-4b47-b0d6-93652c5e27f2.pdf	1714	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	30	1-10 mm	Ovary	NO	A	DECEASED	2001	NA	TCGA-30-1714-01	NA	9b91d688-3f05-43a9-8900-57027113b885	NA	TCGA-30-1714-01	NA	TCGA-30-1714-01A-02D-0563-05	NA	NA	TCGA-30-1714-01A-02W-0633-09	NA	TCGA-30-1714-01A-02D-0559-01	TCGA-30-1714-01	NA	NA	TCGA-30-1714-01A-02D-0559-01	NA	NA	NA	NA	TCGA-30-1714-01	NA	NA	NA	TCGA-30-1714-01A-02R-0566-07	
TCGA-30-1718-01	1	TCGA-30-1718-01	1579	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-30-1718	NA	NA	days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-30-1718-F27534	TCGA-30-1718	TCGA-30-1718-01A	Stage IIIC	-16400	NA	1579	0	1579	NA	896	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.3	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1718.078da76a-b9f5-40d0-9a57-04c306ade36a.pdf	1718	NA	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NO	A	DECEASED	2002	TCGA-30-1718-01	TCGA-30-1718-01	NA	f9ba9bc4-5591-4a79-b8ad-fee2f83ea724	NA	TCGA-30-1718-01	NA	TCGA-30-1718-01A-01D-0563-05	NA	TCGA-30-1718-01A-21-1559-20	TCGA-30-1718-01A-01W-0633-09	5abce979-686d-40c4-acd7-ef9cc5acf26f	TCGA-30-1718-01A-01D-0559-01	TCGA-30-1718-01	bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370	NA	TCGA-30-1718-01A-01D-0559-01	5abce979-686d-40c4-acd7-ef9cc5acf26f	NA	5abce979-686d-40c4-acd7-ef9cc5acf26f	NA	TCGA-30-1718-01	TCGA-30-1718-01	5abce979-686d-40c4-acd7-ef9cc5acf26f	NA	TCGA-30-1718-01A-01R-0566-07	
TCGA-30-1853-01	1	TCGA-30-1853-01	1103	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1853	NA	NA	days	1103	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-30-1853-F27542	TCGA-30-1853	TCGA-30-1853-01A	Stage IIIC	-21404	NA	1103	0	1103	NA	634	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288.pdf	1853	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NA	A	DECEASED	2000	NA	TCGA-30-1853-01	NA	549e923d-4430-4b66-8378-af96f66646b7	NA	TCGA-30-1853-01	NA	TCGA-30-1853-01A-02D-0652-05	NA	NA	NA	NA	TCGA-30-1853-01A-02D-0648-01	TCGA-30-1853-01	NA	NA	TCGA-30-1853-01A-02D-0648-01	NA	NA	NA	TCGA-30-1853-01A-02W-0699-08	TCGA-30-1853-01	NA	NA	TCGA-30-1853-01A-02W-0699-08	TCGA-30-1853-01A-02R-0655-07	
TCGA-30-1855-01	1	TCGA-30-1855-01	75	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-30-1855	NA	NA	days	75	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	61	NA	TCGA-30-1855-F27550	TCGA-30-1855	TCGA-30-1855-01A	Stage IIIC	-22394	NA	75	0	75	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3.pdf	1855	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NO	A	DECEASED	2001	TCGA-30-1855-01	TCGA-30-1855-01	NA	b47399a9-31a2-4721-8da0-63bf21c6fcae	NA	TCGA-30-1855-01	NA	TCGA-30-1855-01A-01D-0581-05	NA	TCGA-30-1855-01A-21-1559-20	TCGA-30-1855-01A-01W-0639-09	732d0664-c343-4a63-9dc3-40985e540a59	TCGA-30-1855-01A-01D-0577-01	TCGA-30-1855-01	6b1438ab-2904-4d21-865d-f14c76777f62	NA	TCGA-30-1855-01A-01D-0577-01	732d0664-c343-4a63-9dc3-40985e540a59	NA	732d0664-c343-4a63-9dc3-40985e540a59	NA	TCGA-30-1855-01	TCGA-30-1855-01	732d0664-c343-4a63-9dc3-40985e540a59	NA	TCGA-30-1855-01A-01R-0584-07	
TCGA-30-1856-01	1	TCGA-30-1856-01	477	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	NA	TCGA-30-1856	NA	NA	days	477	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1856-F27552	TCGA-30-1856	TCGA-30-1856-01A	Stage IIIC	-20626	NA	477	0	477	NA	220	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1856.281005d7-4231-467c-9c6c-43f536fcebe1.pdf	1856	NA	WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NO	A	DECEASED	2001	NA	TCGA-30-1856-01	NA	73874ff9-38f8-4a31-9ac1-923793b88b91	NA	TCGA-30-1856-01	NA	TCGA-30-1856-01A-01D-0581-05	NA	TCGA-30-1856-01A-21-1559-20	TCGA-30-1856-01A-01W-0639-09	NA	TCGA-30-1856-01A-01D-0577-01	TCGA-30-1856-01	60d477e5-467d-4be3-b495-ed511519e4fa	NA	TCGA-30-1856-01A-01D-0577-01	NA	NA	NA	NA	TCGA-30-1856-01	NA	NA	NA	TCGA-30-1856-01A-01R-0584-07	
TCGA-30-1857-01	1	TCGA-30-1857-01	8	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 3	cluster 6	NA	TCGA-30-1857	NA	NA	days	8	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Right	TCGA-30-1857-F27564	TCGA-30-1857	TCGA-30-1857-01A	Stage IV	-23689	NA	8	0	8	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-30-1857.e3d84909-0149-4691-a398-1a6b272dde60.pdf	1857	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	30	NA	Ovary	NA	A	DECEASED	2001	TCGA-30-1857-01	TCGA-30-1857-01	NA	bffff720-6d86-4661-9ae9-85605520064f	NA	TCGA-30-1857-01	NA	TCGA-30-1857-01A-02D-0581-05	NA	NA	TCGA-30-1857-01A-02W-0639-09	7fc46368-c523-4936-84e3-bb3f77db7c48	TCGA-30-1857-01A-02D-0577-01	TCGA-30-1857-01	NA	TCGA-30-1857-01A-02R-1569-13	TCGA-30-1857-01A-02D-0577-01	7fc46368-c523-4936-84e3-bb3f77db7c48	TCGA-30-1857-01A-02R-1569-13	7fc46368-c523-4936-84e3-bb3f77db7c48	NA	TCGA-30-1857-01	TCGA-30-1857-01	7fc46368-c523-4936-84e3-bb3f77db7c48	NA	TCGA-30-1857-01A-02R-0584-07	
TCGA-30-1859-01	1	TCGA-30-1859-01	1463	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	NA	TCGA-30-1859	NA	NA	days	1463	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1859-F27566	TCGA-30-1859	TCGA-30-1859-01A	NA	-20498	NA	1463	0	1463	210	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.3	NO	NA	1	NA	NA	G3	Locoregional Disease	YES	NA	NA	NA	TCGA-30-1859.6c4d66bc-361f-465f-b18a-7bb1a0fc7752.pdf	1859	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	30	1-10 mm	Ovary	NA	A	DECEASED	2002	NA	TCGA-30-1859-01	NA	4618e0b6-9a8d-4843-a67f-a0b0de96b4ec	NA	TCGA-30-1859-01	NA	TCGA-30-1859-01A-01D-0652-05	NA	TCGA-30-1859-01A-21-1559-20	NA	NA	TCGA-30-1859-01A-01D-0648-01	TCGA-30-1859-01	063c9971-7f3f-45f5-8f42-11b3eca461fa	NA	TCGA-30-1859-01A-01D-0648-01	NA	NA	NA	NA	TCGA-30-1859-01	NA	NA	NA	TCGA-30-1859-01A-01R-0655-07	
TCGA-30-1860-01	1	TCGA-30-1860-01	1366	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	NA	TCGA-30-1860	NA	NA	days	1366	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	58	Bilateral	TCGA-30-1860-F27580	TCGA-30-1860	TCGA-30-1860-01A	Stage IIIC	-21406	NA	1366	0	1366	NA	397	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.5	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1860.d5b8e59f-1ae5-4e22-b933-48e48a364788.pdf	1860	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	30	>20 mm	Ovary	NO	A	DECEASED	2002	TCGA-30-1860-01	TCGA-30-1860-01	NA	713acb94-3fd4-444d-ae04-e79c1ee73b3a	NA	TCGA-30-1860-01	NA	TCGA-30-1860-01A-01D-0652-05	NA	TCGA-30-1860-01A-21-1559-20	NA	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	TCGA-30-1860-01A-01D-0648-01	TCGA-30-1860-01	5c4486d9-1d91-4f42-83fd-85526c4f0836	NA	TCGA-30-1860-01A-01D-0648-01	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	NA	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	NA	TCGA-30-1860-01	TCGA-30-1860-01	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	NA	TCGA-30-1860-01A-01R-0655-07	
TCGA-30-1861-01	1	TCGA-30-1861-01	1058	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	NA	TCGA-30-1861	NA	NA	days	1058	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Bilateral	NA	TCGA-30-1861	TCGA-30-1861-01A	Stage IIIC	-27103	NA	1058	0	1058	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.8	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe.pdf	1861	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NA	A	DECEASED	2002	TCGA-30-1861-01	TCGA-30-1861-01	NA	617ac2af-9b70-4c2b-b659-02436e604267	NA	TCGA-30-1861-01	NA	TCGA-30-1861-01A-01D-0652-05	NA	TCGA-30-1861-01A-21-1559-20	NA	32a58029-c8aa-4647-a932-bbf57e82fc48	TCGA-30-1861-01A-01D-0648-01	TCGA-30-1861-01	7e253248-d889-4b00-a098-55cfcb18758b	NA	TCGA-30-1861-01A-01D-0648-01	32a58029-c8aa-4647-a932-bbf57e82fc48	NA	32a58029-c8aa-4647-a932-bbf57e82fc48	NA	TCGA-30-1861-01	TCGA-30-1861-01	32a58029-c8aa-4647-a932-bbf57e82fc48	NA	TCGA-30-1861-01A-01R-0655-07	
TCGA-30-1862-01	1	TCGA-30-1862-01	186	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1862	NA	NA	days	186	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	65	NA	TCGA-30-1862-F27593	TCGA-30-1862	NA	Stage IV	-23895	NA	186	0	186	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G2	NA	NA	NA	NA	NA	NA	1862	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	30	>20 mm	Ovary	NA	NA	DECEASED	2003	TCGA-30-1862-01	TCGA-30-1862-01	NA	b1c27950-57b3-4a9e-96f6-5c7232951f1c	NA	TCGA-30-1862-01	NA	TCGA-30-1862-01A-02D-0652-05	NA	NA	NA	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	TCGA-30-1862-01A-02D-0648-01	TCGA-30-1862-01	NA	NA	TCGA-30-1862-01A-02D-0648-01	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	NA	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	NA	TCGA-30-1862-01	TCGA-30-1862-01	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	TCGA-30-1862-01A-02W-0699-08	TCGA-30-1862-01A-02R-0655-07	
TCGA-30-1866-01	1	TCGA-30-1866-01	1114	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 2	cluster 1	NA	TCGA-30-1866	NA	NA	days	1114	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-30-1866-F27595	TCGA-30-1866	NA	Stage IV	-22562	NA	1114	0	1114	NA	285	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1866	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	30	1-10 mm	Ovary	NA	NA	DECEASED	2003	NA	TCGA-30-1866-01	NA	a334b0fd-05cc-4aa3-bbff-4439e2807085	NA	TCGA-30-1866-01	NA	TCGA-30-1866-01A-02D-0652-05	NA	NA	NA	NA	TCGA-30-1866-01A-02D-0648-01	TCGA-30-1866-01	NA	NA	TCGA-30-1866-01A-02D-0648-01	NA	NA	NA	NA	TCGA-30-1866-01	NA	NA	NA	TCGA-30-1866-01A-02R-0655-07	
TCGA-30-1867-01	1	TCGA-30-1867-01	37	1	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	NA	TCGA-30-1867	NA	NA	days	37	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	NA	TCGA-30-1867-F27605	TCGA-30-1867	TCGA-30-1867-01A	Stage IV	-17159	NA	37	0	37	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.3	NO	NA	0.3	NA	NA	GX	NA	NA	NA	NA	NA	TCGA-30-1867.420a6b8c-33b8-4b1e-8bba-e299c20611c7.pdf	1867	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	30	NA	Ovary	NA	A	DECEASED	2004	NA	TCGA-30-1867-01	NA	105890a2-5198-4ecf-af7f-6538542dc162	NA	TCGA-30-1867-01	NA	TCGA-30-1867-01A-01D-0652-05	NA	NA	NA	NA	TCGA-30-1867-01A-01D-0648-01	TCGA-30-1867-01	NA	NA	TCGA-30-1867-01A-01D-0648-01	NA	NA	NA	NA	TCGA-30-1867-01	NA	NA	NA	TCGA-30-1867-01A-01R-0655-07	
TCGA-30-1869-01	1	TCGA-30-1869-01	1563	1	days	NA	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-30-1869	NA	NA	days	1563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-30-1869-F27607	TCGA-30-1869	TCGA-30-1869-01A	Stage IV	-18398	NA	1563	0	1563	NA	767	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NO	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c.pdf	1869	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	30	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	NA	NA	NA	NA	NA	NA	TCGA-30-1869-01A-01D-0652-05	NA	TCGA-30-1869-01A-21-1559-20	NA	NA	NA	NA	014cbeef-19c7-4ac9-b9a0-5f95e07c5d45	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-30-1880-01	1	TCGA-30-1880-01	1751	1	days	Squamous	NA	Low purity c2	NA	NA	miRNA cluster 1	cluster 3	NA	TCGA-30-1880	NA	NA	days	1751	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1880-F27620	TCGA-30-1880	TCGA-30-1880-01A	Stage IIIC	-20525	NA	1751	0	1751	NA	348	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1880.D23622FE-9648-422D-AE92-B21F9B6E5A51.pdf	1880	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	30	No Macroscopic disease	Ovary	NA	A	DECEASED	2001	NA	TCGA-30-1880-01	NA	2d39ca81-8c8c-43ab-b065-38627152d132	NA	TCGA-30-1880-01	NA	TCGA-30-1880-01A-01D-0652-05	NA	NA	NA	NA	TCGA-30-1880-01A-01D-0648-01	TCGA-30-1880-01	NA	NA	TCGA-30-1880-01A-01D-0648-01	NA	NA	NA	NA	TCGA-30-1880-01	NA	NA	NA	TCGA-30-1880-01A-01R-0655-07	
TCGA-30-1887-01	1	TCGA-30-1887-01	738	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	NA	TCGA-30-1887	NA	NA	days	738	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-30-1887-F27633	TCGA-30-1887	TCGA-30-1887-01A	Stage IIIC	-24495	NA	738	0	738	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	YES	G2	NA	NA	NA	NA	NA	TCGA-30-1887.a074363f-dd94-4193-b583-70885400ff2f.pdf	1887	NA	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	30	1-10 mm	Ovary	YES	A	DECEASED	2005	NA	TCGA-30-1887-01	NA	1065d480-5815-40a4-93c6-faa8712a1e94	NA	TCGA-30-1887-01	NA	TCGA-30-1887-01A-01D-0652-05	NA	TCGA-30-1887-01A-21-1559-20	NA	NA	TCGA-30-1887-01A-01D-0648-01	TCGA-30-1887-01	e26411ea-dc83-4441-a0f4-84fd52798fdd	NA	TCGA-30-1887-01A-01D-0648-01	NA	NA	NA	NA	TCGA-30-1887-01	NA	NA	NA	TCGA-30-1887-01A-01R-0655-07	
TCGA-30-1891-01	1	TCGA-30-1891-01	914	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-30-1891	NA	NA	days	914	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-30-1891-F27640	TCGA-30-1891	TCGA-30-1891-01A	Stage IIIC	-22344	NA	914	0	914	NA	181	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.2	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-30-1891.F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B.pdf	1891	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	30	1-10 mm	Ovary	NO	A	DECEASED	2004	TCGA-30-1891-01	TCGA-30-1891-01	NA	d97a0c15-2c1d-4af3-9e62-ff67cbf7b700	NA	TCGA-30-1891-01	NA	TCGA-30-1891-01A-01D-0652-05	NA	TCGA-30-1891-01A-21-1559-20	NA	690d1437-2a05-4263-8fa7-8f4481893b83	TCGA-30-1891-01A-01D-0648-01	TCGA-30-1891-01	7f8386ef-cf19-4207-86ae-13029c49d944	NA	TCGA-30-1891-01A-01D-0648-01	690d1437-2a05-4263-8fa7-8f4481893b83	NA	690d1437-2a05-4263-8fa7-8f4481893b83	NA	TCGA-30-1891-01	TCGA-30-1891-01	690d1437-2a05-4263-8fa7-8f4481893b83	TCGA-30-1891-01A-01W-0699-08	TCGA-30-1891-01A-01R-0655-07	
TCGA-30-1892-01	1	TCGA-30-1892-01	1484	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	NA	TCGA-30-1892	NA	NA	days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Left	TCGA-30-1892-F27654	TCGA-30-1892	TCGA-30-1892-01A	Stage IIIC	-19256	NA	1484	0	1484	NA	253	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-30-1892.fb7c966c-9b16-4781-9c01-2db480c88d63.pdf	1892	NA	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.3	NA	NA	30	1-10 mm	Ovary	NA	A	DECEASED	2004	NA	TCGA-30-1892-01	NA	e969eb72-cef5-4c16-b1fd-8a97324ce3e4	NA	TCGA-30-1892-01	NA	TCGA-30-1892-01A-01D-0652-05	NA	TCGA-30-1892-01A-21-1559-20	NA	NA	TCGA-30-1892-01A-01D-0648-01	TCGA-30-1892-01	3c68d944-a329-44c2-8697-2f8c50a8b38c	NA	TCGA-30-1892-01A-01D-0648-01	NA	NA	NA	NA	TCGA-30-1892-01	NA	NA	NA	TCGA-30-1892-01A-01R-0655-07	
TCGA-31-1944-01	0	TCGA-31-1944-01	1386	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-31-1944	NA	NA	days	1386	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-31-1944-F27668	TCGA-31-1944	TCGA-31-1944-01A	Stage IIIC	-17207	NA	NA	0	1386	NA	678	NA	NA	NA	2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-31-1944.bd7361f7-07c1-4be8-92c6-4f0a3dea99b2.pdf	1944	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	31	No Macroscopic disease	Ovary	YES	A	LIVING	2005	TCGA-31-1944-01	TCGA-31-1944-01	NA	b9b5c6a5-cbc8-4645-9ce1-131c26e36683	NA	TCGA-31-1944-01	NA	TCGA-31-1944-01A-01D-0652-05	NA	TCGA-31-1944-01A-21-1559-20	NA	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	TCGA-31-1944-01A-01D-0648-01	TCGA-31-1944-01	332735d2-c077-400a-b011-1f0984b07339	NA	TCGA-31-1944-01A-01D-0648-01	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	NA	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	NA	TCGA-31-1944-01	TCGA-31-1944-01	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	NA	TCGA-31-1944-01A-01R-0655-07	
TCGA-31-1946-01	0	TCGA-31-1946-01	918	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-31-1946	NA	NA	days	918	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	30	Bilateral	TCGA-31-1946-F27679	TCGA-31-1946	TCGA-31-1946-01A	Stage IIIC	-11146	NA	NA	0	918	NA	664	NA	NA	NA	2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-31-1946.5ef31a8f-38e7-486b-8efc-99cd8c1ec06d.pdf	1946	NA	WITH TUMOR	YES	NA	Physical Examination	NO	NA	Primary Tumor	01	0.3	NA	NA	31	No Macroscopic disease	Ovary	YES	A	LIVING	2006	TCGA-31-1946-01	TCGA-31-1946-01	NA	fb4cc131-9ac0-4615-b8c1-802273c4c6cf	NA	TCGA-31-1946-01	NA	TCGA-31-1946-01A-01D-0652-05	NA	TCGA-31-1946-01A-21-1559-20	NA	05abb2f5-07c3-42da-92d9-0b4560fb6f09	TCGA-31-1946-01A-01D-0648-01	TCGA-31-1946-01	fb44d557-9e0a-40d5-83c3-3b9431e72d9d	NA	TCGA-31-1946-01A-01D-0648-01	05abb2f5-07c3-42da-92d9-0b4560fb6f09	NA	05abb2f5-07c3-42da-92d9-0b4560fb6f09	NA	TCGA-31-1946-01	TCGA-31-1946-01	05abb2f5-07c3-42da-92d9-0b4560fb6f09	NA	TCGA-31-1946-01A-01R-0655-07	
TCGA-31-1950-01	0	TCGA-31-1950-01	571	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1950	NA	NA	days	571	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-31-1950-F27688	TCGA-31-1950	TCGA-31-1950-01A	Stage IIIC	-28100	NA	NA	0	571	NA	349	1	NA	NA	2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.2	NA	NO	G2	Recurrence	NA	NA	NA	NA	TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73.pdf	1950	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	31	1-10 mm	Ovary	NO	A	LIVING	2007	NA	TCGA-31-1950-01	NA	72689370-cb7a-4e3b-8964-2dcde6633902	NA	TCGA-31-1950-01	NA	TCGA-31-1950-01A-01D-0652-05	NA	TCGA-31-1950-01A-21-1559-20	NA	a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01D-0648-01	TCGA-31-1950-01	6f927c4d-19b8-4bc9-92eb-da2402ed6e31	NA	TCGA-31-1950-01A-01D-0648-01	a32eba80-dbe9-464e-8102-5f77a3c7e177	NA	a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01W-0699-08	TCGA-31-1950-01	NA	a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01W-0699-08	TCGA-31-1950-01A-01R-0655-07	
TCGA-31-1951-01	0	TCGA-31-1951-01	684	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-31-1951	NA	NA	days	684	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Left	TCGA-31-1951-F27692	TCGA-31-1951	TCGA-31-1951-01A	Stage IIIC	-21352	NA	NA	0	684	NA	659	NA	NA	NA	2010-1-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.7	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-31-1951.b10efe75-1420-47d2-9c5b-202b09099357.pdf	1951	NA	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	31	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-31-1951-01	TCGA-31-1951-01	NA	c9806ee2-6323-4078-bfc0-6fc773a7f66e	NA	TCGA-31-1951-01	NA	TCGA-31-1951-01A-01D-0652-05	NA	TCGA-31-1951-01A-21-1559-20	NA	197ea6b5-5716-4e5c-9c7f-92ed4521682a	TCGA-31-1951-01A-01D-0648-01	TCGA-31-1951-01	a6bb52ad-58cf-4ee0-ae89-9615811f4de6	NA	TCGA-31-1951-01A-01D-0648-01	197ea6b5-5716-4e5c-9c7f-92ed4521682a	NA	197ea6b5-5716-4e5c-9c7f-92ed4521682a	NA	TCGA-31-1951-01	TCGA-31-1951-01	197ea6b5-5716-4e5c-9c7f-92ed4521682a	NA	TCGA-31-1951-01A-01R-0655-07	
TCGA-31-1953-01	0	TCGA-31-1953-01	204	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-31-1953	NA	NA	days	204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-31-1953-F27698	TCGA-31-1953	TCGA-31-1953-01A	Stage IIIC	-19064	NA	NA	0	204	NA	70	1	NA	NA	2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-31-1953.c824400d-b062-4a04-b805-f717426d688e.pdf	1953	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.1	NA	NA	31	NA	Ovary	NO	A	LIVING	2008	TCGA-31-1953-01	TCGA-31-1953-01	NA	b3f75e69-3519-46eb-821c-773c2506d7fd	NA	TCGA-31-1953-01	NA	TCGA-31-1953-01A-01D-0652-05	NA	NA	NA	7b31fc47-0299-4449-aa5b-622ba549371f	TCGA-31-1953-01A-01D-0648-01	TCGA-31-1953-01	NA	NA	TCGA-31-1953-01A-01D-0648-01	7b31fc47-0299-4449-aa5b-622ba549371f	NA	7b31fc47-0299-4449-aa5b-622ba549371f	NA	TCGA-31-1953-01	TCGA-31-1953-01	7b31fc47-0299-4449-aa5b-622ba549371f	TCGA-31-1953-01A-01W-0699-08	TCGA-31-1953-01A-01R-0655-07	
TCGA-31-1955-01	0	TCGA-31-1955-01	1293	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-31-1955	NA	NA	days	1293	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	43	Bilateral	TCGA-31-1955-F27704	TCGA-31-1955	TCGA-31-1955-01A	Stage IIIC	-15926	NA	NA	0	1293	NA	918	NA	NA	NA	2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.4	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-31-1955.16f5a24e-2c57-42fe-bd79-ef174d44b8b1.pdf	1955	NA	WITH TUMOR	YES	NA	Physical Examination	YES	NA	Primary Tumor	01	0.4	NA	NA	31	No Macroscopic disease	Ovary	YES	A	LIVING	2005	NA	NA	NA	NA	NA	NA	NA	TCGA-31-1955-01A-01D-0652-05	NA	TCGA-31-1955-01A-21-1559-20	NA	NA	TCGA-31-1955-01A-01D-0648-01	TCGA-31-1955-01	47461ed4-1491-4f27-bd9c-cbd1ee184f5a	NA	TCGA-31-1955-01A-01D-0648-01	NA	NA	NA	NA	TCGA-31-1955-01	NA	NA	NA	TCGA-31-1955-01A-01R-0655-07	
TCGA-31-1956-01	0	TCGA-31-1956-01	1342	0	days	Squamous	NA	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	NA	TCGA-31-1956	NA	NA	days	1342	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Left	TCGA-31-1956-F27711	TCGA-31-1956	TCGA-31-1956-01A	Stage IIIB	-22100	NA	NA	0	1342	119	NA	NA	NA	NA	2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.3	NA	YES	G3	Locoregional Disease	YES	NA	NA	NA	TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c.pdf	1956	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	31	NA	Ovary	NO	A	LIVING	2005	TCGA-31-1956-01	TCGA-31-1956-01	NA	c6dcadc5-be05-4d61-b82a-bc5111fb2634	NA	TCGA-31-1956-01	NA	TCGA-31-1956-01A-01D-0652-05	NA	NA	NA	24cfcfd9-ce30-4e24-9470-60265efd6721	TCGA-31-1956-01A-01D-0648-01	TCGA-31-1956-01	NA	NA	TCGA-31-1956-01A-01D-0648-01	24cfcfd9-ce30-4e24-9470-60265efd6721	NA	24cfcfd9-ce30-4e24-9470-60265efd6721	NA	TCGA-31-1956-01	TCGA-31-1956-01	24cfcfd9-ce30-4e24-9470-60265efd6721	NA	TCGA-31-1956-01A-01R-0655-07	
TCGA-31-1959-01	0	TCGA-31-1959-01	67	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1959	NA	NA	days	67	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Bilateral	TCGA-31-1959-F27715	TCGA-31-1959	TCGA-31-1959-01A	Stage IV	-18247	NA	NA	0	67	NA	NA	NA	NA	NA	2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	0.7	NO	NA	1.1	NA	YES	G2	NA	NA	NA	NA	NA	TCGA-31-1959.c78c6998-1f86-4dd2-bf41-78f12d43c33a.pdf	1959	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	31	NA	Ovary	YES	A	LIVING	2009	TCGA-31-1959-01	TCGA-31-1959-01	NA	427e1629-b22d-4421-b6f5-ffbd672fd164	NA	TCGA-31-1959-01	NA	TCGA-31-1959-01A-01D-0652-05	NA	NA	NA	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	TCGA-31-1959-01A-01D-0648-01	TCGA-31-1959-01	NA	NA	TCGA-31-1959-01A-01D-0648-01	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	NA	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	NA	TCGA-31-1959-01	TCGA-31-1959-01	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	TCGA-31-1959-01A-01W-0699-08	TCGA-31-1959-01A-01R-0655-07	
TCGA-36-1568-01	0	TCGA-36-1568-01	875	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1568	NA	NA	days	875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-36-1568-F27850	TCGA-36-1568	TCGA-36-1568-01A	Stage IIIC	-19311	NA	NA	0	875	NA	548	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.6	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3.pdf	1568	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	36	NA	Ovary	NA	A	LIVING	2007	TCGA-36-1568-01	TCGA-36-1568-01	TCGA-36-1568-01A-01W-0615-10	cde7f1d6-c4c9-4fc3-a6cf-696addee91d6	NA	TCGA-36-1568-01	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01A-01D-0536-05	NA	TCGA-36-1568-01A-21-1558-20	NA	4e539c62-454a-4b1c-bde1-6951ee12d109	TCGA-36-1568-01A-01D-0533-01	TCGA-36-1568-01	b9598717-cdb9-49e1-a8d5-49ec5189cb31	NA	TCGA-36-1568-01A-01D-0533-01	4e539c62-454a-4b1c-bde1-6951ee12d109	NA	4e539c62-454a-4b1c-bde1-6951ee12d109	NA	TCGA-36-1568-01	TCGA-36-1568-01	4e539c62-454a-4b1c-bde1-6951ee12d109	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01A-01R-0540-07	
TCGA-36-1569-01	0	TCGA-36-1569-01	885	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1569	NA	NA	days	885	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-36-1569-F27855	TCGA-36-1569	TCGA-36-1569-01A	Stage IIIC	-19151	NA	NA	0	885	NA	NA	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.9	NO	NA	1.6	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-36-1569.52192360-2ACE-401C-9642-B3D6F677362D.pdf	1569	Preoperative	NA	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	36	1-10 mm	Ovary	NA	A	LIVING	2007	TCGA-36-1569-01	TCGA-36-1569-01	TCGA-36-1569-01A-01W-0615-10	3ae2deaa-bc6d-4b38-b9ea-56e91c83b53a	NA	TCGA-36-1569-01	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01A-01D-0536-05	NA	TCGA-36-1569-01A-21-1558-20	NA	bb12d2f5-1865-435a-8edf-f9ee7689e0a4	TCGA-36-1569-01A-01D-0533-01	TCGA-36-1569-01	44783ce8-15cb-45b3-9a4f-e45925356334	NA	TCGA-36-1569-01A-01D-0533-01	bb12d2f5-1865-435a-8edf-f9ee7689e0a4	NA	bb12d2f5-1865-435a-8edf-f9ee7689e0a4	NA	TCGA-36-1569-01	TCGA-36-1569-01	bb12d2f5-1865-435a-8edf-f9ee7689e0a4	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01A-01R-0540-07	
TCGA-36-1570-01	0	TCGA-36-1570-01	655	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-36-1570	NA	NA	days	655	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-36-1570-F27857	TCGA-36-1570	TCGA-36-1570-01A	Stage IIIC	-17956	NA	NA	0	655	NA	375	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.3	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1570.f83833f4-a820-4fb9-a040-c238084976c3.pdf	1570	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Physical Examination	NO	NA	Primary Tumor	01	0.7	NA	NA	36	>20 mm	Ovary	YES	A	LIVING	2007	TCGA-36-1570-01	TCGA-36-1570-01	TCGA-36-1570-01A-01W-0615-10	2893bba4-3d68-4a21-97d6-51342437a657	NA	TCGA-36-1570-01	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01A-01D-0536-05	NA	TCGA-36-1570-01A-21-1558-20	NA	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	TCGA-36-1570-01A-01D-0533-01	TCGA-36-1570-01	0bd6d1dc-2f53-479b-bbaa-ef70250341a2	NA	TCGA-36-1570-01A-01D-0533-01	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	NA	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	NA	TCGA-36-1570-01	TCGA-36-1570-01	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01A-01R-0540-07	
TCGA-36-1571-01	1	TCGA-36-1571-01	695	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-36-1571	NA	NA	days	695	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-36-1571-F27862	TCGA-36-1571	TCGA-36-1571-01A	Stage IIIB	-19608	NA	695	0	695	NA	375	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.3	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481.pdf	1571	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.9	NA	NA	36	No Macroscopic disease	Ovary	NO	A	DECEASED	2007	TCGA-36-1571-01	TCGA-36-1571-01	TCGA-36-1571-01A-01W-0615-10	62f86b95-1bfe-4123-8f09-311c9c826de0	NA	TCGA-36-1571-01	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01A-01D-0536-05	NA	TCGA-36-1571-01A-21-1558-20	NA	55c68aef-938c-4f68-a74d-f408673fff9c	TCGA-36-1571-01A-01D-0533-01	TCGA-36-1571-01	8add1736-9ac5-4d0e-9969-7ea6ffaf635c	NA	TCGA-36-1571-01A-01D-0533-01	55c68aef-938c-4f68-a74d-f408673fff9c	NA	55c68aef-938c-4f68-a74d-f408673fff9c	NA	TCGA-36-1571-01	TCGA-36-1571-01	55c68aef-938c-4f68-a74d-f408673fff9c	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01A-01R-0540-07	
TCGA-36-1574-01	0	TCGA-36-1574-01	686	0	days	Squamous	C9-OV	Low purity c2	NA	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1574	NA	NA	days	686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-36-1574-F27868	TCGA-36-1574	NA	Stage IIIC	-17847	NA	NA	0	686	NA	648	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1574	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	36	>20 mm	Ovary	NA	NA	LIVING	2007	TCGA-36-1574-01	TCGA-36-1574-01	TCGA-36-1574-01A-01W-0615-10	d83bcf90-4a10-4318-ac80-4ae41ea88894	NA	TCGA-36-1574-01	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01A-01D-0536-05	NA	NA	NA	ff781a4f-7281-4195-880f-3df099a401cc	TCGA-36-1574-01A-01D-0533-01	TCGA-36-1574-01	NA	NA	TCGA-36-1574-01A-01D-0533-01	ff781a4f-7281-4195-880f-3df099a401cc	NA	ff781a4f-7281-4195-880f-3df099a401cc	NA	TCGA-36-1574-01	TCGA-36-1574-01	ff781a4f-7281-4195-880f-3df099a401cc	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01A-01R-0540-07	
TCGA-36-1575-01	0	TCGA-36-1575-01	260	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1575	NA	NA	days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	83	NA	TCGA-36-1575-F27872	TCGA-36-1575	NA	Stage IIIB	-30592	NA	NA	0	260	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	NA	NA	NA	NA	NA	NA	1575	NA	TUMOR FREE	YES	NA	NA	NO	NA	Primary Tumor	01	NA	NA	NA	36	No Macroscopic disease	Ovary	NO	NA	LIVING	2006	TCGA-36-1575-01	TCGA-36-1575-01	TCGA-36-1575-01A-01W-0615-10	fb275fb0-6793-4401-99a0-5d3bdf2a7ac0	NA	TCGA-36-1575-01	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01A-01D-0536-05	NA	TCGA-36-1575-01A-21-1558-20	NA	a28ef775-c78b-416f-afeb-89ba265440f0	TCGA-36-1575-01A-01D-0533-01	TCGA-36-1575-01	ba2a2d99-a0a6-4d8d-a207-d1a82501f18d	NA	TCGA-36-1575-01A-01D-0533-01	a28ef775-c78b-416f-afeb-89ba265440f0	NA	a28ef775-c78b-416f-afeb-89ba265440f0	NA	TCGA-36-1575-01	TCGA-36-1575-01	a28ef775-c78b-416f-afeb-89ba265440f0	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01A-01R-0540-07	
TCGA-36-1576-01	0	TCGA-36-1576-01	915	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-36-1576	NA	NA	days	915	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	NA	TCGA-36-1576-F27874	TCGA-36-1576	TCGA-36-1576-01A	Stage IIIC	-27778	NA	NA	0	915	NA	817	2	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	2.6	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1576.2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f.pdf	1576	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	36	>20 mm	Ovary	YES	A	LIVING	2006	TCGA-36-1576-01	TCGA-36-1576-01	TCGA-36-1576-01A-01W-0615-10	15528051-b343-4e7d-9433-b9fc052e7d77	NA	TCGA-36-1576-01	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01A-01D-0536-05	NA	TCGA-36-1576-01A-21-1558-20	NA	55b6bd7c-e77d-4019-93e9-b5410e4807b2	TCGA-36-1576-01A-01D-0533-01	TCGA-36-1576-01	e1158086-b305-4b38-8ebe-43bd33c73952	NA	TCGA-36-1576-01A-01D-0533-01	55b6bd7c-e77d-4019-93e9-b5410e4807b2	NA	55b6bd7c-e77d-4019-93e9-b5410e4807b2	NA	TCGA-36-1576-01	TCGA-36-1576-01	55b6bd7c-e77d-4019-93e9-b5410e4807b2	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01A-01R-0540-07	
TCGA-36-1577-01	0	TCGA-36-1577-01	783	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1577	NA	NA	days	783	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	43	Bilateral	TCGA-36-1577-F27878	TCGA-36-1577	TCGA-36-1577-01A	Stage IIC	-15804	NA	NA	0	783	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	1.7	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-36-1577.0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc.pdf	1577	NA	TUMOR FREE	YES	Complete Remission/Response	NA	YES	NA	Primary Tumor	01	0.6	NA	NA	36	No Macroscopic disease	Ovary	NA	A	LIVING	2007	TCGA-36-1577-01	TCGA-36-1577-01	TCGA-36-1577-01A-01W-0615-10	ea44120c-4ba1-426a-a989-11ce1ca54e15	NA	TCGA-36-1577-01	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01A-01D-0536-05	NA	TCGA-36-1577-01A-21-1558-20	NA	9ec93bbd-5c62-4974-984f-f86301f0d27e	TCGA-36-1577-01A-01D-0533-01	TCGA-36-1577-01	ec733c30-ab8b-454e-88f9-8ee34bcf0416	NA	TCGA-36-1577-01A-01D-0533-01	9ec93bbd-5c62-4974-984f-f86301f0d27e	NA	9ec93bbd-5c62-4974-984f-f86301f0d27e	NA	TCGA-36-1577-01	TCGA-36-1577-01	9ec93bbd-5c62-4974-984f-f86301f0d27e	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01A-01R-0540-07	
TCGA-36-1578-01	0	TCGA-36-1578-01	847	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1578	NA	NA	days	847	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	NA	TCGA-36-1578-F27884	TCGA-36-1578	TCGA-36-1578-01A	Stage IV	-23329	NA	NA	0	847	NA	310	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	0.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1578.6BD44F43-7D75-4DF3-891D-7E08291F020C.pdf	1578	Preoperative	WITH TUMOR	YES	NA	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	36	>20 mm	Ovary	NO	A	LIVING	2007	TCGA-36-1578-01	TCGA-36-1578-01	TCGA-36-1578-01A-01W-0615-10	644de2b8-bb23-4161-b6dc-dbb926d573f0	NA	TCGA-36-1578-01	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01A-01D-0536-05	NA	TCGA-36-1578-01A-21-1558-20	NA	7ecb58fe-e2fe-4dc8-996b-2b959da43566	TCGA-36-1578-01A-01D-0533-01	TCGA-36-1578-01	cb41005f-cf76-417e-9ce8-8b5d3047609c	NA	TCGA-36-1578-01A-01D-0533-01	7ecb58fe-e2fe-4dc8-996b-2b959da43566	NA	7ecb58fe-e2fe-4dc8-996b-2b959da43566	NA	TCGA-36-1578-01	TCGA-36-1578-01	7ecb58fe-e2fe-4dc8-996b-2b959da43566	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01A-01R-0540-07	
TCGA-36-1580-01	1	TCGA-36-1580-01	737	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-36-1580	NA	NA	days	737	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	82	NA	TCGA-36-1580-F27889	TCGA-36-1580	TCGA-36-1580-01A	Stage IIIC	-29992	NA	737	0	737	NA	440	1	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1	NO	NA	2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98.pdf	1580	Preoperative	WITH TUMOR	YES	NA	Physical Examination	NO	NA	Primary Tumor	01	0.4	NA	NA	36	>20 mm	Ovary	NA	A	DECEASED	2007	TCGA-36-1580-01	TCGA-36-1580-01	TCGA-36-1580-01A-01W-0615-10	2b7461a0-84ad-4a91-b136-395c33f059fc	NA	TCGA-36-1580-01	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01A-01D-0536-05	NA	TCGA-36-1580-01A-21-1558-20	NA	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	TCGA-36-1580-01A-01D-0533-01	TCGA-36-1580-01	1d325272-4508-4a42-97ba-9e59edf59993	NA	TCGA-36-1580-01A-01D-0533-01	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	NA	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	NA	TCGA-36-1580-01	TCGA-36-1580-01	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01A-01R-0540-07	
TCGA-36-1581-01	0	TCGA-36-1581-01	751	0	days	High	C1-LUAD-enriched	Cluster 5	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 6	NA	TCGA-36-1581	NA	NA	days	751	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Left	TCGA-36-1581-F27893	TCGA-36-1581	NA	Stage IIC	-23272	NA	NA	0	751	NA	702	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	1581	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	36	No Macroscopic disease	Ovary	NA	NA	LIVING	2007	TCGA-36-1581-01	TCGA-36-1581-01	NA	ba4c8ab9-f8ee-48ab-a513-ab43f71b8723	NA	TCGA-36-1581-01	NA	TCGA-36-1581-01A-01D-0536-05	NA	TCGA-36-1581-01A-03-1563-20	NA	d84c76a9-dbee-4720-8639-91382101b27a	TCGA-36-1581-01A-01D-0533-01	TCGA-36-1581-01	c3ce568b-8558-45db-97b4-23882e482cbf	NA	TCGA-36-1581-01A-01D-0533-01	d84c76a9-dbee-4720-8639-91382101b27a	NA	d84c76a9-dbee-4720-8639-91382101b27a	NA	TCGA-36-1581-01	TCGA-36-1581-01	d84c76a9-dbee-4720-8639-91382101b27a	NA	TCGA-36-1581-01A-01R-0540-07	
TCGA-36-2529-01	0	TCGA-36-2529-01	1066	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2529	NA	NA	days	1066	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-36-2529-F27897	TCGA-36-2529	NA	Stage IIIC	-26092	NA	NA	0	1066	NA	567	0	NA	NA	2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Recurrence	NA	NA	NA	NA	NA	2529	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	R1	Primary Tumor	01	NA	NA	NA	36	>20 mm	Peritoneum ovary	NA	NA	LIVING	2007	NA	NA	NA	d63b58d4-56b8-4879-b103-74cb3f92c242	NA	NA	NA	TCGA-36-2529-01A-01D-1047-05	NA	TCGA-36-2529-01A-21-1560-20	NA	NA	TCGA-36-2529-01A-01D-1043-01	TCGA-36-2529-01	a954f069-3088-49e6-839f-d823017cfa40	NA	TCGA-36-2529-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2529-01	NA	NA	NA	TCGA-36-2529-01A-01R-1050-07	
TCGA-36-2530-01	0	TCGA-36-2530-01	1004	0	days	Squamous	NA	NA	OV-like c4	NA	NA	NA	NA	TCGA-36-2530	NA	NA	days	1004	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-36-2530-F27906	TCGA-36-2530	NA	Stage IIIC	-13885	NA	NA	0	1004	NA	630	NA	NA	NA	2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NO	G3	Recurrence	NA	NA	NA	NA	NA	2530	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	NA	NA	NA	36	11-20 mm	Ovary	NA	NA	LIVING	2007	NA	NA	NA	f4fa786b-3eaf-45ab-9d3e-4cf7ec61de3c	NA	NA	NA	NA	NA	TCGA-36-2530-01A-21-1560-20	TCGA-36-2530-01A-01D-1526-09	NA	TCGA-36-2530-01A-01D-1043-01	TCGA-36-2530-01	ae583504-181e-4199-a79c-8fd11d3c99af	NA	TCGA-36-2530-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2530-01	NA	NA	NA	TCGA-36-2530-01A-01R-1050-07	
TCGA-36-2532-01	0	TCGA-36-2532-01	897	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2532	NA	NA	days	897	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	61	Bilateral	TCGA-36-2532-F27913	TCGA-36-2532	TCGA-36-2532-01A	Stage IIIC	-22333	NA	NA	0	897	NA	NA	NA	NA	NA	2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	0.9	NO	NA	2.7	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-36-2532.d99b756c-2a3c-48cd-844e-ce61f811c3a0.pdf	2532	NA	WITH TUMOR	YES	NA	NA	NO	R0	Primary Tumor	01	0.7	NA	NA	36	No Macroscopic disease	Ovary	YES	A	LIVING	2007	NA	NA	NA	0830b9f6-0220-4c58-9c8b-58478ac2f49e	NA	NA	NA	TCGA-36-2532-01A-01D-1047-05	NA	TCGA-36-2532-01A-21-1560-20	TCGA-36-2532-01A-01D-1526-09	NA	TCGA-36-2532-01A-01D-1043-01	TCGA-36-2532-01	0ee5a901-a30a-493d-895a-6e674967a5eb	NA	TCGA-36-2532-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2532-01	NA	NA	NA	TCGA-36-2532-01A-01R-1050-07	
TCGA-36-2533-01	NA	TCGA-36-2533-01	NA	NA	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2533	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Right	NA	TCGA-36-2533	TCGA-36-2533-01A	Stage IIIC	-20187	NA	NA	0	0	NA	NA	NA	NA	NA	2010-9-14	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-36-2533.ebe9dfc0-28ac-4d22-a18b-b910aa2814e0.pdf	2533	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	36	NA	Ovary	NA	A	NA	2007	NA	NA	NA	06bf48f2-1c9a-42eb-bf68-505501a4c354	NA	NA	NA	TCGA-36-2533-01A-01D-1047-05	NA	TCGA-36-2533-01A-21-1560-20	TCGA-36-2533-01A-01D-1526-09	NA	TCGA-36-2533-01A-01D-1043-01	TCGA-36-2533-01	6b83e35e-5d42-43db-a0cc-a5979af12af3	NA	TCGA-36-2533-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2533-01	NA	NA	NA	TCGA-36-2533-01A-01R-1050-07	
TCGA-36-2534-01	0	TCGA-36-2534-01	907	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2534	NA	NA	days	907	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Right	TCGA-36-2534-F27918	TCGA-36-2534	TCGA-36-2534-01A	Stage IIIC	-26621	NA	NA	0	907	NA	383	1	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.5	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-36-2534.b62a4922-ad09-4422-8cb2-bea80a0fe533.pdf	2534	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5	NA	NA	36	>20 mm	Ovary	NA	A	LIVING	2007	NA	NA	NA	39d1a308-db4f-4161-ad51-7cb9ccb4d059	NA	NA	NA	TCGA-36-2534-01A-01D-1047-05	NA	TCGA-36-2534-01A-21-1560-20	TCGA-36-2534-01A-01D-1526-09	NA	TCGA-36-2534-01A-01D-1043-01	TCGA-36-2534-01	d32b063f-7dc4-4081-8ba5-301ea0f98089	NA	TCGA-36-2534-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2534-01	NA	NA	NA	TCGA-36-2534-01A-01R-1050-07	
TCGA-36-2537-01	0	TCGA-36-2537-01	788	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2537	NA	NA	days	788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	39	Bilateral	TCGA-36-2537-F27923	TCGA-36-2537	TCGA-36-2537-01A	Stage IIIC	-14595	NA	NA	0	788	NA	431	2	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.2	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905.pdf	2537	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.8	NA	NA	36	>20 mm	Ovary	NA	A	LIVING	2008	NA	NA	NA	74f16c9d-4f75-4307-a243-35a387eb20db	NA	NA	NA	TCGA-36-2537-01A-01D-1047-05	NA	TCGA-36-2537-01A-21-1560-20	TCGA-36-2537-01A-01D-1526-09	NA	TCGA-36-2537-01A-01D-1043-01	TCGA-36-2537-01	dab8df2a-7a8a-4735-9548-ebac64341b3a	NA	TCGA-36-2537-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2537-01	NA	NA	NA	TCGA-36-2537-01A-01R-1050-07	
TCGA-36-2538-01	0	TCGA-36-2538-01	763	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2538	NA	NA	days	763	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	37	Right	TCGA-36-2538-F27930	TCGA-36-2538	TCGA-36-2538-01A	Stage IIIB	-13681	NA	NA	0	763	NA	523	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.7	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-36-2538.e78dd67e-58f2-4b75-b3a5-1ca9ee6e01e5.pdf	2538	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.3	NA	NA	36	11-20 mm	Ovary	NO	A	LIVING	2008	NA	NA	NA	8e5e1961-d950-4ae8-9f07-1c5a10c82ad4	NA	NA	NA	TCGA-36-2538-01A-01D-1047-05	NA	TCGA-36-2538-01A-21-20	TCGA-36-2538-01A-01D-1526-09	NA	TCGA-36-2538-01A-01D-1043-01	TCGA-36-2538-01	da67724e-5273-48f5-8545-56c9a944c0a8	NA	TCGA-36-2538-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2538-01	NA	NA	NA	TCGA-36-2538-01A-01R-1050-07	
TCGA-36-2539-01	NA	TCGA-36-2539-01	NA	NA	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2539	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-36-2539-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.6	NO	NA	1.3	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-36-2539.c388f1d4-53dd-4e8b-bc68-ded38c816530.pdf	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	f335ca72-d387-445f-a46c-542b608b2646	NA	NA	NA	TCGA-36-2539-01A-01D-1047-05	NA	TCGA-36-2539-01A-21-20	TCGA-36-2539-01A-01D-1526-09	NA	TCGA-36-2539-01A-01D-1043-01	NA	22ebbb58-a3c5-4473-82e6-4c4e0a5995e5	NA	TCGA-36-2539-01A-01D-1043-01	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-36-2539-01A-01R-1050-07	
TCGA-36-2540-01	0	TCGA-36-2540-01	724	0	days	Kirc+	NA	Low purity c2	OV-like c4	NA	NA	NA	NA	TCGA-36-2540	NA	NA	days	724	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	26	Bilateral	TCGA-36-2540-F27936	TCGA-36-2540	TCGA-36-2540-01A	Stage IIIC	-9760	NA	NA	0	724	NA	665	0	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.3	NA	YES	G1	Recurrence	NA	NA	NA	NA	TCGA-36-2540.d66d4750-20f9-4e75-bdb7-b48de6dbc449.pdf	2540	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.2	NA	NA	36	>20 mm	Ovary	YES	A	LIVING	2008	NA	NA	NA	75cee431-5541-49ea-a935-5e3b287f367b	NA	NA	NA	TCGA-36-2540-01A-01D-1047-05	NA	TCGA-36-2540-01A-21-20	TCGA-36-2540-01A-01D-1526-09	NA	TCGA-36-2540-01A-01D-1043-01	TCGA-36-2540-01	72b43e39-cb64-4610-b39e-02cc4b39c541	NA	TCGA-36-2540-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2540-01	NA	NA	NA	TCGA-36-2540-01A-01R-1050-07	
TCGA-36-2542-01	0	TCGA-36-2542-01	657	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2542	NA	NA	days	657	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-36-2542-F27942	TCGA-36-2542	NA	Stage IIIB	-21902	NA	NA	0	657	NA	NA	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G3	NA	NA	NA	NA	NA	NA	2542	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R1	Primary Tumor	01	NA	NA	NA	36	1-10 mm	Ovary	NA	NA	LIVING	2008	NA	NA	NA	e4d9b54f-bf90-484f-9f85-06cd87712fd7	NA	NA	NA	TCGA-36-2542-01A-01D-1047-05	NA	TCGA-36-2542-01A-21-20	TCGA-36-2542-01A-01D-1526-09	NA	TCGA-36-2542-01A-01D-1043-01	TCGA-36-2542-01	e58dd1a4-afb0-40c4-a0b2-aad520bcd0c9	NA	TCGA-36-2542-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2542-01	NA	NA	NA	TCGA-36-2542-01A-01R-1050-07	
TCGA-36-2543-01	1	TCGA-36-2543-01	68	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2543	NA	NA	days	68	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	85	Bilateral	TCGA-36-2543-F27946	TCGA-36-2543	TCGA-36-2543-01A	Stage IIIC	-31211	NA	68	0	68	NA	27	3	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.5	NO	NA	1.6	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-36-2543.ec25ac8e-1a07-459b-a986-c78edfff88c0.pdf	2543	Other	WITH TUMOR	NO	Progressive Disease	NA	NO	R1	Primary Tumor	01	0.4	NA	NA	36	>20 mm	Ovary	NA	A	DECEASED	2008	NA	NA	NA	c25023f6-f376-41b0-8346-3f898a11fd1f	NA	NA	NA	TCGA-36-2543-01A-01D-1047-05	NA	TCGA-36-2543-01A-21-20	TCGA-36-2543-01A-01D-1526-09	NA	TCGA-36-2543-01A-01D-1043-01	TCGA-36-2543-01	2146a3b5-3eb9-47be-9143-3a5de8c4a0d5	NA	TCGA-36-2543-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2543-01	NA	NA	NA	TCGA-36-2543-01A-01R-1050-07	
TCGA-36-2544-01	0	TCGA-36-2544-01	638	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2544	NA	NA	days	638	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-36-2544-F27948	TCGA-36-2544	TCGA-36-2544-01A	Stage IIIC	-21384	NA	NA	0	638	NA	325	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	2.3	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-36-2544.87f69148-d6fb-4b70-8404-c24b106b6195.pdf	2544	NA	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.7	NA	NA	36	>20 mm	Ovary	NA	A	LIVING	2008	NA	NA	NA	7f53f5f6-c900-4ebb-87d8-9e1edcbe1de5	NA	NA	NA	TCGA-36-2544-01A-01D-1047-05	NA	TCGA-36-2544-01A-21-20	TCGA-36-2544-01A-01D-1526-09	NA	TCGA-36-2544-01A-01D-1043-01	TCGA-36-2544-01	5ef7b46e-b379-4137-a5ab-91c9d6de74a3	NA	TCGA-36-2544-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2544-01	NA	NA	NA	TCGA-36-2544-01A-01R-1050-07	
TCGA-36-2545-01	0	TCGA-36-2545-01	557	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2545	NA	NA	days	557	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	42	Bilateral	TCGA-36-2545-F27954	TCGA-36-2545	TCGA-36-2545-01A	Stage IIIA	-15444	NA	NA	0	557	NA	NA	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-36-2545.e8e6f050-7372-41f3-b198-72ddb241fb08.pdf	2545	NA	TUMOR FREE	YES	NA	NA	NO	R0	Primary Tumor	01	0.8	NA	NA	36	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	NA	NA	625f1165-c70d-4a7f-be3b-ff55aca5ca12	NA	NA	NA	TCGA-36-2545-01A-01D-1047-05	NA	TCGA-36-2545-01A-21-20	TCGA-36-2545-01A-01D-1526-09	NA	TCGA-36-2545-01A-01D-1043-01	TCGA-36-2545-01	ecfb4f91-8c7a-465b-86f0-054855f71fe5	NA	TCGA-36-2545-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2545-01	NA	NA	NA	TCGA-36-2545-01A-01R-1050-07	
TCGA-36-2547-01	0	TCGA-36-2547-01	624	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2547	NA	NA	days	624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Left	TCGA-36-2547-F27958	TCGA-36-2547	TCGA-36-2547-01A	Stage IIIC	-23706	NA	NA	0	624	NA	NA	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.7	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-36-2547.f615f400-96c3-42f3-bee9-c273b1a16b63.pdf	2547	NA	NA	YES	NA	NA	NO	R0	Primary Tumor	01	0.7	NA	NA	36	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	NA	NA	40ca7354-e907-4a61-853e-c1d66651f9a3	NA	NA	NA	TCGA-36-2547-01A-01D-1047-05	NA	TCGA-36-2547-01A-21-20	TCGA-36-2547-01A-01D-1526-09	NA	TCGA-36-2547-01A-01D-1043-01	TCGA-36-2547-01	48b9af43-88a1-46c9-b6c7-ec1d1ac9e5f9	NA	TCGA-36-2547-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2547-01	NA	NA	NA	TCGA-36-2547-01A-01R-1050-07	
TCGA-36-2548-01	0	TCGA-36-2548-01	431	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2548	NA	NA	days	431	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Right	TCGA-36-2548-F27962	TCGA-36-2548	TCGA-36-2548-01A	Stage IIIC	-20897	NA	NA	0	431	NA	395	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Other method, specify:	NA	0.7	NO	NA	1.3	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-36-2548.68bf291c-3320-46f9-8e5f-7de81f0c6964.pdf	2548	NA	WITH TUMOR	YES	NA	Imaging Study	NO	R1	Primary Tumor	01	0.7	NA	NA	36	>20 mm	Ovary	NA	A	LIVING	2008	NA	NA	NA	abe78829-2661-4c6e-ba83-03e06963d9aa	NA	NA	NA	TCGA-36-2548-01A-01D-1047-05	NA	TCGA-36-2548-01A-21-20	TCGA-36-2548-01A-01D-1526-09	NA	TCGA-36-2548-01A-01D-1043-01	TCGA-36-2548-01	4794aace-89fb-4e9e-b117-3234ef1fc792	NA	TCGA-36-2548-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2548-01	NA	NA	NA	TCGA-36-2548-01A-01R-1050-07	
TCGA-36-2549-01	0	TCGA-36-2549-01	184	0	days	BRCA-LUAD+	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2549	NA	NA	days	184	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	54	Bilateral	TCGA-36-2549-F27966	TCGA-36-2549	TCGA-36-2549-01A	Stage IIC	-20076	NA	NA	0	184	NA	NA	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.4	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-36-2549.42b18428-81f6-48d0-8a5f-fd08926128b1.pdf	2549	NA	TUMOR FREE	YES	NA	NA	NO	R0	Primary Tumor	01	0.6	NA	NA	36	No Macroscopic disease	Ovary	NA	A	LIVING	2008	NA	NA	NA	3dac49f4-f485-4050-93d1-cbc22eef91d9	NA	NA	NA	TCGA-36-2549-01A-01D-1047-05	NA	TCGA-36-2549-01A-21-20	NA	NA	TCGA-36-2549-01A-01D-1043-01	TCGA-36-2549-01	0b81fd60-103b-484a-a954-839f7941bf98	NA	TCGA-36-2549-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2549-01	NA	NA	NA	TCGA-36-2549-01A-01R-1050-07	
TCGA-36-2551-01	0	TCGA-36-2551-01	492	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2551	NA	NA	days	492	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-36-2551-F27970	TCGA-36-2551	TCGA-36-2551-01A	Stage IIIC	-21045	NA	NA	0	492	NA	338	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.7	NO	NA	1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-36-2551.c3e022a3-b58d-437b-a990-691730e9daf1.pdf	2551	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.3	NA	NA	36	>20 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	543cc9e3-5fb6-4229-aedb-a55273230b98	NA	NA	NA	TCGA-36-2551-01A-01D-1047-05	NA	TCGA-36-2551-01A-21-20	TCGA-36-2551-01A-01D-1526-09	NA	TCGA-36-2551-01A-01D-1043-01	TCGA-36-2551-01	ceb02af7-9228-4bfa-812b-f1d88482c383	NA	TCGA-36-2551-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2551-01	NA	NA	NA	TCGA-36-2551-01A-01R-1050-07	
TCGA-36-2552-01	0	TCGA-36-2552-01	349	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-36-2552	NA	NA	days	349	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	64	Bilateral	TCGA-36-2552-F27976	TCGA-36-2552	TCGA-36-2552-01A	Stage IIC	-23379	NA	NA	0	349	NA	NA	NA	NA	NA	2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf	2552	NA	TUMOR FREE	YES	NA	NA	NO	R0	Primary Tumor	01	0.8	NA	NA	36	No Macroscopic disease	Ovary	NA	A	LIVING	2009	NA	NA	NA	4f0b1c4b-e033-4679-a32a-9bf80ff6d42d	NA	NA	NA	TCGA-36-2552-01A-01D-1047-05	NA	TCGA-36-2552-01A-21-20	TCGA-36-2552-01A-01D-1526-09	NA	TCGA-36-2552-01A-01D-1043-01	TCGA-36-2552-01	984b6351-1d3e-4ef1-99c4-d99895a3a49b	NA	TCGA-36-2552-01A-01D-1043-01	NA	NA	NA	NA	TCGA-36-2552-01	NA	NA	NA	TCGA-36-2552-01A-01R-1050-07	
TCGA-3P-A9WA-01	0	TCGA-3P-A9WA-01	420	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-3P-A9WA	420	0	days	420	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Left	TCGA-3P-A9WA-F67273	TCGA-3P-A9WA	TCGA-3P-A9WA-01A	Stage IIB	-20211	126	NA	0	420	NA	NA	NA	Scheduled Follow-up Submission	Complete Remission/Response	2014-11-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8440/3	C56.9	YES	Other method, specify:	660	NA	NO	100	NA	NO	NA	G3	NA	NA	NO	false	Yes, History of Synchronous/Bilateral Malignancy	TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16.pdf	A9WA	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	RX	Primary Tumor	01	NA	YES	NO	3P	NA	Ovary	NA	A	LIVING	2013	TCGA-3P-A9WA-01	TCGA-3P-A9WA-01	NA	NA	TCGA-3P-A9WA-01A-11D-A409-05	TCGA-3P-A9WA-01	NA	NA	NA	NA	NA	94e91d8c-244a-48cf-af09-9412659e6759	TCGA-3P-A9WA-01A-11D-A402-01	NA	7C867DDB-C776-4764-8E77-F2CE4D474116	TCGA-3P-A9WA-01A-11R-A406-31	TCGA-3P-A9WA-01A-11D-A402-01	94e91d8c-244a-48cf-af09-9412659e6759	TCGA-3P-A9WA-01A-11R-A406-31	94e91d8c-244a-48cf-af09-9412659e6759	NA	NA	TCGA-3P-A9WA-01	94e91d8c-244a-48cf-af09-9412659e6759	NA	NA	
TCGA-42-2582-01	1	TCGA-42-2582-01	1447	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2582	1179	1	days	1447	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	49	Bilateral	TCGA-42-2582-F34657	TCGA-42-2582	TCGA-42-2582-01A	Stage IIIC	-17961	NA	1447	0	435	NA	1179	1	Additional New Tumor Event	Progressive Disease	2013-3-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.3	NO	YES	G3	Progression of Disease	NA	YES	NA	NA	TCGA-42-2582.04201F3C-F4FF-4F85-8C14-F1D754DAFDD6.pdf	2582	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R0	Primary Tumor	01	0.2	NA	NA	42	No Macroscopic disease	Ovary	NA	A	DECEASED	2009	NA	NA	NA	7f63006e-7016-483d-9a09-7d535a342d3a	NA	NA	NA	TCGA-42-2582-01A-01D-1047-05	NA	TCGA-42-2582-01A-21-20	TCGA-42-2582-01A-01D-1526-09	NA	TCGA-42-2582-01A-01D-1043-01	TCGA-42-2582-01	61f8ad02-1fe9-48ca-b317-c573aba61c08	NA	TCGA-42-2582-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2582-01	NA	NA	NA	TCGA-42-2582-01A-01R-1231-07	
TCGA-42-2587-01	0	TCGA-42-2587-01	722	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2587	NA	NA	days	722	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	75	Bilateral	TCGA-42-2587-F28795	TCGA-42-2587	TCGA-42-2587-01A	Stage IIIC	-27510	NA	NA	0	722	NA	NA	NA	NA	NA	2011-8-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.4	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-42-2587.dc4896ef-1797-4796-8869-e9f5d19456d2.pdf	2587	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R1	Primary Tumor	01	0.6	NA	NA	42	>20 mm	Ovary	YES	A	LIVING	2009	NA	NA	NA	e8013ca8-18e0-42ee-aa94-b7171902da03	NA	NA	NA	TCGA-42-2587-01A-01D-1047-05	NA	TCGA-42-2587-01A-21-1563-20	TCGA-42-2587-01A-01D-1526-09	NA	TCGA-42-2587-01A-01D-1043-01	TCGA-42-2587-01	934207be-d750-48bc-a51a-c6740d415d56	NA	TCGA-42-2587-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2587-01	NA	NA	NA	TCGA-42-2587-01A-01R-1050-07	
TCGA-42-2588-01	1	TCGA-42-2588-01	880	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2588	NA	NA	days	880	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-42-2588-F28821	TCGA-42-2588	NA	Stage IV	-22377	NA	880	0	287	NA	267	2	NA	NA	2012-1-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	YES	G3	Progression of Disease	NA	NA	NA	NA	NA	2588	Preoperative	WITH TUMOR	YES	Progressive Disease	NA	NO	R2	Primary Tumor	01	NA	NA	NA	42	>20 mm	Ovary	NA	NA	DECEASED	2009	NA	NA	NA	fd52301b-6882-4868-95e8-501ec794f7a8	NA	NA	NA	TCGA-42-2588-01A-01D-1047-05	NA	TCGA-42-2588-01A-21-20	TCGA-42-2588-01A-01D-1526-09	NA	TCGA-42-2588-01A-01D-1043-01	TCGA-42-2588-01	ba162045-6055-466e-bf4d-ff04006919db	NA	TCGA-42-2588-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2588-01	NA	NA	NA	TCGA-42-2588-01A-01R-1050-07	
TCGA-42-2589-01	0	TCGA-42-2589-01	1278	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2589	1274	1	days	1278	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	54	Bilateral	TCGA-42-2589-F41366	TCGA-42-2589	TCGA-42-2589-01A	Stage IIIC	-19852	NA	NA	0	1278	NA	1274	NA	Additional New Tumor Event	Progressive Disease	2013-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy	NA	1	NO	NA	1	NO	YES	G3	NA	NA	YES	NA	NA	TCGA-42-2589.07cceb21-4aca-4343-965e-81960a40cff2.pdf	2589	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	0.5	NA	NA	42	1-10 mm	Ovary	NA	A	LIVING	2009	NA	NA	NA	9add86b7-a9d7-41ea-8536-41a204c97ae1	NA	NA	NA	TCGA-42-2589-01A-01D-1047-05	NA	TCGA-42-2589-01A-21-20	TCGA-42-2589-01A-01D-1526-09	NA	TCGA-42-2589-01A-01D-1043-01	TCGA-42-2589-01	77d0cab8-5a58-4fed-ac41-68dff4f946cd	NA	TCGA-42-2589-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2589-01	NA	NA	NA	TCGA-42-2589-01A-01R-1050-07	
TCGA-42-2590-01	1	TCGA-42-2590-01	317	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2590	NA	NA	days	317	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-42-2590-F28809	TCGA-42-2590	TCGA-42-2590-01A	Stage IV	-20965	NA	317	0	227	NA	226	1	NA	NA	2011-5-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	2.2	NA	NA	G2	Progression of Disease	NA	NA	NA	NA	TCGA-42-2590.9c7c0209-b1d6-4174-b57e-e8bcd3e5d766.pdf	2590	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	R1	Primary Tumor	01	0.4	NA	NA	42	>20 mm	Ovary	NA	A	DECEASED	2009	NA	NA	NA	919946b9-3135-45fd-9fdd-b2d40c8bc3ba	NA	NA	NA	TCGA-42-2590-01A-01D-1047-05	NA	TCGA-42-2590-01A-21-20	TCGA-42-2590-01A-01D-1526-09	NA	TCGA-42-2590-01A-01D-1043-01	TCGA-42-2590-01	043ea617-6eec-43ae-a45c-b5cffacc7695	NA	TCGA-42-2590-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2590-01	NA	NA	NA	TCGA-42-2590-01A-01R-1050-07	
TCGA-42-2591-01	0	TCGA-42-2591-01	1240	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2591	1240	0	days	1240	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-42-2591-F41420	TCGA-42-2591	TCGA-42-2591-01A	Stage IIIC	-18654	NA	NA	0	1240	NA	NA	NA	Scheduled Follow-up Submission	Complete Remission/Response	2013-3-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.5	NO	YES	GX	NA	NA	NO	NA	NA	TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097.pdf	2591	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	42	No Macroscopic disease	Ovary	NA	A	LIVING	2009	NA	NA	NA	5c6e2798-32a6-4fb9-b246-c6267f7dfc51	NA	NA	NA	TCGA-42-2591-01A-01D-1047-05	NA	TCGA-42-2591-01A-21-20	TCGA-42-2591-01A-01D-1526-09	NA	TCGA-42-2591-01A-01D-1043-01	TCGA-42-2591-01	0a1bb74b-fa00-4320-b966-ea146e76c9fa	NA	TCGA-42-2591-01A-01D-1043-01	NA	NA	NA	NA	TCGA-42-2591-01	NA	NA	NA	TCGA-42-2591-01A-01R-1050-07	
TCGA-42-2593-01	1	TCGA-42-2593-01	45	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-42-2593	45	0	days	45	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	67	Bilateral	TCGA-42-2593-F39341	TCGA-42-2593	TCGA-42-2593-01A	Stage IIIC	-24823	NA	45	0	NA	NA	NA	4	Scheduled Follow-up Submission	NA	2013-1-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.9	NO	YES	G3	NA	NA	NO	NA	NA	TCGA-42-2593.302c2898-9b19-494b-86a5-f0ff3cab7163.pdf	2593	Other	WITH TUMOR	NO	NA	NA	NO	R2	Primary Tumor	01	0.4	YES	NO	42	>20 mm	Ovary	YES	A	DECEASED	2009	NA	NA	NA	f5e8a865-c4eb-4043-9a8f-7979d3fe6532	NA	NA	NA	TCGA-42-2593-01A-01D-1047-05	NA	TCGA-42-2593-01A-21-20	NA	NA	TCGA-42-2593-01A-01D-1043-01	NA	8ae9695c-082b-4011-b078-f55aa285fa11	NA	TCGA-42-2593-01A-01D-1043-01	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-42-2593-01A-01R-1050-07	
TCGA-57-1582-01	1	TCGA-57-1582-01	731	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-57-1582	NA	NA	days	731	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Left	TCGA-57-1582-F28059	TCGA-57-1582	TCGA-57-1582-01A	Stage IIIC	NA	NA	731	0	731	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-57-1582.0ed35510-c6ad-416b-8b57-e97005471dc1.pdf	1582	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	57	1-10 mm	Ovary	YES	A	DECEASED	2006	TCGA-57-1582-01	TCGA-57-1582-01	TCGA-57-1582-01A-01W-0615-10	18e8fac4-913e-4c0f-bb6e-3d19b58518cc	NA	TCGA-57-1582-01	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01A-01D-0536-05	NA	NA	NA	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	TCGA-57-1582-01A-01D-0533-01	TCGA-57-1582-01	NA	NA	TCGA-57-1582-01A-01D-0533-01	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	NA	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	NA	TCGA-57-1582-01	TCGA-57-1582-01	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01A-01R-0540-07	
TCGA-57-1583-01	1	TCGA-57-1583-01	346	1	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-57-1583	NA	NA	days	346	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Left	TCGA-57-1583-F28068	TCGA-57-1583	TCGA-57-1583-01A	Stage IIIC	-21167	NA	346	0	346	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-57-1583.b899b485-621f-46df-8bda-97b0fbe10b6d.pdf	1583	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	57	No Macroscopic disease	Ovary	NO	A	DECEASED	2006	TCGA-57-1583-01	TCGA-57-1583-01	TCGA-57-1583-01A-01W-0615-10	bb6bfbc9-0379-4f74-8720-186fa0a165b9	NA	TCGA-57-1583-01	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01A-01D-0536-05	NA	NA	NA	3a37e320-0301-4f2b-bf09-f102c12502b1	TCGA-57-1583-01A-01D-0533-01	TCGA-57-1583-01	NA	NA	TCGA-57-1583-01A-01D-0533-01	3a37e320-0301-4f2b-bf09-f102c12502b1	NA	3a37e320-0301-4f2b-bf09-f102c12502b1	NA	TCGA-57-1583-01	TCGA-57-1583-01	3a37e320-0301-4f2b-bf09-f102c12502b1	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01A-01R-0540-07	
TCGA-57-1584-01	0	TCGA-57-1584-01	643	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 3	TCGA-57-1584	NA	NA	days	643	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-57-1584-F28072	TCGA-57-1584	NA	Stage IIIC	-17263	NA	NA	0	643	NA	530	0	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1584	Pre-Adjuvant Therapy	WITH TUMOR	NO	NA	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	57	1-10 mm	Ovary	YES	NA	LIVING	2007	TCGA-57-1584-01	TCGA-57-1584-01	TCGA-57-1584-01A-01W-0615-10	e10d4b1f-cba8-4e34-af2e-331949b18dba	NA	TCGA-57-1584-01	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01A-01D-0536-05	NA	NA	NA	e92b95df-bacb-4083-b2de-78e540ec0e68	TCGA-57-1584-01A-01D-0533-01	TCGA-57-1584-01	NA	NA	TCGA-57-1584-01A-01D-0533-01	e92b95df-bacb-4083-b2de-78e540ec0e68	NA	e92b95df-bacb-4083-b2de-78e540ec0e68	NA	TCGA-57-1584-01	TCGA-57-1584-01	e92b95df-bacb-4083-b2de-78e540ec0e68	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01A-01R-0540-07	
TCGA-57-1585-01	1	TCGA-57-1585-01	53	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 3	cluster 6	NA	TCGA-57-1585	NA	NA	days	53	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Bilateral	TCGA-57-1585-F28076	TCGA-57-1585	TCGA-57-1585-01A	Stage IIIC	-20862	NA	53	0	53	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	0.8	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-57-1585.2c748aca-e5b2-4418-9820-1343293d379f.pdf	1585	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	57	11-20 mm	Ovary	YES	A	DECEASED	2007	TCGA-57-1585-01	TCGA-57-1585-01	NA	9485c5c9-3fa8-48a3-bb75-a152f1547ae3	NA	TCGA-57-1585-01	NA	TCGA-57-1585-01A-01D-0536-05	NA	NA	NA	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5	TCGA-57-1585-01A-01D-0533-01	TCGA-57-1585-01	NA	NA	TCGA-57-1585-01A-01D-0533-01	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5	NA	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5	NA	TCGA-57-1585-01	TCGA-57-1585-01	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5	NA	TCGA-57-1585-01A-01R-0540-07	
TCGA-57-1586-01	0	TCGA-57-1586-01	679	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-57-1586	NA	NA	days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-57-1586-F28080	TCGA-57-1586	NA	Stage IIIC	-24304	NA	NA	0	679	NA	259	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Recurrence	NA	NA	NA	NA	NA	1586	NA	WITH TUMOR	YES	NA	Molecular Markers	NO	NA	Primary Tumor	01	NA	NA	NA	57	11-20 mm	Ovary	YES	NA	LIVING	2007	NA	TCGA-57-1586-01	NA	ec771953-9297-4d7d-aa29-531499b3e2eb	NA	TCGA-57-1586-01	NA	TCGA-57-1586-01A-02D-0563-05	NA	TCGA-57-1586-01A-03-1563-20	TCGA-57-1586-01A-02W-0633-09	NA	TCGA-57-1586-01A-02D-0559-01	TCGA-57-1586-01	a93a15b9-aef1-403b-85c4-1d5203e6d9dc	NA	TCGA-57-1586-01A-02D-0559-01	NA	NA	NA	NA	TCGA-57-1586-01	NA	NA	NA	TCGA-57-1586-01A-02R-0566-07	
TCGA-57-1992-01	0	TCGA-57-1992-01	882	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-57-1992	NA	NA	days	882	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Left	TCGA-57-1992-F28090	TCGA-57-1992	TCGA-57-1992-01A	Stage IC	NA	NA	NA	0	882	NA	NA	NA	NA	NA	2009-12-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.3	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-57-1992.77c742d8-bb0b-4ea9-9f61-9606c78c438e.pdf	1992	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	57	No Macroscopic disease	Ovary	YES	A	LIVING	2006	NA	NA	NA	6fcb27b1-5f0d-4c30-b9a4-205f60bc880b	NA	NA	NA	TCGA-57-1992-01A-01D-0652-05	NA	NA	NA	NA	TCGA-57-1992-01A-01D-0648-01	TCGA-57-1992-01	NA	NA	TCGA-57-1992-01A-01D-0648-01	NA	NA	NA	NA	TCGA-57-1992-01	NA	NA	NA	TCGA-57-1992-01A-01R-0655-07	
TCGA-57-1993-01	0	TCGA-57-1993-01	763	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-57-1993	NA	NA	days	763	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	Bilateral	TCGA-57-1993-F28092	TCGA-57-1993	TCGA-57-1993-01A	Stage IIIC	-20498	NA	NA	0	763	NA	NA	NA	NA	NA	2010-1-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea.pdf	1993	NA	TUMOR FREE	YES	NA	NA	NO	R0	Primary Tumor	01	0.5	NA	NA	57	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-57-1993-01	TCGA-57-1993-01	NA	f8c91078-d156-4ee9-96c9-7ec6937c40b3	NA	TCGA-57-1993-01	NA	TCGA-57-1993-01A-01D-0652-05	NA	NA	NA	55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01D-0648-01	TCGA-57-1993-01	NA	NA	TCGA-57-1993-01A-01D-0648-01	55f9061c-54e7-465c-af61-21d8bc8ecbe0	NA	55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01W-0699-08	TCGA-57-1993-01	TCGA-57-1993-01	55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01W-0699-08	TCGA-57-1993-01A-01R-0655-07	
TCGA-57-1994-01	0	TCGA-57-1994-01	761	0	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-57-1994	NA	NA	days	761	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	NA	TCGA-57-1994-F28096	TCGA-57-1994	TCGA-57-1994-01A	NA	-23062	NA	NA	0	761	NA	NA	NA	NA	NA	2011-6-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.5	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb.pdf	1994	NA	NA	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	57	NA	Ovary	NA	A	LIVING	2004	TCGA-57-1994-01	TCGA-57-1994-01	NA	24fbfb49-2a8c-40af-b607-577cc3001b2d	NA	TCGA-57-1994-01	NA	TCGA-57-1994-01A-01D-0652-05	NA	NA	NA	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	TCGA-57-1994-01A-01D-0648-01	TCGA-57-1994-01	NA	NA	TCGA-57-1994-01A-01D-0648-01	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	NA	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	NA	TCGA-57-1994-01	TCGA-57-1994-01	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	NA	TCGA-57-1994-01A-01R-0655-07	
TCGA-59-2348-01	0	TCGA-59-2348-01	5481	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2348	NA	NA	days	5481	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	59	Bilateral	TCGA-59-2348-F28098	TCGA-59-2348	TCGA-59-2348-01A	Stage IIIC	NA	NA	NA	0	5481	NA	NA	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-59-2348.ffb300e9-cb06-4162-a751-f079fec57153.pdf	2348	NA	TUMOR FREE	NA	Complete Remission/Response	NA	NA	NA	Primary Tumor	01	0.4	NA	NA	59	NA	Ovary	NA	A	LIVING	1994	TCGA-59-2348-01	TCGA-59-2348-01	NA	139d2d19-f3e9-46fc-bd88-b57709af9ec5	NA	TCGA-59-2348-01	NA	TCGA-59-2348-01A-01D-0708-05	NA	TCGA-59-2348-01A-21-1560-20	NA	7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01D-0704-01	TCGA-59-2348-01	c37d3098-f79e-4ce7-9ed5-884d82725dff	NA	TCGA-59-2348-01A-01D-0704-01	7162d809-ff1a-4346-bb00-c8086386ec46	NA	7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01W-0799-08	TCGA-59-2348-01	TCGA-59-2348-01	7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01W-0799-08	TCGA-59-2348-01A-01R-0711-07	
TCGA-59-2349-01	1	TCGA-59-2349-01	2437	1	days	Kirc+	NA	Cluster 5	BRCA basal-like c6	NA	NA	NA	NA	TCGA-59-2349	NA	NA	days	2437	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Left	TCGA-59-2349-F28100	TCGA-59-2349	TCGA-59-2349-01A	Stage IA	NA	NA	2437	0	NA	NA	NA	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.3	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-59-2349.a56064eb-651a-4a7d-b32c-5c890821e338.pdf	2349	NA	NA	NA	Complete Remission/Response	NA	NA	NA	Primary Tumor	01	0.3	NO	YES	59	No Macroscopic disease	Ovary	NA	A	DECEASED	1994	NA	NA	NA	7557f686-ae87-4ab8-b7df-b1f1b0850e51	NA	NA	NA	TCGA-59-2349-01A-01D-0708-05	NA	TCGA-59-2349-01A-21-1560-20	NA	NA	TCGA-59-2349-01A-01D-0704-01	TCGA-59-2349-01	96c57593-695a-4b64-997b-b465ed28917c	NA	TCGA-59-2349-01A-01D-0704-01	NA	NA	NA	NA	TCGA-59-2349-01	NA	NA	NA	TCGA-59-2349-01A-01R-0711-07	
TCGA-59-2350-01	1	TCGA-59-2350-01	679	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-59-2350	NA	NA	days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	44	Bilateral	TCGA-59-2350-F28102	TCGA-59-2350	NA	Stage IV	NA	NA	679	0	NA	NA	211	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	NA	2350	NA	WITH TUMOR	NA	Partial Remission/Response	NA	NA	NA	Primary Tumor	01	NA	NO	YES	59	1-10 mm	Ovary	NA	NA	DECEASED	1995	TCGA-59-2350-01	TCGA-59-2350-01	NA	e5b094fc-335d-4a9e-9ead-d0bda9695e33	NA	TCGA-59-2350-01	NA	TCGA-59-2350-01A-01D-0708-05	NA	NA	NA	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01D-0704-01	TCGA-59-2350-01	NA	NA	TCGA-59-2350-01A-01D-0704-01	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	NA	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01W-0799-08	TCGA-59-2350-01	TCGA-59-2350-01	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01W-0799-08	TCGA-59-2350-01A-01R-0711-07	
TCGA-59-2351-01	0	TCGA-59-2351-01	3532	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-59-2351	NA	NA	days	3532	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-59-2351-F28104	TCGA-59-2351	TCGA-59-2351-01A	Stage IIIC	NA	NA	NA	0	3532	NA	2139	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	2	NA	NA	G3	Progression of Disease	NA	NA	NA	NA	TCGA-59-2351.6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad.pdf	2351	NA	TUMOR FREE	NA	Complete Remission/Response	Imaging Study	NA	NA	Primary Tumor	01	0.4	NO	YES	59	1-10 mm	Ovary	NA	A	LIVING	1999	TCGA-59-2351-01	TCGA-59-2351-01	NA	2c72e167-d9b6-47e2-ae10-3183a6d13e7a	NA	TCGA-59-2351-01	NA	TCGA-59-2351-01A-01D-0708-05	NA	TCGA-59-2351-01A-21-1560-20	NA	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01D-0704-01	TCGA-59-2351-01	2cdeaf4d-f2c6-44fd-872e-965ef80e505b	NA	TCGA-59-2351-01A-01D-0704-01	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	NA	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01W-0799-08	TCGA-59-2351-01	TCGA-59-2351-01	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01W-0799-08	TCGA-59-2351-01A-01R-0711-07	
TCGA-59-2352-01	1	TCGA-59-2352-01	286	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2352	NA	NA	days	286	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Right	NA	TCGA-59-2352	TCGA-59-2352-01A	Stage IIIC	NA	NA	286	0	NA	NA	NA	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.2	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-59-2352.15f65643-b84c-4239-bc14-0ddacdfe0425.pdf	2352	NA	WITH TUMOR	NA	NA	NA	NA	NA	Primary Tumor	01	0.4	NO	YES	59	NA	Ovary	NA	A	DECEASED	2002	TCGA-59-2352-01	TCGA-59-2352-01	NA	87ec1cd8-27d3-4cde-a59b-58c82ab8cbbe	NA	TCGA-59-2352-01	NA	TCGA-59-2352-01A-01D-0708-05	NA	TCGA-59-2352-01A-21-1560-20	NA	a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01D-0704-01	TCGA-59-2352-01	d9066d98-0039-4956-9e7e-9931b8c28379	NA	TCGA-59-2352-01A-01D-0704-01	a209a8f4-9462-4ade-be57-caaec54999cb	NA	a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01W-0799-08	TCGA-59-2352-01	TCGA-59-2352-01	a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01W-0799-08	TCGA-59-2352-01A-01R-0711-07	
TCGA-59-2354-01	1	TCGA-59-2354-01	1046	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2354	NA	NA	days	1046	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Left	TCGA-59-2354-F28107	TCGA-59-2354	TCGA-59-2354-01A	Stage IIIC	NA	NA	1046	0	NA	NA	462	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	2.4	NA	YES	G3	Progression of Disease	NA	NA	NA	NA	TCGA-59-2354.cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc.pdf	2354	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NA	NA	Primary Tumor	01	0.3	NA	NA	59	1-10 mm	Ovary	NA	A	DECEASED	2005	TCGA-59-2354-01	TCGA-59-2354-01	NA	e0e3aedf-ace3-4525-83c2-887b517837c0	NA	TCGA-59-2354-01	NA	TCGA-59-2354-01A-01D-0708-05	NA	TCGA-59-2354-01A-21-1560-20	NA	33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01D-0704-01	TCGA-59-2354-01	d80db939-9815-4d8b-8d3d-927a54355003	NA	TCGA-59-2354-01A-01D-0704-01	33367eb6-4ca9-4daf-9e47-30a47a78e144	NA	33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01W-0799-08	TCGA-59-2354-01	TCGA-59-2354-01	33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01W-0799-08	TCGA-59-2354-01A-01R-0711-07	
TCGA-59-2355-01	1	TCGA-59-2355-01	65	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2355	NA	NA	days	65	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	58	Right	TCGA-59-2355-F28111	TCGA-59-2355	TCGA-59-2355-01A	Stage IV	NA	NA	65	0	NA	NA	NA	NA	NA	NA	2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.6	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-59-2355.322bedf6-e6b5-4275-a186-0075a2ec271e.pdf	2355	NA	WITH TUMOR	YES	NA	NA	NA	NA	Primary Tumor	01	0.2	NA	NA	59	>20 mm	Ovary	NA	A	DECEASED	2006	TCGA-59-2355-01	TCGA-59-2355-01	NA	9c18086a-f203-48f5-af4c-d756fe1b266b	NA	TCGA-59-2355-01	NA	TCGA-59-2355-01A-01D-0708-05	NA	NA	NA	866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01D-0704-01	TCGA-59-2355-01	NA	NA	TCGA-59-2355-01A-01D-0704-01	866c7355-e2ec-4816-953f-7bf791033283	NA	866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01W-0799-08	TCGA-59-2355-01	TCGA-59-2355-01	866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01W-0799-08	TCGA-59-2355-01A-01R-0711-07	
TCGA-59-2363-01	0	TCGA-59-2363-01	165	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2363	NA	NA	days	165	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	40	Bilateral	TCGA-59-2363-F28115	TCGA-59-2363	TCGA-59-2363-01A	Stage IIIA	NA	NA	NA	0	165	NA	NA	NA	NA	NA	2010-2-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-59-2363.9b047485-eb2b-4fc1-a22a-d96046b63bf2.pdf	2363	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	0.4	NA	NA	59	No Macroscopic disease	Ovary	NO	A	LIVING	2007	TCGA-59-2363-01	TCGA-59-2363-01	NA	0ef0c1bf-9885-4be9-85b1-ed400a1a940f	NA	TCGA-59-2363-01	NA	TCGA-59-2363-01A-01D-0708-05	NA	TCGA-59-2363-01A-21-1560-20	NA	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01D-0704-01	TCGA-59-2363-01	abdc5a45-9e20-4c0e-b854-9a2ec535245a	NA	TCGA-59-2363-01A-01D-0704-01	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	NA	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01W-0799-08	TCGA-59-2363-01	TCGA-59-2363-01	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01W-0799-08	TCGA-59-2363-01A-01R-0711-07	
TCGA-59-2372-01	1	TCGA-59-2372-01	1363	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-59-2372	NA	NA	days	1363	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	73	Bilateral	TCGA-59-2372-F28119	TCGA-59-2372	TCGA-59-2372-01A	Stage IIIC	NA	NA	1363	0	NA	NA	NA	NA	NA	NA	2010-2-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NO	G2	NA	NA	NA	NA	NA	TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09.pdf	2372	NA	NA	YES	NA	NA	NO	R0	Primary Tumor	01	0.5	NA	NA	59	No Macroscopic disease	Ovary	NO	A	DECEASED	2005	NA	NA	NA	b368a37f-fa86-47ae-9a1c-d1038f19a663	NA	NA	NA	TCGA-59-2372-01A-01D-1047-05	NA	TCGA-59-2372-01A-21-1560-20	TCGA-59-2372-01A-01D-1526-09	NA	TCGA-59-2372-01A-01D-1043-01	TCGA-59-2372-01	7d66df01-e224-4584-8c36-f54735a2fc53	NA	TCGA-59-2372-01A-01D-1043-01	NA	NA	NA	NA	TCGA-59-2372-01	NA	NA	NA	TCGA-59-2372-01A-01R-1050-07	
TCGA-59-A5PD-01	1	TCGA-59-A5PD-01	624	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-59-A5PD	NA	NA	days	624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Right	NA	TCGA-59-A5PD	TCGA-59-A5PD-01A	Stage IC	-20263	730	624	0	NA	NA	NA	0	NA	NA	2013-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	130	NA	NO	100	NA	NA	YES	G3	NA	NA	YES	false	Yes, History of Synchronous/Bilateral Malignancy	TCGA-59-A5PD.9A3CB382-654F-4DFD-BF41-7615710D2825.pdf	A5PD	Preoperative	WITH TUMOR	NO	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NO	YES	59	NA	Ovary	YES	A	DECEASED	2011	TCGA-59-A5PD-01	TCGA-59-A5PD-01	NA	NA	TCGA-59-A5PD-01A-11D-A409-05	TCGA-59-A5PD-01	NA	NA	NA	NA	NA	356a00a0-d19a-498c-8ed7-20ce89cd21eb	TCGA-59-A5PD-01A-11D-A402-01	NA	8E787AAF-9659-4F93-97F9-CD58BD1FEC1D	TCGA-59-A5PD-01A-11R-A406-31	TCGA-59-A5PD-01A-11D-A402-01	356a00a0-d19a-498c-8ed7-20ce89cd21eb	TCGA-59-A5PD-01A-11R-A406-31	356a00a0-d19a-498c-8ed7-20ce89cd21eb	NA	NA	TCGA-59-A5PD-01	356a00a0-d19a-498c-8ed7-20ce89cd21eb	NA	NA	
TCGA-5X-AA5U-01	0	TCGA-5X-AA5U-01	361	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-5X-AA5U	361	0	days	361	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	61	Right	TCGA-5X-AA5U-F69358	TCGA-5X-AA5U	TCGA-5X-AA5U-01A	Stage IIC	-22438	11	NA	0	361	NA	NA	0	Scheduled Follow-up Submission	Complete Remission/Response	2015-1-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	230	NA	NO	100	NA	NO	NO	GX	NA	NA	NO	true	Yes, History of Synchronous/Bilateral Malignancy	TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE.pdf	AA5U	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NA	NO	R0	Primary Tumor	01	NA	YES	NO	5X	NA	Ovary	NO	A	LIVING	2013	TCGA-5X-AA5U-01	TCGA-5X-AA5U-01	NA	NA	TCGA-5X-AA5U-01A-11D-A409-05	TCGA-5X-AA5U-01	NA	NA	NA	NA	NA	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	TCGA-5X-AA5U-01A-11D-A402-01	NA	3372257B-B9F7-42AF-8EC4-AC69618A0A35	TCGA-5X-AA5U-01A-11R-A406-31	TCGA-5X-AA5U-01A-11D-A402-01	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	TCGA-5X-AA5U-01A-11R-A406-31	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	NA	NA	TCGA-5X-AA5U-01	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	NA	NA	
TCGA-61-1721-01	0	TCGA-61-1721-01	338	0	days	Quiet	C5-KIRC	Low purity c2	OV-like c4	GBM-like c6	miRNA cluster 3	cluster 6	NA	TCGA-61-1721	NA	NA	days	338	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	38	Bilateral	TCGA-61-1721-F28123	TCGA-61-1721	TCGA-61-1721-01A	Stage IV	-13894	NA	NA	0	338	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	Yes	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	0.9	NO	NA	1	NA	YES	G1	NA	NA	NA	NA	NA	TCGA-61-1721.f44d906c-f069-45e6-9cc4-49eb0da74226.pdf	1721	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	NA	Ovary	YES	A	LIVING	2008	TCGA-61-1721-01	TCGA-61-1721-01	NA	13cc06b1-0e57-4cfe-bfe1-b6ec96321199	NA	TCGA-61-1721-01	NA	TCGA-61-1721-01A-01D-0652-05	NA	TCGA-61-1721-01A-21-1559-20	NA	226f9774-e22b-4b8b-8259-934edb649fc3	TCGA-61-1721-01A-01D-0648-01	TCGA-61-1721-01	0479fc63-879d-4b50-b014-20d276a2d13d	NA	TCGA-61-1721-01A-01D-0648-01	226f9774-e22b-4b8b-8259-934edb649fc3	NA	226f9774-e22b-4b8b-8259-934edb649fc3	NA	TCGA-61-1721-01	TCGA-61-1721-01	226f9774-e22b-4b8b-8259-934edb649fc3	NA	TCGA-61-1721-01A-01R-0655-07	
TCGA-61-1722-01	0	TCGA-61-1722-01	246	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1722	NA	NA	days	246	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	89	Bilateral	TCGA-61-1722-F28129	TCGA-61-1722	TCGA-61-1722-01A	Stage IB	-32853	NA	NA	0	246	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc.pdf	1722	NA	WITH TUMOR	NO	Stable Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2008	NA	NA	NA	79b7ffda-716b-4253-a580-4b1372a8f152	NA	NA	NA	TCGA-61-1722-01A-01D-0581-05	NA	TCGA-61-1722-01A-21-1559-20	TCGA-61-1722-01A-01D-1556-09	NA	TCGA-61-1722-01A-01D-0577-01	TCGA-61-1722-01	b17eace3-8ff6-4e2c-abd1-81f67343d8d1	NA	TCGA-61-1722-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1722-01	NA	NA	NA	TCGA-61-1722-01A-01R-0584-07	
TCGA-61-1724-01	1	TCGA-61-1724-01	637	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 5	NA	TCGA-61-1724	NA	NA	days	637	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-61-1724-F28135	TCGA-61-1724	NA	Stage IIIC	-17168	NA	637	0	637	187	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G3	Locoregional Disease	YES	NA	NA	NA	NA	1724	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	61	No Macroscopic disease	Ovary	YES	NA	DECEASED	2007	TCGA-61-1724-01	TCGA-61-1724-01	NA	af7c2e4b-c7c1-46d1-854e-c75365f3c967	NA	TCGA-61-1724-01	NA	TCGA-61-1724-01A-01D-0652-05	NA	TCGA-61-1724-01A-21-1559-20	NA	faab5b85-3c69-4c64-bba0-a8d5404939a2	TCGA-61-1724-01A-01D-0648-01	TCGA-61-1724-01	eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd	NA	TCGA-61-1724-01A-01D-0648-01	faab5b85-3c69-4c64-bba0-a8d5404939a2	NA	faab5b85-3c69-4c64-bba0-a8d5404939a2	NA	TCGA-61-1724-01	TCGA-61-1724-01	faab5b85-3c69-4c64-bba0-a8d5404939a2	NA	TCGA-61-1724-01A-01R-0655-07	
TCGA-61-1725-01	0	TCGA-61-1725-01	956	0	days	Squamous	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-61-1725	NA	NA	days	956	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-1725-F28143	TCGA-61-1725	TCGA-61-1725-01A	Stage IIIC	-14782	NA	NA	0	956	NA	844	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1725.8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04.pdf	1725	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	11-20 mm	Ovary	YES	A	LIVING	2007	TCGA-61-1725-01	TCGA-61-1725-01	NA	be16e66f-a839-44c7-b700-4a95d366435f	NA	TCGA-61-1725-01	NA	TCGA-61-1725-01A-01D-0581-05	NA	NA	TCGA-61-1725-01A-01W-0639-09	748ff969-cb49-4f22-994f-6debe734c38f	TCGA-61-1725-01A-01D-0577-01	TCGA-61-1725-01	NA	NA	TCGA-61-1725-01A-01D-0577-01	748ff969-cb49-4f22-994f-6debe734c38f	NA	748ff969-cb49-4f22-994f-6debe734c38f	NA	TCGA-61-1725-01	TCGA-61-1725-01	748ff969-cb49-4f22-994f-6debe734c38f	NA	TCGA-61-1725-01A-01R-0584-07	
TCGA-61-1727-01	0	TCGA-61-1727-01	564	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1727	NA	NA	days	564	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Right	TCGA-61-1727-F28152	TCGA-61-1727	TCGA-61-1727-01A	Stage IC	-27203	NA	NA	0	564	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1727.f8e2cbf2-911a-48a7-ad80-c23124af44fe.pdf	1727	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2007	NA	NA	NA	ea305cbb-1171-49bd-be79-debefe08023f	NA	NA	NA	TCGA-61-1727-01A-01D-0581-05	NA	TCGA-61-1727-01A-21-1559-20	TCGA-61-1727-01A-01W-0639-09	NA	TCGA-61-1727-01A-01D-0577-01	TCGA-61-1727-01	3d14831f-1ab6-43e9-bd15-0c6e930304e8	NA	TCGA-61-1727-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1727-01	NA	NA	NA	TCGA-61-1727-01A-01R-0584-07	
TCGA-61-1728-01	0	TCGA-61-1728-01	848	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1728	NA	NA	days	848	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-61-1728-F28156	TCGA-61-1728	TCGA-61-1728-01A	Stage IV	-21582	NA	NA	0	848	NA	533	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.1	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1728.7611c4d4-f58b-404e-93f1-949c865c9e12.pdf	1728	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	1-10 mm	Ovary	NO	A	LIVING	2007	TCGA-61-1728-01	TCGA-61-1728-01	NA	54635249-84d5-466b-b956-e125a7113132	NA	TCGA-61-1728-01	NA	TCGA-61-1728-01A-01D-0652-05	NA	NA	NA	bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01D-0648-01	TCGA-61-1728-01	NA	NA	TCGA-61-1728-01A-01D-0648-01	bf909020-d6a1-49f1-8007-4192d39abd04	NA	bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01W-0699-08	TCGA-61-1728-01	TCGA-61-1728-01	bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01W-0699-08	TCGA-61-1728-01A-01R-0655-07	
TCGA-61-1730-01	1	TCGA-61-1730-01	132	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1730	NA	NA	days	132	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Left	TCGA-61-1730-F28161	TCGA-61-1730	TCGA-61-1730-01A	Stage IC	-28508	NA	132	0	132	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.2	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-1730.4624968a-27c1-4f4f-b9f1-3e6997c15a21.pdf	1730	NA	WITH TUMOR	NO	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	1-10 mm	Ovary	NO	A	DECEASED	2007	NA	NA	NA	59246787-027e-4aea-8a7e-04521b0f96a6	NA	NA	NA	TCGA-61-1730-01A-01D-0581-05	NA	TCGA-61-1730-01A-21-1559-20	TCGA-61-1730-01A-01W-0639-09	NA	TCGA-61-1730-01A-01D-0577-01	TCGA-61-1730-01	1a49f3dd-f92d-4206-bce7-05a2ff6df71e	NA	TCGA-61-1730-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1730-01	NA	NA	NA	TCGA-61-1730-01A-01R-0584-07	
TCGA-61-1733-01	0	TCGA-61-1733-01	967	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-61-1733	NA	NA	days	967	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-61-1733-F28163	TCGA-61-1733	TCGA-61-1733-01A	Stage IIIC	-26180	NA	NA	0	967	NA	175	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1733.bc4e6e92-d716-4ab3-8459-4f339caecffd.pdf	1733	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	No Macroscopic disease	Ovary	YES	A	LIVING	2006	TCGA-61-1733-01	TCGA-61-1733-01	NA	dd206c0f-dd03-40ee-ad76-e6b3bf84ffc8	NA	TCGA-61-1733-01	NA	TCGA-61-1733-01A-01D-0581-05	NA	TCGA-61-1733-01A-21-1559-20	TCGA-61-1733-01A-01W-0639-09	e6f856bf-0694-4c21-aecc-0d8dd54761f1	TCGA-61-1733-01A-01D-0577-01	TCGA-61-1733-01	1b2390f5-f59e-4c94-8586-35b620e0dc4d	NA	TCGA-61-1733-01A-01D-0577-01	e6f856bf-0694-4c21-aecc-0d8dd54761f1	NA	e6f856bf-0694-4c21-aecc-0d8dd54761f1	NA	TCGA-61-1733-01	TCGA-61-1733-01	e6f856bf-0694-4c21-aecc-0d8dd54761f1	NA	TCGA-61-1733-01A-01R-0584-07	
TCGA-61-1734-01	0	TCGA-61-1734-01	866	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1734	NA	NA	days	866	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-61-1734-F28171	TCGA-61-1734	TCGA-61-1734-01B	Stage IC	-19026	NA	NA	0	866	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1734.32d02aa2-1c81-417b-87a8-a5ed4035f5c0.pdf	1734	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	NA	Ovary	YES	B	LIVING	2006	NA	NA	NA	b3b6480c-a96b-44c5-9590-e0659b2fc9ad	NA	NA	NA	TCGA-61-1734-01B-01D-0667-05	NA	TCGA-61-1734-01B-21-1559-20	NA	NA	TCGA-61-1734-01B-01D-0663-01	TCGA-61-1734-01	8d84c559-ee21-4b79-a879-99d3bc6a624e	NA	TCGA-61-1734-01B-01D-0663-01	NA	NA	NA	NA	TCGA-61-1734-01	NA	NA	NA	TCGA-61-1734-01B-01R-0670-07	
TCGA-61-1736-01	1	TCGA-61-1736-01	1484	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-1736	NA	NA	days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-61-1736-F28175	TCGA-61-1736	TCGA-61-1736-01B	Stage IIIC	-16613	NA	1484	0	1484	NA	764	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy	NA	0.8	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1736.c034e484-683b-463c-999d-eb1fd9741292.pdf	1736	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	YES	B	DECEASED	2005	TCGA-61-1736-01	TCGA-61-1736-01	NA	4f3d65e1-2001-48dc-bded-b8dd0a949c2c	NA	TCGA-61-1736-01	NA	TCGA-61-1736-01B-01D-0667-05	NA	TCGA-61-1736-01B-21-1559-20	NA	89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01D-0663-01	TCGA-61-1736-01	de7da1bd-3d13-495a-a931-5ae952aa5ea3	NA	TCGA-61-1736-01B-01D-0663-01	89f1ae39-c387-4dff-be38-e3b7265222bb	NA	89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01W-0722-08	TCGA-61-1736-01	TCGA-61-1736-01	89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01W-0722-08	TCGA-61-1736-01B-01R-0670-07	
TCGA-61-1737-01	0	TCGA-61-1737-01	1364	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 5	NA	TCGA-61-1737	NA	NA	days	1364	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	42	Bilateral	TCGA-61-1737-F28182	TCGA-61-1737	TCGA-61-1737-01A	Stage IV	-15515	NA	NA	0	1364	NA	NA	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.3	NO	NA	0.7	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1737.2fa09bf8-8be5-411c-a9cf-16c12ed1390f.pdf	1737	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2005	TCGA-61-1737-01	TCGA-61-1737-01	NA	478e4825-4983-4315-aeda-12145a87f92b	NA	TCGA-61-1737-01	NA	TCGA-61-1737-01A-01D-0581-05	NA	NA	TCGA-61-1737-01A-01W-0639-09	b442230a-d330-45da-adf7-76873d18645c	TCGA-61-1737-01A-01D-0577-01	TCGA-61-1737-01	NA	NA	TCGA-61-1737-01A-01D-0577-01	b442230a-d330-45da-adf7-76873d18645c	NA	b442230a-d330-45da-adf7-76873d18645c	NA	TCGA-61-1737-01	TCGA-61-1737-01	b442230a-d330-45da-adf7-76873d18645c	NA	TCGA-61-1737-01A-01R-0584-07	
TCGA-61-1738-01	1	TCGA-61-1738-01	1089	1	days	High	C9-OV	UCEC Serous c4	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-61-1738	NA	NA	days	1089	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Right	TCGA-61-1738-F28190	TCGA-61-1738	TCGA-61-1738-01A	Stage IIIC	-21965	NA	1089	0	1089	NA	276	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1738.05898c76-9832-4724-ada5-ff47eb3838b5.pdf	1738	NA	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	61	1-10 mm	Ovary	YES	A	DECEASED	2005	TCGA-61-1738-01	TCGA-61-1738-01	NA	4c4af8bd-a614-4875-bdb5-4e8c64c4d134	NA	TCGA-61-1738-01	NA	TCGA-61-1738-01A-01D-0581-05	NA	TCGA-61-1738-01A-21-1559-20	TCGA-61-1738-01A-01W-0639-09	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	TCGA-61-1738-01A-01D-0577-01	TCGA-61-1738-01	3fed489e-8243-43c5-8ca2-37979d540d22	NA	TCGA-61-1738-01A-01D-0577-01	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	NA	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	NA	TCGA-61-1738-01	TCGA-61-1738-01	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	NA	TCGA-61-1738-01A-01R-0584-07	
TCGA-61-1740-01	1	TCGA-61-1740-01	74	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	NA	TCGA-61-1740	NA	NA	days	74	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Right	TCGA-61-1740-F28198	TCGA-61-1740	TCGA-61-1740-01A	Stage IIIC	-26169	NA	74	0	74	NA	NA	3	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.6	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf	1740	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	>20 mm	Ovary	YES	A	DECEASED	2005	TCGA-61-1740-01	TCGA-61-1740-01	NA	7e650317-6bd3-4ad9-b4ad-47178983707c	NA	TCGA-61-1740-01	NA	TCGA-61-1740-01A-01D-0581-05	NA	TCGA-61-1740-01A-21-1559-20	TCGA-61-1740-01A-01W-0639-09	e7825482-380d-4323-a4fb-d11b365c7073	TCGA-61-1740-01A-01D-0577-01	TCGA-61-1740-01	3349b819-24fe-404f-a480-0e94ed56a1cd	NA	TCGA-61-1740-01A-01D-0577-01	e7825482-380d-4323-a4fb-d11b365c7073	NA	e7825482-380d-4323-a4fb-d11b365c7073	NA	TCGA-61-1740-01	TCGA-61-1740-01	e7825482-380d-4323-a4fb-d11b365c7073	NA	TCGA-61-1740-01A-01R-0584-07	
TCGA-61-1741-01	1	TCGA-61-1741-01	1024	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	NA	TCGA-61-1741	NA	NA	days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-61-1741-F28201	TCGA-61-1741	TCGA-61-1741-01A	Stage IIIB	-27762	NA	1024	0	1024	NA	488	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1741.e2d0ec41-559c-48d4-8c4d-59e0f9d48823.pdf	1741	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	>20 mm	Ovary	NO	A	DECEASED	2004	TCGA-61-1741-01	TCGA-61-1741-01	NA	fba783f9-28fc-41c2-b82a-1fcc55d19941	NA	TCGA-61-1741-01	NA	TCGA-61-1741-01A-02D-0581-05	NA	TCGA-61-1741-01A-11-1563-20	TCGA-61-1741-01A-02W-0639-09	92d5764e-c576-47cd-a6bd-68ed0365c213	TCGA-61-1741-01A-02D-0577-01	TCGA-61-1741-01	4da87c92-0d8f-4475-b5c8-332329e3d7b2	NA	TCGA-61-1741-01A-02D-0577-01	92d5764e-c576-47cd-a6bd-68ed0365c213	NA	92d5764e-c576-47cd-a6bd-68ed0365c213	NA	TCGA-61-1741-01	TCGA-61-1741-01	92d5764e-c576-47cd-a6bd-68ed0365c213	NA	TCGA-61-1741-01A-02R-0584-07	
TCGA-61-1743-01	1	TCGA-61-1743-01	1329	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 1	NA	TCGA-61-1743	NA	NA	days	1329	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NO	53	Bilateral	TCGA-61-1743-F28209	TCGA-61-1743	TCGA-61-1743-01A	Stage IIC	-19365	NA	1329	0	1329	NA	809	NA	NA	NA	2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1.pdf	1743	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	No Macroscopic disease	Ovary	NA	A	DECEASED	2004	TCGA-61-1743-01	TCGA-61-1743-01	NA	5e99b999-2c02-4a1b-97b6-176afa3edfb3	NA	TCGA-61-1743-01	NA	TCGA-61-1743-01A-01D-0652-05	NA	TCGA-61-1743-01A-21-1559-20	NA	f3277084-b0a8-43df-946e-dc792bbb8cdb	TCGA-61-1743-01A-01D-0648-01	TCGA-61-1743-01	a6fffcf6-69f4-4c40-b183-a0345dacff1a	NA	TCGA-61-1743-01A-01D-0648-01	f3277084-b0a8-43df-946e-dc792bbb8cdb	NA	f3277084-b0a8-43df-946e-dc792bbb8cdb	NA	TCGA-61-1743-01	TCGA-61-1743-01	f3277084-b0a8-43df-946e-dc792bbb8cdb	NA	TCGA-61-1743-01A-01R-0655-07	
TCGA-61-1895-01	0	TCGA-61-1895-01	44	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-61-1895	NA	NA	days	44	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	52	Bilateral	TCGA-61-1895-F28213	TCGA-61-1895	TCGA-61-1895-01A	Stage IIIB	-19060	NA	NA	0	44	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1895.b33d3a26-d864-4669-b06e-1335be4e9e3a.pdf	1895	NA	TUMOR FREE	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	YES	A	LIVING	2009	NA	TCGA-61-1895-01	NA	7ca1db65-98e8-471a-81d5-063d6c3c3a0c	NA	TCGA-61-1895-01	NA	TCGA-61-1895-01A-01D-0581-05	NA	TCGA-61-1895-01A-21-1559-20	TCGA-61-1895-01A-01W-0639-09	NA	TCGA-61-1895-01A-01D-0577-01	TCGA-61-1895-01	9525c377-b25f-422f-8da7-60319fc43d79	NA	TCGA-61-1895-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1895-01	NA	NA	NA	TCGA-61-1895-01A-01R-0584-07	
TCGA-61-1899-01	0	TCGA-61-1899-01	256	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-61-1899	NA	NA	days	256	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	81	Left	TCGA-61-1899-F28217	TCGA-61-1899	TCGA-61-1899-01A	Stage IIIC	-29692	NA	NA	0	256	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1899.0b416e24-55c4-4235-b56b-9dc1507ee5ef.pdf	1899	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2008	NA	TCGA-61-1899-01	NA	06aa647b-fe58-4a63-976b-9bd171297b87	NA	TCGA-61-1899-01	NA	TCGA-61-1899-01A-01D-0581-05	NA	TCGA-61-1899-01A-21-1559-20	TCGA-61-1899-01A-01W-0639-09	NA	TCGA-61-1899-01A-01D-0577-01	TCGA-61-1899-01	fdb5929a-eedd-48b3-9938-5d08ac8ba4fc	NA	TCGA-61-1899-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1899-01	NA	NA	NA	TCGA-61-1899-01A-01R-0584-07	
TCGA-61-1900-01	0	TCGA-61-1900-01	176	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-61-1900	NA	NA	days	176	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-61-1900-F28221	TCGA-61-1900	TCGA-61-1900-01A	Stage IIIB	-18963	NA	NA	0	176	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.9	NO	NA	1.5	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-1900.b0dd202d-16dc-42ec-ad83-6f02b37b919f.pdf	1900	NA	TUMOR FREE	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.6	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2008	TCGA-61-1900-01	TCGA-61-1900-01	NA	c5d1eb0e-d7a4-49e1-9a07-1abe99e33881	NA	TCGA-61-1900-01	NA	TCGA-61-1900-01A-01D-0581-05	NA	TCGA-61-1900-01A-21-1559-20	TCGA-61-1900-01A-01W-0639-09	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	TCGA-61-1900-01A-01D-0577-01	TCGA-61-1900-01	c3a92cba-410a-4853-8bae-4bec74b693d7	NA	TCGA-61-1900-01A-01D-0577-01	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	NA	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	NA	TCGA-61-1900-01	TCGA-61-1900-01	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	NA	TCGA-61-1900-01A-01R-0584-07	
TCGA-61-1901-01	1	TCGA-61-1901-01	347	1	days	Squamous	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 6	NA	TCGA-61-1901	NA	NA	days	347	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	65	Bilateral	TCGA-61-1901-F28226	TCGA-61-1901	NA	Stage IV	-24042	NA	347	0	347	NA	329	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	YES	G3	Progression of Disease	NA	NA	NA	NA	NA	1901	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	NA	NA	NA	61	NA	Ovary	YES	NA	DECEASED	2008	NA	TCGA-61-1901-01	NA	e34c17f8-b6a2-4c24-bba7-d9548a0cca89	NA	TCGA-61-1901-01	NA	TCGA-61-1901-01A-01D-0581-05	NA	NA	TCGA-61-1901-01A-01W-0639-09	NA	TCGA-61-1901-01A-01D-0577-01	TCGA-61-1901-01	NA	NA	TCGA-61-1901-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1901-01	NA	NA	NA	TCGA-61-1901-01A-01R-0584-07	
TCGA-61-1903-01	0	TCGA-61-1903-01	396	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1903	NA	NA	days	396	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Bilateral	TCGA-61-1903-F28231	TCGA-61-1903	TCGA-61-1903-01A	Stage IB	-20381	NA	NA	0	396	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-1903.879ac4e3-cb0d-4fcb-a51d-8cbc6ad0c4a0.pdf	1903	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	NO	A	LIVING	2007	NA	NA	NA	9bcc6171-29ca-40b3-880a-2e3e95a95f94	NA	NA	NA	TCGA-61-1903-01A-01D-0581-05	NA	TCGA-61-1903-01A-21-1559-20	TCGA-61-1903-01A-01W-0639-09	NA	TCGA-61-1903-01A-01D-0577-01	TCGA-61-1903-01	57c3b3e8-b200-43e1-9f63-f7e0f872ca8c	NA	TCGA-61-1903-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1903-01	NA	NA	NA	TCGA-61-1903-01A-01R-0584-07	
TCGA-61-1904-01	0	TCGA-61-1904-01	276	0	days	High	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-61-1904	NA	NA	days	276	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-61-1904-F28236	TCGA-61-1904	NA	Stage IIIC	-22009	NA	NA	0	276	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	NA	NA	NA	NA	NA	NA	1904	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	61	1-10 mm	Ovary	NO	NA	LIVING	2007	NA	NA	NA	ac3f73b4-4953-4836-8834-43729c647ac3	NA	NA	NA	TCGA-61-1904-01A-01D-0581-05	NA	NA	TCGA-61-1904-01A-01W-0639-09	NA	TCGA-61-1904-01A-01D-0577-01	TCGA-61-1904-01	NA	NA	TCGA-61-1904-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1904-01	NA	NA	NA	TCGA-61-1904-01A-01R-0584-07	
TCGA-61-1906-01	1	TCGA-61-1906-01	1038	1	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	NA	TCGA-61-1906	NA	NA	days	1038	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-61-1906-F28240	TCGA-61-1906	TCGA-61-1906-01A	Stage IIIC	-20378	NA	1038	0	1038	NA	236	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1906.a540b6e3-4a34-4546-a91a-a6bcd09921bd.pdf	1906	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	61	11-20 mm	Ovary	YES	A	DECEASED	2006	NA	TCGA-61-1906-01	NA	9e164e07-0887-4e9d-8e54-92e2b9621257	NA	TCGA-61-1906-01	NA	TCGA-61-1906-01A-01D-0581-05	NA	TCGA-61-1906-01A-21-1559-20	TCGA-61-1906-01A-01W-0639-09	NA	TCGA-61-1906-01A-01D-0577-01	TCGA-61-1906-01	f3b04ec3-bd80-437b-be87-aa7b75249821	NA	TCGA-61-1906-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1906-01	NA	NA	NA	TCGA-61-1906-01A-01R-0584-07	
TCGA-61-1907-01	0	TCGA-61-1907-01	952	0	days	Squamous	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-61-1907	NA	NA	days	952	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-61-1907-F28250	TCGA-61-1907	TCGA-61-1907-01A	Stage IIIC	-23204	NA	NA	0	952	NA	743	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.9	NO	NA	1.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1907.ae7e4795-496e-47d0-ad60-cec04e5876b0.pdf	1907	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	11-20 mm	Ovary	YES	A	LIVING	2006	TCGA-61-1907-01	TCGA-61-1907-01	NA	429e7e1a-3ded-46a3-9eee-aa048cbfade2	NA	TCGA-61-1907-01	NA	TCGA-61-1907-01A-01D-0581-05	NA	TCGA-61-1907-01A-21-1559-20	TCGA-61-1907-01A-01W-0639-09	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	TCGA-61-1907-01A-01D-0577-01	TCGA-61-1907-01	2356261e-fe60-47da-9f8e-c06bfe510a03	NA	TCGA-61-1907-01A-01D-0577-01	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	NA	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	NA	TCGA-61-1907-01	TCGA-61-1907-01	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	NA	TCGA-61-1907-01A-01R-0584-07	
TCGA-61-1910-01	0	TCGA-61-1910-01	1127	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	NA	TCGA-61-1910	NA	NA	days	1127	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	56	Bilateral	TCGA-61-1910-F28256	TCGA-61-1910	TCGA-61-1910-01A	Stage IIC	-20779	NA	NA	0	1127	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40.pdf	1910	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2006	TCGA-61-1910-01	TCGA-61-1910-01	NA	e61d1b4c-7a8a-431c-bef5-1be42deda0c1	NA	TCGA-61-1910-01	NA	TCGA-61-1910-01A-01D-0581-05	NA	TCGA-61-1910-01A-21-1559-20	TCGA-61-1910-01A-01W-0639-09	65e4e40b-f27f-4b84-9979-af659564363d	TCGA-61-1910-01A-01D-0577-01	TCGA-61-1910-01	18b958a6-f51e-4fb3-a240-cfe22c05d967	NA	TCGA-61-1910-01A-01D-0577-01	65e4e40b-f27f-4b84-9979-af659564363d	NA	65e4e40b-f27f-4b84-9979-af659564363d	NA	TCGA-61-1910-01	TCGA-61-1910-01	65e4e40b-f27f-4b84-9979-af659564363d	NA	TCGA-61-1910-01A-01R-0584-07	
TCGA-61-1911-01	0	TCGA-61-1911-01	1293	0	days	High	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 2	NA	TCGA-61-1911	NA	NA	days	1293	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Left	TCGA-61-1911-F28260	TCGA-61-1911	TCGA-61-1911-01A	Stage IIA	-20144	NA	NA	0	1293	NA	844	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8.pdf	1911	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	YES	A	LIVING	2005	NA	TCGA-61-1911-01	NA	70685d12-f206-43bd-bc6d-1954ffa1b600	NA	TCGA-61-1911-01	NA	TCGA-61-1911-01A-01D-0581-05	NA	TCGA-61-1911-01A-21-1559-20	TCGA-61-1911-01A-01W-0639-09	NA	TCGA-61-1911-01A-01D-0577-01	TCGA-61-1911-01	18959b13-60ff-43b5-8f53-acee023d775a	NA	TCGA-61-1911-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1911-01	NA	NA	NA	TCGA-61-1911-01A-01R-0584-07	
TCGA-61-1913-01	0	TCGA-61-1913-01	1488	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-61-1913	NA	NA	days	1488	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Right	TCGA-61-1913-F28269	TCGA-61-1913	TCGA-61-1913-01A	Stage IIIB	-17575	NA	NA	0	1488	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1913.b789ee6d-d1e2-4836-8bdc-3c59b0729ee1.pdf	1913	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2005	NA	TCGA-61-1913-01	NA	7b569b43-ae4c-4611-8852-1e8213c1d7ae	NA	TCGA-61-1913-01	NA	TCGA-61-1913-01A-01D-0581-05	NA	TCGA-61-1913-01A-21-1559-20	TCGA-61-1913-01A-01W-0639-09	NA	TCGA-61-1913-01A-01D-0577-01	TCGA-61-1913-01	a97ee569-979a-4d19-bf30-61dd734ed78d	NA	TCGA-61-1913-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1913-01	NA	NA	NA	TCGA-61-1913-01A-01R-0584-07	
TCGA-61-1914-01	0	TCGA-61-1914-01	1722	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	NA	TCGA-61-1914	NA	NA	days	1722	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-61-1914-F28273	TCGA-61-1914	TCGA-61-1914-01A	Stage IIIC	-23850	NA	NA	0	1722	NA	1674	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1914.b634b2cf-9e8d-4dd4-8442-337c22522a43.pdf	1914	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	>20 mm	Ovary	YES	A	LIVING	2003	TCGA-61-1914-01	TCGA-61-1914-01	NA	32a0bd09-8cc4-46e6-a36d-67478fab51fc	NA	TCGA-61-1914-01	NA	TCGA-61-1914-01A-01D-0581-05	NA	TCGA-61-1914-01A-21-1559-20	TCGA-61-1914-01A-01W-0639-09	0d75483f-eab3-41c8-b2cc-453af29b6f44	TCGA-61-1914-01A-01D-0577-01	TCGA-61-1914-01	7497a274-7ee4-423f-a0bd-59afb02a305e	NA	TCGA-61-1914-01A-01D-0577-01	0d75483f-eab3-41c8-b2cc-453af29b6f44	NA	0d75483f-eab3-41c8-b2cc-453af29b6f44	NA	TCGA-61-1914-01	TCGA-61-1914-01	0d75483f-eab3-41c8-b2cc-453af29b6f44	NA	TCGA-61-1914-01A-01R-0584-07	
TCGA-61-1915-01	0	TCGA-61-1915-01	2061	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 4	NA	TCGA-61-1915	NA	NA	days	2061	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	50	Bilateral	TCGA-61-1915-F28280	TCGA-61-1915	TCGA-61-1915-01A	Stage IIC	-18424	NA	NA	0	2061	NA	NA	NA	NA	NA	2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1915.1c305700-d86f-449a-a556-02f32484dda1.pdf	1915	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	YES	A	LIVING	2003	NA	TCGA-61-1915-01	NA	4c9b5377-7e2c-4a97-9663-3ff18822053c	NA	TCGA-61-1915-01	NA	TCGA-61-1915-01A-01D-0581-05	NA	TCGA-61-1915-01A-21-1559-20	TCGA-61-1915-01A-01W-0639-09	NA	TCGA-61-1915-01A-01D-0577-01	TCGA-61-1915-01	407fd5a4-3e13-42c6-9f10-424562adfee5	NA	TCGA-61-1915-01A-01D-0577-01	NA	NA	NA	NA	TCGA-61-1915-01	NA	NA	NA	TCGA-61-1915-01A-01R-0584-07	
TCGA-61-1916-01	1	TCGA-61-1916-01	475	1	days	Quiet	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-1916	NA	NA	days	475	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	53	Bilateral	TCGA-61-1916-F28284	TCGA-61-1916	NA	Stage IIIC	-19463	NA	475	0	475	NA	326	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	NA	NA	NA	NA	NA	NA	G2	Recurrence	NA	NA	NA	NA	NA	1916	NA	NA	YES	NA	NA	NO	R1	Primary Tumor	01	NA	NA	NA	61	1-10 mm	Ovary	YES	NA	DECEASED	2002	NA	NA	NA	aab4f5cd-7169-41e6-ae24-2bddbd752f62	NA	NA	NA	TCGA-61-1916-01A-01D-0807-05	NA	TCGA-61-1916-01A-21-1559-20	NA	NA	NA	TCGA-61-1916-01	e7b8ce5d-a28b-44c9-8b3a-d52882fce319	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-1916-01A-01R-0810-07	
TCGA-61-1916-02	1	TCGA-61-1916-02	475	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-61-1916	NA	NA	days	475	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	53	Bilateral	TCGA-61-1916-F28284	TCGA-61-1916	TCGA-61-1916-02A	Stage IIIC	-19463	NA	475	0	475	NA	326	NA	NA	NA	2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.3	NO	NA	1.8	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-1916.C85D2BF7-498B-4E17-9F13-899AC8D6EC88.pdf	1916	NA	NA	YES	NA	NA	NO	R1	Recurrent Tumor	02	0.3	NA	NA	61	1-10 mm	Ovary	YES	A	DECEASED	2002	NA	NA	NA	6490d8bc-620c-45d2-9314-97ec1b52e4d0	NA	NA	NA	TCGA-61-1916-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-1916-02A-01R-0810-07	
TCGA-61-1917-01	1	TCGA-61-1917-01	1321	1	days	High	NA	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	NA	TCGA-61-1917	NA	NA	days	1321	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	60	Bilateral	TCGA-61-1917-F28290	TCGA-61-1917	TCGA-61-1917-01A	Stage IIIB	-21972	NA	1321	0	1321	NA	NA	NA	NA	NA	2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-1917.ebb81051-f181-4878-85ac-7e00ad6aca85.pdf	1917	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	61	NA	Ovary	NO	A	DECEASED	2002	TCGA-61-1917-01	TCGA-61-1917-01	NA	5005b439-42ac-4dc7-aa13-3817d6091536	NA	TCGA-61-1917-01	NA	TCGA-61-1917-01A-01D-0652-05	NA	NA	NA	519aea8b-5e08-47b2-bb98-b311f2dba540	TCGA-61-1917-01A-01D-0648-01	TCGA-61-1917-01	NA	NA	TCGA-61-1917-01A-01D-0648-01	519aea8b-5e08-47b2-bb98-b311f2dba540	NA	519aea8b-5e08-47b2-bb98-b311f2dba540	NA	TCGA-61-1917-01	TCGA-61-1917-01	519aea8b-5e08-47b2-bb98-b311f2dba540	NA	TCGA-61-1917-01A-01R-0655-07	
TCGA-61-1918-01	1	TCGA-61-1918-01	479	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	NA	TCGA-61-1918	NA	NA	days	479	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-61-1918-F28295	TCGA-61-1918	TCGA-61-1918-01A	Stage IV	-16689	NA	479	0	479	NA	413	NA	NA	NA	2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-1918.6c95bd12-e871-4e4e-961f-09a64c1fe2de.pdf	1918	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	YES	A	DECEASED	2002	TCGA-61-1918-01	TCGA-61-1918-01	NA	5f2955fc-dc80-4ce8-93d6-6db708af6ea4	NA	TCGA-61-1918-01	NA	TCGA-61-1918-01A-01D-0652-05	NA	TCGA-61-1918-01A-21-1559-20	NA	62f75d97-ea9e-4694-8c83-1a0e6d137a02	TCGA-61-1918-01A-01D-0648-01	TCGA-61-1918-01	8c7cf533-1039-4e1a-9a0a-83c8d8c2e597	NA	TCGA-61-1918-01A-01D-0648-01	62f75d97-ea9e-4694-8c83-1a0e6d137a02	NA	62f75d97-ea9e-4694-8c83-1a0e6d137a02	NA	TCGA-61-1918-01	TCGA-61-1918-01	62f75d97-ea9e-4694-8c83-1a0e6d137a02	NA	TCGA-61-1918-01A-01R-0655-07	
TCGA-61-1919-01	1	TCGA-61-1919-01	1161	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-1919	NA	NA	days	1161	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-61-1919-F28300	TCGA-61-1919	TCGA-61-1919-01A	Stage IIIC	-21199	NA	1161	0	1161	NA	439	NA	NA	NA	2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-1919.240a49a3-b611-4949-b3b9-3799d8c0dc46.pdf	1919	NA	NA	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	NA	A	DECEASED	2001	TCGA-61-1919-01	TCGA-61-1919-01	NA	e2935fb6-7c83-4691-b144-029cd17eadac	NA	TCGA-61-1919-01	NA	TCGA-61-1919-01A-01D-0652-05	NA	TCGA-61-1919-01A-21-1559-20	NA	056cca38-92df-42ff-b064-b0c243f8a82f	TCGA-61-1919-01A-01D-0648-01	TCGA-61-1919-01	278e1675-c8e6-4578-b83d-4cd82de93d4b	NA	TCGA-61-1919-01A-01D-0648-01	056cca38-92df-42ff-b064-b0c243f8a82f	NA	056cca38-92df-42ff-b064-b0c243f8a82f	NA	TCGA-61-1919-01	TCGA-61-1919-01	056cca38-92df-42ff-b064-b0c243f8a82f	TCGA-61-1919-01A-01W-0699-08	TCGA-61-1919-01A-01R-0655-07	
TCGA-61-1995-01	0	TCGA-61-1995-01	61	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-61-1995	NA	NA	days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	43	Bilateral	TCGA-61-1995-F28302	TCGA-61-1995	TCGA-61-1995-01A	Stage IIIC	-16016	NA	NA	0	61	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	1.1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d.pdf	1995	NA	WITH TUMOR	YES	Stable Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2009	TCGA-61-1995-01	TCGA-61-1995-01	NA	180584fa-7aa6-4182-b57b-4e02365663e1	NA	TCGA-61-1995-01	NA	TCGA-61-1995-01A-01D-0667-05	NA	TCGA-61-1995-01A-21-1559-20	NA	13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01D-0663-01	TCGA-61-1995-01	1bdc5555-06ec-496c-ac44-b8847ca95fb5	NA	TCGA-61-1995-01A-01D-0663-01	13b2c972-c6ef-4d1f-8ada-f831d2606023	NA	13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01W-0722-08	TCGA-61-1995-01	TCGA-61-1995-01	13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01W-0722-08	TCGA-61-1995-01A-01R-0670-07	
TCGA-61-1998-01	0	TCGA-61-1998-01	168	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1998	NA	NA	days	168	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Bilateral	TCGA-61-1998-F28306	TCGA-61-1998	TCGA-61-1998-01A	Stage IIIC	-17855	NA	NA	0	168	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a.pdf	1998	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2009	TCGA-61-1998-01	TCGA-61-1998-01	NA	03f33fd8-fd9b-46b0-8291-ba92d1d32102	NA	TCGA-61-1998-01	NA	TCGA-61-1998-01A-01D-0667-05	NA	NA	NA	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01D-0663-01	TCGA-61-1998-01	NA	NA	TCGA-61-1998-01A-01D-0663-01	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	NA	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01W-0722-08	TCGA-61-1998-01	TCGA-61-1998-01	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01W-0722-08	TCGA-61-1998-01A-01R-0670-07	
TCGA-61-2000-01	0	TCGA-61-2000-01	441	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2000	NA	NA	days	441	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-61-2000-F28311	TCGA-61-2000	TCGA-61-2000-01A	Stage IIIC	-24723	NA	NA	0	441	NA	339	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2000.4e13b897-c34a-4422-9c66-7ca8b2734ef2.pdf	2000	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	YES	A	LIVING	2008	TCGA-61-2000-01	TCGA-61-2000-01	NA	4150fb96-e722-40db-a6d0-d55e60cc30f6	NA	TCGA-61-2000-01	NA	TCGA-61-2000-01A-01D-0667-05	NA	TCGA-61-2000-01A-21-1559-20	NA	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01D-0663-01	TCGA-61-2000-01	c7083eed-998f-456d-b294-5fbcf50eff88	NA	TCGA-61-2000-01A-01D-0663-01	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	NA	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01W-0722-08	TCGA-61-2000-01	TCGA-61-2000-01	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01W-0722-08	TCGA-61-2000-01A-01R-0670-07	
TCGA-61-2002-01	0	TCGA-61-2002-01	547	0	days	High	NA	OV-like c1	NA	NA	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2002	NA	NA	days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	46	Bilateral	TCGA-61-2002-F28321	TCGA-61-2002	TCGA-61-2002-01A	Stage IIIC	-17115	NA	NA	0	547	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1.2	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-2002.8030b8aa-9686-45b3-bf39-1889a6b8b36f.pdf	2002	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	11-20 mm	Ovary	YES	A	LIVING	2008	TCGA-61-2002-01	TCGA-61-2002-01	NA	a31ab004-2dce-4cd6-a015-88c43ca44086	NA	TCGA-61-2002-01	NA	TCGA-61-2002-01A-01D-0667-05	NA	NA	NA	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01D-0663-01	TCGA-61-2002-01	NA	NA	TCGA-61-2002-01A-01D-0663-01	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	NA	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01W-0722-08	TCGA-61-2002-01	TCGA-61-2002-01	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01W-0722-08	TCGA-61-2002-01A-01R-0670-07	
TCGA-61-2003-01	0	TCGA-61-2003-01	122	0	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2003	NA	NA	days	122	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	53	Bilateral	TCGA-61-2003-F28327	TCGA-61-2003	TCGA-61-2003-01A	Stage IIIC	-19605	NA	NA	0	122	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	1.4	NO	NA	1.5	NA	YES	G2	NA	NA	NA	NA	NA	TCGA-61-2003.79c66510-6e38-470f-9e91-d774665d39a6.pdf	2003	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.2	NA	NA	61	1-10 mm	Ovary	YES	A	LIVING	2008	TCGA-61-2003-01	TCGA-61-2003-01	NA	a878c841-59fa-4ef2-af20-dc8937f92b9b	NA	TCGA-61-2003-01	NA	TCGA-61-2003-01A-01D-0667-05	NA	TCGA-61-2003-01A-21-1559-20	NA	bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01D-0663-01	TCGA-61-2003-01	379f3f36-fb28-4eb4-8c56-24c0382bf38f	NA	TCGA-61-2003-01A-01D-0663-01	bc200f3a-6d31-4480-8785-987f14cfa319	NA	bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01W-0722-08	TCGA-61-2003-01	TCGA-61-2003-01	bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01W-0722-08	TCGA-61-2003-01A-01R-0670-07	
TCGA-61-2008-01	0	TCGA-61-2008-01	932	0	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2008	NA	NA	days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2008-F28334	TCGA-61-2008	TCGA-61-2008-01A	Stage IIC	-14791	NA	NA	0	932	NA	818	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	1.2	NA	YES	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2008.25448427-9a2c-4c36-bc9d-40a82d6e3710.pdf	2008	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-61-2008-01	TCGA-61-2008-01	NA	5df0fa21-8263-4992-a797-44e2a1981b93	NA	TCGA-61-2008-01	NA	TCGA-61-2008-01A-02D-0667-05	NA	NA	NA	10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02D-0663-01	TCGA-61-2008-01	53527bf6-168b-469b-bbb3-d5e7640ee38a	NA	TCGA-61-2008-01A-02D-0663-01	10271f7f-cce6-44fd-8754-7a4beabfb394	NA	10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02W-0722-08	TCGA-61-2008-01	TCGA-61-2008-01	10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02W-0722-08	TCGA-61-2008-01A-02R-0670-07	
TCGA-61-2008-02	0	TCGA-61-2008-02	932	0	days	NA	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	NA	mutation cluster 5	TCGA-61-2008	NA	NA	days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2008-F28334	TCGA-61-2008	TCGA-61-2008-02A	Stage IIC	-14791	NA	NA	0	932	NA	818	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.5	NO	NA	2	NA	YES	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2008.614D7B6A-B3B4-4F1B-9762-0749D559247F.pdf	2008	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.3	NA	NA	61	No Macroscopic disease	Ovary	YES	A	LIVING	2007	NA	TCGA-61-2008-02	NA	0d478984-a92d-491d-88e6-4a7621463012	NA	TCGA-61-2008-02	NA	TCGA-61-2008-02A-01D-0807-05	NA	NA	NA	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	NA	NA	540b245e-be19-4b26-a9fa-a4b3dd9a2975	NA	NA	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	NA	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	NA	NA	NA	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	NA	TCGA-61-2008-02A-01R-0810-07	
TCGA-61-2009-01	0	TCGA-61-2009-01	1212	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 2	TCGA-61-2009	NA	NA	days	1212	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-61-2009-F28341	TCGA-61-2009	TCGA-61-2009-01A	Stage IIIC	-23772	NA	NA	0	1212	NA	101	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2009.39de8c59-e593-47d3-932d-575a4537b4dc.pdf	2009	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.2	NA	NA	61	11-20 mm	Ovary	YES	A	LIVING	2006	TCGA-61-2009-01	TCGA-61-2009-01	NA	c8e01e3b-9789-4216-b771-18ac3b062a4c	NA	TCGA-61-2009-01	NA	TCGA-61-2009-01A-01D-0667-05	NA	TCGA-61-2009-01A-21-1559-20	NA	b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01D-0663-01	TCGA-61-2009-01	8e12e5af-19de-4c90-a0b6-da67eeb438f4	NA	TCGA-61-2009-01A-01D-0663-01	b6ed2184-0885-49ba-8b00-a3e57e4e5500	NA	b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01W-0722-08	TCGA-61-2009-01	TCGA-61-2009-01	b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01W-0722-08	TCGA-61-2009-01A-01R-0670-07	
TCGA-61-2012-01	0	TCGA-61-2012-01	932	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-61-2012	NA	NA	days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	81	Left	TCGA-61-2012-F28352	TCGA-61-2012	TCGA-61-2012-01A	Stage IIC	-29830	NA	NA	0	932	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.6	NA	YES	G2	NA	NA	NA	NA	NA	TCGA-61-2012.534e3236-b9e7-4b0b-a2a3-2fc3a96fac81.pdf	2012	NA	NA	YES	NA	NA	YES	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	YES	A	LIVING	2006	TCGA-61-2012-01	TCGA-61-2012-01	NA	12b5e477-31d5-4ec1-ac90-989ce781c36a	NA	TCGA-61-2012-01	NA	TCGA-61-2012-01A-01D-0667-05	NA	TCGA-61-2012-01A-21-1559-20	NA	929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01D-0663-01	TCGA-61-2012-01	6eb6997b-a982-44b0-ab5a-5faaa1b0c2be	NA	TCGA-61-2012-01A-01D-0663-01	929c2bc4-4cee-4f82-b336-918fe041a588	NA	929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01W-0722-08	TCGA-61-2012-01	TCGA-61-2012-01	929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01W-0722-08	TCGA-61-2012-01A-01R-0670-07	
TCGA-61-2016-01	1	TCGA-61-2016-01	36	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2016	NA	NA	days	36	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-61-2016-F28357	TCGA-61-2016	TCGA-61-2016-01A	Stage IIIC	-18788	NA	36	0	NA	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	YES	G3	NA	NA	NA	NA	NA	TCGA-61-2016.1bb87fde-9ff0-4c33-a388-b655f9647407.pdf	2016	NA	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	0.1	NA	NA	61	No Macroscopic disease	Ovary	YES	A	DECEASED	2006	TCGA-61-2016-01	TCGA-61-2016-01	NA	4e470958-8a7a-4a48-a609-2d7f49b49bbf	NA	TCGA-61-2016-01	NA	TCGA-61-2016-01A-01D-0667-05	NA	NA	NA	a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01D-0663-01	TCGA-61-2016-01	NA	NA	TCGA-61-2016-01A-01D-0663-01	a391b870-b6fb-4ca8-b425-2331fceae442	NA	a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01W-0722-08	TCGA-61-2016-01	TCGA-61-2016-01	a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01W-0722-08	TCGA-61-2016-01A-01R-0670-07	
TCGA-61-2017-01	0	TCGA-61-2017-01	1398	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2017	NA	NA	days	1398	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Bilateral	TCGA-61-2017-F28359	TCGA-61-2017	TCGA-61-2017-01A	Stage IIIC	-23509	NA	NA	0	1398	NA	1006	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	0.8	NA	NO	G1	Recurrence	NA	NA	NA	NA	TCGA-61-2017.b24757fc-4585-496e-b89e-f3dafac36b8b.pdf	2017	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.3	NA	NA	61	1-10 mm	Ovary	NO	A	LIVING	2005	NA	NA	NA	7cfe4d7d-392d-4612-a29a-80ddafdfcbd0	NA	NA	NA	TCGA-61-2017-01A-01D-0667-05	NA	TCGA-61-2017-01A-21-1559-20	NA	NA	TCGA-61-2017-01A-01D-0663-01	TCGA-61-2017-01	62d181c0-c0fb-44b3-9837-040f5780c2ff	NA	TCGA-61-2017-01A-01D-0663-01	NA	NA	NA	NA	TCGA-61-2017-01	NA	NA	NA	TCGA-61-2017-01A-01R-0670-07	
TCGA-61-2018-01	0	TCGA-61-2018-01	1381	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2018	NA	NA	days	1381	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-61-2018-F28366	TCGA-61-2018	TCGA-61-2018-01A	Stage IC	-22929	NA	NA	0	1381	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.9	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7.pdf	2018	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2005	NA	NA	NA	a13bb1ee-868f-4891-921f-d0005ebe1ab8	NA	NA	NA	TCGA-61-2018-01A-01D-0667-05	NA	TCGA-61-2018-01A-21-1559-20	NA	NA	TCGA-61-2018-01A-01D-0663-01	TCGA-61-2018-01	99bf9379-737b-4b8c-9196-2c1fa0148eae	NA	TCGA-61-2018-01A-01D-0663-01	NA	NA	NA	NA	TCGA-61-2018-01	NA	NA	NA	TCGA-61-2018-01A-01R-0670-07	
TCGA-61-2087-01	0	TCGA-61-2087-01	146	0	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2087	NA	NA	days	146	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	49	Left	TCGA-61-2087-F28372	TCGA-61-2087	NA	Stage IC	-18182	NA	NA	0	146	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	NO	G3	NA	NA	NA	NA	NA	NA	2087	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	61	No Macroscopic disease	Ovary	NO	NA	LIVING	2009	NA	NA	NA	a60b189b-6316-4098-adc7-fefca69b803b	NA	NA	NA	TCGA-61-2087-01A-01D-0667-05	NA	TCGA-61-2087-01A-21-1560-20	NA	NA	TCGA-61-2087-01A-01D-0663-01	TCGA-61-2087-01	b59fdd2e-4ec7-4e64-95fd-f5777ecdc89b	NA	TCGA-61-2087-01A-01D-0663-01	NA	NA	NA	NA	TCGA-61-2087-01	NA	NA	NA	TCGA-61-2087-01A-01R-0670-07	
TCGA-61-2088-01	0	TCGA-61-2088-01	145	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-61-2088	NA	NA	days	145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	51	Bilateral	TCGA-61-2088-F28377	TCGA-61-2088	TCGA-61-2088-01A	Stage IIIC	-18770	NA	NA	0	145	NA	NA	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.4	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3.pdf	2088	NA	TUMOR FREE	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2009	TCGA-61-2088-01	TCGA-61-2088-01	NA	9959458a-de14-4d2d-b13f-9ab2f0c88bf1	NA	TCGA-61-2088-01	NA	TCGA-61-2088-01A-01D-0667-05	NA	TCGA-61-2088-01A-21-1560-20	NA	62fdea50-f152-4f43-9130-a93079b5e61f	TCGA-61-2088-01A-01D-0663-01	TCGA-61-2088-01	2b716c21-1692-4b95-9363-0c6a23de28d6	NA	TCGA-61-2088-01A-01D-0663-01	62fdea50-f152-4f43-9130-a93079b5e61f	NA	62fdea50-f152-4f43-9130-a93079b5e61f	NA	TCGA-61-2088-01	TCGA-61-2088-01	62fdea50-f152-4f43-9130-a93079b5e61f	TCGA-61-2088-01A-01W-0722-08	TCGA-61-2088-01A-01R-0670-07	
TCGA-61-2092-01	0	TCGA-61-2092-01	1573	0	days	BRCA-LUAD+	C9-OV	UCEC non-CIMP c3	OV-like c4	COADREAD-like c15	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2092	NA	NA	days	1573	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	57	Bilateral	TCGA-61-2092-F28381	TCGA-61-2092	TCGA-61-2092-01A	Stage IIIC	-21072	NA	NA	0	1573	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.2	NO	NA	1.3	NA	NO	G3	NA	NA	NA	NA	NA	TCGA-61-2092.35b4bfa3-e6a5-4b55-a7f1-bc39953422c0.pdf	2092	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2004	TCGA-61-2092-01	TCGA-61-2092-01	NA	cf1288eb-e5c8-4c90-9f83-f3bdcbd94a96	NA	TCGA-61-2092-01	NA	TCGA-61-2092-01A-01D-0667-05	NA	TCGA-61-2092-01A-21-1560-20	NA	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01D-0663-01	TCGA-61-2092-01	94487130-5cc1-4f68-beab-57c211204449	NA	TCGA-61-2092-01A-01D-0663-01	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	NA	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01W-0722-08	TCGA-61-2092-01	TCGA-61-2092-01	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01W-0722-08	TCGA-61-2092-01A-01R-0670-07	
TCGA-61-2094-01	0	TCGA-61-2094-01	2182	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2094	NA	NA	days	2182	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	63	Bilateral	TCGA-61-2094-F28385	TCGA-61-2094	TCGA-61-2094-01A	Stage IIIC	-23273	NA	NA	0	2182	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.1	NO	NA	2	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75.pdf	2094	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	NA	Ovary	NA	A	LIVING	2003	TCGA-61-2094-01	TCGA-61-2094-01	NA	1429ef11-964e-4e8b-afbb-8f38b75ad39f	NA	TCGA-61-2094-01	NA	TCGA-61-2094-01A-01D-0667-05	NA	TCGA-61-2094-01A-21-1560-20	NA	c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01D-0663-01	TCGA-61-2094-01	1ac0ed16-0e91-4c45-9b9d-b68ceb9940da	NA	TCGA-61-2094-01A-01D-0663-01	c6e1c591-3225-482a-8350-112b664a37e6	NA	c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01W-0722-08	TCGA-61-2094-01	TCGA-61-2094-01	c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01W-0722-08	TCGA-61-2094-01A-01R-0670-07	
TCGA-61-2095-01	1	TCGA-61-2095-01	1875	1	days	Kirc+	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-61-2095	NA	NA	days	1875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-61-2095-F28389	TCGA-61-2095	TCGA-61-2095-01A	Stage IIIC	-19797	NA	1875	0	NA	NA	445	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1.2	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2095.3e08408b-b76a-4a32-b3f1-4590459f4af8.pdf	2095	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003	TCGA-61-2095-01	TCGA-61-2095-01	NA	5229ff68-9cae-49dc-aba8-757026e6e452	NA	TCGA-61-2095-01	NA	TCGA-61-2095-01A-01D-0667-05	NA	TCGA-61-2095-01A-21-1560-20	NA	15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01D-0663-01	TCGA-61-2095-01	74a1f15a-05c4-4d85-a731-9a4e5281f644	NA	TCGA-61-2095-01A-01D-0663-01	15a11ef0-5e18-44d0-ba50-73cf356b8408	NA	15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01W-0722-08	TCGA-61-2095-01	TCGA-61-2095-01	15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01W-0722-08	TCGA-61-2095-01A-01R-0670-07	
TCGA-61-2095-02	1	TCGA-61-2095-02	1875	1	days	NA	C9-OV	OV-like c1	NA	NA	NA	NA	mutation c1uster 9	TCGA-61-2095	NA	NA	days	1875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-61-2095-F28389	TCGA-61-2095	TCGA-61-2095-02A	Stage IIIC	-19797	NA	1875	0	NA	NA	445	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.6	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2095.309AA9DC-F958-45C3-B596-362ADA553B8C.pdf	2095	NA	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	NA	Recurrent Tumor	02	0.3	NA	NA	61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003	NA	NA	NA	9105d49a-b3ca-4453-95c7-3bb78b3e9e80	NA	NA	NA	TCGA-61-2095-02A-01D-0807-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-2095-02A-01R-0810-07	
TCGA-61-2096-01	0	TCGA-61-2096-01	1776	0	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2096	NA	NA	days	1776	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Right	TCGA-61-2096-F28398	TCGA-61-2096	TCGA-61-2096-01A	Stage IC	-20663	NA	NA	0	1776	NA	421	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2096.9f95fe7d-4865-4ca5-bb57-9d47c388a7ed.pdf	2096	NA	TUMOR FREE	YES	Progressive Disease	Imaging Study	NO	NA	Primary Tumor	01	0.5	NA	NA	61	No Macroscopic disease	Ovary	NA	A	LIVING	2003	NA	NA	NA	9497f7ac-b177-401b-a063-6297f90f009c	NA	NA	NA	TCGA-61-2096-01A-01D-0667-05	NA	TCGA-61-2096-01A-21-1560-20	NA	NA	TCGA-61-2096-01A-01D-0663-01	TCGA-61-2096-01	91b0b079-17b3-4c29-9ebd-1781ae28c86a	NA	TCGA-61-2096-01A-01D-0663-01	NA	NA	NA	NA	TCGA-61-2096-01	NA	NA	NA	TCGA-61-2096-01A-01R-0670-07	
TCGA-61-2097-01	0	TCGA-61-2097-01	1844	0	days	High	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2097	NA	NA	days	1844	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	71	Bilateral	TCGA-61-2097-F28413	TCGA-61-2097	NA	Stage IIC	-25961	NA	NA	0	1844	NA	NA	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	NA	NA	NA	NA	NA	YES	G2	NA	NA	NA	NA	NA	NA	2097	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	NA	NA	NA	61	1-10 mm	Ovary	YES	NA	LIVING	2003	TCGA-61-2097-01	TCGA-61-2097-01	NA	c1da73c7-9f61-41b6-90a1-fdc7bbf4ecd3	NA	TCGA-61-2097-01	NA	TCGA-61-2097-01A-02D-0667-05	NA	NA	NA	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02D-0663-01	TCGA-61-2097-01	NA	NA	TCGA-61-2097-01A-02D-0663-01	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	NA	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02W-0722-08	TCGA-61-2097-01	TCGA-61-2097-01	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02W-0722-08	TCGA-61-2097-01A-02R-0670-07	
TCGA-61-2098-01	0	TCGA-61-2098-01	1993	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	NA	TCGA-61-2098	NA	NA	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	62	Bilateral	TCGA-61-2098-F28418	TCGA-61-2098	TCGA-61-2098-01A	Stage IIIC	-22876	NA	NA	0	1993	NA	NA	NA	NA	NA	2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.7	NO	NA	2	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-61-2098.d1c8ab49-5ba0-46c3-8205-53b4e39808b3.pdf	2098	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	NA	Primary Tumor	01	0.5	NA	NA	61	11-20 mm	Ovary	NO	A	LIVING	2003	TCGA-61-2098-01	TCGA-61-2098-01	NA	0a007e29-e769-44ca-b0a8-465df5d46f4e	NA	TCGA-61-2098-01	NA	TCGA-61-2098-01A-01D-0667-05	NA	TCGA-61-2098-01A-21-1560-20	NA	d855f86a-f302-47fb-aa9f-5977632c695a	TCGA-61-2098-01A-01D-0663-01	TCGA-61-2098-01	f69ce3d8-2a32-4048-a786-50d7e153c051	NA	TCGA-61-2098-01A-01D-0663-01	d855f86a-f302-47fb-aa9f-5977632c695a	NA	d855f86a-f302-47fb-aa9f-5977632c695a	NA	TCGA-61-2098-01	TCGA-61-2098-01	d855f86a-f302-47fb-aa9f-5977632c695a	NA	TCGA-61-2098-01A-01R-0670-07	
TCGA-61-2101-01	1	TCGA-61-2101-01	1688	1	days	High	C9-OV	OV-like c1	OV-like c4	NA	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2101	NA	NA	days	1688	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Bilateral	TCGA-61-2101-F28422	TCGA-61-2101	TCGA-61-2101-01A	Stage IIIC	-20287	NA	1688	0	NA	NA	NA	0	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	100	1.5	NA	NA	G2	NA	NA	NA	NA	NA	TCGA-61-2101.b9d85995-85dd-4b00-b93f-3387cd018475.pdf	2101	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	11-20 mm	Ovary	NA	A	DECEASED	1999	TCGA-61-2101-01	TCGA-61-2101-01	NA	504e1539-a518-4ef6-90b0-4ec6cd2ffbe8	NA	TCGA-61-2101-01	NA	TCGA-61-2101-01A-01D-0667-05	NA	TCGA-61-2101-01A-21-1560-20	NA	95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01D-0663-01	TCGA-61-2101-01	c33bc4d6-607a-425b-bffd-e818b69949f8	NA	TCGA-61-2101-01A-01D-0663-01	95970bdb-e1f2-49dc-903b-c30088cef71d	NA	95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01W-0722-08	TCGA-61-2101-01	TCGA-61-2101-01	95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01W-0722-08	TCGA-61-2101-01A-01R-0670-07	
TCGA-61-2102-01	1	TCGA-61-2102-01	197	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-61-2102	NA	NA	days	197	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	74	Right	TCGA-61-2102-F28438	TCGA-61-2102	TCGA-61-2102-01A	Stage IIIC	-27256	NA	197	0	197	NA	NA	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.5	NA	NA	G3	NA	NA	NA	NA	NA	TCGA-61-2102.f0521e47-1cc3-4f72-9efd-3d128f57e614.pdf	2102	NA	WITH TUMOR	YES	NA	NA	NO	NA	Primary Tumor	01	0.3	NA	NA	61	NA	Ovary	NA	A	DECEASED	1999	TCGA-61-2102-01	TCGA-61-2102-01	NA	5b4f1e0c-f04d-4aa1-a794-5936189506d7	NA	TCGA-61-2102-01	NA	TCGA-61-2102-01A-01D-0667-05	NA	TCGA-61-2102-01A-21-1560-20	NA	7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01D-0663-01	TCGA-61-2102-01	0f492d79-0174-4e9f-8693-2827ba83fd7c	NA	TCGA-61-2102-01A-01D-0663-01	7ac6af79-c14a-4026-84aa-a288afcb96da	NA	7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01W-0722-08	TCGA-61-2102-01	TCGA-61-2102-01	7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01W-0722-08	TCGA-61-2102-01A-01R-0670-07	
TCGA-61-2104-01	0	TCGA-61-2104-01	2338	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2104	NA	NA	days	2338	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-61-2104-F28442	TCGA-61-2104	TCGA-61-2104-01A	Stage IIC	-19432	NA	NA	0	2338	NA	1680	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.6	NO	NA	1.5	NA	NA	G2	Recurrence	NA	NA	NA	NA	TCGA-61-2104.38d2e115-ec9a-40e5-bfa0-30fb1db60691.pdf	2104	NA	NA	YES	Complete Remission/Response	Imaging Study	NO	NA	Primary Tumor	01	0.4	NA	NA	61	No Macroscopic disease	Ovary	NO	A	LIVING	2003	TCGA-61-2104-01	TCGA-61-2104-01	NA	28510e09-fb60-4595-802a-48b0aafc09b9	NA	TCGA-61-2104-01	NA	TCGA-61-2104-01A-01D-0667-05	NA	TCGA-61-2104-01A-21-1560-20	NA	721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01D-0663-01	TCGA-61-2104-01	14d97fdf-fcf4-4471-8595-4b6b5401caf6	NA	TCGA-61-2104-01A-01D-0663-01	721a8fc8-bb54-4ec3-a19c-340c35f05280	NA	721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01W-0722-08	TCGA-61-2104-01	TCGA-61-2104-01	721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01W-0722-08	TCGA-61-2104-01A-01R-0670-07	
TCGA-61-2109-01	1	TCGA-61-2109-01	629	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2109	NA	NA	days	629	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2109-F28450	TCGA-61-2109	TCGA-61-2109-01A	Stage IIIC	-14900	NA	629	0	629	NA	465	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.8	NO	NA	1.7	NA	NO	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2109.c16bfe93-016f-49d4-8895-05b9055344c9.pdf	2109	NA	WITH TUMOR	YES	NA	Molecular Markers	NO	NA	Primary Tumor	01	0.2	NA	NA	61	>20 mm	Ovary	NO	A	DECEASED	1999	TCGA-61-2109-01	TCGA-61-2109-01	NA	37fc46df-f46d-462f-8761-d82c66b8a3a1	NA	TCGA-61-2109-01	NA	TCGA-61-2109-01A-01D-0667-05	NA	TCGA-61-2109-01A-21-1560-20	NA	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01D-0663-01	TCGA-61-2109-01	d3e2505d-0838-4a9c-a626-ad04f9254dd1	NA	TCGA-61-2109-01A-01D-0663-01	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	NA	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01W-0722-08	TCGA-61-2109-01	TCGA-61-2109-01	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01W-0722-08	TCGA-61-2109-01A-01R-0670-07	
TCGA-61-2110-01	1	TCGA-61-2110-01	1354	1	days	Squamous	C9-OV	OV-like c1	NA	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-61-2110	NA	NA	days	1354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	56	Bilateral	TCGA-61-2110-F28456	TCGA-61-2110	TCGA-61-2110-01A	Stage IIIC	-20718	NA	1354	0	1354	NA	213	NA	NA	NA	2009-12-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	0.4	NA	NA	NA	Recurrence	NA	NA	NA	NA	TCGA-61-2110.d7a597dc-d607-4e20-90a9-a181d6c11d17.pdf	2110	NA	WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO	NA	Primary Tumor	01	0.1	NA	NA	61	No Macroscopic disease	Ovary	NA	A	DECEASED	1998	TCGA-61-2110-01	TCGA-61-2110-01	NA	8f17192c-1ecb-4f31-8df0-a6dde0b8ce96	NA	TCGA-61-2110-01	NA	TCGA-61-2110-01A-01D-0667-05	NA	NA	NA	6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01D-0663-01	TCGA-61-2110-01	NA	NA	TCGA-61-2110-01A-01D-0663-01	6561cdb8-8499-41a6-8a79-ef0119e34c66	NA	6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01W-0722-08	TCGA-61-2110-01	TCGA-61-2110-01	6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01W-0722-08	TCGA-61-2110-01A-01R-0670-07	
TCGA-61-2111-01	0	TCGA-61-2111-01	3825	0	days	Squamous	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA c1uster 10	cluster 5	mutation cluster 5	TCGA-61-2111	NA	NA	days	3825	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Left	TCGA-61-2111-F28467	TCGA-61-2111	TCGA-61-2111-01A	Stage IV	-22517	NA	NA	0	3825	NA	2205	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1.4	NO	NA	1.5	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2111.351930bc-ac4d-468e-9fe2-ba6f16c01444.pdf	2111	NA	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	NA	Primary Tumor	01	0.3	NA	NA	61	NA	Ovary	NA	A	LIVING	1998	TCGA-61-2111-01	TCGA-61-2111-01	NA	3ee05aa8-a556-4d87-8aab-a76491d30640	NA	TCGA-61-2111-01	NA	TCGA-61-2111-01A-01D-0667-05	NA	TCGA-61-2111-01A-21-1560-20	NA	25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01D-0663-01	TCGA-61-2111-01	975fb889-32f1-46e2-a558-b32d8a1b353f	NA	TCGA-61-2111-01A-01D-0663-01	25c0888a-25b9-4cc0-a02f-6d363a341e8f	NA	25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01W-0722-08	TCGA-61-2111-01	TCGA-61-2111-01	25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01W-0722-08	TCGA-61-2111-01A-01R-0670-07	
TCGA-61-2113-01	1	TCGA-61-2113-01	676	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-61-2113	NA	NA	days	676	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Right	TCGA-61-2113-F28479	TCGA-61-2113	TCGA-61-2113-01A	Stage IIC	-19722	NA	676	0	676	NA	291	NA	NA	NA	2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.8	NO	NA	1.6	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2113.d10e1b61-73c4-4ab7-bc4b-8c7827856602.pdf	2113	NA	NA	YES	NA	NA	NO	NA	Primary Tumor	01	0.4	NA	NA	61	NA	Ovary	YES	A	DECEASED	1999	TCGA-61-2113-01	TCGA-61-2113-01	NA	9467c678-f573-4a50-83d9-ae3a0880354b	NA	TCGA-61-2113-01	NA	TCGA-61-2113-01A-01D-0667-05	NA	TCGA-61-2113-01A-21-1562-20	NA	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01D-0663-01	TCGA-61-2113-01	a8827db2-9eab-4285-bf50-ab2b9e19be57	NA	TCGA-61-2113-01A-01D-0663-01	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	NA	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01W-0722-08	TCGA-61-2113-01	TCGA-61-2113-01	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01W-0722-08	TCGA-61-2113-01A-01R-0670-07	
TCGA-61-2610-01	1	TCGA-61-2610-01	1579	1	days	NA	NA	NA	OV-like c4	NA	NA	NA	NA	TCGA-61-2610	NA	NA	days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Left	TCGA-61-2610-F28484	TCGA-61-2610	TCGA-61-2610-01A	Stage IIIC	-22481	NA	1579	0	1579	NA	524	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	1	NO	NA	1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2610.a5914371-94ab-4079-a6ea-11c79e9db4a1.pdf	2610	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.4	NA	NA	61	11-20 mm	Ovary	NA	A	DECEASED	1998	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-2610-01A-21-20	NA	NA	NA	NA	a3cbaeb1-63e7-4818-aa6b-ce817827231b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-61-2610-02	1	TCGA-61-2610-02	1579	1	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-61-2610	NA	NA	days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Left	TCGA-61-2610-F28484	TCGA-61-2610	TCGA-61-2610-02A	Stage IIIC	-22481	NA	1579	0	1579	NA	524	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	0.6	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2610.361A67F5-2116-457D-988A-5B1E5D1A689B.pdf	2610	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Recurrent Tumor	02	0.3	NA	NA	61	11-20 mm	Ovary	NA	A	DECEASED	1998	NA	NA	NA	30ed8178-1e57-4d4e-af54-ea8097a33bbe	NA	NA	NA	TCGA-61-2610-02A-01D-1138-05	NA	NA	TCGA-61-2610-02A-01W-1092-09	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-2610-02A-01R-1141-07	
TCGA-61-2611-02	1	TCGA-61-2611-02	483	1	days	NA	NA	Low purity c2	NA	NA	NA	NA	NA	TCGA-61-2611	NA	NA	days	483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2611-F28491	TCGA-61-2611	TCGA-61-2611-02A	Stage IIIC	-14782	NA	483	0	483	NA	383	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)	NA	0.6	NO	NA	0.7	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2611.29965B48-14CA-467F-B825-8BC99A99544B.pdf	2611	NA	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	R1	Recurrent Tumor	02	0.3	NA	NA	61	1-10 mm	Ovary	YES	A	DECEASED	2008	NA	NA	NA	2983d372-ea74-4ceb-a26e-7b4e6a8acf8f	NA	NA	NA	TCGA-61-2611-02A-01D-1138-05	NA	NA	TCGA-61-2611-02A-01W-1092-09	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-61-2611-02A-01R-1141-07	
TCGA-61-2612-01	1	TCGA-61-2612-01	193	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2612	NA	NA	days	193	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-61-2612-F28496	TCGA-61-2612	TCGA-61-2612-01A	Stage IIIC	-23074	NA	193	0	193	NA	179	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	2	NO	NA	2.5	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2612.48d32d40-9eef-43d2-beb6-75fcc071c52b.pdf	2612	NA	WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO	R1	Primary Tumor	01	0.4	NA	NA	61	1-10 mm	Ovary	YES	A	DECEASED	2002	NA	NA	NA	9b739900-7aff-4e27-aa8b-5feaaaa77247	NA	NA	NA	TCGA-61-2612-01A-01D-1138-05	NA	TCGA-61-2612-01A-21-20	TCGA-61-2612-01A-01W-1092-09	NA	TCGA-61-2612-01A-01D-1134-01	TCGA-61-2612-01	7055e7b7-38bb-4fe4-841b-1419a6273bad	NA	TCGA-61-2612-01A-01D-1134-01	NA	NA	NA	NA	TCGA-61-2612-01	NA	NA	NA	TCGA-61-2612-01A-01R-1141-07	
TCGA-61-2613-01	1	TCGA-61-2613-01	945	1	days	Squamous	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2613	NA	NA	days	945	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-61-2613-F28500	TCGA-61-2613	TCGA-61-2613-01A	Stage IIIC	-26779	NA	945	0	945	NA	358	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.5	NO	NA	1.1	NA	NA	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2613.6d7a40b1-02f0-4d7e-b3e2-e467e404a241.pdf	2613	NA	WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.3	NA	NA	61	11-20 mm	Ovary	NA	A	DECEASED	1998	NA	NA	NA	4f3e6b8b-2c5b-4c59-aca0-d3a6b7ee46b5	NA	NA	NA	TCGA-61-2613-01A-01D-1138-05	NA	TCGA-61-2613-01A-21-20	TCGA-61-2613-01A-01W-1092-09	NA	TCGA-61-2613-01A-01D-1134-01	TCGA-61-2613-01	fce6b5fb-7b97-4af7-a919-0215363156f0	NA	TCGA-61-2613-01A-01D-1134-01	NA	NA	NA	NA	TCGA-61-2613-01	NA	NA	NA	TCGA-61-2613-01A-01R-1141-07	
TCGA-61-2614-01	1	TCGA-61-2614-01	262	1	days	High	NA	OV-like c1	OV-like c4	NA	NA	NA	NA	TCGA-61-2614	NA	NA	days	262	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-61-2614-F28505	TCGA-61-2614	TCGA-61-2614-01A	Stage IIIC	-26142	NA	262	0	262	NA	38	NA	NA	NA	2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	NA	0.4	NO	NA	1.6	NA	YES	G3	Recurrence	NA	NA	NA	NA	TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b.pdf	2614	NA	WITH TUMOR	NO	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.3	NA	NA	61	1-10 mm	Ovary	YES	A	DECEASED	2007	NA	NA	NA	59193352-8a67-49d4-9ca0-430c36fe0d12	NA	NA	NA	TCGA-61-2614-01A-01D-1138-05	NA	TCGA-61-2614-01A-21-20	TCGA-61-2614-01A-01W-1092-09	NA	TCGA-61-2614-01A-01D-1134-01	TCGA-61-2614-01	81ab2618-ccb2-4a64-bab2-83e69633defe	NA	TCGA-61-2614-01A-01D-1134-01	NA	NA	NA	NA	TCGA-61-2614-01	NA	NA	NA	TCGA-61-2614-01A-01R-1141-07	
TCGA-72-4231-01	NA	TCGA-72-4231-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4231	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4231-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.3	NO	NA	0.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4231-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4231-01A-01D-1017-01	NA	NA	NA	TCGA-72-4231-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4232-01	NA	TCGA-72-4232-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4232	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4232-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5	NO	NA	0.6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4232-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4232-01A-01D-1017-01	NA	NA	NA	TCGA-72-4232-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4233-01	NA	TCGA-72-4233-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4233	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4233-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.3	NO	NA	0.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4233-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4233-01A-01D-1017-01	NA	NA	NA	TCGA-72-4233-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4234-01	NA	TCGA-72-4234-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4234	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4234-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2	NO	NA	1.2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4234-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4234-01A-01D-1017-01	NA	NA	NA	TCGA-72-4234-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4235-01	NA	TCGA-72-4235-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4235	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4235-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.6	NO	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4235-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4235-01A-01D-1017-01	NA	NA	NA	TCGA-72-4235-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4236-01	NA	TCGA-72-4236-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4236	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4236-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2	NO	NA	0.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4236-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4236-01A-01D-1017-01	NA	NA	NA	TCGA-72-4236-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4237-01	NA	TCGA-72-4237-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4237	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4237-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.3	NO	NA	1.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4237-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4237-01A-01D-1017-01	NA	NA	NA	TCGA-72-4237-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4238-01	NA	TCGA-72-4238-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4238	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4238-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.4	NO	NA	1.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4238-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4238-01A-01D-1017-01	NA	NA	NA	TCGA-72-4238-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4240-01	NA	TCGA-72-4240-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4240	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4240-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NO	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4240-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4240-01A-01D-1017-01	NA	NA	NA	TCGA-72-4240-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-72-4241-01	NA	TCGA-72-4241-01	NA	NA	days	NA	NA	OV-like c1	NA	NA	NA	NA	NA	TCGA-72-4241	NA	NA	days	NA	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	NA	NA	NA	NA	TCGA-72-4241-01A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.3	NO	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Primary Tumor	01	0.1	NA	NA	NA	NA	NA	NA	A	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-72-4241-01A-01D-1011-05	NA	NA	NA	NA	TCGA-72-4241-01A-01D-1017-01	NA	NA	NA	TCGA-72-4241-01A-01D-1017-01	NA	NA	NA	NA	NA	NA	NA	NA	NA	
TCGA-OY-A56P-01	0	TCGA-OY-A56P-01	1207	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-OY-A56P	NA	NA	days	1207	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	48	Right	TCGA-OY-A56P-F56664	TCGA-OY-A56P	TCGA-OY-A56P-01A	Stage IIIB	-17580	796	NA	0	1207	NA	NA	NA	Scheduled Follow-up Submission	Stable Disease	2014-2-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	390	NA	NO	NA	NA	NO	NO	G3	NA	NA	YES	false	No	TCGA-OY-A56P.D916ED58-54D5-43FC-A5B0-6E4844A7F677.pdf	A56P	NA	WITH TUMOR	YES	Complete Remission/Response	NA	NO	R2	Primary Tumor	01	NA	YES	NO	OY	1-10 mm	Ovary	NO	A	LIVING	2010	TCGA-OY-A56P-01	TCGA-OY-A56P-01	NA	NA	TCGA-OY-A56P-01A-12D-A409-05	TCGA-OY-A56P-01	NA	NA	NA	NA	NA	05689fed-96dd-4c52-b51d-5dc799422b9a	TCGA-OY-A56P-01A-12D-A402-01	NA	31FB79CF-D6E4-48CF-8EFD-45A81701E359	TCGA-OY-A56P-01A-12R-A406-31	TCGA-OY-A56P-01A-12D-A402-01	05689fed-96dd-4c52-b51d-5dc799422b9a	TCGA-OY-A56P-01A-12R-A406-31	05689fed-96dd-4c52-b51d-5dc799422b9a	NA	NA	TCGA-OY-A56P-01	05689fed-96dd-4c52-b51d-5dc799422b9a	NA	NA	
TCGA-OY-A56Q-01	0	TCGA-OY-A56Q-01	576	0	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-OY-A56Q	576	0	days	576	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	78	Left	TCGA-OY-A56Q-F57585	TCGA-OY-A56Q	TCGA-OY-A56Q-01A	Stage IIA	-28623	120	NA	0	576	NA	NA	NA	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	370	NA	NO	NA	NA	NO	NO	G3	NA	NA	NO	false	No	TCGA-OY-A56Q.3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D.pdf	A56Q	NA	TUMOR FREE	YES	Complete Remission/Response	NA	NO	RX	Primary Tumor	01	NA	YES	NO	OY	No Macroscopic disease	Ovary	NO	A	LIVING	2012	TCGA-OY-A56Q-01	TCGA-OY-A56Q-01	NA	NA	TCGA-OY-A56Q-01A-11D-A409-05	TCGA-OY-A56Q-01	NA	NA	NA	NA	NA	3a1867ff-7c1e-47c1-854f-90c0af4b2d03	TCGA-OY-A56Q-01A-11D-A402-01	NA	7029EE0E-6B69-4B6F-8648-FA831B7B70A5	TCGA-OY-A56Q-01A-11R-A406-31	TCGA-OY-A56Q-01A-11D-A402-01	3a1867ff-7c1e-47c1-854f-90c0af4b2d03	TCGA-OY-A56Q-01A-11R-A406-31	3a1867ff-7c1e-47c1-854f-90c0af4b2d03	NA	NA	TCGA-OY-A56Q-01	3a1867ff-7c1e-47c1-854f-90c0af4b2d03	NA	NA	
TCGA-VG-A8LO-01	1	TCGA-VG-A8LO-01	24	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-VG-A8LO	24	0	days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	55	Right	NA	TCGA-VG-A8LO	TCGA-VG-A8LO-01A	Stage IV	-20274	122	24	0	NA	NA	NA	4	NA	NA	2014-3-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Excisional Biopsy	260	NA	NO	50	NA	NA	NA	GB	NA	NA	NO	false	No	TCGA-VG-A8LO.6FF4C359-F127-44E6-A1A2-641D60A3665F.pdf	A8LO	Other	WITH TUMOR	YES	NA	NA	NO	R2	Primary Tumor	01	NA	YES	NO	VG	>20 mm	Ovary	NA	A	DECEASED	2013	TCGA-VG-A8LO-01	TCGA-VG-A8LO-01	NA	NA	TCGA-VG-A8LO-01A-11D-A409-05	TCGA-VG-A8LO-01	NA	NA	NA	NA	NA	fbad0ba1-131d-48af-9957-e9ca56f54e84	TCGA-VG-A8LO-01A-11D-A402-01	NA	0AA665F9-6A46-4A4C-B2E1-11D8EE17B447	TCGA-VG-A8LO-01A-11R-A406-31	TCGA-VG-A8LO-01A-11D-A402-01	fbad0ba1-131d-48af-9957-e9ca56f54e84	TCGA-VG-A8LO-01A-11R-A406-31	fbad0ba1-131d-48af-9957-e9ca56f54e84	NA	NA	TCGA-VG-A8LO-01	fbad0ba1-131d-48af-9957-e9ca56f54e84	NA	NA	
TCGA-WR-A838-01	1	TCGA-WR-A838-01	304	1	days	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-WR-A838	304	0	days	304	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	NA	NA	72	Right	TCGA-WR-A838-F66184	TCGA-WR-A838	TCGA-WR-A838-01A	Stage IIIC	-26418	110	304	0	245	NA	245	1	Scheduled Follow-up Submission	Progressive Disease	2014-10-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	200	NA	NO	NA	NA	NO	YES	G3	Progression of Disease	NA	NO	false	No	TCGA-WR-A838.8F364931-727D-4099-A1D2-E96C61461479.pdf	A838	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NA	NO	NA	Primary Tumor	01	NA	NO	YES	WR	NA	Ovary	YES	A	DECEASED	2013	TCGA-WR-A838-01	TCGA-WR-A838-01	NA	NA	TCGA-WR-A838-01A-12D-A409-05	TCGA-WR-A838-01	NA	NA	NA	NA	NA	010e9bf0-b7a0-4c68-b028-90299840fbaf	TCGA-WR-A838-01A-12D-A402-01	NA	95C1EF06-FB7C-4817-86A5-1E608DDA7102	TCGA-WR-A838-01A-12R-A406-31	TCGA-WR-A838-01A-12D-A402-01	010e9bf0-b7a0-4c68-b028-90299840fbaf	TCGA-WR-A838-01A-12R-A406-31	010e9bf0-b7a0-4c68-b028-90299840fbaf	NA	NA	TCGA-WR-A838-01	010e9bf0-b7a0-4c68-b028-90299840fbaf	NA	NA	
